Difference between revisions of "LncRNAWiki:Featured"
| Line 7: | Line 7: | ||
!width="50"|Biological Process | !width="50"|Biological Process | ||
!width="50"|Disease | !width="50"|Disease | ||
| + | !width="50"|Mesh Ontology | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141612 HSALNG0141612] |
|HPVC1 | |HPVC1 | ||
|PE5L,HPV18E5L | |PE5L,HPV18E5L | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141720 HSALNG0141720] |
|Alpha 250/ Alpha 280 | |Alpha 250/ Alpha 280 | ||
|NONHSAT104559,lnc-C9orf53-2:1 | |NONHSAT104559,lnc-C9orf53-2:1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 25: | Line 28: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0096226 HSALNG0096226] |
|N4BP2L2-IT2 | |N4BP2L2-IT2 | ||
|CG030 | |CG030 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 33: | Line 37: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082161 HSALNG0082161] |
|LINC01150 | |LINC01150 | ||
|2G7,TCONS_00019134 | |2G7,TCONS_00019134 | ||
| Line 39: | Line 43: | ||
|pathogenic process | |pathogenic process | ||
|Wilms' tumor | |Wilms' tumor | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0032599 HSALNG0032599] |
|LINC01587 | |LINC01587 | ||
|C4orf6,aC1 | |C4orf6,aC1 | ||
| Line 47: | Line 52: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142220 HSALNG0142220] |
|NTT | |NTT | ||
|NONHSAT115106 | |NONHSAT115106 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 57: | Line 64: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0053252 HSALNG0053252] |
|RNF217-AS1 | |RNF217-AS1 | ||
|STL | |STL | ||
| Line 63: | Line 70: | ||
|pathogenic process | |pathogenic process | ||
|acute lymphoblastic leukemia | |acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0136795 HSALNG0136795] |
|INE2 | |INE2 | ||
|NCRNA00011 | |NCRNA00011 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 73: | Line 82: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0137683 HSALNG0137683] |
|INE1 | |INE1 | ||
|NCRNA00010 | |NCRNA00010 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 81: | Line 91: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141622 HSALNG0141622] |
|LINC01565 | |LINC01565 | ||
|C3orf27,GR6 | |C3orf27,GR6 | ||
| Line 87: | Line 97: | ||
|pathogenic process | |pathogenic process | ||
|leukemia | |leukemia | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0006924 HSALNG0006924] |
|LINC00869 | |LINC00869 | ||
|KIAA0493 | |KIAA0493 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 97: | Line 109: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026312 HSALNG0026312] |
|ERC2-IT1 | |ERC2-IT1 | ||
|C1orf1,C3orf51,Po42 | |C1orf1,C3orf51,Po42 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142509 HSALNG0142509] |
|Y RNAs | |Y RNAs | ||
|lnc-PDIA4-1:1 | |lnc-PDIA4-1:1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 113: | Line 127: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0032409 HSALNG0032409] |
|NOP14-AS1 | |NOP14-AS1 | ||
|C4orf10,RES4-24 | |C4orf10,RES4-24 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 121: | Line 136: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142424 HSALNG0142424] |
|TncRNA | |TncRNA | ||
|NONHSAT022116,AF080092,TSU | |NONHSAT022116,AF080092,TSU | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045080 HSALNG0045080] |
|SMAD5-AS1 | |SMAD5-AS1 | ||
|SMAD5O,DAMS | |SMAD5O,DAMS | ||
| Line 135: | Line 151: | ||
|pathogenic process | |pathogenic process | ||
|malignant hematopoietic | |malignant hematopoietic | ||
| + | |Cell Physiological Phenomena | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062672 HSALNG0062672] |
|LINC00244 | |LINC00244 | ||
|C7orf4,NCRNA00244 | |C7orf4,NCRNA00244 | ||
| Line 143: | Line 160: | ||
|pathogenic process | |pathogenic process | ||
|preaxial polydactyly | |preaxial polydactyly | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0055219 HSALNG0055219] |
|KIF25-AS1 | |KIF25-AS1 | ||
|C6orf54,NCRNA00300,HGC6.1.1 | |C6orf54,NCRNA00300,HGC6.1.1 | ||
| Line 151: | Line 169: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0055207 HSALNG0055207] |
|LINC01558 | |LINC01558 | ||
|C6orf123,LINC01557,HGC6.2,dJ431P23.4 | |C6orf123,LINC01557,HGC6.2,dJ431P23.4 | ||
| Line 159: | Line 178: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0055209 HSALNG0055209] |
|AFDN-AS1 | |AFDN-AS1 | ||
|C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 | |C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0135027 HSALNG0135027] |
|RFPL3S | |RFPL3S | ||
|RFPL3-AS1,RFPL3-A, NCRNA00005 | |RFPL3-AS1,RFPL3-A, NCRNA00005 | ||
| Line 175: | Line 196: | ||
|pathogenic process | |pathogenic process | ||
|opitz syndrome | |opitz syndrome | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134830 HSALNG0134830] |
|RFPL1S | |RFPL1S | ||
|RFPL1-AS1,RFPL1-A, NCRNA00006 | |RFPL1-AS1,RFPL1-A, NCRNA00006 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141611 HSALNG0141611] |
|HCG4B | |HCG4B | ||
|HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 | |HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 193: | Line 217: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142009 HSALNG0142009] |
|LINC00294 | |LINC00294 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 201: | Line 226: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140599 HSALNG0140599] |
|LINC00893 | |LINC00893 | ||
|NA | |NA | ||
| Line 207: | Line 232: | ||
|pathogenic process | |pathogenic process | ||
|hunter syndrome | |hunter syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142248 HSALNG0142248] |
|PCBP3-OT1 | |PCBP3-OT1 | ||
|PCBP3-OT1,FLJ44028 | |PCBP3-OT1,FLJ44028 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 217: | Line 244: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141599 HSALNG0141599] |
|BPESC1 | |BPESC1 | ||
|NCRNA00187 | |NCRNA00187 | ||
| Line 223: | Line 250: | ||
|pathogenic process | |pathogenic process | ||
|blepharophimosis syndrome | |blepharophimosis syndrome | ||
| + | |Eye Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141827 HSALNG0141827] |
|COPG2IT1 | |COPG2IT1 | ||
|CIT1,NCRNA00170,COPG2AS | |CIT1,NCRNA00170,COPG2AS | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 233: | Line 262: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0128978 HSALNG0128978] |
|LINC00652 | |LINC00652 | ||
|HSPC072 | |HSPC072 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0108689 HSALNG0108689] |
|WASIR2 | |WASIR2 | ||
|NCRNA00286A | |NCRNA00286A | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 249: | Line 280: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119601 HSALNG0119601] |
|LINC00470 | |LINC00470 | ||
|C18orf2 | |C18orf2 | ||
| Line 255: | Line 286: | ||
|pathogenic process | |pathogenic process | ||
|age-related macular degeneration | |age-related macular degeneration | ||
| + | |Eye Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141618 HSALNG0141618] |
|LINC00588 | |LINC00588 | ||
|C8orf71,DKFZP434F122 | |C8orf71,DKFZP434F122 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 265: | Line 298: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134754 HSALNG0134754] |
|TTC28-AS1 | |TTC28-AS1 | ||
|TTC28AS,TTC28-AS,KIAA1648 | |TTC28AS,TTC28-AS,KIAA1648 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 273: | Line 307: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0114754 HSALNG0114754] |
|CDRT7 | |CDRT7 | ||
|NCRNA00025,LINC00025 | |NCRNA00025,LINC00025 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 281: | Line 316: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0114755 HSALNG0114755] |
|CDRT8 | |CDRT8 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 289: | Line 325: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133887 HSALNG0133887] |
|CECR3 | |CECR3 | ||
|NA | |NA | ||
| Line 295: | Line 331: | ||
|pathogenic process | |pathogenic process | ||
|cat eye syndrome | |cat eye syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133890 HSALNG0133890] |
|CECR9 | |CECR9 | ||
|NA | |NA | ||
| Line 303: | Line 340: | ||
|pathogenic process | |pathogenic process | ||
|cat eye syndrome | |cat eye syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133878 HSALNG0133878] |
|HDHD5-AS1 | |HDHD5-AS1 | ||
|CECR4,CECR5-AS1,NCRNA00017 | |CECR4,CECR5-AS1,NCRNA00017 | ||
| Line 311: | Line 349: | ||
|pathogenic process | |pathogenic process | ||
|cat eye syndrome | |cat eye syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133878 HSALNG0133878] |
|CECR5-AS1 | |CECR5-AS1 | ||
|NCRNA00017 | |NCRNA00017 | ||
| Line 319: | Line 358: | ||
|pathogenic process | |pathogenic process | ||
|cat eye syndrome | |cat eye syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0029809 HSALNG0029809] |
|CLRN1-AS1 | |CLRN1-AS1 | ||
|CLRN1O,UCRP | |CLRN1O,UCRP | ||
| Line 327: | Line 367: | ||
|pathogenic process | |pathogenic process | ||
|usher syndrome type 3 | |usher syndrome type 3 | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082585 HSALNG0082585] |
|TMEM9B-AS1 | |TMEM9B-AS1 | ||
|C11orf18 | |C11orf18 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 337: | Line 379: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133586 HSALNG0133586] |
|LINC01547 | |LINC01547 | ||
|C21orf69,C21orf67 | |C21orf69,C21orf67 | ||
| Line 343: | Line 385: | ||
|pathogenic process | |pathogenic process | ||
|Down syndrome | |Down syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0131587 HSALNG0131587] |
|LINC00029 | |LINC00029 | ||
|C20orf51,NCRNA00029,bA305P22.4 | |C20orf51,NCRNA00029,bA305P22.4 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 353: | Line 397: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141634 HSALNG0141634] |
|LINC00529 | |LINC00529 | ||
|C8orf8 | |C8orf8 | ||
| Line 359: | Line 403: | ||
|pathogenic process | |pathogenic process | ||
|keratolytic winter erythema | |keratolytic winter erythema | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0010403 HSALNG0010403] |
|FLVCR1-AS1 | |FLVCR1-AS1 | ||
|FLVCR1-DT,LQK1 | |FLVCR1-DT,LQK1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 369: | Line 415: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0114969 HSALNG0114969] |
|SMCR2 | |SMCR2 | ||
|NA | |NA | ||
| Line 375: | Line 421: | ||
|pathogenic process | |pathogenic process | ||
|Smith-Magenis syndrome | |Smith-Magenis syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0114982 HSALNG0114982] |
|SMCR5 | |SMCR5 | ||
|NCRNA00034 | |NCRNA00034 | ||
| Line 383: | Line 430: | ||
|pathogenic process | |pathogenic process | ||
|Smith-Magenis syndrome | |Smith-Magenis syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142361 HSALNG0142361] |
|SMCR6 | |SMCR6 | ||
|NA | |NA | ||
| Line 391: | Line 439: | ||
|pathogenic process | |pathogenic process | ||
|Smith-Magenis syndrome | |Smith-Magenis syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133620 HSALNG0133620] |
|LINC00205 | |LINC00205 | ||
|C21orf86,NCRNA00205, | |C21orf86,NCRNA00205, | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132117 HSALNG0132117] |
|C21orf91-OT1 | |C21orf91-OT1 | ||
|NCRNA00285,D21S2089E | |NCRNA00285,D21S2089E | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 409: | Line 460: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132582 HSALNG0132582] |
|LINC00307 | |LINC00307 | ||
|NCRNA00307,D21S2091E | |NCRNA00307,D21S2091E | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 417: | Line 469: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133549 HSALNG0133549] |
|TSPEAR-AS2 | |TSPEAR-AS2 | ||
|C21orf90 | |C21orf90 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 425: | Line 478: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133721 HSALNG0133721] |
|MCM3AP-AS1 | |MCM3AP-AS1 | ||
|C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 | |C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 433: | Line 487: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133144 HSALNG0133144] |
|B3GALT5-AS1 | |B3GALT5-AS1 | ||
|C21orf88 | |C21orf88 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 441: | Line 496: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133127 HSALNG0133127] |
|BRWD1-AS2 | |BRWD1-AS2 | ||
|C21orf87,NCRNA00257,BRWD1-IT2 | |C21orf87,NCRNA00257,BRWD1-IT2 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 449: | Line 505: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133621 HSALNG0133621] |
|LINC00315 | |LINC00315 | ||
|C21orf93,NCRNA00315 | |C21orf93,NCRNA00315 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 457: | Line 514: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133612 HSALNG0133612] |
|LINC00334 | |LINC00334 | ||
|C21orf89,NCRNA00334 | |C21orf89,NCRNA00334 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 465: | Line 523: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132477 HSALNG0132477] |
|LINC00314 | |LINC00314 | ||
|C21orf94,NCRNA00314 | |C21orf94,NCRNA00314 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 473: | Line 532: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132261 HSALNG0132261] |
|LINC00308 | |LINC00308 | ||
|C21orf74,NCRNA00308,PRED16 | |C21orf74,NCRNA00308,PRED16 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132537 HSALNG0132537] |
|LINC00189 | |LINC00189 | ||
|C21orf109,NCRNA00189 | |C21orf109,NCRNA00189 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0042788 HSALNG0042788] |
|NCRUPAR | |NCRUPAR | ||
|ncR-uPAR,ncRuPAR,NCRNA00193 | |ncR-uPAR,ncRuPAR,NCRNA00193 | ||
|transcriptional regulation | |transcriptional regulation | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133048 HSALNG0133048] |
|DSCR10 | |DSCR10 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 505: | Line 568: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132984 HSALNG0132984] |
|DSCR9 | |DSCR9 | ||
|NCRNA00038 | |NCRNA00038 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 513: | Line 577: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142166 HSALNG0142166] |
|MDS2 | |MDS2 | ||
|NA | |NA | ||
| Line 519: | Line 583: | ||
|pathogenic process | |pathogenic process | ||
|myelodysplastic syndrome | |myelodysplastic syndrome | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060777 HSALNG0060777] |
|ST7-AS2 | |ST7-AS2 | ||
|ST7OT2,ST7AS2 | |ST7OT2,ST7AS2 | ||
| Line 527: | Line 592: | ||
|pathogenic process | |pathogenic process | ||
|autism | |autism | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060778 HSALNG0060778] |
|ST7-OT3 | |ST7-OT3 | ||
|ST7OT3,NCRNA00026 | |ST7OT3,NCRNA00026 | ||
| Line 535: | Line 601: | ||
|pathogenic process | |pathogenic process | ||
|autism | |autism | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142373 HSALNG0142373] |
|ST7-OT4 | |ST7-OT4 | ||
|NA | |NA | ||
| Line 543: | Line 610: | ||
|pathogenic process | |pathogenic process | ||
|autism | |autism | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142372 HSALNG0142372] |
|ST7OT | |ST7OT | ||
|NONHSAT122926 | |NONHSAT122926 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 553: | Line 622: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074272 HSALNG0074272] |
|MIR600HG | |MIR600HG | ||
|C9orf45,NCRNA00287,GL012,FLJ22161 | |C9orf45,NCRNA00287,GL012,FLJ22161 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 561: | Line 631: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0006325 HSALNG0006325] |
|ATP1A1-AS1 | |ATP1A1-AS1 | ||
|C1orf203,ATP1A1OS,MGC16179 | |C1orf203,ATP1A1OS,MGC16179 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 569: | Line 640: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0022910 HSALNG0022910] |
|SPATA3-AS1 | |SPATA3-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 577: | Line 649: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0024100 HSALNG0024100] |
|LINC00852 | |LINC00852 | ||
|C3orf42,GHRLOS2,NAG73,GHRL-AS2 | |C3orf42,GHRLOS2,NAG73,GHRL-AS2 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 585: | Line 658: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0033002 HSALNG0033002] |
|LINC01096 | |LINC01096 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 593: | Line 667: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0034486 HSALNG0034486] |
|LINC02260 | |LINC02260 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 601: | Line 676: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0036896 HSALNG0036896] |
|LINC01091 | |LINC01091 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 609: | Line 685: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0046004 HSALNG0046004] |
|SAP30L-AS1 | |SAP30L-AS1 | ||
|FLJ38109,GALNT10-AS1 | |FLJ38109,GALNT10-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 617: | Line 694: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0046927 HSALNG0046927] |
|PRR7-AS1 | |PRR7-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 625: | Line 703: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0047338 HSALNG0047338] |
|LINC01622 | |LINC01622 | ||
|TCONS_00011202 | |TCONS_00011202 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 633: | Line 712: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0053588 HSALNG0053588] |
|LINC01312 | |LINC01312 | ||
|MGC34034 | |MGC34034 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 641: | Line 721: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0064240 HSALNG0064240] |
|EXTL3-AS1 | |EXTL3-AS1 | ||
|C8orf50 | |C8orf50 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 649: | Line 730: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0065979 HSALNG0065979] |
|C8orf34-AS1 | |C8orf34-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 657: | Line 739: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074139 HSALNG0074139] |
|PSMD5-AS1 | |PSMD5-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 665: | Line 748: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0078227 HSALNG0078227] |
|LINC01553 | |LINC01553 | ||
|C10orf40,AC023904.2 | |C10orf40,AC023904.2 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 673: | Line 757: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0084463 HSALNG0084463] |
|LINC00301 | |LINC00301 | ||
|C11orf64,NCRNA00301,MGC39681 | |C11orf64,NCRNA00301,MGC39681 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 681: | Line 766: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119722 HSALNG0119722] |
|DLGAP1-AS3 | |DLGAP1-AS3 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 689: | Line 775: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0123001 HSALNG0123001] |
|CIRBP-AS1 | |CIRBP-AS1 | ||
|C19orf23,MGC39338 | |C19orf23,MGC39338 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 697: | Line 784: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0124987 HSALNG0124987] |
|LINC01785 | |LINC01785 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 705: | Line 793: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0127139 HSALNG0127139] |
|LINC01869 | |LINC01869 | ||
|MGC45922 | |MGC45922 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 713: | Line 802: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0131262 HSALNG0131262] |
|LINC01711 | |LINC01711 | ||
|MGC4294 | |MGC4294 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 721: | Line 811: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141311 HSALNG0141311] |
|FAM41AY1 | |FAM41AY1 | ||
|FAM41AY | |FAM41AY | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 729: | Line 820: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045020 HSALNG0045020] |
|C5orf66-AS2 | |C5orf66-AS2 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 737: | Line 829: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0083517 HSALNG0083517] |
|CSTF3-AS1 | |CSTF3-AS1 | ||
|CSTF3-DT | |CSTF3-DT | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 745: | Line 838: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0014289 HSALNG0014289] |
|CYP1B1-AS1 | |CYP1B1-AS1 | ||
|C2orf58,MGC34824 | |C2orf58,MGC34824 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 753: | Line 847: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0025315 HSALNG0025315] |
|ENTPD3-AS1 | |ENTPD3-AS1 | ||
|FLJ36665 | |FLJ36665 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 761: | Line 856: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0071511 HSALNG0071511] |
|FAM27E3 | |FAM27E3 | ||
|MGC42630 | |MGC42630 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 769: | Line 865: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000046 HSALNG0000046] |
|FAM41C | |FAM41C | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 777: | Line 874: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007223 HSALNG0007223] |
|FLG-AS1 | |FLG-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 785: | Line 883: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105871 HSALNG0105871] |
|GABPB1-IT1 | |GABPB1-IT1 | ||
|FLJ10038 | |FLJ10038 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 793: | Line 892: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0123950 HSALNG0123950] |
|ILF3-AS1 | |ILF3-AS1 | ||
|ILF3-DT | |ILF3-DT | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 801: | Line 901: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0097943 HSALNG0097943] |
|LINC00347 | |LINC00347 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 809: | Line 910: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004105 HSALNG0004105] |
|LINC00466 | |LINC00466 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 817: | Line 919: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0022951 HSALNG0022951] |
|LINC00471 | |LINC00471 | ||
|C2orf52,MGC43122 | |C2orf52,MGC43122 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 825: | Line 928: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119752 HSALNG0119752] |
|LINC00526 | |LINC00526 | ||
|C18orf18,MGC17515,HsT959 | |C18orf18,MGC17515,HsT959 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 833: | Line 937: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0106873 HSALNG0106873] |
|LINC00593 | |LINC00593 | ||
|C15orf50,MGC42951 | |C15orf50,MGC42951 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 841: | Line 946: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0022320 HSALNG0022320] |
|LINC00608 | |LINC00608 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 849: | Line 955: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104144 HSALNG0104144] |
|LINC00638 | |LINC00638 | ||
|MGC23270 | |MGC23270 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 857: | Line 964: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0124410 HSALNG0124410] |
|LINC00661 | |LINC00661 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 865: | Line 973: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0125113 HSALNG0125113] |
|LINC00662 | |LINC00662 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 873: | Line 982: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0024755 HSALNG0024755] |
|LINC00692 | |LINC00692 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 881: | Line 991: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075805 HSALNG0075805] |
|LINC00705 | |LINC00705 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 889: | Line 1,000: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0118878 HSALNG0118878] |
|LINC00868 | |LINC00868 | ||
|C17orf52 | |C17orf52 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 897: | Line 1,009: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062275 HSALNG0062275] |
|LINC00996 | |LINC00996 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 905: | Line 1,018: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089327 HSALNG0089327] |
|LINC01252 | |LINC01252 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 913: | Line 1,027: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113283 HSALNG0113283] |
|LINC02135 | |LINC02135 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 921: | Line 1,036: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0018445 HSALNG0018445] |
|NIFK-AS1 | |NIFK-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 929: | Line 1,045: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008972 HSALNG0008972] |
|SMG7-AS1 | |SMG7-AS1 | ||
|DKFZP564C196 | |DKFZP564C196 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 937: | Line 1,054: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113528 HSALNG0113528] |
|SNAI3-AS1 | |SNAI3-AS1 | ||
|MGC23284 | |MGC23284 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 945: | Line 1,063: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0103442 HSALNG0103442] |
|SNHG10 | |SNHG10 | ||
|C14orf62,FLJ40557,NCRNA00063,LINC00063 | |C14orf62,FLJ40557,NCRNA00063,LINC00063 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 953: | Line 1,072: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0109122 HSALNG0109122] |
|ZNF205-AS1 | |ZNF205-AS1 | ||
|MGC3771 | |MGC3771 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 961: | Line 1,081: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0009820 HSALNG0009820] |
|LINC00260 | |LINC00260 | ||
|C1orf217,NCRNA00260,MGC5457 | |C1orf217,NCRNA00260,MGC5457 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 969: | Line 1,090: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000511 HSALNG0000511] |
|LINC00337 | |LINC00337 | ||
|C1orf211,NCRNA00337,MGC40168 | |C1orf211,NCRNA00337,MGC40168 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 977: | Line 1,099: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0076905 HSALNG0076905] |
|WAC-AS1 | |WAC-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 985: | Line 1,108: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0077486 HSALNG0077486] |
|LINC00839 | |LINC00839 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 993: | Line 1,117: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089110 HSALNG0089110] |
|LINC00612 | |LINC00612 | ||
|C12orf33,MGC40170,FLJ41814 | |C12orf33,MGC40170,FLJ41814 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,001: | Line 1,126: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0124755 HSALNG0124755] |
|LINC00663 | |LINC00663 | ||
|MGC39821 | |MGC39821 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,009: | Line 1,135: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0130611 HSALNG0130611] |
|LINC00494 | |LINC00494 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,017: | Line 1,144: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039733 HSALNG0039733] |
|LINC01019 | |LINC01019 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,025: | Line 1,153: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0057380 HSALNG0057380] |
|LINC00265 | |LINC00265 | ||
|NCRNA00265,NCRNA00265-1 | |NCRNA00265,NCRNA00265-1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,033: | Line 1,162: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062824 HSALNG0062824] |
|LINC00689 | |LINC00689 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,041: | Line 1,171: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068847 HSALNG0068847] |
|LINC01591 | |LINC01591 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,049: | Line 1,180: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0072666 HSALNG0072666] |
|LINC01501 | |LINC01501 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,057: | Line 1,189: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0137712 HSALNG0137712] |
|LINC01560 | |LINC01560 | ||
|CXorf24 | |CXorf24 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,065: | Line 1,198: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045051 HSALNG0045051] |
|LINC01959 | |LINC01959 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,073: | Line 1,207: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0110333 HSALNG0110333] |
|LINC02175 | |LINC02175 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,081: | Line 1,216: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0064321 HSALNG0064321] |
|LINC02209 | |LINC02209 | ||
|FAM183CP | |FAM183CP | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,089: | Line 1,225: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0107406 HSALNG0107406] |
|LINGO1-AS1 | |LINGO1-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,097: | Line 1,234: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119342 HSALNG0119342] |
|MAFG-AS1 | |MAFG-AS1 | ||
|MAFG-DT | |MAFG-DT | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,105: | Line 1,243: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0139326 HSALNG0139326] |
|MORF4L2-AS1 | |MORF4L2-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,113: | Line 1,252: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0029035 HSALNG0029035] |
|NPHP3-AS1 | |NPHP3-AS1 | ||
|NCRNA00119 | |NCRNA00119 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,121: | Line 1,261: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062543 HSALNG0062543] |
|PAXIP1-AS1 | |PAXIP1-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,129: | Line 1,270: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082091 HSALNG0082091] |
|TOLLIP-AS1 | |TOLLIP-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,137: | Line 1,279: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113198 HSALNG0113198] |
|LINC00311 | |LINC00311 | ||
|TMEM148,NCRNA00311,MGC22001 | |TMEM148,NCRNA00311,MGC22001 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,145: | Line 1,288: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069500 HSALNG0069500] |
|ZNF252P-AS1 | |ZNF252P-AS1 | ||
|C8orf77 | |C8orf77 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,153: | Line 1,297: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0001624 HSALNG0001624] |
|ZNF436-AS1 | |ZNF436-AS1 | ||
|C1orf213,FLJ90508 | |C1orf213,FLJ90508 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,161: | Line 1,306: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0029047 HSALNG0029047] |
|BFSP2-AS1 | |BFSP2-AS1 | ||
|MGC2848 | |MGC2848 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,169: | Line 1,315: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0032263 HSALNG0032263] |
|CTBP1-AS1 | |CTBP1-AS1 | ||
|C4orf42,CTBP1-DT,CTBP1-DT,MGC21675 | |C4orf42,CTBP1-DT,CTBP1-DT,MGC21675 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,177: | Line 1,324: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039444 HSALNG0039444] |
|EXOC3-AS1 | |EXOC3-AS1 | ||
|C5orf55 | |C5orf55 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,185: | Line 1,333: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049246 HSALNG0049246] |
|HCG27 | |HCG27 | ||
|bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 | |bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,193: | Line 1,342: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0067505 HSALNG0067505] |
|BAALC-AS2 | |BAALC-AS2 | ||
|C8orf56,BAALCOS,MGC39526 | |C8orf56,BAALCOS,MGC39526 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,201: | Line 1,351: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062877 HSALNG0062877] |
|FAM87A | |FAM87A | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,209: | Line 1,360: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0078365 HSALNG0078365] |
|JMJD1C-AS1 | |JMJD1C-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,217: | Line 1,369: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0092957 HSALNG0092957] |
|ATP2B1-AS1 | |ATP2B1-AS1 | ||
|LINC00936 | |LINC00936 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,225: | Line 1,378: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0093183 HSALNG0093183] |
|CEP83-AS1 | |CEP83-AS1 | ||
|CEP83-DT | |CEP83-DT | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,233: | Line 1,387: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0107054 HSALNG0107054] |
|HEXA-AS1 | |HEXA-AS1 | ||
|C15orf34,FLJ13315 | |C15orf34,FLJ13315 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,241: | Line 1,396: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141598 HSALNG0141598] |
|BIN3-IT1 | |BIN3-IT1 | ||
|FLJ14107 | |FLJ14107 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,249: | Line 1,405: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141601 HSALNG0141601] |
|CSNK1G2-AS1 | |CSNK1G2-AS1 | ||
|C19orf34,MGC39696 | |C19orf34,MGC39696 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,257: | Line 1,414: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141619 HSALNG0141619] |
|LINC00634 | |LINC00634 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,265: | Line 1,423: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141621 HSALNG0141621] |
|LINC00685 | |LINC00685 | ||
|CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 | |CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,273: | Line 1,432: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141626 HSALNG0141626] |
|SHANK2-AS3 | |SHANK2-AS3 | ||
|C11orf76 | |C11orf76 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,281: | Line 1,441: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142188 HSALNG0142188] |
|NCBP2-AS2 | |NCBP2-AS2 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,289: | Line 1,450: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141613 HSALNG0141613] |
|KCNIP4-IT1 | |KCNIP4-IT1 | ||
|NCRNA00099,UM9-5 | |NCRNA00099,UM9-5 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,297: | Line 1,459: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141971 HSALNG0141971] |
|GTSCR1 | |GTSCR1 | ||
|NA | |NA | ||
| Line 1,303: | Line 1,465: | ||
|pathogenic process | |pathogenic process | ||
|Gilles de la Tourette syndrome | |Gilles de la Tourette syndrome | ||
| + | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008917 HSALNG0008917] |
|LINC00272 | |LINC00272 | ||
|C1orf120,NCRNA00272,RP1-223H12.3 | |C1orf120,NCRNA00272,RP1-223H12.3 | ||
| Line 1,311: | Line 1,474: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141348 HSALNG0141348] |
|TTTY9B | |TTTY9B | ||
|NCRNA00132 | |NCRNA00132 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,321: | Line 1,486: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142270 HSALNG0142270] |
|Prion-associated RNAs | |Prion-associated RNAs | ||
|NA | |NA | ||
| Line 1,327: | Line 1,492: | ||
|pathogenic process | |pathogenic process | ||
|prion disease | |prion disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062567 HSALNG0062567] |
|BLACE | |BLACE | ||
|NA | |NA | ||
| Line 1,335: | Line 1,501: | ||
|pathogenic process | |pathogenic process | ||
|acute B lymphoblastic leukemias | |acute B lymphoblastic leukemias | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0028877 HSALNG0028877] |
|H1FX-AS1 | |H1FX-AS1 | ||
|C3orf47,FLJ34151 | |C3orf47,FLJ34151 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,345: | Line 1,513: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089868 HSALNG0089868] |
|LINC00477 | |LINC00477 | ||
|C12orf67,FLJ32894,FAM191B | |C12orf67,FLJ32894,FAM191B | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,353: | Line 1,522: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133923 HSALNG0133923] |
|LINC00528 | |LINC00528 | ||
|C22orf37,FLJ40542 | |C22orf37,FLJ40542 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,361: | Line 1,531: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140941 HSALNG0140941] |
|ASMTL-AS1 | |ASMTL-AS1 | ||
|CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 | |CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,369: | Line 1,540: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0106820 HSALNG0106820] |
|ANP32A-IT1 | |ANP32A-IT1 | ||
|C15orf28,NCRNA00321,FLJ11722,HsT18971 | |C15orf28,NCRNA00321,FLJ11722,HsT18971 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,377: | Line 1,549: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289370 HSALNT0289370] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289370 HSALNT0289370] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0010128 HSALNG0010128] |
|MIR29B2CHG | |MIR29B2CHG | ||
|C1orf132,FLJ35650 | |C1orf132,FLJ35650 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,385: | Line 1,558: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007497 HSALNG0007497] |
|RUSC1-AS1 | |RUSC1-AS1 | ||
|C1orf104,FLJ35976 | |C1orf104,FLJ35976 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,393: | Line 1,567: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0040236 HSALNG0040236] |
|LINC01194 | |LINC01194 | ||
|CT49,TAG | |CT49,TAG | ||
| Line 1,399: | Line 1,573: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0103838 HSALNG0103838] |
|DIO3OS | |DIO3OS | ||
|C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 | |C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,409: | Line 1,585: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0057178 HSALNG0057178] |
|NPSR1-AS1 | |NPSR1-AS1 | ||
|AAA1,IMAGE:4827585 | |AAA1,IMAGE:4827585 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,417: | Line 1,594: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0035535 HSALNG0035535] |
|LINC00575 | |LINC00575 | ||
|C4orf11 | |C4orf11 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0065537 HSALNG0065537] |
|LINC01602 | |LINC01602 | ||
|T1560 | |T1560 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0035768 HSALNG0035768] |
|FAM13A-AS1 | |FAM13A-AS1 | ||
|FAM13A1OS,FAM13AOS,NCRNA00039 | |FAM13A1OS,FAM13AOS,NCRNA00039 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,441: | Line 1,621: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0072891 HSALNG0072891] |
|MIRLET7DHG | |MIRLET7DHG | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,449: | Line 1,630: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074353 HSALNG0074353] |
|MIR181A2HG | |MIR181A2HG | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,457: | Line 1,639: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0035624 HSALNG0035624] |
|WDFY3-AS2 | |WDFY3-AS2 | ||
|C4orf12,NCRNA00247,FBI4 | |C4orf12,NCRNA00247,FBI4 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,465: | Line 1,648: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0073990 HSALNG0073990] |
|PAPPA-AS1 | |PAPPA-AS1 | ||
|PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 | |PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,473: | Line 1,657: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0065020 HSALNG0065020] |
|LINC00293 | |LINC00293 | ||
|BEYLA | |BEYLA | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0014614 HSALNG0014614] |
|SIX3-AS1 | |SIX3-AS1 | ||
|SIX3OS | |SIX3OS | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0101546 HSALNG0101546] |
|OTX2-AS1 | |OTX2-AS1 | ||
|OTX2OS1 | |OTX2OS1 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0030360 HSALNG0030360] |
|LINC01192 | |LINC01192 | ||
|CT64 | |CT64 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,505: | Line 1,693: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104394 HSALNG0104394] |
|LINC01193 | |LINC01193 | ||
|CT60,LOC348120 | |CT60,LOC348120 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,513: | Line 1,702: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141779 HSALNG0141779] |
|C1QTNF9B-AS1 | |C1QTNF9B-AS1 | ||
|PCOTH | |PCOTH | ||
| Line 1,519: | Line 1,708: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141738 HSALNG0141738] |
|ATP6V1G2-DDX39B | |ATP6V1G2-DDX39B | ||
|NA | |NA | ||
| Line 1,527: | Line 1,717: | ||
|pathogenic process | |pathogenic process | ||
|dilated cardiomyopathy | |dilated cardiomyopathy | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141609 HSALNG0141609] |
|FAM226B | |FAM226B | ||
|CXorf50B,NCRNA00246B,LINC00246B | |CXorf50B,NCRNA00246B,LINC00246B | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,537: | Line 1,729: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133590 HSALNG0133590] |
|LINC00163 | |LINC00163 | ||
|C21orf134,NCRNA00163,NLC1-A,NLC1A | |C21orf134,NCRNA00163,NLC1-A,NLC1A | ||
| Line 1,543: | Line 1,735: | ||
|pathogenic process | |pathogenic process | ||
|narcolepsy | |narcolepsy | ||
| + | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141616 HSALNG0141616] |
|LINC00165 | |LINC00165 | ||
|C21orf135,NCRNA00165,NLC1-B | |C21orf135,NCRNA00165,NLC1-B | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,553: | Line 1,747: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142412 HSALNG0142412] |
|TEA-ncRNAs | |TEA-ncRNAs | ||
|ENSG00000251002 | |ENSG00000251002 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,561: | Line 1,756: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133403 HSALNG0133403] |
|LINC00322 | |LINC00322 | ||
|C21orf136,NCRNA00322,FLJ16545 | |C21orf136,NCRNA00322,FLJ16545 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,569: | Line 1,765: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141856 HSALNG0141856] |
|DHFR upstream transcripts | |DHFR upstream transcripts | ||
|DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 | |DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141642 HSALNG0141642] |
|21A | |21A | ||
|ncRNA 21A,NONHSAT128494 | |ncRNA 21A,NONHSAT128494 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,585: | Line 1,783: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0080181 HSALNG0080181] |
|TLX1NB | |TLX1NB | ||
|TD1,TDI,APT-B7 | |TD1,TDI,APT-B7 | ||
| Line 1,591: | Line 1,789: | ||
|pathogenic process | |pathogenic process | ||
|leukemogenesis | |leukemogenesis | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141777 HSALNG0141777] |
|C15orf2 | |C15orf2 | ||
|NA | |NA | ||
| Line 1,599: | Line 1,798: | ||
|pathogenic process | |pathogenic process | ||
|Angelman syndrome | |Angelman syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142212 HSALNG0142212] |
|NPAP1 | |NPAP1 | ||
|NA | |NA | ||
| Line 1,607: | Line 1,807: | ||
|pathogenic process | |pathogenic process | ||
|Angelman syndrome | |Angelman syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104530 HSALNG0104530] |
|PWRN2 | |PWRN2 | ||
|NCRNA00199 | |NCRNA00199 | ||
| Line 1,615: | Line 1,816: | ||
|pathogenic process | |pathogenic process | ||
|Prader-Willi syndrome | |Prader-Willi syndrome | ||
| + | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104528 HSALNG0104528] |
|PWRN1 | |PWRN1 | ||
|NCRNA00198 | |NCRNA00198 | ||
| Line 1,623: | Line 1,825: | ||
|pathogenic process | |pathogenic process | ||
|Prader-Willi syndrome | |Prader-Willi syndrome | ||
| + | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0127793 HSALNG0127793] |
|MIMT1 | |MIMT1 | ||
|MIM1,NCRNA00067,LINC00067 | |MIM1,NCRNA00067,LINC00067 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,633: | Line 1,837: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000682 HSALNG0000682] |
|MIR34AHG | |MIR34AHG | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,641: | Line 1,846: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049203 HSALNG0049203] |
|LINC02570 | |LINC02570 | ||
|XXbac-BPG27H4.8 | |XXbac-BPG27H4.8 | ||
| Line 1,647: | Line 1,852: | ||
|pathogenic process | |pathogenic process | ||
|MHC-associated diseases | |MHC-associated diseases | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142292 HSALNG0142292] |
|RNY1 | |RNY1 | ||
|NA | |NA | ||
| Line 1,655: | Line 1,861: | ||
|pathogenic process | |pathogenic process | ||
|cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer | |cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129114 HSALNG0129114] |
|NKX2-2-AS1 | |NKX2-2-AS1 | ||
|NKX2-2AS | |NKX2-2AS | ||
|transcriptional regulation | |transcriptional regulation | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142266 HSALNG0142266] |
|PR antisense transcripts | |PR antisense transcripts | ||
|FJ515872.1,NONHSAT023851 | |FJ515872.1,NONHSAT023851 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0180290 HSALNT0180290] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0180290 HSALNT0180290] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0086714 HSALNG0086714] |
|PGR-AS1,PR antisense transcripts | |PGR-AS1,PR antisense transcripts | ||
|AT1,AT2,AT3 | |AT1,AT2,AT3 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,681: | Line 1,891: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141722 HSALNG0141722] |
|anti-NOS2A | |anti-NOS2A | ||
|NA | |NA | ||
| Line 1,687: | Line 1,897: | ||
|pathogenic process | |pathogenic process | ||
|meningioma;glioblastoma | |meningioma;glioblastoma | ||
| + | |Neoplasms;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141802 HSALNG0141802] |
|CDKN1A-AS1 | |CDKN1A-AS1 | ||
|p21NAT | |p21NAT | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289166 HSALNT0289166] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289166 HSALNT0289166] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0103805 HSALNG0103805] |
|MEG9 | |MEG9 | ||
|LINC00584 | |LINC00584 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,705: | Line 1,918: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0055114 HSALNG0055114] |
|RPS6KA2-AS1 | |RPS6KA2-AS1 | ||
|NA | |NA | ||
| Line 1,711: | Line 1,924: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0073983 HSALNG0073983] |
|PAPPA-AS2 | |PAPPA-AS2 | ||
|AGU1 | |AGU1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,721: | Line 1,936: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0127785 HSALNG0127785] |
|ZIM2-AS1 | |ZIM2-AS1 | ||
|ZIM2as | |ZIM2as | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,729: | Line 1,945: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141939 HSALNG0141939] |
|Evf2 | |Evf2 | ||
|Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 | |Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134495 HSALNG0134495] |
|ADORA2A-AS1 | |ADORA2A-AS1 | ||
|C22orf45,FLJ34651 | |C22orf45,FLJ34651 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,745: | Line 1,963: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142261 HSALNG0142261] |
|POU5F1P4 | |POU5F1P4 | ||
|NA | |NA | ||
| Line 1,751: | Line 1,969: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142148 HSALNG0142148] |
|LSINCT1 | |LSINCT1 | ||
|NA | |NA | ||
| Line 1,759: | Line 1,978: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142149 HSALNG0142149] |
|LSINCT10 | |LSINCT10 | ||
|NA | |NA | ||
| Line 1,767: | Line 1,987: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142150 HSALNG0142150] |
|LSINCT11 | |LSINCT11 | ||
|NA | |NA | ||
| Line 1,775: | Line 1,996: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142151 HSALNG0142151] |
|LSINCT12 | |LSINCT12 | ||
|NA | |NA | ||
| Line 1,783: | Line 2,005: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142152 HSALNG0142152] |
|LSINCT2 | |LSINCT2 | ||
|NA | |NA | ||
| Line 1,791: | Line 2,014: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142153 HSALNG0142153] |
|LSINCT3 | |LSINCT3 | ||
|NA | |NA | ||
| Line 1,799: | Line 2,023: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142154 HSALNG0142154] |
|LSINCT4 | |LSINCT4 | ||
|NA | |NA | ||
| Line 1,807: | Line 2,032: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142156 HSALNG0142156] |
|LSINCT6 | |LSINCT6 | ||
|NA | |NA | ||
| Line 1,815: | Line 2,041: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142157 HSALNG0142157] |
|LSINCT7 | |LSINCT7 | ||
|NA | |NA | ||
| Line 1,823: | Line 2,050: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142158 HSALNG0142158] |
|LSINCT8 | |LSINCT8 | ||
|NA | |NA | ||
| Line 1,831: | Line 2,059: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142159 HSALNG0142159] |
|LSINCT9 | |LSINCT9 | ||
|NA | |NA | ||
| Line 1,839: | Line 2,068: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer | |lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141791 HSALNG0141791] |
|CAR Intergenic 10 | |CAR Intergenic 10 | ||
|FLJ31066,NONHSAT016928,lnc-FANK1-3:1 | |FLJ31066,NONHSAT016928,lnc-FANK1-3:1 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142147 HSALNG0142147] |
|LRRC3DN | |LRRC3DN | ||
|C21orf30,DKFZP434C128 | |C21orf30,DKFZP434C128 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129985 HSALNG0129985] |
|SNHG11 | |SNHG11 | ||
|C20orf198,LINC00101,NCRNA00101 | |C20orf198,LINC00101,NCRNA00101 | ||
| Line 1,863: | Line 2,095: | ||
|pathogenic process | |pathogenic process | ||
|obesity | |obesity | ||
| + | |Nutritional and Metabolic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141995 HSALNG0141995] |
|KRASP1 | |KRASP1 | ||
|NONHSAT113225,ENSG00000220635 | |NONHSAT113225,ENSG00000220635 | ||
|ceRNA | |ceRNA | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0003376 HSALNG0003376] |
|CYP4A22-AS1 | |CYP4A22-AS1 | ||
|ncRNA-a3 | |ncRNA-a3 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0013045 HSALNG0013045] |
|LINC00570 | |LINC00570 | ||
|ncRNA-a5 | |ncRNA-a5 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0003381 HSALNG0003381] |
|LINC00853 | |LINC00853 | ||
|PDZK1IP1-AS1,ncRNA-a4 | |PDZK1IP1-AS1,ncRNA-a4 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142051 HSALNG0142051] |
|lincRNA-ROR | |lincRNA-ROR | ||
|ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 | |ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,905: | Line 2,143: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141820 HSALNG0141820] |
|CHL1-AS2 | |CHL1-AS2 | ||
|NA | |NA | ||
| Line 1,911: | Line 2,149: | ||
|pathogenic process | |pathogenic process | ||
|adolescent idiopathic scoliosis | |adolescent idiopathic scoliosis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0036316 HSALNG0036316] |
|SEC24B-AS1 | |SEC24B-AS1 | ||
|1/2-SBSRNA4 | |1/2-SBSRNA4 | ||
|siRNA | |siRNA | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142252 HSALNG0142252] |
|PDZRN3-AS1 | |PDZRN3-AS1 | ||
|NA | |NA | ||
| Line 1,927: | Line 2,167: | ||
|pathogenic process | |pathogenic process | ||
|type 2 diabetes | |type 2 diabetes | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142352 HSALNG0142352] |
|SCAANT1 | |SCAANT1 | ||
|ATXN7-AS1 | |ATXN7-AS1 | ||
| Line 1,935: | Line 2,176: | ||
|pathogenic process | |pathogenic process | ||
|spinocerebellar ataxia | |spinocerebellar ataxia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141709 HSALNG0141709] |
|AK123790 | |AK123790 | ||
|NA | |NA | ||
| Line 1,943: | Line 2,185: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142026 HSALNG0142026] |
|LINC01451 | |LINC01451 | ||
|NA | |NA | ||
| Line 1,951: | Line 2,194: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142516 HSALNG0142516] |
|ZNF350-AS1 | |ZNF350-AS1 | ||
|NA | |NA | ||
| Line 1,959: | Line 2,203: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141960 HSALNG0141960] |
|GADD45G | |GADD45G | ||
|NA | |NA | ||
| Line 1,967: | Line 2,212: | ||
|pathogenic process | |pathogenic process | ||
|pituitary adenoma | |pituitary adenoma | ||
| + | |Endocrine System Diseases;Neoplasms;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043357 HSALNG0043357] |
|TMEM161B-AS1 | |TMEM161B-AS1 | ||
|AK082072,linc-POLR3G-8,ENSG00000247828 | |AK082072,linc-POLR3G-8,ENSG00000247828 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 1,977: | Line 2,224: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141851 HSALNG0141851] |
|DAPK1 | |DAPK1 | ||
|NA | |NA | ||
| Line 1,983: | Line 2,230: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142163 HSALNG0142163] |
|MAP3K14 | |MAP3K14 | ||
|MAP3K14 | |MAP3K14 | ||
| Line 1,991: | Line 2,239: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142265 HSALNG0142265] |
|PPP3CB | |PPP3CB | ||
|NA | |NA | ||
| Line 1,999: | Line 2,248: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0072477 HSALNG0072477] |
|DAPK1-IT1 | |DAPK1-IT1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0041256 HSALNG0041256] |
|GDNF-AS1 | |GDNF-AS1 | ||
|GDNFOS | |GDNFOS | ||
| Line 2,015: | Line 2,266: | ||
|pathogenic process | |pathogenic process | ||
|Alzheimer's disease | |Alzheimer's disease | ||
| + | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0014093 HSALNG0014093] |
|BIRC6-AS2 | |BIRC6-AS2 | ||
|megamind | |megamind | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0014085 HSALNG0014085] |
|BIRC6-AS1 | |BIRC6-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,033: | Line 2,287: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0116623 HSALNG0116623] |
|LINC00854 | |LINC00854 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,041: | Line 2,296: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142447 HSALNG0142447] |
|uc.73 | |uc.73 | ||
|NA | |NA | ||
| Line 2,047: | Line 2,302: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141956 HSALNG0141956] |
|FR0257520 | |FR0257520 | ||
|NA | |NA | ||
| Line 2,055: | Line 2,311: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142219 HSALNG0142219] |
|NRG1 | |NRG1 | ||
|NA | |NA | ||
| Line 2,063: | Line 2,320: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141804 HSALNG0141804] |
|CDKN2B-AS11 | |CDKN2B-AS11 | ||
|NA | |NA | ||
| Line 2,071: | Line 2,329: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|stroke | |stroke | ||
| + | |Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141805 HSALNG0141805] |
|CDKN2B-AS12 | |CDKN2B-AS12 | ||
|NA | |NA | ||
| Line 2,079: | Line 2,338: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141806 HSALNG0141806] |
|CDKN2B-AS13 | |CDKN2B-AS13 | ||
|NA | |NA | ||
| Line 2,087: | Line 2,347: | ||
|pathogenic process | |pathogenic process | ||
|plexiform neurofibroma | |plexiform neurofibroma | ||
| + | |Neoplasms;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141812 HSALNG0141812] |
|CDKN2B-AS7 | |CDKN2B-AS7 | ||
|NA | |NA | ||
| Line 2,095: | Line 2,356: | ||
|pathogenic process | |pathogenic process | ||
|acute lymphoblastic leukemia | |acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141941 HSALNG0141941] |
|FADS1 | |FADS1 | ||
|NA | |NA | ||
| Line 2,103: | Line 2,365: | ||
|pathogenic process | |pathogenic process | ||
|lipid metabolism disorder | |lipid metabolism disorder | ||
| + | |Nutritional and Metabolic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141813 HSALNG0141813] |
|CDKN2B-AS8 | |CDKN2B-AS8 | ||
|NA | |NA | ||
| Line 2,111: | Line 2,374: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141811 HSALNG0141811] |
|CDKN2B-AS6 | |CDKN2B-AS6 | ||
|NA | |NA | ||
| Line 2,119: | Line 2,383: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141814 HSALNG0141814] |
|CDKN2B-AS9 | |CDKN2B-AS9 | ||
|NA | |NA | ||
| Line 2,127: | Line 2,392: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141803 HSALNG0141803] |
|CDKN2B-AS10 | |CDKN2B-AS10 | ||
|NA | |NA | ||
| Line 2,135: | Line 2,401: | ||
|pathogenic process | |pathogenic process | ||
|stroke | |stroke | ||
| + | |Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0031716 HSALNG0031716] |
|ENST00000456816 | |ENST00000456816 | ||
|NA | |NA | ||
| Line 2,143: | Line 2,410: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142136 HSALNG0142136] |
|LOC389332 | |LOC389332 | ||
|NA | |NA | ||
| Line 2,151: | Line 2,419: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142421 HSALNG0142421] |
|TMEM72 | |TMEM72 | ||
|NA | |NA | ||
| Line 2,159: | Line 2,428: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141756 HSALNG0141756] |
|BC029135 | |BC029135 | ||
|NA | |NA | ||
| Line 2,167: | Line 2,437: | ||
|pathogenic process | |pathogenic process | ||
|renal clear cell cancer | |renal clear cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142489 HSALNG0142489] |
|X91348 | |X91348 | ||
|NA | |NA | ||
| Line 2,175: | Line 2,446: | ||
|pathogenic process | |pathogenic process | ||
|renal clear cell cancer | |renal clear cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141809 HSALNG0141809] |
|CDKN2B-AS4 | |CDKN2B-AS4 | ||
|NA | |NA | ||
| Line 2,183: | Line 2,455: | ||
|pathogenic process | |pathogenic process | ||
|cancer | |cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141807 HSALNG0141807] |
|CDKN2B-AS2 | |CDKN2B-AS2 | ||
|NA | |NA | ||
| Line 2,191: | Line 2,464: | ||
|pathogenic process | |pathogenic process | ||
|coronary heart disease | |coronary heart disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141808 HSALNG0141808] |
|CDKN2B-AS3 | |CDKN2B-AS3 | ||
|NA | |NA | ||
| Line 2,199: | Line 2,473: | ||
|pathogenic process | |pathogenic process | ||
|intracranial aneurysm | |intracranial aneurysm | ||
| + | |Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141810 HSALNG0141810] |
|CDKN2B-AS5 | |CDKN2B-AS5 | ||
|NA | |NA | ||
| Line 2,207: | Line 2,482: | ||
|pathogenic process | |pathogenic process | ||
|type 2 diabetes | |type 2 diabetes | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142434 HSALNG0142434] |
|T-UCRs | |T-UCRs | ||
|NA | |NA | ||
| Line 2,215: | Line 2,491: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141645 HSALNG0141645] |
|51A | |51A | ||
|NA | |NA | ||
| Line 2,223: | Line 2,500: | ||
|pathogenic process | |pathogenic process | ||
|Alzheimer's disease | |Alzheimer's disease | ||
| + | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142278 HSALNG0142278] |
|RAB4B-EGLN2 | |RAB4B-EGLN2 | ||
|NA | |NA | ||
| Line 2,231: | Line 2,509: | ||
|pathogenic process | |pathogenic process | ||
|cancer | |cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142282 HSALNG0142282] |
|RERT | |RERT | ||
|NA | |NA | ||
| Line 2,239: | Line 2,518: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129088 HSALNG0129088] |
|LINC00237 | |LINC00237 | ||
|NCRNA00237 | |NCRNA00237 | ||
| Line 2,247: | Line 2,527: | ||
|pathogenic process | |pathogenic process | ||
|macrocephaly;obesity | |macrocephaly;obesity | ||
| + | |Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0130081 HSALNG0130081] |
|LINC01370 | |LINC01370 | ||
|HI-LNC25,HILNC25 | |HI-LNC25,HILNC25 | ||
| Line 2,255: | Line 2,536: | ||
|pathogenic process | |pathogenic process | ||
|type 2 diabetes | |type 2 diabetes | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0046884 HSALNG0046884] |
|LINC01574 | |LINC01574 | ||
|HI-LNC12,TCONS_00009551 | |HI-LNC12,TCONS_00009551 | ||
| Line 2,263: | Line 2,545: | ||
|pathogenic process | |pathogenic process | ||
|type 2 diabetes | |type 2 diabetes | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142274 HSALNG0142274] |
|PTHLH | |PTHLH | ||
|NA | |NA | ||
| Line 2,271: | Line 2,554: | ||
|pathogenic process | |pathogenic process | ||
|brachydactyly | |brachydactyly | ||
| + | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091306 HSALNG0091306] |
|CISTR | |CISTR | ||
|CISTR-ACT,CISTRACT,re52431 | |CISTR-ACT,CISTRACT,re52431 | ||
| Line 2,279: | Line 2,563: | ||
|pathogenic process | |pathogenic process | ||
|brachydactyly | |brachydactyly | ||
| + | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141977 HSALNG0141977] |
|HELLPAR | |HELLPAR | ||
|LINC-HELLP | |LINC-HELLP | ||
| Line 2,287: | Line 2,572: | ||
|pathogenic process | |pathogenic process | ||
|HELLP syndrome | |HELLP syndrome | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142019 HSALNG0142019] |
|LINC01125 | |LINC01125 | ||
|NA | |NA | ||
| Line 2,295: | Line 2,581: | ||
|pathogenic process | |pathogenic process | ||
|uremia | |uremia | ||
| + | |Male Urogenital Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141659 HSALNG0141659] |
|AC002511.1 | |AC002511.1 | ||
|LINC01531 | |LINC01531 | ||
| Line 2,303: | Line 2,590: | ||
|pathogenic process | |pathogenic process | ||
|enterovirus 71 infection | |enterovirus 71 infection | ||
| + | |Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141724 HSALNG0141724] |
|AP000688.29 | |AP000688.29 | ||
|AP000688.2 | |AP000688.2 | ||
| Line 2,311: | Line 2,599: | ||
|pathogenic process | |pathogenic process | ||
|enterovirus 71 infection | |enterovirus 71 infection | ||
| + | |Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141947 HSALNG0141947] |
|FFAR2 | |FFAR2 | ||
|NA | |NA | ||
| Line 2,319: | Line 2,608: | ||
|pathogenic process | |pathogenic process | ||
|enterovirus 71 infection | |enterovirus 71 infection | ||
| + | |Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142337 HSALNG0142337] |
|RP4-620F22.3 | |RP4-620F22.3 | ||
|AC099063.2 | |AC099063.2 | ||
| Line 2,327: | Line 2,617: | ||
|pathogenic process | |pathogenic process | ||
|enterovirus 71 infection | |enterovirus 71 infection | ||
| + | |Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142342 HSALNG0142342] |
|RP5-843L14.1 | |RP5-843L14.1 | ||
|LINC01716 | |LINC01716 | ||
| Line 2,335: | Line 2,626: | ||
|pathogenic process | |pathogenic process | ||
|enterovirus 71 infection | |enterovirus 71 infection | ||
| + | |Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140617 HSALNG0140617] |
|MAGEA8-AS1 | |MAGEA8-AS1 | ||
|RP5-869M20.2 | |RP5-869M20.2 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,345: | Line 2,638: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094159 HSALNG0094159] |
|LHX5-AS1 | |LHX5-AS1 | ||
|locus4010 | |locus4010 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,353: | Line 2,647: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0023597 HSALNG0023597] |
|CAPN10-AS1 | |CAPN10-AS1 | ||
|CAPN10-DT,locus959 | |CAPN10-DT,locus959 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,361: | Line 2,656: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0076463 HSALNG0076463] |
|STAM-AS1 | |STAM-AS1 | ||
|locus3182 | |locus3182 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,369: | Line 2,665: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0070806 HSALNG0070806] |
|PTENP1-AS | |PTENP1-AS | ||
|PTENpg1-asRNA | |PTENpg1-asRNA | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141677 HSALNG0141677] |
|AF116616 | |AF116616 | ||
|NA | |NA | ||
| Line 2,383: | Line 2,680: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141704 HSALNG0141704] |
|AK094838 | |AK094838 | ||
|NA | |NA | ||
| Line 2,391: | Line 2,689: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNT0289620] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNT0289620] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141735 HSALNG0141735] |
|ASLNC00339 | |ASLNC00339 | ||
|NA | |NA | ||
| Line 2,399: | Line 2,698: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNT0289629] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNT0289629] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141744 HSALNG0141744] |
|BC002350 | |BC002350 | ||
|NA | |NA | ||
| Line 2,407: | Line 2,707: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNT0289651] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNT0289651] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141766 HSALNG0141766] |
|BC091525 | |BC091525 | ||
|NA | |NA | ||
| Line 2,415: | Line 2,716: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNT0289652] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNT0289652] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141767 HSALNG0141767] |
|BE503655 | |BE503655 | ||
|NA | |NA | ||
| Line 2,423: | Line 2,725: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNT0289753] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNT0289753] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141868 HSALNG0141868] |
|ENO1 | |ENO1 | ||
|NA | |NA | ||
| Line 2,431: | Line 2,734: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNT0289835] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNT0289835] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141950 HSALNG0141950] |
|FKBP10 | |FKBP10 | ||
|NA | |NA | ||
| Line 2,439: | Line 2,743: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNT0290064] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNT0290064] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142179 HSALNG0142179] |
|MYHAS | |MYHAS | ||
|NA | |NA | ||
| Line 2,447: | Line 2,752: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNT0289985] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNT0289985] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142100 HSALNG0142100] |
|LncRNA-LALR1 | |LncRNA-LALR1 | ||
|NA | |NA | ||
| Line 2,455: | Line 2,761: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289934 HSALNT0289934] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289934 HSALNT0289934] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142049 HSALNG0142049] |
|lincRNA-LALR1 | |lincRNA-LALR1 | ||
|NA | |NA | ||
|transcriptional regulation | |transcriptional regulation | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNT0091577] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNT0091577] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043527 HSALNG0043527] |
|NR2F1-AS1 | |NR2F1-AS1 | ||
|FLJ42709 | |FLJ42709 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,473: | Line 2,782: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNT0289709] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNT0289709] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141824 HSALNG0141824] |
|CK19 | |CK19 | ||
|NA | |NA | ||
| Line 2,479: | Line 2,788: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNT0289943] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNT0289943] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142058 HSALNG0142058] |
|Llme23 | |Llme23 | ||
|NA | |NA | ||
| Line 2,487: | Line 2,797: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNT0289553] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNT0289553] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141668 HSALNG0141668] |
|AC096655.1 | |AC096655.1 | ||
|NA | |NA | ||
| Line 2,495: | Line 2,806: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNT0289178] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNT0289178] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0137593 HSALNG0137593] |
|MIR222HG | |MIR222HG | ||
|Lnc-Ang362 | |Lnc-Ang362 | ||
| Line 2,503: | Line 2,815: | ||
|pathogenic process | |pathogenic process | ||
|Ang II-associated cardiovascular disease | |Ang II-associated cardiovascular disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNT0289261] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNT0289261] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0032541 HSALNG0032541] |
|STX18-AS1 | |STX18-AS1 | ||
|LOC100507266 | |LOC100507266 | ||
| Line 2,511: | Line 2,824: | ||
|pathogenic process | |pathogenic process | ||
|atrial septal defect | |atrial septal defect | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNT0289849] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNT0289849] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141964 HSALNG0141964] |
|GHSR | |GHSR | ||
|NA | |NA | ||
| Line 2,519: | Line 2,833: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289850 HSALNT0289850] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289850 HSALNT0289850] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141965 HSALNG0141965] |
|GHSROS | |GHSROS | ||
|NA | |NA | ||
| Line 2,527: | Line 2,842: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNT0289210] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNT0289210] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0072923 HSALNG0072923] |
|PCAT7 | |PCAT7 | ||
|PCAN-R2 | |PCAN-R2 | ||
| Line 2,535: | Line 2,851: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNT0289702] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNT0289702] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141817 HSALNG0141817] |
|CES1P1 | |CES1P1 | ||
|NA | |NA | ||
| Line 2,543: | Line 2,860: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNT0289892] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNT0289892] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142007 HSALNG0142007] |
|LINC00210 | |LINC00210 | ||
|NA | |NA | ||
| Line 2,551: | Line 2,869: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNT0290006] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNT0290006] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142121 HSALNG0142121] |
|LOC100506974 | |LOC100506974 | ||
|NA | |NA | ||
| Line 2,559: | Line 2,878: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNT0290219] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNT0290219] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142334 HSALNG0142334] |
|RP3-508I15.14 | |RP3-508I15.14 | ||
|NA | |NA | ||
| Line 2,567: | Line 2,887: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNT0290243] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNT0290243] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142358 HSALNG0142358] |
|SLC6A6 | |SLC6A6 | ||
|NA | |NA | ||
| Line 2,575: | Line 2,896: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNT0290342] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNT0290342] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142457 HSALNG0142457] |
|uc003bgl.1 | |uc003bgl.1 | ||
|NA | |NA | ||
| Line 2,583: | Line 2,905: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNT0289075] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNT0289075] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008302 HSALNG0008302] |
|LINC00970 | |LINC00970 | ||
|NA | |NA | ||
| Line 2,591: | Line 2,914: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNT0211868] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNT0211868] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0101725 HSALNG0101725] |
|SALRNA1 | |SALRNA1 | ||
|SAL-RNA1,XLOC_023166 | |SAL-RNA1,XLOC_023166 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNT0222267] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNT0222267] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0106957 HSALNG0106957] |
|SALRNA3 | |SALRNA3 | ||
|SAL-RNA3,XLOC_025918 | |SAL-RNA3,XLOC_025918 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNT0222274] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNT0222274] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0106960 HSALNG0106960] |
|SALRNA2 | |SALRNA2 | ||
|SAL-RNA2,XLOC_025931 | |SAL-RNA2,XLOC_025931 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNT0289428] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNT0289428] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0021790 HSALNG0021790] |
|GPR1-AS | |GPR1-AS | ||
|GPR1-AS1,GPR1AS | |GPR1-AS1,GPR1AS | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNT0226207] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNT0226207] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0108743 HSALNG0108743] |
|LINC00235 | |LINC00235 | ||
|NA | |NA | ||
| Line 2,631: | Line 2,959: | ||
|pathogenic process | |pathogenic process | ||
|anorexia nervosa | |anorexia nervosa | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNT0289526] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNT0289526] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141641 HSALNG0141641] |
|1B FGF-antisense transcripts | |1B FGF-antisense transcripts | ||
|NA | |NA | ||
| Line 2,639: | Line 2,968: | ||
|pathogenic process | |pathogenic process | ||
|endometriosis | |endometriosis | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNT0290171] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNT0290171] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142286 HSALNG0142286] |
|RNA polymerase III-dependent lncRNAs | |RNA polymerase III-dependent lncRNAs | ||
|NA | |NA | ||
| Line 2,647: | Line 2,977: | ||
|pathogenic process | |pathogenic process | ||
|diffuse cerebral hypomyelination | |diffuse cerebral hypomyelination | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290168 HSALNT0290168] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290168 HSALNT0290168] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142283 HSALNG0142283] |
|REST/CoREST-regulated lncRNAs | |REST/CoREST-regulated lncRNAs | ||
|NA | |NA | ||
| Line 2,655: | Line 2,986: | ||
|pathogenic process | |pathogenic process | ||
|Huntington disease | |Huntington disease | ||
| + | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289606 HSALNT0289606] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289606 HSALNT0289606] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141721 HSALNG0141721] |
|Alu lncRNAs | |Alu lncRNAs | ||
|NA | |NA | ||
| Line 2,663: | Line 2,995: | ||
|pathogenic process | |pathogenic process | ||
|macular degeneration | |macular degeneration | ||
| + | |Eye Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290358 HSALNT0290358] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290358 HSALNT0290358] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142473 HSALNG0142473] |
|UCH1LAS | |UCH1LAS | ||
|NA | |NA | ||
| Line 2,671: | Line 3,004: | ||
|pathogenic process | |pathogenic process | ||
|Parkinson's disease | |Parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290244 HSALNT0290244] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290244 HSALNT0290244] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142359 HSALNG0142359] |
|SLC7A2-IT1A/B | |SLC7A2-IT1A/B | ||
|NA | |NA | ||
| Line 2,679: | Line 3,013: | ||
|pathogenic process | |pathogenic process | ||
|progressive encephalopathy with severe infantile anorexia | |progressive encephalopathy with severe infantile anorexia | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289877 HSALNT0289877] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289877 HSALNT0289877] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141992 HSALNG0141992] |
|Kcna2-AS | |Kcna2-AS | ||
|NA | |NA | ||
| Line 2,687: | Line 3,022: | ||
|pathogenic process | |pathogenic process | ||
|neuropathic pain | |neuropathic pain | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289191 HSALNT0289191] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289191 HSALNT0289191] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0053305 HSALNG0053305] |
|NCOA7-AS1 | |NCOA7-AS1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290020 HSALNT0290020] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290020 HSALNT0290020] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142135 HSALNG0142135] |
|LOC389023 | |LOC389023 | ||
|NA | |NA | ||
| Line 2,703: | Line 3,040: | ||
|pathogenic process | |pathogenic process | ||
|psychiatric disease | |psychiatric disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175124 HSALNT0175124] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175124 HSALNT0175124] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0084108 HSALNG0084108] |
|PTPRJ-AS1 | |PTPRJ-AS1 | ||
|NA | |NA | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289654 HSALNT0289654] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289654 HSALNT0289654] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141769 HSALNG0141769] |
|BM742401 | |BM742401 | ||
|NA | |NA | ||
| Line 2,719: | Line 3,058: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289331 HSALNT0289331] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289331 HSALNT0289331] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049950 HSALNG0049950] |
|LINC00951 | |LINC00951 | ||
|lincRNA-uc003opf.1,FLJ41649 | |lincRNA-uc003opf.1,FLJ41649 | ||
| Line 2,727: | Line 3,067: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290130 HSALNT0290130] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290130 HSALNT0290130] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142245 HSALNG0142245] |
|PAWR | |PAWR | ||
|NA | |NA | ||
| Line 2,735: | Line 3,076: | ||
|pathogenic process | |pathogenic process | ||
|acute lymphoblastic leukemia | |acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290264 HSALNT0290264] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290264 HSALNT0290264] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142379 HSALNG0142379] |
|T-ALL-R-LncR1 | |T-ALL-R-LncR1 | ||
|NA | |NA | ||
| Line 2,743: | Line 3,085: | ||
|pathogenic process | |pathogenic process | ||
|acute lymphoblastic leukemia | |acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289599 HSALNT0289599] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289599 HSALNT0289599] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141714 HSALNG0141714] |
|AK130977 | |AK130977 | ||
|NA | |NA | ||
| Line 2,751: | Line 3,094: | ||
|pathogenic process | |pathogenic process | ||
|malignant pleural mesothelioma | |malignant pleural mesothelioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289625 HSALNT0289625] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289625 HSALNT0289625] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141740 HSALNG0141740] |
|AX746718 | |AX746718 | ||
|NA | |NA | ||
| Line 2,759: | Line 3,103: | ||
|pathogenic process | |pathogenic process | ||
|malignant pleural mesothelioma | |malignant pleural mesothelioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289738 HSALNT0289738] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289738 HSALNT0289738] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141853 HSALNG0141853] |
|DDR2 | |DDR2 | ||
|NA | |NA | ||
| Line 2,767: | Line 3,112: | ||
|pathogenic process | |pathogenic process | ||
|malignant pleural mesothelioma | |malignant pleural mesothelioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290003 HSALNT0290003] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290003 HSALNT0290003] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142118 HSALNG0142118] |
|LOC100131831 | |LOC100131831 | ||
|NA | |NA | ||
| Line 2,775: | Line 3,121: | ||
|pathogenic process | |pathogenic process | ||
|malignant pleural mesothelioma | |malignant pleural mesothelioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290144 HSALNT0290144] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290144 HSALNT0290144] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142259 HSALNG0142259] |
|POT1-AS1 | |POT1-AS1 | ||
|NA | |NA | ||
| Line 2,783: | Line 3,130: | ||
|pathogenic process | |pathogenic process | ||
|malignant pleural mesothelioma | |malignant pleural mesothelioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290253 HSALNT0290253] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290253 HSALNT0290253] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142368 HSALNG0142368] |
|SNORA17B | |SNORA17B | ||
|NA | |NA | ||
| Line 2,791: | Line 3,139: | ||
|pathogenic process | |pathogenic process | ||
|malignant pleural mesothelioma | |malignant pleural mesothelioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207421 HSALNT0207421] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207421 HSALNT0207421] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0099625 HSALNG0099625] |
|GAS6-AS1 | |GAS6-AS1 | ||
|NA | |NA | ||
| Line 2,799: | Line 3,148: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289838 HSALNT0289838] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289838 HSALNT0289838] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141953 HSALNG0141953] |
|FMR5 | |FMR5 | ||
|NA | |NA | ||
| Line 2,807: | Line 3,157: | ||
|pathogenic process | |pathogenic process | ||
|fragile X syndrome | |fragile X syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208907 HSALNT0208907] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208907 HSALNT0208907] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0100287 HSALNG0100287] |
|FOXG1-AS1 | |FOXG1-AS1 | ||
|FOXG1-AS | |FOXG1-AS | ||
| Line 2,815: | Line 3,166: | ||
|pathogenic process | |pathogenic process | ||
|autism spectrum disorder | |autism spectrum disorder | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290263 HSALNT0290263] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290263 HSALNT0290263] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142378 HSALNG0142378] |
|SYNGAP1-AS1 | |SYNGAP1-AS1 | ||
|SYNGAP1-AS | |SYNGAP1-AS | ||
| Line 2,823: | Line 3,175: | ||
|pathogenic process | |pathogenic process | ||
|autism spectrum disorder | |autism spectrum disorder | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290176 HSALNT0290176] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290176 HSALNT0290176] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142291 HSALNG0142291] |
|RNase MRP | |RNase MRP | ||
|NA | |NA | ||
| Line 2,831: | Line 3,184: | ||
|pathogenic process | |pathogenic process | ||
|cartilage hair hypoplaisia | |cartilage hair hypoplaisia | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289469 HSALNT0289469] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289469 HSALNT0289469] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105872 HSALNG0105872] |
|GABPB1-AS1 | |GABPB1-AS1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289009 HSALNT0289009] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289009 HSALNT0289009] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075528 HSALNG0075528] |
|IDI2-AS1 | |IDI2-AS1 | ||
|C10orf110,IDI2-A,HT009,Em:AC022536.4 | |C10orf110,IDI2-A,HT009,Em:AC022536.4 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,849: | Line 3,205: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289093 HSALNT0289093] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289093 HSALNT0289093] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0044716 HSALNG0044716] |
|LINC01184 | |LINC01184 | ||
|FLJ33630 | |FLJ33630 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 2,857: | Line 3,214: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290108 HSALNT0290108] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290108 HSALNT0290108] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142223 HSALNG0142223] |
|OGT | |OGT | ||
|NA | |NA | ||
| Line 2,863: | Line 3,220: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290077 HSALNT0290077] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290077 HSALNT0290077] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142192 HSALNG0142192] |
|ncNRFR | |ncNRFR | ||
|NA | |NA | ||
| Line 2,871: | Line 3,229: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290337 HSALNT0290337] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290337 HSALNT0290337] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142452 HSALNG0142452] |
|uc001lsz | |uc001lsz | ||
|NA | |NA | ||
| Line 2,879: | Line 3,238: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;prostate cancer;liver cancer;lung cancer | |gastric cancer;prostate cancer;liver cancer;lung cancer | ||
| + | |Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289087 HSALNT0289087] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289087 HSALNT0289087] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0021008 HSALNG0021008] |
|LINC01090 | |LINC01090 | ||
|NA | |NA | ||
| Line 2,887: | Line 3,247: | ||
|pathogenic process | |pathogenic process | ||
|post-traumatic stress disorder | |post-traumatic stress disorder | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289746 HSALNT0289746] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289746 HSALNT0289746] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141861 HSALNG0141861] |
|DQ786227 | |DQ786227 | ||
|NA | |NA | ||
| Line 2,895: | Line 3,256: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289981 HSALNT0289981] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289981 HSALNT0289981] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142096 HSALNG0142096] |
|lncRNA-DQ786227 | |lncRNA-DQ786227 | ||
|NA | |NA | ||
| Line 2,903: | Line 3,265: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289876 HSALNT0289876] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289876 HSALNT0289876] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141991 HSALNG0141991] |
|JADRR | |JADRR | ||
|LINC00915,lncRNA-JADE | |LINC00915,lncRNA-JADE | ||
| Line 2,911: | Line 3,274: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290254 HSALNT0290254] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290254 HSALNT0290254] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142369 HSALNG0142369] |
|SOX2OT-S1 | |SOX2OT-S1 | ||
|NA | |NA | ||
| Line 2,919: | Line 3,283: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290404 HSALNT0290404] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290404 HSALNT0290404] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142519 HSALNG0142519] |
|SOX2OT-S2 | |SOX2OT-S2 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289870 HSALNT0289870] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289870 HSALNT0289870] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141985 HSALNG0141985] |
|HOXA13 | |HOXA13 | ||
|NA | |NA | ||
| Line 2,935: | Line 3,301: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078946 HSALNT0078946] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078946 HSALNT0078946] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0037661 HSALNG0037661] |
|SMAD1-AS1 | |SMAD1-AS1 | ||
|ENST00000513542 | |ENST00000513542 | ||
| Line 2,943: | Line 3,310: | ||
|pathogenic process | |pathogenic process | ||
|ventricular septal defects | |ventricular septal defects | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087329 HSALNT0087329] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087329 HSALNT0087329] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0041545 HSALNG0041545] |
|FGF10-AS1 | |FGF10-AS1 | ||
|RP11-473L15.2 | |RP11-473L15.2 | ||
| Line 2,951: | Line 3,319: | ||
|pathogenic process | |pathogenic process | ||
|ventricular septal defects | |ventricular septal defects | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290318 HSALNT0290318] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290318 HSALNT0290318] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142433 HSALNG0142433] |
|TUC339 | |TUC339 | ||
|NA | |NA | ||
| Line 2,959: | Line 3,328: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289819 HSALNT0289819] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289819 HSALNT0289819] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141934 HSALNG0141934] |
|ERICD | |ERICD | ||
|LINC01130,TCONS_00014875,ERIC | |LINC01130,TCONS_00014875,ERIC | ||
| Line 2,967: | Line 3,337: | ||
|pathogenic process | |pathogenic process | ||
|retinoblastoma | |retinoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289615 HSALNT0289615] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289615 HSALNT0289615] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141730 HSALNG0141730] |
|ARA | |ARA | ||
|NA | |NA | ||
| Line 2,975: | Line 3,346: | ||
|pathogenic process | |pathogenic process | ||
|cancer | |cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289822 HSALNT0289822] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289822 HSALNT0289822] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141937 HSALNG0141937] |
|ESCCAL-5 | |ESCCAL-5 | ||
|NA | |NA | ||
| Line 2,983: | Line 3,355: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290074 HSALNT0290074] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290074 HSALNT0290074] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142189 HSALNG0142189] |
|ncC11orf49 | |ncC11orf49 | ||
|NA | |NA | ||
| Line 2,991: | Line 3,364: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290076 HSALNT0290076] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290076 HSALNT0290076] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142191 HSALNG0142191] |
|ncHDAC5 | |ncHDAC5 | ||
|NA | |NA | ||
| Line 2,999: | Line 3,373: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290078 HSALNT0290078] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290078 HSALNT0290078] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142193 HSALNG0142193] |
|ncRAB31 | |ncRAB31 | ||
|NA | |NA | ||
| Line 3,007: | Line 3,382: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290080 HSALNT0290080] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290080 HSALNT0290080] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142195 HSALNG0142195] |
|ncSRPK1 | |ncSRPK1 | ||
|NA | |NA | ||
| Line 3,015: | Line 3,391: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018253 HSALNT0018253] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018253 HSALNT0018253] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008819 HSALNG0008819] |
|OVAAL | |OVAAL | ||
|LINC01131,OVAL | |LINC01131,OVAL | ||
| Line 3,023: | Line 3,400: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289884 HSALNT0289884] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289884 HSALNT0289884] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141999 HSALNG0141999] |
|LALR | |LALR | ||
|NA | |NA | ||
| Line 3,031: | Line 3,409: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289701 HSALNT0289701] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289701 HSALNT0289701] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141816 HSALNG0141816] |
|CEACAMP8 | |CEACAMP8 | ||
|CEACAMP8 | |CEACAMP8 | ||
| Line 3,039: | Line 3,418: | ||
|pathogenic process | |pathogenic process | ||
|pre-eclampsia | |pre-eclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290018 HSALNT0290018] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290018 HSALNT0290018] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142133 HSALNG0142133] |
|LOC284100 | |LOC284100 | ||
|NA | |NA | ||
| Line 3,047: | Line 3,427: | ||
|pathogenic process | |pathogenic process | ||
|pre-eclampsia | |pre-eclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290023 HSALNT0290023] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290023 HSALNT0290023] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142138 HSALNG0142138] |
|LOC391533 | |LOC391533 | ||
|NA | |NA | ||
| Line 3,055: | Line 3,436: | ||
|pathogenic process | |pathogenic process | ||
|pre-eclampsia | |pre-eclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189558 HSALNT0189558] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189558 HSALNT0189558] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091365 HSALNG0091365] |
|LINC01154 | |LINC01154 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 3,065: | Line 3,448: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196616 HSALNT0196616] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196616 HSALNT0196616] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094870 HSALNG0094870] |
|THRIL | |THRIL | ||
|BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260 | |BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260 | ||
| Line 3,071: | Line 3,454: | ||
|pathogenic process | |pathogenic process | ||
|Kawasaki disease | |Kawasaki disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289235 HSALNT0289235] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289235 HSALNT0289235] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0098080 HSALNG0098080] |
|RNF219-AS1 | |RNF219-AS1 | ||
|NA | |NA | ||
| Line 3,079: | Line 3,463: | ||
|pathogenic process | |pathogenic process | ||
|blood pressure | |blood pressure | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289561 HSALNT0289561] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289561 HSALNT0289561] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141676 HSALNG0141676] |
|AF086415 | |AF086415 | ||
|NA | |NA | ||
| Line 3,087: | Line 3,472: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289583 HSALNT0289583] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289583 HSALNT0289583] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141698 HSALNG0141698] |
|AK056098 | |AK056098 | ||
|NA | |NA | ||
| Line 3,095: | Line 3,481: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289590 HSALNT0289590] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289590 HSALNT0289590] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141705 HSALNG0141705] |
|AK095147 | |AK095147 | ||
|NA | |NA | ||
| Line 3,103: | Line 3,490: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289600 HSALNT0289600] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289600 HSALNT0289600] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141715 HSALNG0141715] |
|AK294004 | |AK294004 | ||
|NA | |NA | ||
| Line 3,111: | Line 3,499: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289612 HSALNT0289612] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289612 HSALNT0289612] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141727 HSALNG0141727] |
|AP5M1 | |AP5M1 | ||
|NA | |NA | ||
| Line 3,119: | Line 3,508: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290110 HSALNT0290110] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290110 HSALNT0290110] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142225 HSALNG0142225] |
|ORAOV1 | |ORAOV1 | ||
|NA | |NA | ||
| Line 3,127: | Line 3,517: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290210 HSALNT0290210] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290210 HSALNT0290210] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142325 HSALNG0142325] |
|RP1-179N16.3 | |RP1-179N16.3 | ||
|Z95152.1 | |Z95152.1 | ||
| Line 3,135: | Line 3,526: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037026 HSALNT0037026] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037026 HSALNT0037026] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0017545 HSALNG0017545] |
|LINC01159 | |LINC01159 | ||
|linc-Brn1b | |linc-Brn1b | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289014 HSALNT0289014] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289014 HSALNT0289014] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0137988 HSALNG0137988] |
|KANTR | |KANTR | ||
|KDM5C adjacent non-coding transcript | |KDM5C adjacent non-coding transcript | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289905 HSALNT0289905] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289905 HSALNT0289905] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142020 HSALNG0142020] |
|LINC01157 | |LINC01157 | ||
|TCONS_00010378,linc-Enc1 | |TCONS_00010378,linc-Enc1 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289460 HSALNT0289460] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289460 HSALNT0289460] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0087416 HSALNG0087416] |
|APOA1-AS | |APOA1-AS | ||
|NA | |NA | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290400 HSALNT0290400] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290400 HSALNT0290400] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142515 HSALNG0142515] |
|ZNF300P1 | |ZNF300P1 | ||
|ZNF300P1 | |ZNF300P1 | ||
| Line 3,175: | Line 3,571: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289750 HSALNT0289750] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289750 HSALNT0289750] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141865 HSALNG0141865] |
|EEF1A1P9 | |EEF1A1P9 | ||
|NA | |NA | ||
| Line 3,183: | Line 3,580: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289796 HSALNT0289796] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289796 HSALNT0289796] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141911 HSALNG0141911] |
|ENST00000318333 | |ENST00000318333 | ||
|NA | |NA | ||
| Line 3,191: | Line 3,589: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289797 HSALNT0289797] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289797 HSALNT0289797] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141912 HSALNG0141912] |
|ENST00000374520 | |ENST00000374520 | ||
|NA | |NA | ||
| Line 3,199: | Line 3,598: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289800 HSALNT0289800] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289800 HSALNT0289800] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141915 HSALNG0141915] |
|ENST00000422362 | |ENST00000422362 | ||
|NA | |NA | ||
| Line 3,207: | Line 3,607: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289808 HSALNT0289808] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289808 HSALNT0289808] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141923 HSALNG0141923] |
|ENST00000455912 | |ENST00000455912 | ||
|NA | |NA | ||
| Line 3,215: | Line 3,616: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289809 HSALNT0289809] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289809 HSALNT0289809] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141924 HSALNG0141924] |
|ENST00000456007 | |ENST00000456007 | ||
|NA | |NA | ||
| Line 3,223: | Line 3,625: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289810 HSALNT0289810] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289810 HSALNT0289810] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141925 HSALNG0141925] |
|ENST00000456185 | |ENST00000456185 | ||
|NA | |NA | ||
| Line 3,231: | Line 3,634: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289817 HSALNT0289817] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289817 HSALNT0289817] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141932 HSALNG0141932] |
|EPOR | |EPOR | ||
|NA | |NA | ||
| Line 3,239: | Line 3,643: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289913 HSALNT0289913] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289913 HSALNT0289913] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142028 HSALNG0142028] |
|LINC01550 | |LINC01550 | ||
|NA | |NA | ||
| Line 3,247: | Line 3,652: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290142 HSALNT0290142] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290142 HSALNT0290142] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142257 HSALNG0142257] |
|PMS2P5 | |PMS2P5 | ||
|NA | |NA | ||
| Line 3,255: | Line 3,661: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290269 HSALNT0290269] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290269 HSALNT0290269] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142384 HSALNG0142384] |
|TCF7 | |TCF7 | ||
|NA | |NA | ||
| Line 3,263: | Line 3,670: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290345 HSALNT0290345] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290345 HSALNT0290345] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142460 HSALNG0142460] |
|uc003jfz.2 | |uc003jfz.2 | ||
|NA | |NA | ||
| Line 3,271: | Line 3,679: | ||
|pathogenic process | |pathogenic process | ||
|gastric cardia adenocarcinoma | |gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289095 HSALNT0289095] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289095 HSALNT0289095] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0018112 HSALNG0018112] |
|LINC01191 | |LINC01191 | ||
|VIN,lnc-ACTR3 | |VIN,lnc-ACTR3 | ||
| Line 3,279: | Line 3,688: | ||
|pathogenic process | |pathogenic process | ||
|influenza A virus | |influenza A virus | ||
| + | |Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288976 HSALNT0288976] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288976 HSALNT0288976] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140165 HSALNG0140165] |
|FIRRE | |FIRRE | ||
|LINC01200 | |LINC01200 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289097 HSALNT0289097] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289097 HSALNT0289097] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0046284 HSALNG0046284] |
|LINC01202 | |LINC01202 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 3,297: | Line 3,709: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290271 HSALNT0290271] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290271 HSALNT0290271] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142386 HSALNG0142386] |
|TCONS_00014512 | |TCONS_00014512 | ||
|NA | |NA | ||
| Line 3,303: | Line 3,715: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290272 HSALNT0290272] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290272 HSALNT0290272] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142387 HSALNG0142387] |
|TCONS_00014978 | |TCONS_00014978 | ||
|NA | |NA | ||
| Line 3,311: | Line 3,724: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290274 HSALNT0290274] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290274 HSALNT0290274] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142389 HSALNG0142389] |
|TCONS_00024647 | |TCONS_00024647 | ||
|NA | |NA | ||
| Line 3,319: | Line 3,733: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290279 HSALNT0290279] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290279 HSALNT0290279] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142394 HSALNG0142394] |
|TCONS_00090092_MEG3 | |TCONS_00090092_MEG3 | ||
|NA | |NA | ||
| Line 3,327: | Line 3,742: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290280 HSALNT0290280] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290280 HSALNT0290280] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142395 HSALNG0142395] |
|TCONS_l2_00000179 | |TCONS_l2_00000179 | ||
|NA | |NA | ||
| Line 3,335: | Line 3,751: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290283 HSALNT0290283] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290283 HSALNT0290283] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142398 HSALNG0142398] |
|TCONS_l2_00004424 | |TCONS_l2_00004424 | ||
|NA | |NA | ||
| Line 3,343: | Line 3,760: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290284 HSALNT0290284] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290284 HSALNT0290284] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142399 HSALNG0142399] |
|TCONS_l2_00006843 | |TCONS_l2_00006843 | ||
|NA | |NA | ||
| Line 3,351: | Line 3,769: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290289 HSALNT0290289] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290289 HSALNT0290289] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142404 HSALNG0142404] |
|TCONS_l2_00014091 | |TCONS_l2_00014091 | ||
|NA | |NA | ||
| Line 3,359: | Line 3,778: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290291 HSALNT0290291] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290291 HSALNT0290291] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142406 HSALNG0142406] |
|TCONS_l2_00018070 | |TCONS_l2_00018070 | ||
|NA | |NA | ||
| Line 3,367: | Line 3,787: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290292 HSALNT0290292] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290292 HSALNT0290292] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142407 HSALNG0142407] |
|TCONS_l2_00020565 | |TCONS_l2_00020565 | ||
|NA | |NA | ||
| Line 3,375: | Line 3,796: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290293 HSALNT0290293] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290293 HSALNT0290293] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142408 HSALNG0142408] |
|TCONS_l2_00021262 | |TCONS_l2_00021262 | ||
|NA | |NA | ||
| Line 3,383: | Line 3,805: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290296 HSALNT0290296] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290296 HSALNT0290296] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142411 HSALNG0142411] |
|TCONS_l2_00030560 | |TCONS_l2_00030560 | ||
|NA | |NA | ||
| Line 3,391: | Line 3,814: | ||
|pathogenic process | |pathogenic process | ||
|hepatoblastoma | |hepatoblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289927 HSALNT0289927] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289927 HSALNT0289927] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142042 HSALNG0142042] |
|lincRNA1611 | |lincRNA1611 | ||
|NA | |NA | ||
| Line 3,399: | Line 3,823: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290149 HSALNT0290149] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290149 HSALNT0290149] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142264 HSALNG0142264] |
|Ppp3ca | |Ppp3ca | ||
|NA | |NA | ||
| Line 3,407: | Line 3,832: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290265 HSALNT0290265] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290265 HSALNT0290265] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142380 HSALNG0142380] |
|TC0100223 | |TC0100223 | ||
|NA | |NA | ||
| Line 3,415: | Line 3,841: | ||
|pathogenic process | |pathogenic process | ||
|epithelial ovarian cancer | |epithelial ovarian cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290267 HSALNT0290267] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290267 HSALNT0290267] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142382 HSALNG0142382] |
|TC0101686 | |TC0101686 | ||
|NA | |NA | ||
| Line 3,423: | Line 3,850: | ||
|pathogenic process | |pathogenic process | ||
|epithelial ovarian cancer | |epithelial ovarian cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290268 HSALNT0290268] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290268 HSALNT0290268] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142383 HSALNG0142383] |
|TC1500845 | |TC1500845 | ||
|NA | |NA | ||
| Line 3,431: | Line 3,859: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289318 HSALNT0289318] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289318 HSALNT0289318] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0128589 HSALNG0128589] |
|LAMP5-AS1 | |LAMP5-AS1 | ||
|NA | |NA | ||
| Line 3,439: | Line 3,868: | ||
|pathogenic process | |pathogenic process | ||
|acute lymphoblastic leukemia | |acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234022 HSALNT0234022] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234022 HSALNT0234022] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0112916 HSALNG0112916] |
|LINC01228 | |LINC01228 | ||
|lincRNA-DYNLRB2-2 | |lincRNA-DYNLRB2-2 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162654 HSALNT0162654] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162654 HSALNT0162654] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0077963 HSALNG0077963] |
|SGMS1-AS1 | |SGMS1-AS1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289206 HSALNT0289206] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289206 HSALNT0289206] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0126202 HSALNG0126202] |
|PCAT19 | |PCAT19 | ||
|LOC100505495,LINC01190 | |LOC100505495,LINC01190 | ||
| Line 3,463: | Line 3,895: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289521 HSALNT0289521] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289521 HSALNT0289521] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0115583 HSALNG0115583] |
|ABHD15-AS1 | |ABHD15-AS1 | ||
|linc-TP53I13,lnc-TP53I13 | |linc-TP53I13,lnc-TP53I13 | ||
| Line 3,471: | Line 3,904: | ||
|pathogenic process | |pathogenic process | ||
|cardiometabolic disease | |cardiometabolic disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289100 HSALNT0289100] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289100 HSALNT0289100] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069570 HSALNG0069570] |
|LINC01230 | |LINC01230 | ||
|linc-DMRT2,lnc-DRMT2,TCONS_00015639 | |linc-DMRT2,lnc-DRMT2,TCONS_00015639 | ||
| Line 3,479: | Line 3,913: | ||
|pathogenic process | |pathogenic process | ||
|cardiometabolic disease | |cardiometabolic disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0249183 HSALNT0249183] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0249183 HSALNT0249183] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0120583 HSALNG0120583] |
|PCAT18 | |PCAT18 | ||
|LINC01092 | |LINC01092 | ||
| Line 3,487: | Line 3,922: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290029 HSALNT0290029] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290029 HSALNT0290029] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142144 HSALNG0142144] |
|LOC728606 | |LOC728606 | ||
|NA | |NA | ||
| Line 3,495: | Line 3,931: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094171 HSALNG0094171] |
|ENST00000547963.1 | |ENST00000547963.1 | ||
|NA | |NA | ||
| Line 3,503: | Line 3,940: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289802 HSALNT0289802] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289802 HSALNT0289802] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141917 HSALNG0141917] |
|ENST00000435885 | |ENST00000435885 | ||
|NA | |NA | ||
| Line 3,511: | Line 3,949: | ||
|pathogenic process | |pathogenic process | ||
|oesophageal squamous cell cancer | |oesophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205898 HSALNT0205898] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205898 HSALNT0205898] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0098920 HSALNG0098920] |
|LINC01232 | |LINC01232 | ||
|FLJ41590,TCONS_00021520 | |FLJ41590,TCONS_00021520 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257311 HSALNT0257311] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257311 HSALNT0257311] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0124979 HSALNG0124979] |
|LINC01233 | |LINC01233 | ||
|XLOC_013014 | |XLOC_013014 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183247 HSALNT0183247] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183247 HSALNT0183247] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088110 HSALNG0088110] |
|SENCR | |SENCR | ||
|FLI1-AS1 | |FLI1-AS1 | ||
| Line 3,535: | Line 3,976: | ||
|pathogenic process | |pathogenic process | ||
|vascular SMC phenotype | |vascular SMC phenotype | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289296 HSALNT0289296] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289296 HSALNT0289296] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0010286 HSALNG0010286] |
|LINC00467 | |LINC00467 | ||
|C1orf97,MGC14801 | |C1orf97,MGC14801 | ||
| Line 3,543: | Line 3,985: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143586 HSALNT0143586] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143586 HSALNT0143586] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068435 HSALNG0068435] |
|CASC21 | |CASC21 | ||
|LINC01244,CARLo-2 | |LINC01244,CARLo-2 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288906 HSALNT0288906] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288906 HSALNT0288906] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068424 HSALNG0068424] |
|CASC19 | |CASC19 | ||
|LINC01245,CARLo-6 | |LINC01245,CARLo-6 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289754 HSALNT0289754] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289754 HSALNT0289754] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141869 HSALNG0141869] |
|ENSG00000135253.9 | |ENSG00000135253.9 | ||
|NA | |NA | ||
| Line 3,567: | Line 4,012: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289755 HSALNT0289755] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289755 HSALNT0289755] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141870 HSALNG0141870] |
|ENSG00000147753.5 | |ENSG00000147753.5 | ||
|NA | |NA | ||
| Line 3,575: | Line 4,021: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289756 HSALNT0289756] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289756 HSALNT0289756] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141871 HSALNG0141871] |
|ENSG00000196096 | |ENSG00000196096 | ||
|AC079610.1 | |AC079610.1 | ||
| Line 3,583: | Line 4,030: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289757 HSALNT0289757] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289757 HSALNT0289757] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141872 HSALNG0141872] |
|ENSG00000197251.3 | |ENSG00000197251.3 | ||
|NA | |NA | ||
| Line 3,591: | Line 4,039: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289758 HSALNT0289758] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289758 HSALNT0289758] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141873 HSALNG0141873] |
|ENSG00000203325 | |ENSG00000203325 | ||
|AL445248.1 | |AL445248.1 | ||
| Line 3,599: | Line 4,048: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289759 HSALNT0289759] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289759 HSALNT0289759] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141874 HSALNG0141874] |
|ENSG00000206129 | |ENSG00000206129 | ||
|AC006305.1 | |AC006305.1 | ||
| Line 3,607: | Line 4,057: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289760 HSALNT0289760] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289760 HSALNT0289760] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141875 HSALNG0141875] |
|ENSG00000215231.3 | |ENSG00000215231.3 | ||
|NA | |NA | ||
| Line 3,615: | Line 4,066: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289761 HSALNT0289761] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289761 HSALNT0289761] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141876 HSALNG0141876] |
|ENSG00000215374.4 | |ENSG00000215374.4 | ||
|NA | |NA | ||
| Line 3,623: | Line 4,075: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289762 HSALNT0289762] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289762 HSALNT0289762] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141877 HSALNG0141877] |
|ENSG00000215808.2 | |ENSG00000215808.2 | ||
|NA | |NA | ||
| Line 3,631: | Line 4,084: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289763 HSALNT0289763] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289763 HSALNT0289763] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141878 HSALNG0141878] |
|ENSG00000226496.1 | |ENSG00000226496.1 | ||
|NA | |NA | ||
| Line 3,639: | Line 4,093: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289764 HSALNT0289764] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289764 HSALNT0289764] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141879 HSALNG0141879] |
|ENSG00000229563.1 | |ENSG00000229563.1 | ||
|NA | |NA | ||
| Line 3,647: | Line 4,102: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289765 HSALNT0289765] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289765 HSALNT0289765] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141880 HSALNG0141880] |
|ENSG00000230133.1 | |ENSG00000230133.1 | ||
|NA | |NA | ||
| Line 3,655: | Line 4,111: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289766 HSALNT0289766] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289766 HSALNT0289766] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141881 HSALNG0141881] |
|ENSG00000230544.1 | |ENSG00000230544.1 | ||
|NA | |NA | ||
| Line 3,663: | Line 4,120: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289767 HSALNT0289767] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289767 HSALNT0289767] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141882 HSALNG0141882] |
|ENSG00000231133.1 | |ENSG00000231133.1 | ||
|NA | |NA | ||
| Line 3,671: | Line 4,129: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289768 HSALNT0289768] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289768 HSALNT0289768] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141883 HSALNG0141883] |
|ENSG00000231185 | |ENSG00000231185 | ||
|AC010317.1 | |AC010317.1 | ||
| Line 3,679: | Line 4,138: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289769 HSALNT0289769] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289769 HSALNT0289769] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141884 HSALNG0141884] |
|ENSG00000232021.2 | |ENSG00000232021.2 | ||
|NA | |NA | ||
| Line 3,687: | Line 4,147: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289770 HSALNT0289770] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289770 HSALNT0289770] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141885 HSALNG0141885] |
|ENSG00000232046.1 | |ENSG00000232046.1 | ||
|NA | |NA | ||
| Line 3,695: | Line 4,156: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289771 HSALNT0289771] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289771 HSALNT0289771] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141886 HSALNG0141886] |
|ENSG00000232956.3 | |ENSG00000232956.3 | ||
|NA | |NA | ||
| Line 3,703: | Line 4,165: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289772 HSALNT0289772] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289772 HSALNT0289772] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141887 HSALNG0141887] |
|ENSG00000233154.1 | |ENSG00000233154.1 | ||
|NA | |NA | ||
| Line 3,711: | Line 4,174: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289773 HSALNT0289773] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289773 HSALNT0289773] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141888 HSALNG0141888] |
|ENSG00000233251 | |ENSG00000233251 | ||
|AC007743.1 | |AC007743.1 | ||
| Line 3,719: | Line 4,183: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289774 HSALNT0289774] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289774 HSALNT0289774] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141889 HSALNG0141889] |
|ENSG00000235285.1 | |ENSG00000235285.1 | ||
|NA | |NA | ||
| Line 3,727: | Line 4,192: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289775 HSALNT0289775] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289775 HSALNT0289775] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141890 HSALNG0141890] |
|ENSG00000237036.3 | |ENSG00000237036.3 | ||
|NA | |NA | ||
| Line 3,735: | Line 4,201: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289776 HSALNT0289776] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289776 HSALNT0289776] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141891 HSALNG0141891] |
|ENSG00000237548.1 | |ENSG00000237548.1 | ||
|NA | |NA | ||
| Line 3,743: | Line 4,210: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289777 HSALNT0289777] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289777 HSALNT0289777] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141892 HSALNG0141892] |
|ENSG00000240453.1 | |ENSG00000240453.1 | ||
|NA | |NA | ||
| Line 3,751: | Line 4,219: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289778 HSALNT0289778] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289778 HSALNT0289778] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141893 HSALNG0141893] |
|ENSG00000241269.1 | |ENSG00000241269.1 | ||
|NA | |NA | ||
| Line 3,759: | Line 4,228: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289779 HSALNT0289779] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289779 HSALNT0289779] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141894 HSALNG0141894] |
|ENSG00000245910.3 | |ENSG00000245910.3 | ||
|NA | |NA | ||
| Line 3,767: | Line 4,237: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289780 HSALNT0289780] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289780 HSALNT0289780] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141895 HSALNG0141895] |
|ENSG00000248176 | |ENSG00000248176 | ||
|AC109349.1 | |AC109349.1 | ||
| Line 3,775: | Line 4,246: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289781 HSALNT0289781] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289781 HSALNT0289781] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141896 HSALNG0141896] |
|ENSG00000249364 | |ENSG00000249364 | ||
|AC112206.2 | |AC112206.2 | ||
| Line 3,783: | Line 4,255: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289782 HSALNT0289782] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289782 HSALNT0289782] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141897 HSALNG0141897] |
|ENSG00000249772 | |ENSG00000249772 | ||
|AC026427.1 | |AC026427.1 | ||
| Line 3,791: | Line 4,264: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289783 HSALNT0289783] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289783 HSALNT0289783] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141898 HSALNG0141898] |
|ENSG00000250195 | |ENSG00000250195 | ||
|AC109927.1 | |AC109927.1 | ||
| Line 3,799: | Line 4,273: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289784 HSALNT0289784] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289784 HSALNT0289784] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141899 HSALNG0141899] |
|ENSG00000250608 | |ENSG00000250608 | ||
|AC010210.1 | |AC010210.1 | ||
| Line 3,807: | Line 4,282: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289785 HSALNT0289785] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289785 HSALNT0289785] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141900 HSALNG0141900] |
|ENSG00000254154 | |ENSG00000254154 | ||
|AL359075.2 | |AL359075.2 | ||
| Line 3,815: | Line 4,291: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289786 HSALNT0289786] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289786 HSALNT0289786] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141901 HSALNG0141901] |
|ENSG00000255471 | |ENSG00000255471 | ||
|AP001528.2 | |AP001528.2 | ||
| Line 3,823: | Line 4,300: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289787 HSALNT0289787] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289787 HSALNT0289787] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141902 HSALNG0141902] |
|ENSG00000256218 | |ENSG00000256218 | ||
|AC007848.2 | |AC007848.2 | ||
| Line 3,831: | Line 4,309: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289788 HSALNT0289788] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289788 HSALNT0289788] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141903 HSALNG0141903] |
|ENSG00000259150.1 | |ENSG00000259150.1 | ||
|NA | |NA | ||
| Line 3,839: | Line 4,318: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289789 HSALNT0289789] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289789 HSALNT0289789] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141904 HSALNG0141904] |
|ENSG00000259334.1 | |ENSG00000259334.1 | ||
|NA | |NA | ||
| Line 3,847: | Line 4,327: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289790 HSALNT0289790] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289790 HSALNT0289790] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141905 HSALNG0141905] |
|ENSG00000259484.1 | |ENSG00000259484.1 | ||
|NA | |NA | ||
| Line 3,855: | Line 4,336: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289791 HSALNT0289791] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289791 HSALNT0289791] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141906 HSALNG0141906] |
|ENSG00000259758.1 | |ENSG00000259758.1 | ||
|NA | |NA | ||
| Line 3,863: | Line 4,345: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289793 HSALNT0289793] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289793 HSALNT0289793] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141908 HSALNG0141908] |
|ENSG00000263753.1 | |ENSG00000263753.1 | ||
|NA | |NA | ||
| Line 3,871: | Line 4,354: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289794 HSALNT0289794] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289794 HSALNT0289794] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141909 HSALNG0141909] |
|ENSG00000264772 | |ENSG00000264772 | ||
|AC016876.2 | |AC016876.2 | ||
| Line 3,879: | Line 4,363: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289795 HSALNT0289795] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289795 HSALNT0289795] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141910 HSALNG0141910] |
|ENSG00000266952.1 | |ENSG00000266952.1 | ||
|NA | |NA | ||
| Line 3,887: | Line 4,372: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289828 HSALNT0289828] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289828 HSALNT0289828] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141943 HSALNG0141943] |
|FAM66B | |FAM66B | ||
|FAM66E | |FAM66E | ||
| Line 3,895: | Line 4,381: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289895 HSALNT0289895] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289895 HSALNT0289895] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142010 HSALNG0142010] |
|LINC00336 | |LINC00336 | ||
|C6orf227,NCRNA00336 | |C6orf227,NCRNA00336 | ||
| Line 3,903: | Line 4,390: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289899 HSALNT0289899] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289899 HSALNT0289899] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142014 HSALNG0142014] |
|LINC00929 | |LINC00929 | ||
|NA | |NA | ||
| Line 3,911: | Line 4,399: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289906 HSALNT0289906] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289906 HSALNT0289906] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142021 HSALNG0142021] |
|LINC01204 | |LINC01204 | ||
|NA | |NA | ||
| Line 3,919: | Line 4,408: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289912 HSALNT0289912] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289912 HSALNT0289912] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142027 HSALNG0142027] |
|LINC01538 | |LINC01538 | ||
|NA | |NA | ||
| Line 3,927: | Line 4,417: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289915 HSALNT0289915] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289915 HSALNT0289915] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142030 HSALNG0142030] |
|LINC01721 | |LINC01721 | ||
|NA | |NA | ||
| Line 3,935: | Line 4,426: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289916 HSALNT0289916] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289916 HSALNT0289916] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142031 HSALNG0142031] |
|LINC01762 | |LINC01762 | ||
|NA | |NA | ||
| Line 3,943: | Line 4,435: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289917 HSALNT0289917] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289917 HSALNT0289917] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142032 HSALNG0142032] |
|LINC01798 | |LINC01798 | ||
|NA | |NA | ||
| Line 3,951: | Line 4,444: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290247 HSALNT0290247] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290247 HSALNT0290247] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142362 HSALNG0142362] |
|SMIM2-IT1 | |SMIM2-IT1 | ||
|C13orf44-IT1 | |C13orf44-IT1 | ||
| Line 3,959: | Line 4,453: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290316 HSALNT0290316] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290316 HSALNT0290316] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142431 HSALNG0142431] |
|TTTY7 | |TTTY7 | ||
|CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7 | |CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7 | ||
| Line 3,967: | Line 4,462: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289872 HSALNT0289872] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289872 HSALNT0289872] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141987 HSALNG0141987] |
|HTTAS_v1 | |HTTAS_v1 | ||
|NA | |NA | ||
| Line 3,975: | Line 4,471: | ||
|pathogenic process | |pathogenic process | ||
|Huntington disease | |Huntington disease | ||
| + | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290175 HSALNT0290175] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290175 HSALNT0290175] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142290 HSALNG0142290] |
|RNA-a | |RNA-a | ||
|NA | |NA | ||
| Line 3,983: | Line 4,480: | ||
|pathogenic process | |pathogenic process | ||
|Opitz-Kaveggia syndrome | |Opitz-Kaveggia syndrome | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289525 HSALNT0289525] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289525 HSALNT0289525] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141640 HSALNG0141640] |
|116HG | |116HG | ||
|NA | |NA | ||
| Line 3,991: | Line 4,489: | ||
|pathogenic process | |pathogenic process | ||
|Prader-Willi syndrome | |Prader-Willi syndrome | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290320 HSALNT0290320] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290320 HSALNT0290320] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142435 HSALNG0142435] |
|U1 spliceosomal lncRNA | |U1 spliceosomal lncRNA | ||
|NA | |NA | ||
| Line 3,999: | Line 4,498: | ||
|pathogenic process | |pathogenic process | ||
|Parkinson's disease | |Parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289102 HSALNT0289102] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289102 HSALNT0289102] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039360 HSALNG0039360] |
|LINC01262 | |LINC01262 | ||
|TCONS_l2_00021807,RP11-462G22.1 | |TCONS_l2_00021807,RP11-462G22.1 | ||
| Line 4,007: | Line 4,507: | ||
|pathogenic process | |pathogenic process | ||
|Parkinson's disease | |Parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289681 HSALNT0289681] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289681 HSALNT0289681] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141796 HSALNG0141796] |
|CCAT1-L | |CCAT1-L | ||
|NA | |NA | ||
| Line 4,015: | Line 4,516: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290062 HSALNT0290062] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290062 HSALNT0290062] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142177 HSALNG0142177] |
|MT-LIPCAR | |MT-LIPCAR | ||
|uc022bqs.1,LIPCAR | |uc022bqs.1,LIPCAR | ||
| Line 4,023: | Line 4,525: | ||
|pathogenic process | |pathogenic process | ||
|heart disease | |heart disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289941 HSALNT0289941] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289941 HSALNT0289941] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142056 HSALNG0142056] |
|LIPCAR | |LIPCAR | ||
|NA | |NA | ||
| Line 4,031: | Line 4,534: | ||
|pathogenic process | |pathogenic process | ||
|heart failure | |heart failure | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200965 HSALNT0200965] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200965 HSALNT0200965] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0096756 HSALNG0096756] |
|TUSC8 | |TUSC8 | ||
|LINC01071,XLOC_010588 | |LINC01071,XLOC_010588 | ||
| Line 4,039: | Line 4,543: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0161787 HSALNT0161787] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0161787 HSALNT0161787] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0077519 HSALNG0077519] |
|LINC01264 | |LINC01264 | ||
|RP11-124O11.2 | |RP11-124O11.2 | ||
| Line 4,047: | Line 4,552: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289733 HSALNT0289733] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289733 HSALNT0289733] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141848 HSALNG0141848] |
|D4Z4 | |D4Z4 | ||
|NA | |NA | ||
| Line 4,055: | Line 4,561: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|facioscapulohumeral muscular dystrophy | |facioscapulohumeral muscular dystrophy | ||
| + | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289678 HSALNT0289678] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289678 HSALNT0289678] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141793 HSALNG0141793] |
|CARL | |CARL | ||
|NA | |NA | ||
| Line 4,063: | Line 4,570: | ||
|pathogenic process | |pathogenic process | ||
|myocardial infarction | |myocardial infarction | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289923 HSALNT0289923] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289923 HSALNT0289923] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142038 HSALNG0142038] |
|linc-CBR1-2 | |linc-CBR1-2 | ||
|NA | |NA | ||
| Line 4,071: | Line 4,579: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0243354 HSALNT0243354] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0243354 HSALNT0243354] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0117819 HSALNG0117819] |
|WFDC21P | |WFDC21P | ||
|WAP four-disulfide core domain 21,pseudogene | |WAP four-disulfide core domain 21,pseudogene | ||
| Line 4,079: | Line 4,588: | ||
|pathogenic process | |pathogenic process | ||
|DC dysfunction | |DC dysfunction | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290232 HSALNT0290232] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290232 HSALNT0290232] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142347 HSALNG0142347] |
|RUNX1 | |RUNX1 | ||
|NA | |NA | ||
| Line 4,087: | Line 4,597: | ||
|pathogenic process | |pathogenic process | ||
|acute myeloid leukemia | |acute myeloid leukemia | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290234 HSALNT0290234] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290234 HSALNT0290234] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142349 HSALNG0142349] |
|RUNXOR | |RUNXOR | ||
|NA | |NA | ||
| Line 4,095: | Line 4,606: | ||
|pathogenic process | |pathogenic process | ||
|hematopoietic malignancies | |hematopoietic malignancies | ||
| + | |Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289979 HSALNT0289979] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289979 HSALNT0289979] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142094 HSALNG0142094] |
|lncRNA-CIR | |lncRNA-CIR | ||
|NA | |NA | ||
| Line 4,103: | Line 4,615: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis | |osteoarthritis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290368 HSALNT0290368] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290368 HSALNT0290368] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142483 HSALNG0142483] |
|VIM2P | |VIM2P | ||
|NA | |NA | ||
| Line 4,111: | Line 4,624: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis | |osteoarthritis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289879 HSALNT0289879] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289879 HSALNT0289879] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141994 HSALNG0141994] |
|KRAS1P | |KRAS1P | ||
|NA | |NA | ||
| Line 4,119: | Line 4,633: | ||
|pathogenic process | |pathogenic process | ||
|cancer | |cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290054 HSALNT0290054] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290054 HSALNT0290054] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142169 HSALNG0142169] |
|MINA | |MINA | ||
|NA | |NA | ||
| Line 4,127: | Line 4,642: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer | |esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289270 HSALNT0289270] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289270 HSALNT0289270] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0117279 HSALNG0117279] |
|TMEM92-AS1 | |TMEM92-AS1 | ||
|RP11-893F2.9,lncRNA-508851,TCONS_00025237 | |RP11-893F2.9,lncRNA-508851,TCONS_00025237 | ||
| Line 4,135: | Line 4,651: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288900 HSALNT0288900] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288900 HSALNT0288900] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0054937 HSALNG0054937] |
|CAHM | |CAHM | ||
|LINC00468 | |LINC00468 | ||
| Line 4,143: | Line 4,660: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289593 HSALNT0289593] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289593 HSALNT0289593] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141708 HSALNG0141708] |
|AK123657 | |AK123657 | ||
|NA | |NA | ||
| Line 4,151: | Line 4,669: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289659 HSALNT0289659] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289659 HSALNT0289659] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141774 HSALNG0141774] |
|BX648207 | |BX648207 | ||
|NA | |NA | ||
| Line 4,159: | Line 4,678: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289660 HSALNT0289660] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289660 HSALNT0289660] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141775 HSALNG0141775] |
|BX649059 | |BX649059 | ||
|NA | |NA | ||
| Line 4,167: | Line 4,687: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289846 HSALNT0289846] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289846 HSALNT0289846] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141961 HSALNG0141961] |
|GAS2L3 | |GAS2L3 | ||
|NA | |NA | ||
| Line 4,175: | Line 4,696: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289633 HSALNT0289633] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289633 HSALNT0289633] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141748 HSALNG0141748] |
|BC011663 | |BC011663 | ||
|NA | |NA | ||
| Line 4,183: | Line 4,705: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289867 HSALNT0289867] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289867 HSALNT0289867] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141982 HSALNG0141982] |
|HIV1230 | |HIV1230 | ||
|NA | |NA | ||
| Line 4,191: | Line 4,714: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290045 HSALNT0290045] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290045 HSALNT0290045] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142160 HSALNG0142160] |
|M14574 | |M14574 | ||
|NA | |NA | ||
| Line 4,199: | Line 4,723: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290245 HSALNT0290245] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290245 HSALNT0290245] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142360 HSALNG0142360] |
|SLCO5A1 | |SLCO5A1 | ||
|NA | |NA | ||
| Line 4,207: | Line 4,732: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290326 HSALNT0290326] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290326 HSALNT0290326] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142441 HSALNG0142441] |
|uc.341 | |uc.341 | ||
|NA | |NA | ||
| Line 4,215: | Line 4,741: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290344 HSALNT0290344] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290344 HSALNT0290344] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142459 HSALNG0142459] |
|uc003iqu | |uc003iqu | ||
|NA | |NA | ||
| Line 4,223: | Line 4,750: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290346 HSALNT0290346] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290346 HSALNT0290346] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142461 HSALNG0142461] |
|uc003tfx | |uc003tfx | ||
|NA | |NA | ||
| Line 4,231: | Line 4,759: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289950 HSALNT0289950] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289950 HSALNT0289950] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142065 HSALNG0142065] |
|lnc-AL355149.1-1 | |lnc-AL355149.1-1 | ||
|NA | |NA | ||
| Line 4,239: | Line 4,768: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290001 HSALNT0290001] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290001 HSALNT0290001] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142116 HSALNG0142116] |
|lnc-ZNF674-1 | |lnc-ZNF674-1 | ||
|NA | |NA | ||
| Line 4,247: | Line 4,777: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286909 HSALNT0286909] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286909 HSALNT0286909] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140423 HSALNG0140423] |
|LINC00632 | |LINC00632 | ||
|NA | |NA | ||
| Line 4,255: | Line 4,786: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289105 HSALNT0289105] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289105 HSALNT0289105] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0014134 HSALNG0014134] |
|LINC01317 | |LINC01317 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 4,265: | Line 4,798: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234804 HSALNT0234804] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234804 HSALNT0234804] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113279 HSALNG0113279] |
|LINC01081 | |LINC01081 | ||
|TCONS_00024764 | |TCONS_00024764 | ||
| Line 4,271: | Line 4,804: | ||
|pathogenic process | |pathogenic process | ||
|alveolar capillary dysplasia | |alveolar capillary dysplasia | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289840 HSALNT0289840] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289840 HSALNT0289840] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141955 HSALNG0141955] |
|FOSB | |FOSB | ||
|NA | |NA | ||
| Line 4,279: | Line 4,813: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289587 HSALNT0289587] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289587 HSALNT0289587] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141702 HSALNG0141702] |
|AK093543 | |AK093543 | ||
|NA | |NA | ||
| Line 4,287: | Line 4,822: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289732 HSALNT0289732] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289732 HSALNT0289732] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141847 HSALNG0141847] |
|D16366 | |D16366 | ||
|NA | |NA | ||
| Line 4,295: | Line 4,831: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289814 HSALNT0289814] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289814 HSALNT0289814] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141929 HSALNG0141929] |
|ENST00000501583 | |ENST00000501583 | ||
|NA | |NA | ||
| Line 4,303: | Line 4,840: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290273 HSALNT0290273] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290273 HSALNT0290273] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142388 HSALNG0142388] |
|TCONS_00018278 | |TCONS_00018278 | ||
|NA | |NA | ||
| Line 4,311: | Line 4,849: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289907 HSALNT0289907] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289907 HSALNT0289907] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142022 HSALNG0142022] |
|LINC01374 | |LINC01374 | ||
|TCONS_00018278 | |TCONS_00018278 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231106 HSALNT0231106] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231106 HSALNT0231106] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0111452 HSALNG0111452] |
|CASC22 | |CASC22 | ||
|LINC01373,TCONS_00024290,LincRNA-ENST00000515084 | |LINC01373,TCONS_00024290,LincRNA-ENST00000515084 | ||
| Line 4,327: | Line 4,867: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058246 HSALNT0058246] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058246 HSALNT0058246] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0027843 HSALNG0027843] |
|LINC00882 | |LINC00882 | ||
|NA | |NA | ||
| Line 4,335: | Line 4,876: | ||
|pathogenic process | |pathogenic process | ||
|airway diseases | |airway diseases | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018288 HSALNT0018288] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018288 HSALNT0018288] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008840 HSALNG0008840] |
|KIAA1614-AS1 | |KIAA1614-AS1 | ||
|RP11-46A10.4 | |RP11-46A10.4 | ||
| Line 4,343: | Line 4,885: | ||
|pathogenic process | |pathogenic process | ||
|airway smooth muscle (ASM) disease | |airway smooth muscle (ASM) disease | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142310 HSALNT0142310] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142310 HSALNT0142310] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0067913 HSALNG0067913] |
|LINC00536 | |LINC00536 | ||
|NA | |NA | ||
| Line 4,351: | Line 4,894: | ||
|pathogenic process | |pathogenic process | ||
|trichorhinophalangeal syndrome | |trichorhinophalangeal syndrome | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0034200 HSALNT0034200] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0034200 HSALNT0034200] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0016063 HSALNG0016063] |
|LBX2-AS1 | |LBX2-AS1 | ||
|NA | |NA | ||
| Line 4,359: | Line 4,903: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149799 HSALNT0149799] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149799 HSALNT0149799] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0071679 HSALNG0071679] |
|ENST00000414223 | |ENST00000414223 | ||
|NA | |NA | ||
| Line 4,367: | Line 4,912: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290012 HSALNT0290012] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290012 HSALNT0290012] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142127 HSALNG0142127] |
|LOC105374631 | |LOC105374631 | ||
|NA | |NA | ||
| Line 4,375: | Line 4,921: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290305 HSALNT0290305] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290305 HSALNT0290305] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142420 HSALNG0142420] |
|TMEM179 | |TMEM179 | ||
|NA | |NA | ||
| Line 4,383: | Line 4,930: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290315 HSALNT0290315] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290315 HSALNT0290315] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142430 HSALNG0142430] |
|TSPAN8 | |TSPAN8 | ||
|NA | |NA | ||
| Line 4,391: | Line 4,939: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290334 HSALNT0290334] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290334 HSALNT0290334] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142449 HSALNG0142449] |
|uc001aka.2 | |uc001aka.2 | ||
|NA | |NA | ||
| Line 4,399: | Line 4,948: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290339 HSALNT0290339] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290339 HSALNT0290339] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142454 HSALNG0142454] |
|uc001vjj.1 | |uc001vjj.1 | ||
|NA | |NA | ||
| Line 4,407: | Line 4,957: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290343 HSALNT0290343] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290343 HSALNT0290343] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142458 HSALNG0142458] |
|uc003erl.1 | |uc003erl.1 | ||
|NA | |NA | ||
| Line 4,415: | Line 4,966: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290354 HSALNT0290354] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290354 HSALNT0290354] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142469 HSALNG0142469] |
|uc009wkz.1 | |uc009wkz.1 | ||
|NA | |NA | ||
| Line 4,423: | Line 4,975: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027893 HSALNT0027893] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027893 HSALNT0027893] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0013204 HSALNG0013204] |
|MYCNUT | |MYCNUT | ||
|MYCNUN,lncUSMycN | |MYCNUN,lncUSMycN | ||
| Line 4,431: | Line 4,984: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273205 HSALNT0273205] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273205 HSALNT0273205] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132900 HSALNG0132900] |
|LINC01436 | |LINC01436 | ||
|AP000688.8 | |AP000688.8 | ||
| Line 4,439: | Line 4,993: | ||
|pathogenic process | |pathogenic process | ||
|Down syndrome | |Down syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266116 HSALNT0266116] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266116 HSALNT0266116] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129435 HSALNG0129435] |
|MIR663AHG | |MIR663AHG | ||
|RP3-410C9.1 | |RP3-410C9.1 | ||
| Line 4,447: | Line 5,002: | ||
|pathogenic process | |pathogenic process | ||
|turner syndrome | |turner syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289108 HSALNT0289108] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289108 HSALNT0289108] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0080498 HSALNG0080498] |
|LINC01435 | |LINC01435 | ||
|RP11-215N21.1,TCONS_00018040 | |RP11-215N21.1,TCONS_00018040 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289674 HSALNT0289674] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289674 HSALNT0289674] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141789 HSALNG0141789] |
|CADM3-AS1 | |CADM3-AS1 | ||
|NA | |NA | ||
| Line 4,463: | Line 5,020: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289882 HSALNT0289882] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289882 HSALNT0289882] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141997 HSALNG0141997] |
|KRT19P3 | |KRT19P3 | ||
|NA | |NA | ||
| Line 4,471: | Line 5,029: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290310 HSALNT0290310] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290310 HSALNT0290310] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142425 HSALNG0142425] |
|TNXA | |TNXA | ||
|NA | |NA | ||
| Line 4,479: | Line 5,038: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008750 HSALNT0008750] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008750 HSALNT0008750] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004412 HSALNG0004412] |
|ZRANB2-AS2 | |ZRANB2-AS2 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 4,489: | Line 5,050: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289745 HSALNT0289745] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289745 HSALNT0289745] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141860 HSALNG0141860] |
|DMTF1 | |DMTF1 | ||
|NA | |NA | ||
| Line 4,495: | Line 5,056: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290059 HSALNT0290059] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290059 HSALNT0290059] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142174 HSALNG0142174] |
|MRUL | |MRUL | ||
|NA | |NA | ||
| Line 4,503: | Line 5,065: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185163 HSALNT0185163] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185163 HSALNT0185163] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089050 HSALNG0089050] |
|FAM66C | |FAM66C | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 4,513: | Line 5,077: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289476 HSALNT0289476] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289476 HSALNT0289476] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132414 HSALNG0132414] |
|CYYR1-AS1 | |CYYR1-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 4,521: | Line 5,086: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289535 HSALNT0289535] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289535 HSALNT0289535] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141650 HSALNG0141650] |
|AA174084 | |AA174084 | ||
|NA | |NA | ||
| Line 4,527: | Line 5,092: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266298 HSALNT0266298] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266298 HSALNT0266298] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129511 HSALNG0129511] |
|ABALON | |ABALON | ||
|INXS | |INXS | ||
| Line 4,535: | Line 5,101: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290370 HSALNT0290370] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290370 HSALNT0290370] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142485 HSALNG0142485] |
|VTRNA2-1 | |VTRNA2-1 | ||
|CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a | |CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a | ||
| Line 4,543: | Line 5,110: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289619 HSALNT0289619] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289619 HSALNT0289619] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141734 HSALNG0141734] |
|ASK00420 | |ASK00420 | ||
|NA | |NA | ||
| Line 4,551: | Line 5,119: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289749 HSALNT0289749] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289749 HSALNT0289749] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141864 HSALNG0141864] |
|EBIC | |EBIC | ||
|NA | |NA | ||
| Line 4,559: | Line 5,128: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290299 HSALNT0290299] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290299 HSALNT0290299] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142414 HSALNG0142414] |
|TI09485 | |TI09485 | ||
|NA | |NA | ||
| Line 4,567: | Line 5,137: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290300 HSALNT0290300] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290300 HSALNT0290300] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142415 HSALNG0142415] |
|TI10124 | |TI10124 | ||
|NA | |NA | ||
| Line 4,575: | Line 5,146: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290301 HSALNT0290301] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290301 HSALNT0290301] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142416 HSALNG0142416] |
|TI13831 | |TI13831 | ||
|NA | |NA | ||
| Line 4,583: | Line 5,155: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290302 HSALNT0290302] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290302 HSALNT0290302] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142417 HSALNG0142417] |
|TI18318 | |TI18318 | ||
|NA | |NA | ||
| Line 4,591: | Line 5,164: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290303 HSALNT0290303] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290303 HSALNT0290303] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142418 HSALNG0142418] |
|TI21327 | |TI21327 | ||
|NA | |NA | ||
| Line 4,599: | Line 5,173: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290304 HSALNT0290304] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290304 HSALNT0290304] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142419 HSALNG0142419] |
|TI22687 | |TI22687 | ||
|NA | |NA | ||
| Line 4,607: | Line 5,182: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290307 HSALNT0290307] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290307 HSALNT0290307] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142422 HSALNG0142422] |
|TMPOP2 | |TMPOP2 | ||
|NA | |NA | ||
| Line 4,615: | Line 5,191: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289570 HSALNT0289570] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289570 HSALNT0289570] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141685 HSALNG0141685] |
|AK021444 | |AK021444 | ||
|NA | |NA | ||
| Line 4,623: | Line 5,200: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289601 HSALNT0289601] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289601 HSALNT0289601] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141716 HSALNG0141716] |
|AK307796 | |AK307796 | ||
|NA | |NA | ||
| Line 4,631: | Line 5,209: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289801 HSALNT0289801] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289801 HSALNT0289801] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141916 HSALNG0141916] |
|ENST00000425785 | |ENST00000425785 | ||
|SEC63P1 | |SEC63P1 | ||
| Line 4,639: | Line 5,218: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289871 HSALNT0289871] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289871 HSALNT0289871] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141986 HSALNG0141986] |
|HOXB-AS3 | |HOXB-AS3 | ||
|NA | |NA | ||
| Line 4,647: | Line 5,227: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290367 HSALNT0290367] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290367 HSALNT0290367] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142482 HSALNG0142482] |
|URHC | |URHC | ||
|NA | |NA | ||
| Line 4,655: | Line 5,236: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289085 HSALNT0289085] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289085 HSALNT0289085] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0098166 HSALNG0098166] |
|LINC01080 | |LINC01080 | ||
|TCONS_00021856 | |TCONS_00021856 | ||
| Line 4,663: | Line 5,245: | ||
|pathogenic process | |pathogenic process | ||
|Alzheimer's disease | |Alzheimer's disease | ||
| + | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289751 HSALNT0289751] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289751 HSALNT0289751] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141866 HSALNG0141866] |
|EFNA3 | |EFNA3 | ||
|NA | |NA | ||
| Line 4,671: | Line 5,254: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289798 HSALNT0289798] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289798 HSALNT0289798] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141913 HSALNG0141913] |
|ENST00000395084 | |ENST00000395084 | ||
|NA | |NA | ||
| Line 4,679: | Line 5,263: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289829 HSALNT0289829] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289829 HSALNT0289829] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141944 HSALNG0141944] |
|FAM83A-AS1 | |FAM83A-AS1 | ||
|NA | |NA | ||
| Line 4,687: | Line 5,272: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290164 HSALNT0290164] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290164 HSALNT0290164] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142279 HSALNG0142279] |
|RAD1 | |RAD1 | ||
|NA | |NA | ||
| Line 4,695: | Line 5,281: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289585 HSALNT0289585] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289585 HSALNT0289585] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141700 HSALNG0141700] |
|AK056988 | |AK056988 | ||
|NA | |NA | ||
| Line 4,703: | Line 5,290: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289638 HSALNT0289638] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289638 HSALNT0289638] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141753 HSALNG0141753] |
|BC017743 | |BC017743 | ||
|NA | |NA | ||
| Line 4,711: | Line 5,299: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290156 HSALNT0290156] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290156 HSALNT0290156] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142271 HSALNG0142271] |
|PRR26 | |PRR26 | ||
|C10orf108 | |C10orf108 | ||
| Line 4,719: | Line 5,308: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290349 HSALNT0290349] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290349 HSALNT0290349] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142464 HSALNG0142464] |
|uc003yqb.1 | |uc003yqb.1 | ||
|NA | |NA | ||
| Line 4,727: | Line 5,317: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289675 HSALNT0289675] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289675 HSALNT0289675] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141790 HSALNG0141790] |
|CAI2 | |CAI2 | ||
|NA | |NA | ||
| Line 4,735: | Line 5,326: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289673 HSALNT0289673] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289673 HSALNT0289673] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141788 HSALNG0141788] |
|CADM1-AS1 | |CADM1-AS1 | ||
|NA | |NA | ||
| Line 4,743: | Line 5,335: | ||
|pathogenic process | |pathogenic process | ||
|renal clear cell cancer | |renal clear cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290313 HSALNT0290313] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290313 HSALNT0290313] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142428 HSALNG0142428] |
|TSLC1-AS1 | |TSLC1-AS1 | ||
|NA | |NA | ||
| Line 4,751: | Line 5,344: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013359 HSALNT0013359] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013359 HSALNT0013359] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0006378 HSALNG0006378] |
|LINC01525 | |LINC01525 | ||
|lnc-MAN1A2-1 | |lnc-MAN1A2-1 | ||
| Line 4,759: | Line 5,353: | ||
|pathogenic process | |pathogenic process | ||
|squamous cell cancer | |squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0109106 HSALNT0109106] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0109106 HSALNT0109106] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0051540 HSALNG0051540] |
|LINC01526 | |LINC01526 | ||
|Lnc-FAM46A-1 | |Lnc-FAM46A-1 | ||
| Line 4,767: | Line 5,362: | ||
|pathogenic process | |pathogenic process | ||
|squamous cell cancer | |squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162774 HSALNT0162774] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162774 HSALNT0162774] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0078013 HSALNG0078013] |
|LINC01468 | |LINC01468 | ||
|lnc-MBL2-4 | |lnc-MBL2-4 | ||
| Line 4,775: | Line 5,371: | ||
|pathogenic process | |pathogenic process | ||
|squamous cell cancer | |squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNT0289110] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNT0289110] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074718 HSALNG0074718] |
|LINC01503 | |LINC01503 | ||
|lnc-PPP2R4-5 | |lnc-PPP2R4-5 | ||
| Line 4,783: | Line 5,380: | ||
|pathogenic process | |pathogenic process | ||
|tongue squamous cell cancer | |tongue squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289968 HSALNT0289968] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289968 HSALNT0289968] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142083 HSALNG0142083] |
|lnc-MBL2-4:3 | |lnc-MBL2-4:3 | ||
|NA | |NA | ||
| Line 4,791: | Line 5,389: | ||
|pathogenic process | |pathogenic process | ||
|tongue squamous cell cancer | |tongue squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289993 HSALNT0289993] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289993 HSALNT0289993] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142108 HSALNG0142108] |
|lnc-STXBP5-1 | |lnc-STXBP5-1 | ||
|NA | |NA | ||
| Line 4,799: | Line 5,398: | ||
|pathogenic process | |pathogenic process | ||
|tongue squamous cell cancer | |tongue squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289563 HSALNT0289563] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289563 HSALNT0289563] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141678 HSALNG0141678] |
|AF118081 | |AF118081 | ||
|NA | |NA | ||
| Line 4,807: | Line 5,407: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289597 HSALNT0289597] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289597 HSALNT0289597] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141712 HSALNG0141712] |
|AK124939 | |AK124939 | ||
|NA | |NA | ||
| Line 4,815: | Line 5,416: | ||
|pathogenic process | |pathogenic process | ||
|pulmonary adenocarcinoma | |pulmonary adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290153 HSALNT0290153] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290153 HSALNT0290153] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142268 HSALNG0142268] |
|PRAS | |PRAS | ||
|NA | |NA | ||
| Line 4,823: | Line 5,425: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290249 HSALNT0290249] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290249 HSALNT0290249] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142364 HSALNG0142364] |
|SNAR-A1 | |SNAR-A1 | ||
|NA | |NA | ||
| Line 4,831: | Line 5,434: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289929 HSALNT0289929] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289929 HSALNT0289929] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142044 HSALNG0142044] |
|lincRNA-BC2 | |lincRNA-BC2 | ||
|NA | |NA | ||
| Line 4,839: | Line 5,443: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289930 HSALNT0289930] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289930 HSALNT0289930] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142045 HSALNG0142045] |
|lincRNA-BC4 | |lincRNA-BC4 | ||
|NA | |NA | ||
| Line 4,847: | Line 5,452: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289931 HSALNT0289931] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289931 HSALNT0289931] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142046 HSALNG0142046] |
|lincRNA-BC5 | |lincRNA-BC5 | ||
|NA | |NA | ||
| Line 4,855: | Line 5,461: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289932 HSALNT0289932] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289932 HSALNT0289932] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142047 HSALNG0142047] |
|lincRNA-BC8 | |lincRNA-BC8 | ||
|NA | |NA | ||
| Line 4,863: | Line 5,470: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039551 HSALNG0039551] |
|LINC01511 | |LINC01511 | ||
|RP11-325I22.2 | |RP11-325I22.2 | ||
| Line 4,871: | Line 5,479: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290026 HSALNT0290026] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290026 HSALNT0290026] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142141 HSALNG0142141] |
|LOC440905 | |LOC440905 | ||
|NA | |NA | ||
| Line 4,879: | Line 5,488: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039551 HSALNG0039551] |
|LINC01511 | |LINC01511 | ||
|RP11-325I22.2 | |RP11-325I22.2 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 4,889: | Line 5,500: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289552 HSALNT0289552] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289552 HSALNT0289552] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141667 HSALNG0141667] |
|AC079776.2 | |AC079776.2 | ||
|NA | |NA | ||
| Line 4,895: | Line 5,506: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289720 HSALNT0289720] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289720 HSALNT0289720] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141835 HSALNG0141835] |
|CTA-363E6.2 | |CTA-363E6.2 | ||
|NA | |NA | ||
| Line 4,903: | Line 5,515: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289901 HSALNT0289901] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289901 HSALNT0289901] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142016 HSALNG0142016] |
|LINC00987 | |LINC00987 | ||
|NA | |NA | ||
| Line 4,911: | Line 5,524: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290185 HSALNT0290185] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290185 HSALNT0290185] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142300 HSALNG0142300] |
|RP11-1C1.7 | |RP11-1C1.7 | ||
|NA | |NA | ||
| Line 4,919: | Line 5,533: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290197 HSALNT0290197] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290197 HSALNT0290197] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142312 HSALNG0142312] |
|RP11-445K13.2 | |RP11-445K13.2 | ||
|NA | |NA | ||
| Line 4,927: | Line 5,542: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290199 HSALNT0290199] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290199 HSALNT0290199] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142314 HSALNG0142314] |
|RP11-473M20.11 | |RP11-473M20.11 | ||
|NA | |NA | ||
| Line 4,935: | Line 5,551: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290213 HSALNT0290213] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290213 HSALNT0290213] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142328 HSALNG0142328] |
|RP11-893F2.6 | |RP11-893F2.6 | ||
|NA | |NA | ||
| Line 4,943: | Line 5,560: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290217 HSALNT0290217] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290217 HSALNT0290217] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142332 HSALNG0142332] |
|RP13-514E23.1 | |RP13-514E23.1 | ||
|NA | |NA | ||
| Line 4,951: | Line 5,569: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290218 HSALNT0290218] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290218 HSALNT0290218] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142333 HSALNG0142333] |
|RP1-90D4.3 | |RP1-90D4.3 | ||
|NA | |NA | ||
| Line 4,959: | Line 5,578: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290220 HSALNT0290220] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290220 HSALNT0290220] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142335 HSALNG0142335] |
|RP4-575N6.5 | |RP4-575N6.5 | ||
|NA | |NA | ||
| Line 4,967: | Line 5,587: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290226 HSALNT0290226] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290226 HSALNT0290226] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142341 HSALNG0142341] |
|RP5-826L7.1 | |RP5-826L7.1 | ||
|NA | |NA | ||
| Line 4,975: | Line 5,596: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290378 HSALNT0290378] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290378 HSALNT0290378] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142493 HSALNG0142493] |
|XLOC_003286 | |XLOC_003286 | ||
|NA | |NA | ||
| Line 4,983: | Line 5,605: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290379 HSALNT0290379] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290379 HSALNT0290379] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142494 HSALNG0142494] |
|XLOC_003405 | |XLOC_003405 | ||
|NA | |NA | ||
| Line 4,991: | Line 5,614: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290389 HSALNT0290389] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290389 HSALNT0290389] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142504 HSALNG0142504] |
|XLOC_012255 | |XLOC_012255 | ||
|NA | |NA | ||
| Line 4,999: | Line 5,623: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290056 HSALNT0290056] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290056 HSALNT0290056] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142171 HSALNG0142171] |
|MIR21 | |MIR21 | ||
|NA | |NA | ||
| Line 5,007: | Line 5,632: | ||
|pathogenic process | |pathogenic process | ||
|laryngeal squamous cell cancer | |laryngeal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289621 HSALNT0289621] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289621 HSALNT0289621] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141736 HSALNG0141736] |
|ASncmtRNAs | |ASncmtRNAs | ||
|NA | |NA | ||
| Line 5,015: | Line 5,641: | ||
|pathogenic process | |pathogenic process | ||
|cancer | |cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289316 HSALNT0289316] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289316 HSALNT0289316] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0022090 HSALNG0022090] |
|LINC01614 | |LINC01614 | ||
|LCAL4,TCONS_00003105 | |LCAL4,TCONS_00003105 | ||
| Line 5,023: | Line 5,650: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289982 HSALNT0289982] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289982 HSALNT0289982] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142097 HSALNG0142097] |
|lncRNA-FER1L4 | |lncRNA-FER1L4 | ||
|NA | |NA | ||
| Line 5,031: | Line 5,659: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290016 HSALNT0290016] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290016 HSALNT0290016] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142131 HSALNG0142131] |
|LOC283177 | |LOC283177 | ||
|NA | |NA | ||
| Line 5,039: | Line 5,668: | ||
|pathogenic process | |pathogenic process | ||
|diffuse large B-cell lymphoma | |diffuse large B-cell lymphoma | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289003 HSALNT0289003] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289003 HSALNT0289003] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134860 HSALNG0134860] |
|HORMAD2-AS1 | |HORMAD2-AS1 | ||
|MTMR3-AS1,NONHSAG033653 | |MTMR3-AS1,NONHSAG033653 | ||
| Line 5,047: | Line 5,677: | ||
|pathogenic process | |pathogenic process | ||
|type 1 diabetes;bowel disease | |type 1 diabetes;bowel disease | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290372 HSALNT0290372] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290372 HSALNT0290372] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142487 HSALNG0142487] |
|WNT4 | |WNT4 | ||
|NA | |NA | ||
| Line 5,055: | Line 5,686: | ||
|pathogenic process | |pathogenic process | ||
|endometriosis | |endometriosis | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289540 HSALNT0289540] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289540 HSALNT0289540] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141655 HSALNG0141655] |
|AB074278 | |AB074278 | ||
|NA | |NA | ||
| Line 5,063: | Line 5,695: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290166 HSALNT0290166] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290166 HSALNT0290166] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142281 HSALNG0142281] |
|RCCRT1 | |RCCRT1 | ||
|NA | |NA | ||
| Line 5,071: | Line 5,704: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289043 HSALNT0289043] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289043 HSALNT0289043] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043862 HSALNG0043862] |
|LINC00491 | |LINC00491 | ||
|BC008363 | |BC008363 | ||
| Line 5,079: | Line 5,713: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic ductal adenocarcinoma | |pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289632 HSALNT0289632] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289632 HSALNT0289632] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141747 HSALNG0141747] |
|BC008363 | |BC008363 | ||
|NA | |NA | ||
| Line 5,087: | Line 5,722: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289858 HSALNT0289858] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289858 HSALNT0289858] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141973 HSALNG0141973] |
|H1.3 | |H1.3 | ||
|NA | |NA | ||
| Line 5,095: | Line 5,731: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289896 HSALNT0289896] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289896 HSALNT0289896] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142011 HSALNG0142011] |
|LINC00582 | |LINC00582 | ||
|NA | |NA | ||
| Line 5,103: | Line 5,740: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289301 HSALNT0289301] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289301 HSALNT0289301] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141635 HSALNG0141635] |
|LINC01537 | |LINC01537 | ||
|RP11-169D4.1-001 | |RP11-169D4.1-001 | ||
| Line 5,111: | Line 5,749: | ||
|pathogenic process | |pathogenic process | ||
|laryngeal squamous cell cancer | |laryngeal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289551 HSALNT0289551] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289551 HSALNT0289551] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141666 HSALNG0141666] |
|AC026166.2 | |AC026166.2 | ||
|MTCO1P5 | |MTCO1P5 | ||
| Line 5,119: | Line 5,758: | ||
|pathogenic process | |pathogenic process | ||
|laryngeal squamous cell cancer | |laryngeal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290184 HSALNT0290184] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290184 HSALNT0290184] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142299 HSALNG0142299] |
|RP11-169D4.1-001 | |RP11-169D4.1-001 | ||
|NA | |NA | ||
| Line 5,127: | Line 5,767: | ||
|pathogenic process | |pathogenic process | ||
|laryngeal squamous cell cancer | |laryngeal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289545 HSALNT0289545] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289545 HSALNT0289545] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141660 HSALNG0141660] |
|AC006050.3 | |AC006050.3 | ||
|NA | |NA | ||
| Line 5,135: | Line 5,776: | ||
|pathogenic process | |pathogenic process | ||
|lung squamous cell cancer | |lung squamous cell cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289556 HSALNT0289556] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289556 HSALNT0289556] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141671 HSALNG0141671] |
|AC138128.1 | |AC138128.1 | ||
|NA | |NA | ||
| Line 5,143: | Line 5,785: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289818 HSALNT0289818] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289818 HSALNT0289818] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141933 HSALNG0141933] |
|ERCC1 | |ERCC1 | ||
|NA | |NA | ||
| Line 5,151: | Line 5,794: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290061 HSALNT0290061] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290061 HSALNT0290061] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142176 HSALNG0142176] |
|MT1DP | |MT1DP | ||
|MT1DP | |MT1DP | ||
| Line 5,159: | Line 5,803: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289578 HSALNT0289578] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289578 HSALNT0289578] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141693 HSALNG0141693] |
|AK023096 | |AK023096 | ||
|NA | |NA | ||
| Line 5,167: | Line 5,812: | ||
|pathogenic process | |pathogenic process | ||
|Wilmsâ tumor;uterine leiomyomas | |Wilmsâ tumor;uterine leiomyomas | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289112 HSALNT0289112] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289112 HSALNT0289112] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0003560 HSALNG0003560] |
|LINC01562 | |LINC01562 | ||
|RP11-296A18.3 | |RP11-296A18.3 | ||
| Line 5,175: | Line 5,821: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration | |intervertebral disc degeneration | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289567 HSALNT0289567] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289567 HSALNT0289567] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141682 HSALNG0141682] |
|AK000974 | |AK000974 | ||
|NA | |NA | ||
| Line 5,183: | Line 5,830: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289579 HSALNT0289579] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289579 HSALNT0289579] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141694 HSALNG0141694] |
|AK024118 | |AK024118 | ||
|NA | |NA | ||
| Line 5,191: | Line 5,839: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289645 HSALNT0289645] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289645 HSALNT0289645] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141760 HSALNG0141760] |
|BC040204 | |BC040204 | ||
|NA | |NA | ||
| Line 5,199: | Line 5,848: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290321 HSALNT0290321] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290321 HSALNT0290321] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142436 HSALNG0142436] |
|U79277 | |U79277 | ||
|NA | |NA | ||
| Line 5,207: | Line 5,857: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289869 HSALNT0289869] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289869 HSALNT0289869] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141984 HSALNG0141984] |
|HOST2 | |HOST2 | ||
|NA | |NA | ||
| Line 5,215: | Line 5,866: | ||
|pathogenic process | |pathogenic process | ||
|epithelial ovarian cancer | |epithelial ovarian cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289368 HSALNT0289368] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289368 HSALNT0289368] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0135509 HSALNG0135509] |
|MGAT3-AS1 | |MGAT3-AS1 | ||
|TapSAKI | |TapSAKI | ||
| Line 5,223: | Line 5,875: | ||
|pathogenic process | |pathogenic process | ||
|acute kidney injury | |acute kidney injury | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289624 HSALNT0289624] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289624 HSALNT0289624] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141739 HSALNG0141739] |
|ATXN7L3B | |ATXN7L3B | ||
|NA | |NA | ||
| Line 5,231: | Line 5,884: | ||
|pathogenic process | |pathogenic process | ||
|spinocerebellar ataxia | |spinocerebellar ataxia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289990 HSALNT0289990] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289990 HSALNT0289990] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142105 HSALNG0142105] |
|lnc-SCA7 | |lnc-SCA7 | ||
|NA | |NA | ||
| Line 5,239: | Line 5,893: | ||
|pathogenic process | |pathogenic process | ||
|spinocerebellar ataxia | |spinocerebellar ataxia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290004 HSALNT0290004] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290004 HSALNT0290004] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142119 HSALNG0142119] |
|LOC100287482 | |LOC100287482 | ||
|NA | |NA | ||
| Line 5,247: | Line 5,902: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290383 HSALNT0290383] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290383 HSALNT0290383] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142498 HSALNG0142498] |
|XLOC_007697 | |XLOC_007697 | ||
|NA | |NA | ||
| Line 5,255: | Line 5,911: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290384 HSALNT0290384] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290384 HSALNT0290384] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142499 HSALNG0142499] |
|XLOC_008559 | |XLOC_008559 | ||
|NA | |NA | ||
| Line 5,263: | Line 5,920: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290385 HSALNT0290385] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290385 HSALNT0290385] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142500 HSALNG0142500] |
|XLOC_009911 | |XLOC_009911 | ||
|NA | |NA | ||
| Line 5,271: | Line 5,929: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289813 HSALNT0289813] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289813 HSALNT0289813] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141928 HSALNG0141928] |
|ENST00000480739 | |ENST00000480739 | ||
|RPL13AP23 | |RPL13AP23 | ||
| Line 5,279: | Line 5,938: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290111 HSALNT0290111] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290111 HSALNT0290111] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142226 HSALNG0142226] |
|OS9 | |OS9 | ||
|NA | |NA | ||
| Line 5,287: | Line 5,947: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290324 HSALNT0290324] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290324 HSALNT0290324] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142439 HSALNG0142439] |
|uc.283-plus | |uc.283-plus | ||
|NA | |NA | ||
| Line 5,295: | Line 5,956: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289117 HSALNT0289117] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289117 HSALNT0289117] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0051652 HSALNG0051652] |
|LINC01611 | |LINC01611 | ||
|RP1-90L14.1,TCONS_l2_00025430 | |RP1-90L14.1,TCONS_l2_00025430 | ||
| Line 5,303: | Line 5,965: | ||
|pathogenic process | |pathogenic process | ||
|diabetic retinopathy | |diabetic retinopathy | ||
| + | |Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289529 HSALNT0289529] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289529 HSALNT0289529] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141644 HSALNG0141644] |
|2900055J20Rik | |2900055J20Rik | ||
|2900055J20Rik | |2900055J20Rik | ||
| Line 5,311: | Line 5,974: | ||
|pathogenic process | |pathogenic process | ||
|left ventricular hypertrophy | |left ventricular hypertrophy | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289792 HSALNT0289792] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289792 HSALNT0289792] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141907 HSALNG0141907] |
|ENSG00000261777 | |ENSG00000261777 | ||
|AC012184.3 | |AC012184.3 | ||
| Line 5,319: | Line 5,983: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289618 HSALNT0289618] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289618 HSALNT0289618] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141733 HSALNG0141733] |
|Asb3 | |Asb3 | ||
|NA | |NA | ||
| Line 5,327: | Line 5,992: | ||
|pathogenic process | |pathogenic process | ||
|cardiovascular and renal disease | |cardiovascular and renal disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289703 HSALNT0289703] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289703 HSALNT0289703] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141818 HSALNG0141818] |
|Chac2 | |Chac2 | ||
|NA | |NA | ||
| Line 5,335: | Line 6,001: | ||
|pathogenic process | |pathogenic process | ||
|cardiovascular and renal disease | |cardiovascular and renal disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290139 HSALNT0290139] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290139 HSALNT0290139] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142254 HSALNG0142254] |
|Pex11b | |Pex11b | ||
|NA | |NA | ||
| Line 5,343: | Line 6,010: | ||
|pathogenic process | |pathogenic process | ||
|cardiovascular and renal disease | |cardiovascular and renal disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290255 HSALNT0290255] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290255 HSALNT0290255] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142370 HSALNG0142370] |
|Sp5 | |Sp5 | ||
|NA | |NA | ||
| Line 5,351: | Line 6,019: | ||
|pathogenic process | |pathogenic process | ||
|cardiovascular and renal disease | |cardiovascular and renal disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211639 HSALNT0211639] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211639 HSALNT0211639] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0101614 HSALNG0101614] |
|PSMA3-AS1 | |PSMA3-AS1 | ||
|FLJ31306 | |FLJ31306 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289319 HSALNT0289319] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289319 HSALNT0289319] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141639 HSALNG0141639] |
|LINC00493 | |LINC00493 | ||
|LOC388789 | |LOC388789 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288903 HSALNT0288903] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288903 HSALNT0288903] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0126842 HSALNG0126842] |
|CARD8-AS1 | |CARD8-AS1 | ||
|LOC100505812 | |LOC100505812 | ||
| Line 5,375: | Line 6,046: | ||
|pathogenic process | |pathogenic process | ||
|leukemia and neuroblastoma | |leukemia and neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0064729 HSALNT0064729] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0064729 HSALNT0064729] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0030929 HSALNG0030929] |
|KCNMB2-AS1 | |KCNMB2-AS1 | ||
|RP11-385J1.2 | |RP11-385J1.2 | ||
| Line 5,383: | Line 6,055: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289548 HSALNT0289548] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289548 HSALNT0289548] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141663 HSALNG0141663] |
|AC013264.2 | |AC013264.2 | ||
|NA | |NA | ||
| Line 5,391: | Line 6,064: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289857 HSALNT0289857] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289857 HSALNT0289857] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141972 HSALNG0141972] |
|GUCY1B2 | |GUCY1B2 | ||
|NA | |NA | ||
| Line 5,399: | Line 6,073: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290190 HSALNT0290190] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290190 HSALNT0290190] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142305 HSALNG0142305] |
|RP11-385J1.2 | |RP11-385J1.2 | ||
|NA | |NA | ||
| Line 5,407: | Line 6,082: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290216 HSALNT0290216] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290216 HSALNT0290216] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142331 HSALNG0142331] |
|RP1-317E23.3 | |RP1-317E23.3 | ||
|NA | |NA | ||
| Line 5,415: | Line 6,091: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290317 HSALNT0290317] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290317 HSALNT0290317] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142432 HSALNG0142432] |
|TUBA4B | |TUBA4B | ||
|NA | |NA | ||
| Line 5,423: | Line 6,100: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290375 HSALNT0290375] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290375 HSALNT0290375] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142490 HSALNG0142490] |
|XLOC_000371 | |XLOC_000371 | ||
|NA | |NA | ||
| Line 5,431: | Line 6,109: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290397 HSALNT0290397] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290397 HSALNT0290397] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142512 HSALNG0142512] |
|Z82214.3 | |Z82214.3 | ||
|NA | |NA | ||
| Line 5,439: | Line 6,118: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289735 HSALNT0289735] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289735 HSALNT0289735] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141850 HSALNG0141850] |
|DALIR | |DALIR | ||
|DALI | |DALI | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290376 HSALNT0290376] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290376 HSALNT0290376] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142491 HSALNG0142491] |
|XLOC_000620 | |XLOC_000620 | ||
|NA | |NA | ||
| Line 5,455: | Line 6,136: | ||
|pathogenic process | |pathogenic process | ||
|H. pylori-related diseases | |H. pylori-related diseases | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290380 HSALNT0290380] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290380 HSALNT0290380] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142495 HSALNG0142495] |
|XLOC_004122 | |XLOC_004122 | ||
|NA | |NA | ||
| Line 5,463: | Line 6,145: | ||
|pathogenic process | |pathogenic process | ||
|H. pylori-related diseases | |H. pylori-related diseases | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290381 HSALNT0290381] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290381 HSALNT0290381] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142496 HSALNG0142496] |
|XLOC_004562 | |XLOC_004562 | ||
|NA | |NA | ||
| Line 5,471: | Line 6,154: | ||
|pathogenic process | |pathogenic process | ||
|H. pylori-related diseases | |H. pylori-related diseases | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290382 HSALNT0290382] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290382 HSALNT0290382] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142497 HSALNG0142497] |
|XLOC_005912 | |XLOC_005912 | ||
|NA | |NA | ||
| Line 5,479: | Line 6,163: | ||
|pathogenic process | |pathogenic process | ||
|H. pylori-related diseases | |H. pylori-related diseases | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290391 HSALNT0290391] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290391 HSALNT0290391] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142506 HSALNG0142506] |
|XLOC_014388 | |XLOC_014388 | ||
|NA | |NA | ||
| Line 5,487: | Line 6,172: | ||
|pathogenic process | |pathogenic process | ||
|H. pylori-related diseases | |H. pylori-related diseases | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290028 HSALNT0290028] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290028 HSALNT0290028] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142143 HSALNG0142143] |
|LOC652276 | |LOC652276 | ||
|NA | |NA | ||
| Line 5,495: | Line 6,181: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290162 HSALNT0290162] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290162 HSALNT0290162] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142277 HSALNG0142277] |
|R05532 | |R05532 | ||
|NA | |NA | ||
| Line 5,503: | Line 6,190: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098175 HSALNT0098175] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098175 HSALNT0098175] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0046752 HSALNG0046752] |
|LINC01411 | |LINC01411 | ||
|RP11-267A15.1 | |RP11-267A15.1 | ||
| Line 5,511: | Line 6,199: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290025 HSALNT0290025] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290025 HSALNT0290025] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142140 HSALNG0142140] |
|LOC401317 | |LOC401317 | ||
|NA | |NA | ||
| Line 5,519: | Line 6,208: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289726 HSALNT0289726] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289726 HSALNT0289726] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141841 HSALNG0141841] |
|CTD-2574D22.4 | |CTD-2574D22.4 | ||
|AC120114.2 | |AC120114.2 | ||
| Line 5,527: | Line 6,217: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis | |osteoarthritis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290141 HSALNT0290141] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290141 HSALNT0290141] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142256 HSALNG0142256] |
|PMS2L2 | |PMS2L2 | ||
|NA | |NA | ||
| Line 5,535: | Line 6,226: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis | |osteoarthritis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289974 HSALNT0289974] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289974 HSALNT0289974] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142089 HSALNG0142089] |
|lncRNA-422 | |lncRNA-422 | ||
|NA | |NA | ||
| Line 5,543: | Line 6,235: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289520 HSALNT0289520] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289520 HSALNT0289520] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133454 HSALNG0133454] |
|AATBC | |AATBC | ||
|NA | |NA | ||
| Line 5,551: | Line 6,244: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289311 HSALNT0289311] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289311 HSALNT0289311] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141637 HSALNG0141637] |
|LINC00974 | |LINC00974 | ||
|NA | |NA | ||
| Line 5,559: | Line 6,253: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0089943 HSALNT0089943] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0089943 HSALNT0089943] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0042820 HSALNG0042820] |
|ZBED3-AS1 | |ZBED3-AS1 | ||
|NA | |NA | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289116 HSALNT0289116] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289116 HSALNT0289116] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0135958 HSALNG0135958] |
|LINC01589 | |LINC01589 | ||
|CTA-941F9.9,TCONS_00029353 | |CTA-941F9.9,TCONS_00029353 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289910 HSALNT0289910] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289910 HSALNT0289910] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142025 HSALNG0142025] |
|LINC01426 | |LINC01426 | ||
|NA | |NA | ||
| Line 5,583: | Line 6,280: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290341 HSALNT0290341] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290341 HSALNT0290341] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142456 HSALNG0142456] |
|uc002yug.2 | |uc002yug.2 | ||
|NA | |NA | ||
| Line 5,591: | Line 6,289: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290250 HSALNT0290250] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290250 HSALNT0290250] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142365 HSALNG0142365] |
|SNCG | |SNCG | ||
|NA | |NA | ||
| Line 5,599: | Line 6,298: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289949 HSALNT0289949] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289949 HSALNT0289949] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142064 HSALNG0142064] |
|lnc-AF085935 | |lnc-AF085935 | ||
|NA | |NA | ||
| Line 5,607: | Line 6,307: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289996 HSALNT0289996] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289996 HSALNT0289996] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142111 HSALNG0142111] |
|lnc-uc003wbd | |lnc-uc003wbd | ||
|NA | |NA | ||
| Line 5,615: | Line 6,316: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289559 HSALNT0289559] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289559 HSALNT0289559] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141674 HSALNG0141674] |
|AF085935 | |AF085935 | ||
|NA | |NA | ||
| Line 5,623: | Line 6,325: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290347 HSALNT0290347] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290347 HSALNT0290347] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142462 HSALNG0142462] |
|uc003wbd | |uc003wbd | ||
|NA | |NA | ||
| Line 5,631: | Line 6,334: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290098 HSALNT0290098] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290098 HSALNT0290098] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142213 HSALNG0142213] |
|NR_001284 | |NR_001284 | ||
|TNXA | |TNXA | ||
| Line 5,639: | Line 6,343: | ||
|pathogenic process | |pathogenic process | ||
|chronic thromboembolic pulmonary hypertension | |chronic thromboembolic pulmonary hypertension | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290327 HSALNT0290327] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290327 HSALNT0290327] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142442 HSALNG0142442] |
|uc.343 | |uc.343 | ||
|NA | |NA | ||
| Line 5,647: | Line 6,352: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis | |osteoarthritis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289196 HSALNT0289196] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289196 HSALNT0289196] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094525 HSALNG0094525] |
|NRAV | |NRAV | ||
|DYNLL1-AS1 | |DYNLL1-AS1 | ||
| Line 5,655: | Line 6,361: | ||
|pathogenic process | |pathogenic process | ||
|influenza A virus | |influenza A virus | ||
| + | |Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290140 HSALNT0290140] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290140 HSALNT0290140] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142255 HSALNG0142255] |
|PLEC | |PLEC | ||
|NA | |NA | ||
| Line 5,663: | Line 6,370: | ||
|pathogenic process | |pathogenic process | ||
|chronic obstructive pulmonary disease | |chronic obstructive pulmonary disease | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290172 HSALNT0290172] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290172 HSALNT0290172] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142287 HSALNG0142287] |
|RNA44121|UCSC-2000-3182 | |RNA44121|UCSC-2000-3182 | ||
|NA | |NA | ||
| Line 5,671: | Line 6,379: | ||
|pathogenic process | |pathogenic process | ||
|chronic obstructive pulmonary disease | |chronic obstructive pulmonary disease | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290173 HSALNT0290173] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290173 HSALNT0290173] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142288 HSALNG0142288] |
|RNA50010|UCSC-9199-1005 | |RNA50010|UCSC-9199-1005 | ||
|NA | |NA | ||
| Line 5,679: | Line 6,388: | ||
|pathogenic process | |pathogenic process | ||
|chronic obstructive pulmonary disease | |chronic obstructive pulmonary disease | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290174 HSALNT0290174] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290174 HSALNT0290174] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142289 HSALNG0142289] |
|RNA58351|CombinedLit_316_550 | |RNA58351|CombinedLit_316_550 | ||
|NA | |NA | ||
| Line 5,687: | Line 6,397: | ||
|pathogenic process | |pathogenic process | ||
|chronic obstructive pulmonary disease | |chronic obstructive pulmonary disease | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289714 HSALNT0289714] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289714 HSALNT0289714] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141829 HSALNG0141829] |
|CR613944 | |CR613944 | ||
|NA | |NA | ||
| Line 5,695: | Line 6,406: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289933 HSALNT0289933] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289933 HSALNT0289933] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142048 HSALNG0142048] |
|lincRNA-CALCA | |lincRNA-CALCA | ||
|NA | |NA | ||
| Line 5,703: | Line 6,415: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290200 HSALNT0290200] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290200 HSALNT0290200] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142315 HSALNG0142315] |
|RP11-501G6.1 | |RP11-501G6.1 | ||
|NA | |NA | ||
| Line 5,711: | Line 6,424: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290208 HSALNT0290208] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290208 HSALNT0290208] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142323 HSALNG0142323] |
|RP11-672F9.1 | |RP11-672F9.1 | ||
|NA | |NA | ||
| Line 5,719: | Line 6,433: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290405 HSALNT0290405] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290405 HSALNT0290405] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142520 HSALNG0142520] |
|C14orf132 | |C14orf132 | ||
|NA | |NA | ||
| Line 5,727: | Line 6,442: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289937 HSALNT0289937] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289937 HSALNT0289937] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142052 HSALNG0142052] |
|lincRNA-TSPAN8 | |lincRNA-TSPAN8 | ||
|NA | |NA | ||
| Line 5,735: | Line 6,451: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290225 HSALNT0290225] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290225 HSALNT0290225] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142340 HSALNG0142340] |
|RP5-1014O16.1 | |RP5-1014O16.1 | ||
|AC244098.1 | |AC244098.1 | ||
| Line 5,743: | Line 6,460: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290275 HSALNT0290275] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290275 HSALNT0290275] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142390 HSALNG0142390] |
|TCONS_00026102 | |TCONS_00026102 | ||
|NA | |NA | ||
| Line 5,751: | Line 6,469: | ||
|pathogenic process | |pathogenic process | ||
|atrial fibrillation | |atrial fibrillation | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290277 HSALNT0290277] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290277 HSALNT0290277] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142392 HSALNG0142392] |
|TCONS_00032546 | |TCONS_00032546 | ||
|NA | |NA | ||
| Line 5,759: | Line 6,478: | ||
|pathogenic process | |pathogenic process | ||
|atrial fibrillation | |atrial fibrillation | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289037 HSALNT0289037] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289037 HSALNT0289037] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0096978 HSALNG0096978] |
|LINC00441 | |LINC00441 | ||
|RB1-DT,ncRNA-RB1 | |RB1-DT,ncRNA-RB1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289661 HSALNT0289661] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289661 HSALNT0289661] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141776 HSALNG0141776] |
|C1401f132 | |C1401f132 | ||
|NA | |NA | ||
| Line 5,775: | Line 6,496: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289141 HSALNT0289141] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289141 HSALNT0289141] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039030 HSALNG0039030] |
|LINC02365 | |LINC02365 | ||
|LVCAT8 | |LVCAT8 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288885 HSALNT0288885] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288885 HSALNT0288885] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0095161 HSALNG0095161] |
|ADGRD1-AS1 | |ADGRD1-AS1 | ||
|LACAT8 | |LACAT8 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 5,793: | Line 6,517: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289142 HSALNT0289142] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289142 HSALNT0289142] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0034152 HSALNG0034152] |
|LINC02475 | |LINC02475 | ||
|LVCAT1 | |LVCAT1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 5,801: | Line 6,526: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289542 HSALNT0289542] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289542 HSALNT0289542] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141657 HSALNG0141657] |
|Abhd11os | |Abhd11os | ||
|NA | |NA | ||
| Line 5,807: | Line 6,532: | ||
|pathogenic process | |pathogenic process | ||
|neurodegenerative diseases | |neurodegenerative diseases | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288895 HSALNT0288895] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288895 HSALNT0288895] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0124521 HSALNG0124521] |
|BISPR | |BISPR | ||
|NA | |NA | ||
| Line 5,815: | Line 6,541: | ||
|pathogenic process | |pathogenic process | ||
|virus infection | |virus infection | ||
| + | |Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233975 HSALNT0233975] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233975 HSALNT0233975] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0112910 HSALNG0112910] |
|MAFTRR | |MAFTRR | ||
|linc-MAF-4 | |linc-MAF-4 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290058 HSALNT0290058] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290058 HSALNT0290058] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142173 HSALNG0142173] |
|MRAK052686 | |MRAK052686 | ||
|NA | |NA | ||
| Line 5,831: | Line 6,559: | ||
|pathogenic process | |pathogenic process | ||
|nonalcoholic fatty liver disease | |nonalcoholic fatty liver disease | ||
| + | |Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290221 HSALNT0290221] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290221 HSALNT0290221] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142336 HSALNG0142336] |
|RP4-583P15.10 | |RP4-583P15.10 | ||
|AL121845.1 | |AL121845.1 | ||
| Line 5,839: | Line 6,568: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211341 HSALNT0211341] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211341 HSALNT0211341] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0101470 HSALNG0101470] |
|KTN1-AS1 | |KTN1-AS1 | ||
|C14orf33,MYCLo-3 | |C14orf33,MYCLo-3 | ||
| Line 5,847: | Line 6,577: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266752 HSALNT0266752] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266752 HSALNT0266752] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129835 HSALNG0129835] |
|DLGAP4-AS1 | |DLGAP4-AS1 | ||
|CCAT7 | |CCAT7 | ||
| Line 5,855: | Line 6,586: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289682 HSALNT0289682] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289682 HSALNT0289682] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141797 HSALNG0141797] |
|CCAT3 | |CCAT3 | ||
|NA | |NA | ||
| Line 5,863: | Line 6,595: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289684 HSALNT0289684] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289684 HSALNT0289684] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141799 HSALNG0141799] |
|CCAT8 | |CCAT8 | ||
|NA | |NA | ||
| Line 5,871: | Line 6,604: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289898 HSALNT0289898] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289898 HSALNT0289898] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142013 HSALNG0142013] |
|LINC00659 | |LINC00659 | ||
|NA | |NA | ||
| Line 5,879: | Line 6,613: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289683 HSALNT0289683] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289683 HSALNT0289683] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141798 HSALNG0141798] |
|CCAT7 | |CCAT7 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289627 HSALNT0289627] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289627 HSALNT0289627] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141742 HSALNG0141742] |
|BALR-2 | |BALR-2 | ||
|NA | |NA | ||
| Line 5,895: | Line 6,631: | ||
|pathogenic process | |pathogenic process | ||
|B cell acute lymphoblastic leukemia | |B cell acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289948 HSALNT0289948] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289948 HSALNT0289948] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142063 HSALNG0142063] |
|lnc-ACACA-1 | |lnc-ACACA-1 | ||
|NA | |NA | ||
| Line 5,903: | Line 6,640: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289953 HSALNT0289953] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289953 HSALNT0289953] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142068 HSALNG0142068] |
|lnc-BMP2-2 | |lnc-BMP2-2 | ||
|NA | |NA | ||
| Line 5,911: | Line 6,649: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289955 HSALNT0289955] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289955 HSALNT0289955] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142070 HSALNG0142070] |
|lnc-CPN2-1 | |lnc-CPN2-1 | ||
|NA | |NA | ||
| Line 5,919: | Line 6,658: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289958 HSALNT0289958] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289958 HSALNT0289958] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142073 HSALNG0142073] |
|lnc-FOXG1-2 | |lnc-FOXG1-2 | ||
|NA | |NA | ||
| Line 5,927: | Line 6,667: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289960 HSALNT0289960] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289960 HSALNT0289960] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142075 HSALNG0142075] |
|lnc-FZD1-2 | |lnc-FZD1-2 | ||
|NA | |NA | ||
| Line 5,935: | Line 6,676: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289962 HSALNT0289962] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289962 HSALNT0289962] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142077 HSALNG0142077] |
|lnc-ITPR2-3 | |lnc-ITPR2-3 | ||
|NA | |NA | ||
| Line 5,943: | Line 6,685: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289965 HSALNT0289965] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289965 HSALNT0289965] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142080 HSALNG0142080] |
|lnc-LCP2-2 | |lnc-LCP2-2 | ||
|NA | |NA | ||
| Line 5,951: | Line 6,694: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289988 HSALNT0289988] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289988 HSALNT0289988] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142103 HSALNG0142103] |
|lnc-RP3-368B9 | |lnc-RP3-368B9 | ||
|NA | |NA | ||
| Line 5,959: | Line 6,703: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289991 HSALNT0289991] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289991 HSALNT0289991] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142106 HSALNG0142106] |
|lnc-SLC30A4-1 | |lnc-SLC30A4-1 | ||
|NA | |NA | ||
| Line 5,967: | Line 6,712: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289992 HSALNT0289992] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289992 HSALNT0289992] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142107 HSALNG0142107] |
|lnc-SPAM1-6 | |lnc-SPAM1-6 | ||
|NA | |NA | ||
| Line 5,975: | Line 6,721: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289995 HSALNT0289995] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289995 HSALNT0289995] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142110 HSALNG0142110] |
|lnc-TTC34-3 | |lnc-TTC34-3 | ||
|NA | |NA | ||
| Line 5,983: | Line 6,730: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222064 HSALNT0222064] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222064 HSALNT0222064] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0106856 HSALNG0106856] |
|DRAIC | |DRAIC | ||
|NA | |NA | ||
| Line 5,991: | Line 6,739: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | |prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | ||
| + | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0005037 HSALNT0005037] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0005037 HSALNT0005037] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0002618 HSALNG0002618] |
|LINC01137 | |LINC01137 | ||
|LOC728431 | |LOC728431 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290390 HSALNT0290390] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290390 HSALNT0290390] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142505 HSALNG0142505] |
|XLOC_014172 | |XLOC_014172 | ||
|NA | |NA | ||
| Line 6,007: | Line 6,757: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290014 HSALNT0290014] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290014 HSALNT0290014] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142129 HSALNG0142129] |
|LOC149086 | |LOC149086 | ||
|NA | |NA | ||
| Line 6,015: | Line 6,766: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290183 HSALNT0290183] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290183 HSALNT0290183] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142298 HSALNG0142298] |
|RP11-160H22.5 | |RP11-160H22.5 | ||
|AL121983.2 | |AL121983.2 | ||
| Line 6,023: | Line 6,775: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289945 HSALNT0289945] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289945 HSALNT0289945] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142060 HSALNG0142060] |
|LNC00964-3 | |LNC00964-3 | ||
|NA | |NA | ||
| Line 6,031: | Line 6,784: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289616 HSALNT0289616] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289616 HSALNT0289616] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141731 HSALNG0141731] |
|Arid2-IR | |Arid2-IR | ||
|NA | |NA | ||
| Line 6,039: | Line 6,793: | ||
|pathogenic process | |pathogenic process | ||
|renal inflammation | |renal inflammation | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289716 HSALNT0289716] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289716 HSALNT0289716] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141831 HSALNG0141831] |
|CR619813 | |CR619813 | ||
|NA | |NA | ||
| Line 6,047: | Line 6,802: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289739 HSALNT0289739] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289739 HSALNT0289739] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141854 HSALNG0141854] |
|DDX6P1 | |DDX6P1 | ||
|NA | |NA | ||
| Line 6,055: | Line 6,811: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289938 HSALNT0289938] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289938 HSALNT0289938] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142053 HSALNG0142053] |
|lincRNA-ZNF532 | |lincRNA-ZNF532 | ||
|NA | |NA | ||
| Line 6,063: | Line 6,820: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290011 HSALNT0290011] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290011 HSALNT0290011] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142126 HSALNG0142126] |
|LOC105372753 | |LOC105372753 | ||
|NA | |NA | ||
| Line 6,071: | Line 6,829: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290013 HSALNT0290013] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290013 HSALNT0290013] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142128 HSALNG0142128] |
|LOC105377769 | |LOC105377769 | ||
|NA | |NA | ||
| Line 6,079: | Line 6,838: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290205 HSALNT0290205] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290205 HSALNT0290205] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142320 HSALNG0142320] |
|RP11-58D2.1 | |RP11-58D2.1 | ||
|NA | |NA | ||
| Line 6,087: | Line 6,847: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288946 HSALNT0288946] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288946 HSALNT0288946] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105101 HSALNG0105101] |
|ENST00000434223 | |ENST00000434223 | ||
|NA | |NA | ||
| Line 6,095: | Line 6,856: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288947 HSALNT0288947] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288947 HSALNT0288947] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082178 HSALNG0082178] |
|ENST00000442037 | |ENST00000442037 | ||
|NA | |NA | ||
| Line 6,103: | Line 6,865: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288953 HSALNT0288953] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288953 HSALNT0288953] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088449 HSALNG0088449] |
|ENST00000540136 | |ENST00000540136 | ||
|NA | |NA | ||
| Line 6,111: | Line 6,874: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290103 HSALNT0290103] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290103 HSALNT0290103] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142218 HSALNG0142218] |
|NR_038125 | |NR_038125 | ||
|NA | |NA | ||
| Line 6,119: | Line 6,883: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290136 HSALNT0290136] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290136 HSALNT0290136] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142251 HSALNG0142251] |
|PDLIM3 | |PDLIM3 | ||
|NA | |NA | ||
| Line 6,127: | Line 6,892: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290335 HSALNT0290335] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290335 HSALNT0290335] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142450 HSALNG0142450] |
|uc001gch.1 | |uc001gch.1 | ||
|NA | |NA | ||
| Line 6,135: | Line 6,901: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290336 HSALNT0290336] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290336 HSALNT0290336] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142451 HSALNG0142451] |
|uc001gzl.3 | |uc001gzl.3 | ||
|NA | |NA | ||
| Line 6,143: | Line 6,910: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290351 HSALNT0290351] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290351 HSALNT0290351] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142466 HSALNG0142466] |
|uc004bbl.1 | |uc004bbl.1 | ||
|NA | |NA | ||
| Line 6,151: | Line 6,919: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290369 HSALNT0290369] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290369 HSALNT0290369] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142484 HSALNG0142484] |
|VNN2 | |VNN2 | ||
|NA | |NA | ||
| Line 6,159: | Line 6,928: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289577 HSALNT0289577] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289577 HSALNT0289577] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141692 HSALNG0141692] |
|AK022798 | |AK022798 | ||
|NA | |NA | ||
| Line 6,167: | Line 6,937: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289663 HSALNT0289663] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289663 HSALNT0289663] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141778 HSALNG0141778] |
|C1orf74 | |C1orf74 | ||
|NA | |NA | ||
| Line 6,175: | Line 6,946: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289602 HSALNT0289602] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289602 HSALNT0289602] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141717 HSALNG0141717] |
|AKR7L | |AKR7L | ||
|NA | |NA | ||
| Line 6,183: | Line 6,955: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289711 HSALNT0289711] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289711 HSALNT0289711] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141826 HSALNG0141826] |
|COL3A1 | |COL3A1 | ||
|NA | |NA | ||
| Line 6,191: | Line 6,964: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289878 HSALNT0289878] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289878 HSALNT0289878] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141993 HSALNG0141993] |
|KCNE2 | |KCNE2 | ||
|NA | |NA | ||
| Line 6,199: | Line 6,973: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289636 HSALNT0289636] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289636 HSALNT0289636] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141751 HSALNG0141751] |
|BC015134 | |BC015134 | ||
|NA | |NA | ||
| Line 6,207: | Line 6,982: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289713 HSALNT0289713] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289713 HSALNT0289713] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141828 HSALNG0141828] |
|CR594506 | |CR594506 | ||
|NA | |NA | ||
| Line 6,215: | Line 6,991: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289928 HSALNT0289928] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289928 HSALNT0289928] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142043 HSALNG0142043] |
|lincRNA-BBOX1-2 | |lincRNA-BBOX1-2 | ||
|NA | |NA | ||
| Line 6,223: | Line 7,000: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271719 HSALNT0271719] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271719 HSALNT0271719] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132223 HSALNG0132223] |
|LINC00320 | |LINC00320 | ||
|PRED14,FLJ37539 | |PRED14,FLJ37539 | ||
| Line 6,231: | Line 7,009: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|cortical white matter | |cortical white matter | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289823 HSALNT0289823] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289823 HSALNT0289823] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141938 HSALNG0141938] |
|EVADR | |EVADR | ||
|NA | |NA | ||
| Line 6,239: | Line 7,018: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer;lung cancer;colorectal cancer;rectal cancer | |pancreatic cancer;lung cancer;colorectal cancer;rectal cancer | ||
| + | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289944 HSALNT0289944] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289944 HSALNT0289944] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142059 HSALNG0142059] |
|Lnc_bc060912 | |Lnc_bc060912 | ||
|NA | |NA | ||
| Line 6,247: | Line 7,027: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289952 HSALNT0289952] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289952 HSALNT0289952] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142067 HSALNG0142067] |
|lnc-bc060912 | |lnc-bc060912 | ||
|NA | |NA | ||
| Line 6,255: | Line 7,036: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289613 HSALNT0289613] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289613 HSALNT0289613] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141728 HSALNG0141728] |
|APF | |APF | ||
|NA | |NA | ||
| Line 6,263: | Line 7,045: | ||
|pathogenic process | |pathogenic process | ||
|myocardial infarction | |myocardial infarction | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289617 HSALNT0289617] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289617 HSALNT0289617] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141732 HSALNG0141732] |
|AS Uchl1 | |AS Uchl1 | ||
|NA | |NA | ||
| Line 6,271: | Line 7,054: | ||
|pathogenic process | |pathogenic process | ||
|Parkinson's disease | |Parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289104 HSALNT0289104] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289104 HSALNT0289104] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0099739 HSALNG0099739] |
|LINC01296 | |LINC01296 | ||
|FLJ39632 | |FLJ39632 | ||
| Line 6,279: | Line 7,063: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290403 HSALNT0290403] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290403 HSALNT0290403] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142518 HSALNG0142518] |
|ZXF2 | |ZXF2 | ||
|NA | |NA | ||
| Line 6,287: | Line 7,072: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290113 HSALNT0290113] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290113 HSALNT0290113] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142228 HSALNG0142228] |
|P14695 | |P14695 | ||
|NA | |NA | ||
| Line 6,295: | Line 7,081: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290114 HSALNT0290114] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290114 HSALNT0290114] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142229 HSALNG0142229] |
|P16984 | |P16984 | ||
|NA | |NA | ||
| Line 6,303: | Line 7,090: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290115 HSALNT0290115] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290115 HSALNT0290115] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142230 HSALNG0142230] |
|P19780 | |P19780 | ||
|NA | |NA | ||
| Line 6,311: | Line 7,099: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290116 HSALNT0290116] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290116 HSALNT0290116] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142231 HSALNG0142231] |
|P23099 | |P23099 | ||
|NA | |NA | ||
| Line 6,319: | Line 7,108: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290117 HSALNT0290117] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290117 HSALNT0290117] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142232 HSALNG0142232] |
|P24363 | |P24363 | ||
|NA | |NA | ||
| Line 6,327: | Line 7,117: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290118 HSALNT0290118] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290118 HSALNT0290118] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142233 HSALNG0142233] |
|P28210 | |P28210 | ||
|NA | |NA | ||
| Line 6,335: | Line 7,126: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290120 HSALNT0290120] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290120 HSALNT0290120] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142235 HSALNG0142235] |
|P33863 | |P33863 | ||
|NA | |NA | ||
| Line 6,343: | Line 7,135: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290121 HSALNT0290121] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290121 HSALNT0290121] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142236 HSALNG0142236] |
|P4091 | |P4091 | ||
|NA | |NA | ||
| Line 6,351: | Line 7,144: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290122 HSALNT0290122] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290122 HSALNT0290122] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142237 HSALNG0142237] |
|P6391 | |P6391 | ||
|NA | |NA | ||
| Line 6,359: | Line 7,153: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290123 HSALNT0290123] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290123 HSALNT0290123] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142238 HSALNG0142238] |
|P6488 | |P6488 | ||
|NA | |NA | ||
| Line 6,367: | Line 7,162: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290124 HSALNT0290124] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290124 HSALNT0290124] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142239 HSALNG0142239] |
|P700 | |P700 | ||
|NA | |NA | ||
| Line 6,375: | Line 7,171: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290125 HSALNT0290125] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290125 HSALNT0290125] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142240 HSALNG0142240] |
|P8611 | |P8611 | ||
|NA | |NA | ||
| Line 6,383: | Line 7,180: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290126 HSALNT0290126] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290126 HSALNT0290126] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142241 HSALNG0142241] |
|P8725 | |P8725 | ||
|NA | |NA | ||
| Line 6,391: | Line 7,189: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290127 HSALNT0290127] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290127 HSALNT0290127] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142242 HSALNG0142242] |
|P8860 | |P8860 | ||
|NA | |NA | ||
| Line 6,399: | Line 7,198: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290128 HSALNT0290128] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290128 HSALNT0290128] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142243 HSALNG0142243] |
|P9745 | |P9745 | ||
|NA | |NA | ||
| Line 6,407: | Line 7,207: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289269 HSALNT0289269] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289269 HSALNT0289269] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0044864 HSALNG0044864] |
|TH2LCRR | |TH2LCRR | ||
|TH2-LCR | |TH2-LCR | ||
| Line 6,415: | Line 7,216: | ||
|pathogenic process | |pathogenic process | ||
|allergic asthma | |allergic asthma | ||
| + | |Respiratory Tract Diseases;Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289964 HSALNT0289964] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289964 HSALNT0289964] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142079 HSALNG0142079] |
|lnc-LCE5A-1 | |lnc-LCE5A-1 | ||
|NA | |NA | ||
| Line 6,423: | Line 7,225: | ||
|pathogenic process | |pathogenic process | ||
|laryngeal cancer;head and neck squamous cell cancer | |laryngeal cancer;head and neck squamous cell cancer | ||
| + | |Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055198 HSALNT0055198] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055198 HSALNT0055198] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026441 HSALNG0026441] |
|FAM3D-AS1 | |FAM3D-AS1 | ||
|lnc-KCTD6-3 | |lnc-KCTD6-3 | ||
| Line 6,431: | Line 7,234: | ||
|pathogenic process | |pathogenic process | ||
|tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer | |tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer | ||
| + | |Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289843 HSALNT0289843] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289843 HSALNT0289843] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141958 HSALNG0141958] |
|FRLnc1 | |FRLnc1 | ||
|NA | |NA | ||
| Line 6,439: | Line 7,243: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242005 HSALNT0242005] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242005 HSALNT0242005] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0117109 HSALNG0117109] |
|ENST00000575202 | |ENST00000575202 | ||
|NA | |NA | ||
| Line 6,447: | Line 7,252: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288952 HSALNT0288952] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288952 HSALNT0288952] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089220 HSALNG0089220] |
|ENST00000539009 | |ENST00000539009 | ||
|NA | |NA | ||
| Line 6,455: | Line 7,261: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288954 HSALNT0288954] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288954 HSALNT0288954] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089242 HSALNG0089242] |
|ENST00000544591 | |ENST00000544591 | ||
|NA | |NA | ||
| Line 6,463: | Line 7,270: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289752 HSALNT0289752] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289752 HSALNT0289752] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141867 HSALNG0141867] |
|EHHADH-AS1 | |EHHADH-AS1 | ||
|NA | |NA | ||
| Line 6,471: | Line 7,279: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289812 HSALNT0289812] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289812 HSALNT0289812] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141927 HSALNG0141927] |
|ENST00000468960 | |ENST00000468960 | ||
|NA | |NA | ||
| Line 6,479: | Line 7,288: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290276 HSALNT0290276] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290276 HSALNT0290276] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142391 HSALNG0142391] |
|TCONS_00026506 | |TCONS_00026506 | ||
|NA | |NA | ||
| Line 6,487: | Line 7,297: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189952 HSALNT0189952] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189952 HSALNT0189952] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091595 HSALNG0091595] |
|LRP1-AS | |LRP1-AS | ||
|NA | |NA | ||
| Line 6,495: | Line 7,306: | ||
|pathogenic process | |pathogenic process | ||
|Alzheimer's disease | |Alzheimer's disease | ||
| + | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032045 HSALNT0032045] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032045 HSALNT0032045] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0015125 HSALNG0015125] |
|LINC01122 | |LINC01122 | ||
|FLJ30838,AC007092.1 | |FLJ30838,AC007092.1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 6,505: | Line 7,318: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289565 HSALNT0289565] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289565 HSALNT0289565] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141680 HSALNG0141680] |
|AI364715 | |AI364715 | ||
|NA | |NA | ||
| Line 6,511: | Line 7,324: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289921 HSALNT0289921] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289921 HSALNT0289921] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142036 HSALNG0142036] |
|LINC0949 | |LINC0949 | ||
|NA | |NA | ||
| Line 6,519: | Line 7,333: | ||
|pathogenic process | |pathogenic process | ||
|systemic lupus erythematosus | |systemic lupus erythematosus | ||
| + | |Immune System Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289680 HSALNT0289680] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289680 HSALNT0289680] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141795 HSALNG0141795] |
|CCAL | |CCAL | ||
|NA | |NA | ||
| Line 6,527: | Line 7,342: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289079 HSALNT0289079] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289079 HSALNT0289079] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0077354 HSALNG0077354] |
|LINC00993 | |LINC00993 | ||
|NA | |NA | ||
| Line 6,535: | Line 7,351: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289811 HSALNT0289811] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289811 HSALNT0289811] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141926 HSALNG0141926] |
|ENST00000460164 | |ENST00000460164 | ||
|NA | |NA | ||
| Line 6,543: | Line 7,360: | ||
|pathogenic process | |pathogenic process | ||
|triple-negative breast cancer | |triple-negative breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290282 HSALNT0290282] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290282 HSALNT0290282] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142397 HSALNG0142397] |
|TCONS_l2_00003938 | |TCONS_l2_00003938 | ||
|NA | |NA | ||
| Line 6,551: | Line 7,369: | ||
|pathogenic process | |pathogenic process | ||
|triple-negative breast cancer | |triple-negative breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289888 HSALNT0289888] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289888 HSALNT0289888] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142003 HSALNG0142003] |
|LGALS3 | |LGALS3 | ||
|NA | |NA | ||
| Line 6,559: | Line 7,378: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289963 HSALNT0289963] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289963 HSALNT0289963] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142078 HSALNG0142078] |
|lnc-KCMF1-2:1 | |lnc-KCMF1-2:1 | ||
|NA | |NA | ||
| Line 6,567: | Line 7,387: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289967 HSALNT0289967] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289967 HSALNT0289967] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142082 HSALNG0142082] |
|lnc-LLPH-2:1 | |lnc-LLPH-2:1 | ||
|NA | |NA | ||
| Line 6,575: | Line 7,396: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289971 HSALNT0289971] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289971 HSALNT0289971] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142086 HSALNG0142086] |
|lnc-PLA2R1-1:1 | |lnc-PLA2R1-1:1 | ||
|NA | |NA | ||
| Line 6,583: | Line 7,405: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289972 HSALNT0289972] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289972 HSALNT0289972] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142087 HSALNG0142087] |
|lnc-PSD4-1:14 | |lnc-PSD4-1:14 | ||
|NA | |NA | ||
| Line 6,591: | Line 7,414: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290066 HSALNT0290066] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290066 HSALNT0290066] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142181 HSALNG0142181] |
|n335550 | |n335550 | ||
|NA | |NA | ||
| Line 6,599: | Line 7,423: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290070 HSALNT0290070] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290070 HSALNT0290070] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142185 HSALNG0142185] |
|n340790 | |n340790 | ||
|NA | |NA | ||
| Line 6,607: | Line 7,432: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290072 HSALNT0290072] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290072 HSALNT0290072] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142187 HSALNG0142187] |
|n386477 | |n386477 | ||
|NA | |NA | ||
| Line 6,615: | Line 7,441: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290286 HSALNT0290286] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290286 HSALNT0290286] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142401 HSALNG0142401] |
|TCONS_l2_00010365 | |TCONS_l2_00010365 | ||
|NA | |NA | ||
| Line 6,623: | Line 7,450: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288944 HSALNT0288944] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288944 HSALNT0288944] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129184 HSALNG0129184] |
|ENST00000422494 | |ENST00000422494 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 6,633: | Line 7,462: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289118 HSALNT0289118] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289118 HSALNT0289118] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0038513 HSALNG0038513] |
|LINC01612 | |LINC01612 | ||
|RP11-789C1.1,TCONS_00008319 | |RP11-789C1.1,TCONS_00008319 | ||
| Line 6,639: | Line 7,468: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289610 HSALNT0289610] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289610 HSALNT0289610] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141725 HSALNG0141725] |
|AP001439.2 | |AP001439.2 | ||
|NA | |NA | ||
| Line 6,647: | Line 7,477: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289671 HSALNT0289671] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289671 HSALNT0289671] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141786 HSALNG0141786] |
|CACNAICAS3 | |CACNAICAS3 | ||
|NA | |NA | ||
| Line 6,655: | Line 7,486: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289853 HSALNT0289853] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289853 HSALNT0289853] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141968 HSALNG0141968] |
|GS1-5L10.1 | |GS1-5L10.1 | ||
|NA | |NA | ||
| Line 6,663: | Line 7,495: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289875 HSALNT0289875] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289875 HSALNT0289875] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141990 HSALNG0141990] |
|INTS7 | |INTS7 | ||
|NA | |NA | ||
| Line 6,671: | Line 7,504: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290065 HSALNT0290065] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290065 HSALNT0290065] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142180 HSALNG0142180] |
|MYLK-AS1 | |MYLK-AS1 | ||
|NA | |NA | ||
| Line 6,679: | Line 7,513: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290157 HSALNT0290157] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290157 HSALNT0290157] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142272 HSALNG0142272] |
|PRSS21 | |PRSS21 | ||
|NA | |NA | ||
| Line 6,687: | Line 7,522: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290202 HSALNT0290202] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290202 HSALNT0290202] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142317 HSALNG0142317] |
|RP11-528G1.2 | |RP11-528G1.2 | ||
|NA | |NA | ||
| Line 6,695: | Line 7,531: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290207 HSALNT0290207] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290207 HSALNT0290207] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142322 HSALNG0142322] |
|RP11-643M14.1 | |RP11-643M14.1 | ||
|NA | |NA | ||
| Line 6,703: | Line 7,540: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290209 HSALNT0290209] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290209 HSALNT0290209] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142324 HSALNG0142324] |
|RP11-789C1.1 | |RP11-789C1.1 | ||
|LINC01612 | |LINC01612 | ||
| Line 6,711: | Line 7,549: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290314 HSALNT0290314] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290314 HSALNT0290314] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142429 HSALNG0142429] |
|TSNAX-DISC1 | |TSNAX-DISC1 | ||
|NA | |NA | ||
| Line 6,719: | Line 7,558: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290386 HSALNT0290386] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290386 HSALNT0290386] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142501 HSALNG0142501] |
|XLOC_010235 | |XLOC_010235 | ||
|NA | |NA | ||
| Line 6,727: | Line 7,567: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289558 HSALNT0289558] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289558 HSALNT0289558] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141673 HSALNG0141673] |
|AF075041 | |AF075041 | ||
|NA | |NA | ||
| Line 6,735: | Line 7,576: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289564 HSALNT0289564] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289564 HSALNT0289564] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141679 HSALNG0141679] |
|AF339813 | |AF339813 | ||
|NA | |NA | ||
| Line 6,743: | Line 7,585: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289575 HSALNT0289575] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289575 HSALNT0289575] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141690 HSALNG0141690] |
|AK022029 | |AK022029 | ||
|NA | |NA | ||
| Line 6,751: | Line 7,594: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289576 HSALNT0289576] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289576 HSALNT0289576] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141691 HSALNG0141691] |
|AK022159 | |AK022159 | ||
|NA | |NA | ||
| Line 6,759: | Line 7,603: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289604 HSALNT0289604] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289604 HSALNT0289604] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141719 HSALNG0141719] |
|AL389956 | |AL389956 | ||
|NA | |NA | ||
| Line 6,767: | Line 7,612: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289640 HSALNT0289640] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289640 HSALNT0289640] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141755 HSALNG0141755] |
|BC023629 | |BC023629 | ||
|NA | |NA | ||
| Line 6,775: | Line 7,621: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290096 HSALNT0290096] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290096 HSALNT0290096] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142211 HSALNG0142211] |
|NONHSAT125629 | |NONHSAT125629 | ||
|NA | |NA | ||
| Line 6,783: | Line 7,630: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290393 HSALNT0290393] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290393 HSALNT0290393] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142508 HSALNG0142508] |
|XR_250621.1 | |XR_250621.1 | ||
|NA | |NA | ||
| Line 6,791: | Line 7,639: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288951 HSALNT0288951] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288951 HSALNT0288951] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0033002 HSALNG0033002] |
|ENST00000503938 | |ENST00000503938 | ||
|NA | |NA | ||
| Line 6,799: | Line 7,648: | ||
|pathogenic process | |pathogenic process | ||
|triple-negative breast cancer | |triple-negative breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290085 HSALNT0290085] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290085 HSALNT0290085] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142200 HSALNG0142200] |
|NONHSAT012762 | |NONHSAT012762 | ||
|NA | |NA | ||
| Line 6,807: | Line 7,657: | ||
|pathogenic process | |pathogenic process | ||
|triple-negative breast cancer | |triple-negative breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289151 HSALNT0289151] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289151 HSALNT0289151] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0023952 HSALNG0023952] |
|LMCD1-AS1 | |LMCD1-AS1 | ||
|NA | |NA | ||
| Line 6,815: | Line 7,666: | ||
|pathogenic process | |pathogenic process | ||
|acute kidney injury | |acute kidney injury | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289926 HSALNT0289926] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289926 HSALNT0289926] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142041 HSALNG0142041] |
|linc-PXN-1 | |linc-PXN-1 | ||
|NA | |NA | ||
| Line 6,823: | Line 7,675: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290281 HSALNT0290281] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290281 HSALNT0290281] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142396 HSALNG0142396] |
|TCONS_l2_00001418 | |TCONS_l2_00001418 | ||
|NA | |NA | ||
| Line 6,831: | Line 7,684: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290285 HSALNT0290285] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290285 HSALNT0290285] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142400 HSALNG0142400] |
|TCONS_l2_00008237 | |TCONS_l2_00008237 | ||
|NA | |NA | ||
| Line 6,839: | Line 7,693: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290287 HSALNT0290287] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290287 HSALNT0290287] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142402 HSALNG0142402] |
|TCONS_l2_00011130 | |TCONS_l2_00011130 | ||
|NA | |NA | ||
| Line 6,847: | Line 7,702: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290288 HSALNT0290288] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290288 HSALNT0290288] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142403 HSALNG0142403] |
|TCONS_l2_00013175 | |TCONS_l2_00013175 | ||
|NA | |NA | ||
| Line 6,855: | Line 7,711: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290294 HSALNT0290294] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290294 HSALNT0290294] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142409 HSALNG0142409] |
|TCONS_l2_00022611 | |TCONS_l2_00022611 | ||
|NA | |NA | ||
| Line 6,863: | Line 7,720: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290295 HSALNT0290295] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290295 HSALNT0290295] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142410 HSALNG0142410] |
|TCONS_l2_00022670 | |TCONS_l2_00022670 | ||
|NA | |NA | ||
| Line 6,871: | Line 7,729: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290352 HSALNT0290352] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290352 HSALNT0290352] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142467 HSALNG0142467] |
|uc004bdv.3 | |uc004bdv.3 | ||
|NA | |NA | ||
| Line 6,879: | Line 7,738: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290363 HSALNT0290363] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290363 HSALNT0290363] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142478 HSALNG0142478] |
|ULK4P2 | |ULK4P2 | ||
|NA | |NA | ||
| Line 6,887: | Line 7,747: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289942 HSALNT0289942] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289942 HSALNT0289942] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142057 HSALNG0142057] |
|LK4P2 | |LK4P2 | ||
|NA | |NA | ||
| Line 6,895: | Line 7,756: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289538 HSALNT0289538] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289538 HSALNT0289538] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141653 HSALNG0141653] |
|AB019562 | |AB019562 | ||
|NA | |NA | ||
| Line 6,903: | Line 7,765: | ||
|pathogenic process | |pathogenic process | ||
|hypopharyngeal squamous cell cancer | |hypopharyngeal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091661 HSALNT0091661] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091661 HSALNT0091661] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043585 HSALNG0043585] |
|ENST00000503710 | |ENST00000503710 | ||
|NA | |NA | ||
| Line 6,911: | Line 7,774: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289806 HSALNT0289806] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289806 HSALNT0289806] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141921 HSALNG0141921] |
|ENST00000445734 | |ENST00000445734 | ||
|NA | |NA | ||
| Line 6,919: | Line 7,783: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289807 HSALNT0289807] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289807 HSALNT0289807] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141922 HSALNG0141922] |
|ENST00000448093 | |ENST00000448093 | ||
|NA | |NA | ||
| Line 6,927: | Line 7,792: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289815 HSALNT0289815] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289815 HSALNT0289815] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141930 HSALNG0141930] |
|ENST00000502941 | |ENST00000502941 | ||
|NA | |NA | ||
| Line 6,935: | Line 7,801: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290340 HSALNT0290340] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290340 HSALNT0290340] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142455 HSALNG0142455] |
|uc002nbr.3 | |uc002nbr.3 | ||
|NA | |NA | ||
| Line 6,943: | Line 7,810: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290348 HSALNT0290348] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290348 HSALNT0290348] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142463 HSALNG0142463] |
|uc003xut. | |uc003xut. | ||
|NA | |NA | ||
| Line 6,951: | Line 7,819: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290356 HSALNT0290356] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290356 HSALNT0290356] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142471 HSALNG0142471] |
|uc021re1.1 | |uc021re1.1 | ||
|NA | |NA | ||
| Line 6,959: | Line 7,828: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289549 HSALNT0289549] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289549 HSALNT0289549] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141664 HSALNG0141664] |
|AC016745.3 | |AC016745.3 | ||
|AC016745.1 | |AC016745.1 | ||
| Line 6,967: | Line 7,837: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290180 HSALNT0290180] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290180 HSALNT0290180] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142295 HSALNG0142295] |
|RP11-128A17.1 | |RP11-128A17.1 | ||
|AC078909.1 | |AC078909.1 | ||
| Line 6,975: | Line 7,846: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290377 HSALNT0290377] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290377 HSALNT0290377] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142492 HSALNG0142492] |
|XLOC_001711 | |XLOC_001711 | ||
|NA | |NA | ||
| Line 6,983: | Line 7,855: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289975 HSALNT0289975] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289975 HSALNT0289975] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142090 HSALNG0142090] |
|lncRNA-AK058003 | |lncRNA-AK058003 | ||
|NA | |NA | ||
| Line 6,991: | Line 7,864: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289061 HSALNT0289061] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289061 HSALNT0289061] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0034072 HSALNG0034072] |
|LINC00682 | |LINC00682 | ||
|NA | |NA | ||
| Line 6,999: | Line 7,873: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289305 HSALNT0289305] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289305 HSALNT0289305] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089456 HSALNG0089456] |
|LINC01559 | |LINC01559 | ||
|FLJ33810 | |FLJ33810 | ||
| Line 7,007: | Line 7,882: | ||
|pathogenic process | |pathogenic process | ||
|Huntington disease | |Huntington disease | ||
| + | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289854 HSALNT0289854] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289854 HSALNT0289854] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141969 HSALNG0141969] |
|GSTT1-AS1 | |GSTT1-AS1 | ||
|NA | |NA | ||
| Line 7,015: | Line 7,891: | ||
|pathogenic process | |pathogenic process | ||
|mycobacterium tuberculosis infection | |mycobacterium tuberculosis infection | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289978 HSALNT0289978] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289978 HSALNT0289978] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142093 HSALNG0142093] |
|lncRNA-CD244 | |lncRNA-CD244 | ||
|NA | |NA | ||
| Line 7,023: | Line 7,900: | ||
|pathogenic process | |pathogenic process | ||
|tuberculosis infection | |tuberculosis infection | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289237 HSALNT0289237] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289237 HSALNT0289237] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068014 HSALNG0068014] |
|SAMD12-AS1 | |SAMD12-AS1 | ||
|NA | |NA | ||
| Line 7,031: | Line 7,909: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290179 HSALNT0290179] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290179 HSALNT0290179] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142294 HSALNG0142294] |
|RP11-119F7.4 | |RP11-119F7.4 | ||
|NA | |NA | ||
| Line 7,039: | Line 7,918: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290278 HSALNT0290278] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290278 HSALNT0290278] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142393 HSALNG0142393] |
|TCONS_00068220 | |TCONS_00068220 | ||
|NA | |NA | ||
| Line 7,047: | Line 7,927: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0285573 HSALNT0285573] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0285573 HSALNT0285573] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0139654 HSALNG0139654] |
|DANT1 | |DANT1 | ||
|NA | |NA | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288926 HSALNT0288926] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288926 HSALNT0288926] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0139662 HSALNG0139662] |
|DANT2 | |DANT2 | ||
|NA | |NA | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290399 HSALNT0290399] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290399 HSALNT0290399] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142514 HSALNG0142514] |
|ZMAT1 | |ZMAT1 | ||
|NA | |NA | ||
| Line 7,071: | Line 7,954: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289554 HSALNT0289554] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289554 HSALNT0289554] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141669 HSALNG0141669] |
|AC100865.1 | |AC100865.1 | ||
|NA | |NA | ||
| Line 7,079: | Line 7,963: | ||
|pathogenic process | |pathogenic process | ||
|coronary artery disease | |coronary artery disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289228 HSALNT0289228] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289228 HSALNT0289228] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105273 HSALNG0105273] |
|RAD51-AS1 | |RAD51-AS1 | ||
|TODRA | |TODRA | ||
| Line 7,087: | Line 7,972: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289743 HSALNT0289743] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289743 HSALNT0289743] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141858 HSALNG0141858] |
|DKFZP434K028 | |DKFZP434K028 | ||
|NA | |NA | ||
| Line 7,095: | Line 7,981: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289630 HSALNT0289630] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289630 HSALNT0289630] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141745 HSALNG0141745] |
|BC002811 | |BC002811 | ||
|NA | |NA | ||
| Line 7,103: | Line 7,990: | ||
|pathogenic process | |pathogenic process | ||
|astrocytoma | |astrocytoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290387 HSALNT0290387] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290387 HSALNT0290387] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142502 HSALNG0142502] |
|XLOC_010967 | |XLOC_010967 | ||
|NA | |NA | ||
| Line 7,111: | Line 7,999: | ||
|pathogenic process | |pathogenic process | ||
|astrocytoma | |astrocytoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288955 HSALNT0288955] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288955 HSALNT0288955] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0084672 HSALNG0084672] |
|ENST00000545440 | |ENST00000545440 | ||
|NA | |NA | ||
| Line 7,119: | Line 8,008: | ||
|pathogenic process | |pathogenic process | ||
|pediatric acute myeloid leukemia | |pediatric acute myeloid leukemia | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288981 HSALNT0288981] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288981 HSALNT0288981] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133391 HSALNG0133391] |
|FRGCA | |FRGCA | ||
|LncRNA-AP001631.9 | |LncRNA-AP001631.9 | ||
| Line 7,127: | Line 8,017: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289611 HSALNT0289611] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289611 HSALNT0289611] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141726 HSALNG0141726] |
|AP001631.9 | |AP001631.9 | ||
|NA | |NA | ||
| Line 7,135: | Line 8,026: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289976 HSALNT0289976] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289976 HSALNT0289976] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142091 HSALNG0142091] |
|LncRNA-AP001631.9 | |LncRNA-AP001631.9 | ||
|NA | |NA | ||
| Line 7,143: | Line 8,035: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289686 HSALNT0289686] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289686 HSALNT0289686] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141801 HSALNG0141801] |
|CD99P1 | |CD99P1 | ||
|NA | |NA | ||
| Line 7,151: | Line 8,044: | ||
|pathogenic process | |pathogenic process | ||
|idiopathic pulmonary fibrosis | |idiopathic pulmonary fibrosis | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289119 HSALNT0289119] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289119 HSALNT0289119] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074097 HSALNG0074097] |
|LINC01613 | |LINC01613 | ||
|n341773 | |n341773 | ||
| Line 7,159: | Line 8,053: | ||
|pathogenic process | |pathogenic process | ||
|idiopathic pulmonary fibrosis | |idiopathic pulmonary fibrosis | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289844 HSALNT0289844] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289844 HSALNT0289844] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141959 HSALNG0141959] |
|FTH1P3 | |FTH1P3 | ||
|FTH1P3 | |FTH1P3 | ||
| Line 7,167: | Line 8,062: | ||
|pathogenic process | |pathogenic process | ||
|oral squamous cell cancer | |oral squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289855 HSALNT0289855] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289855 HSALNT0289855] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141970 HSALNG0141970] |
|GTF2IRD2P1 | |GTF2IRD2P1 | ||
|GTF2IRD2P1 | |GTF2IRD2P1 | ||
| Line 7,175: | Line 8,071: | ||
|pathogenic process | |pathogenic process | ||
|oral squamous cell cancer | |oral squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290135 HSALNT0290135] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290135 HSALNT0290135] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142250 HSALNG0142250] |
|PDIA3F | |PDIA3F | ||
|NA | |NA | ||
| Line 7,183: | Line 8,080: | ||
|pathogenic process | |pathogenic process | ||
|oral squamous cell cancer | |oral squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289329 HSALNT0289329] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289329 HSALNT0289329] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026562 HSALNG0026562] |
|LINC00994 | |LINC00994 | ||
|NA | |NA | ||
| Line 7,191: | Line 8,089: | ||
|pathogenic process | |pathogenic process | ||
|inflammatory bowel disease | |inflammatory bowel disease | ||
| + | |Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289208 HSALNT0289208] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289208 HSALNT0289208] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0077290 HSALNG0077290] |
|PCAT5 | |PCAT5 | ||
|LINC01452,TPCAT-10-36067 | |LINC01452,TPCAT-10-36067 | ||
| Line 7,199: | Line 8,098: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114870 HSALNT0114870] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114870 HSALNT0114870] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0054158 HSALNG0054158] |
|LUADT1 | |LUADT1 | ||
|NA | |NA | ||
| Line 7,207: | Line 8,107: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289154 HSALNT0289154] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289154 HSALNT0289154] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0107133 HSALNG0107133] |
|LOXL1-AS1 | |LOXL1-AS1 | ||
|NA | |NA | ||
| Line 7,215: | Line 8,116: | ||
|pathogenic process | |pathogenic process | ||
|exfoliation syndrome | |exfoliation syndrome | ||
| + | |Eye Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289734 HSALNT0289734] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289734 HSALNT0289734] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141849 HSALNG0141849] |
|DACOR1 | |DACOR1 | ||
|TCONS_00023265 | |TCONS_00023265 | ||
| Line 7,223: | Line 8,125: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289060 HSALNT0289060] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289060 HSALNT0289060] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0114548 HSALNG0114548] |
|LINC00675 | |LINC00675 | ||
|NA | |NA | ||
| Line 7,231: | Line 8,134: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288889 HSALNT0288889] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288889 HSALNT0288889] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0070759 HSALNG0070759] |
|B4GALT1-AS1 | |B4GALT1-AS1 | ||
|NA | |NA | ||
|transcriptional regulation | |transcriptional regulation | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289348 HSALNT0289348] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289348 HSALNT0289348] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0083371 HSALNG0083371] |
|LINC01616 | |LINC01616 | ||
|n341006 | |n341006 | ||
| Line 7,247: | Line 8,152: | ||
|pathogenic process | |pathogenic process | ||
|Alzheimer's disease | |Alzheimer's disease | ||
| + | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290068 HSALNT0290068] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290068 HSALNT0290068] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142183 HSALNG0142183] |
|n336934 | |n336934 | ||
|NA | |NA | ||
| Line 7,255: | Line 8,161: | ||
|pathogenic process | |pathogenic process | ||
|Alzheimer's disease | |Alzheimer's disease | ||
| + | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290240 HSALNT0290240] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290240 HSALNT0290240] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142355 HSALNG0142355] |
|SIRT1-AS | |SIRT1-AS | ||
|NA | |NA | ||
| Line 7,263: | Line 8,170: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290198 HSALNT0290198] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290198 HSALNT0290198] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142313 HSALNG0142313] |
|RP11-457M11.2 | |RP11-457M11.2 | ||
|NA | |NA | ||
| Line 7,271: | Line 8,179: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0150768 HSALNT0150768] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0150768 HSALNT0150768] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0072141 HSALNG0072141] |
|LINC01507 | |LINC01507 | ||
|XLOC_000303 | |XLOC_000303 | ||
| Line 7,279: | Line 8,188: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289903 HSALNT0289903] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289903 HSALNT0289903] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142018 HSALNG0142018] |
|LINC01057 | |LINC01057 | ||
|NA | |NA | ||
| Line 7,287: | Line 8,197: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289914 HSALNT0289914] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289914 HSALNT0289914] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142029 HSALNG0142029] |
|LINC01617 | |LINC01617 | ||
|C8orf23,NCRNA00249,XLOC_006844 | |C8orf23,NCRNA00249,XLOC_006844 | ||
| Line 7,295: | Line 8,206: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290015 HSALNT0290015] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290015 HSALNT0290015] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142130 HSALNG0142130] |
|LOC152578 | |LOC152578 | ||
|NA | |NA | ||
| Line 7,303: | Line 8,215: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072252 HSALNT0072252] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072252 HSALNT0072252] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0034426 HSALNG0034426] |
|LINC01618 | |LINC01618 | ||
|LOC152578 | |LOC152578 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0156870 HSALNT0156870] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0156870 HSALNT0156870] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075266 HSALNG0075266] |
|NALT1 | |NALT1 | ||
|MIR4674HG,LINC01573,TCONS_l2_00029132 | |MIR4674HG,LINC01573,TCONS_l2_00029132 | ||
| Line 7,319: | Line 8,233: | ||
|pathogenic process | |pathogenic process | ||
|acute lymphoblastic leukemia | |acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289083 HSALNT0289083] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289083 HSALNT0289083] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045290 HSALNG0045290] |
|MALINC1 | |MALINC1 | ||
|LINC01024,MA-linc1 | |LINC01024,MA-linc1 | ||
| Line 7,327: | Line 8,242: | ||
|pathogenic process | |pathogenic process | ||
|human breast and lung cancer | |human breast and lung cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289902 HSALNT0289902] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289902 HSALNT0289902] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142017 HSALNG0142017] |
|LINC01024 | |LINC01024 | ||
|MA-linc1 | |MA-linc1 | ||
| Line 7,335: | Line 8,251: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;lung cancer | |osteosarcoma;lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289120 HSALNT0289120] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289120 HSALNT0289120] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0071043 HSALNG0071043] |
|LINC01627 | |LINC01627 | ||
|RP11-397D12.4 | |RP11-397D12.4 | ||
| Line 7,343: | Line 8,260: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289121 HSALNT0289121] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289121 HSALNT0289121] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0015617 HSALNG0015617] |
|LINC01628 | |LINC01628 | ||
|AC007403.1 | |AC007403.1 | ||
| Line 7,351: | Line 8,269: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289820 HSALNT0289820] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289820 HSALNT0289820] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141935 HSALNG0141935] |
|ERICH1-AS1 | |ERICH1-AS1 | ||
|NA | |NA | ||
| Line 7,359: | Line 8,278: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290193 HSALNT0290193] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290193 HSALNT0290193] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142308 HSALNG0142308] |
|RP11-397D12.4 | |RP11-397D12.4 | ||
|LINC01627 | |LINC01627 | ||
| Line 7,367: | Line 8,287: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289122 HSALNT0289122] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289122 HSALNT0289122] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0102605 HSALNG0102605] |
|LINC01629 | |LINC01629 | ||
|linc-KIAA1737-2 | |linc-KIAA1737-2 | ||
| Line 7,375: | Line 8,296: | ||
|pathogenic process | |pathogenic process | ||
|hypoxic and inflammatory renal epithelial injury | |hypoxic and inflammatory renal epithelial injury | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290161 HSALNT0290161] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290161 HSALNT0290161] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142276 HSALNG0142276] |
|PTPRG-AS1 | |PTPRG-AS1 | ||
|NA | |NA | ||
| Line 7,383: | Line 8,305: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289980 HSALNT0289980] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289980 HSALNT0289980] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142095 HSALNG0142095] |
|lncRNA-DLEU1 | |lncRNA-DLEU1 | ||
|NA | |NA | ||
| Line 7,391: | Line 8,314: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289983 HSALNT0289983] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289983 HSALNT0289983] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142098 HSALNG0142098] |
|lncRNA-Hh | |lncRNA-Hh | ||
|NA | |NA | ||
| Line 7,399: | Line 8,323: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288986 HSALNT0288986] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288986 HSALNT0288986] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0072437 HSALNG0072437] |
|GAS1RR | |GAS1RR | ||
|LncRNA-Hh | |LncRNA-Hh | ||
| Line 7,407: | Line 8,332: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288908 HSALNT0288908] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288908 HSALNT0288908] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0005250 HSALNG0005250] |
|CCDC18-AS1 | |CCDC18-AS1 | ||
|ENST00000440778.1 | |ENST00000440778.1 | ||
| Line 7,415: | Line 8,341: | ||
|pathogenic process | |pathogenic process | ||
|adolescent idiopathic scoliosis | |adolescent idiopathic scoliosis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289055 HSALNT0289055] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289055 HSALNT0289055] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132813 HSALNG0132813] |
|LINC00649 | |LINC00649 | ||
|TCONS_00028768 | |TCONS_00028768 | ||
| Line 7,423: | Line 8,350: | ||
|pathogenic process | |pathogenic process | ||
|adolescent idiopathic scoliosis | |adolescent idiopathic scoliosis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289219 HSALNT0289219] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289219 HSALNT0289219] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075966 HSALNG0075966] |
|PRKCQ-AS1 | |PRKCQ-AS1 | ||
|ENST00000414894.1 | |ENST00000414894.1 | ||
| Line 7,431: | Line 8,359: | ||
|pathogenic process | |pathogenic process | ||
|adolescent idiopathic scoliosis | |adolescent idiopathic scoliosis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290203 HSALNT0290203] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290203 HSALNT0290203] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142318 HSALNG0142318] |
|RP11-567G11.1 | |RP11-567G11.1 | ||
|LINC02041 | |LINC02041 | ||
| Line 7,439: | Line 8,368: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289805 HSALNT0289805] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289805 HSALNT0289805] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141920 HSALNG0141920] |
|ENST00000438550 | |ENST00000438550 | ||
|RPS24P1 | |RPS24P1 | ||
| Line 7,447: | Line 8,377: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290083 HSALNT0290083] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290083 HSALNT0290083] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142198 HSALNG0142198] |
|NONHSAG011351 | |NONHSAG011351 | ||
|NA | |NA | ||
| Line 7,455: | Line 8,386: | ||
|pathogenic process | |pathogenic process | ||
|type 1 diabetes | |type 1 diabetes | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290049 HSALNT0290049] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290049 HSALNT0290049] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142164 HSALNG0142164] |
|MCHR2-AS1 | |MCHR2-AS1 | ||
|NA | |NA | ||
| Line 7,463: | Line 8,395: | ||
|pathogenic process | |pathogenic process | ||
|psychiatric disease | |psychiatric disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289799 HSALNT0289799] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289799 HSALNT0289799] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141914 HSALNG0141914] |
|ENST00000414355 | |ENST00000414355 | ||
|NA | |NA | ||
| Line 7,471: | Line 8,404: | ||
|pathogenic process | |pathogenic process | ||
|cadmium toxicology | |cadmium toxicology | ||
| + | |Disorders of Environmental Origin | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290241 HSALNT0290241] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290241 HSALNT0290241] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142356 HSALNG0142356] |
|SKP2 | |SKP2 | ||
|NA | |NA | ||
| Line 7,479: | Line 8,413: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289837 HSALNT0289837] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289837 HSALNT0289837] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141952 HSALNG0141952] |
|FLJ90757 | |FLJ90757 | ||
|NA | |NA | ||
| Line 7,487: | Line 8,422: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290017 HSALNT0290017] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290017 HSALNT0290017] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142132 HSALNG0142132] |
|LOC283663 | |LOC283663 | ||
|NA | |NA | ||
| Line 7,495: | Line 8,431: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290019 HSALNT0290019] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290019 HSALNT0290019] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142134 HSALNG0142134] |
|LOC338651 | |LOC338651 | ||
|NA | |NA | ||
| Line 7,503: | Line 8,440: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290132 HSALNT0290132] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290132 HSALNT0290132] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142247 HSALNG0142247] |
|PCATs | |PCATs | ||
|NA | |NA | ||
| Line 7,511: | Line 8,449: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086786 HSALNT0086786] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086786 HSALNT0086786] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0041277 HSALNG0041277] |
|EGFLAM-AS1 | |EGFLAM-AS1 | ||
|lncRNA-LOWEG | |lncRNA-LOWEG | ||
| Line 7,519: | Line 8,458: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290031 HSALNT0290031] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290031 HSALNT0290031] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142146 HSALNG0142146] |
|LOWEG | |LOWEG | ||
|NA | |NA | ||
| Line 7,527: | Line 8,467: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289635 HSALNT0289635] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289635 HSALNT0289635] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141750 HSALNG0141750] |
|BC014579 | |BC014579 | ||
|NA | |NA | ||
| Line 7,535: | Line 8,476: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289721 HSALNT0289721] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289721 HSALNT0289721] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141836 HSALNG0141836] |
|CTB-167B5.2 | |CTB-167B5.2 | ||
|NA | |NA | ||
| Line 7,543: | Line 8,485: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289863 HSALNT0289863] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289863 HSALNT0289863] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141978 HSALNG0141978] |
|HELLS | |HELLS | ||
|NA | |NA | ||
| Line 7,551: | Line 8,494: | ||
|pathogenic process | |pathogenic process | ||
|leukemia | |leukemia | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290195 HSALNT0290195] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290195 HSALNT0290195] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142310 HSALNG0142310] |
|RP11-401P9.4 | |RP11-401P9.4 | ||
|NA | |NA | ||
| Line 7,559: | Line 8,503: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290252 HSALNT0290252] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290252 HSALNT0290252] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142367 HSALNG0142367] |
|SNHG19 | |SNHG19 | ||
|NA | |NA | ||
| Line 7,567: | Line 8,512: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289557 HSALNT0289557] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289557 HSALNT0289557] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141672 HSALNG0141672] |
|AF070632 | |AF070632 | ||
|NA | |NA | ||
| Line 7,575: | Line 8,521: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289569 HSALNT0289569] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289569 HSALNT0289569] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141684 HSALNG0141684] |
|AK021443 | |AK021443 | ||
|NA | |NA | ||
| Line 7,583: | Line 8,530: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289728 HSALNT0289728] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289728 HSALNT0289728] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141843 HSALNG0141843] |
|CTD-3080P12.3 | |CTD-3080P12.3 | ||
|NA | |NA | ||
| Line 7,591: | Line 8,539: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289987 HSALNT0289987] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289987 HSALNT0289987] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142102 HSALNG0142102] |
|lncRNA-n336928 | |lncRNA-n336928 | ||
|NA | |NA | ||
| Line 7,599: | Line 8,548: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289723 HSALNT0289723] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289723 HSALNT0289723] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141838 HSALNG0141838] |
|CTC-523E23.5 | |CTC-523E23.5 | ||
|AC008555.2 | |AC008555.2 | ||
| Line 7,607: | Line 8,557: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration | |intervertebral disc degeneration | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289724 HSALNT0289724] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289724 HSALNT0289724] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141839 HSALNG0141839] |
|CTD-2246P4.1 | |CTD-2246P4.1 | ||
|NA | |NA | ||
| Line 7,615: | Line 8,566: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration | |intervertebral disc degeneration | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290055 HSALNT0290055] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290055 HSALNT0290055] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142170 HSALNG0142170] |
|MIR132 | |MIR132 | ||
|MIRN132,miRNA132,mir-132 | |MIRN132,miRNA132,mir-132 | ||
| Line 7,623: | Line 8,575: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration | |intervertebral disc degeneration | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290189 HSALNT0290189] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290189 HSALNT0290189] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142304 HSALNG0142304] |
|RP11-363G2.4 | |RP11-363G2.4 | ||
|NA | |NA | ||
| Line 7,631: | Line 8,584: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration | |intervertebral disc degeneration | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290191 HSALNT0290191] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290191 HSALNT0290191] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142306 HSALNG0142306] |
|RP11-38F22.1 | |RP11-38F22.1 | ||
|LINC02424 | |LINC02424 | ||
| Line 7,639: | Line 8,593: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration | |intervertebral disc degeneration | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290223 HSALNT0290223] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290223 HSALNT0290223] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142338 HSALNG0142338] |
|RP4-639J15.1 | |RP4-639J15.1 | ||
|AC006967.2 | |AC006967.2 | ||
| Line 7,647: | Line 8,602: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration | |intervertebral disc degeneration | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290233 HSALNT0290233] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290233 HSALNT0290233] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142348 HSALNG0142348] |
|RUNX1-IT1 | |RUNX1-IT1 | ||
|C21orf96 | |C21orf96 | ||
| Line 7,655: | Line 8,611: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288943 HSALNT0288943] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288943 HSALNT0288943] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0053446 HSALNG0053446] |
|ENST00000415964 | |ENST00000415964 | ||
|NA | |NA | ||
| Line 7,663: | Line 8,620: | ||
|pathogenic process | |pathogenic process | ||
|pediatric acute myeloid leukemia | |pediatric acute myeloid leukemia | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290009 HSALNT0290009] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290009 HSALNT0290009] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142124 HSALNG0142124] |
|LOC101927497 | |LOC101927497 | ||
|NA | |NA | ||
| Line 7,671: | Line 8,629: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289956 HSALNT0289956] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289956 HSALNT0289956] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142071 HSALNG0142071] |
|lnc-CYP4A22-2/3 | |lnc-CYP4A22-2/3 | ||
|NA | |NA | ||
| Line 7,679: | Line 8,638: | ||
|pathogenic process | |pathogenic process | ||
|clear cell renal cell cancer | |clear cell renal cell cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289999 HSALNT0289999] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289999 HSALNT0289999] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142114 HSALNG0142114] |
|lnc-ZNF180-2 | |lnc-ZNF180-2 | ||
|NA | |NA | ||
| Line 7,687: | Line 8,647: | ||
|pathogenic process | |pathogenic process | ||
|renal clear cell cancer | |renal clear cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290086 HSALNT0290086] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290086 HSALNT0290086] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142201 HSALNG0142201] |
|NONHSAT037832 | |NONHSAT037832 | ||
|NA | |NA | ||
| Line 7,695: | Line 8,656: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289658 HSALNT0289658] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289658 HSALNT0289658] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141773 HSALNG0141773] |
|BX647187 | |BX647187 | ||
|NA | |NA | ||
| Line 7,703: | Line 8,665: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288920 HSALNT0288920] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288920 HSALNT0288920] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0017086 HSALNG0017086] |
|CNNM3-DT | |CNNM3-DT | ||
|LOC100506036 | |LOC100506036 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 7,713: | Line 8,677: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289584 HSALNT0289584] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289584 HSALNT0289584] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141699 HSALNG0141699] |
|AK056155 | |AK056155 | ||
|NA | |NA | ||
| Line 7,719: | Line 8,683: | ||
|pathogenic process | |pathogenic process | ||
|Loeys-Dietz syndrome | |Loeys-Dietz syndrome | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290057 HSALNT0290057] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290057 HSALNT0290057] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142172 HSALNG0142172] |
|MR1 | |MR1 | ||
|NA | |NA | ||
| Line 7,727: | Line 8,692: | ||
|pathogenic process | |pathogenic process | ||
|Loeys-Dietz syndrome | |Loeys-Dietz syndrome | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289543 HSALNT0289543] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289543 HSALNT0289543] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141658 HSALNG0141658] |
|AC002454.1 | |AC002454.1 | ||
|AC002454.1 | |AC002454.1 | ||
| Line 7,735: | Line 8,701: | ||
|pathogenic process | |pathogenic process | ||
|endometriosis | |endometriosis | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289909 HSALNT0289909] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289909 HSALNT0289909] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142024 HSALNG0142024] |
|LINC01420 | |LINC01420 | ||
|NA | |NA | ||
| Line 7,743: | Line 8,710: | ||
|pathogenic process | |pathogenic process | ||
|systemic lupus erythematosus | |systemic lupus erythematosus | ||
| + | |Immune System Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289531 HSALNT0289531] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289531 HSALNT0289531] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141646 HSALNG0141646] |
|53BP1 | |53BP1 | ||
|NA | |NA | ||
| Line 7,751: | Line 8,719: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290101 HSALNT0290101] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290101 HSALNT0290101] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142216 HSALNG0142216] |
|NR_024118 | |NR_024118 | ||
|NA | |NA | ||
| Line 7,759: | Line 8,728: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290239 HSALNT0290239] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290239 HSALNT0290239] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142354 HSALNG0142354] |
|SGO1-AS1 | |SGO1-AS1 | ||
|SGOL1-AS1 | |SGOL1-AS1 | ||
| Line 7,767: | Line 8,737: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289293 HSALNT0289293] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289293 HSALNT0289293] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0127764 HSALNG0127764] |
|ZNF667-AS1 | |ZNF667-AS1 | ||
|MORT | |MORT | ||
| Line 7,775: | Line 8,746: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289984 HSALNT0289984] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289984 HSALNT0289984] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142099 HSALNG0142099] |
|lncRNA-HIF2PUT | |lncRNA-HIF2PUT | ||
|NA | |NA | ||
| Line 7,783: | Line 8,755: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288945 HSALNT0288945] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288945 HSALNT0288945] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0018617 HSALNG0018617] |
|ENST00000433673 | |ENST00000433673 | ||
|AC068282.1 | |AC068282.1 | ||
| Line 7,791: | Line 8,764: | ||
|pathogenic process | |pathogenic process | ||
|polycystic ovary syndrome | |polycystic ovary syndrome | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288948 HSALNT0288948] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288948 HSALNT0288948] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008353 HSALNG0008353] |
|ENST00000454271 | |ENST00000454271 | ||
|AL021940.1 | |AL021940.1 | ||
| Line 7,799: | Line 8,773: | ||
|pathogenic process | |pathogenic process | ||
|polycystic ovary syndrome | |polycystic ovary syndrome | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289495 HSALNT0289495] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289495 HSALNT0289495] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141606 HSALNG0141606] |
|ENST00000432431 | |ENST00000432431 | ||
|AC023128.1 | |AC023128.1 | ||
| Line 7,807: | Line 8,782: | ||
|pathogenic process | |pathogenic process | ||
|polycystic ovary syndrome | |polycystic ovary syndrome | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289918 HSALNT0289918] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289918 HSALNT0289918] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142033 HSALNG0142033] |
|LINC01828 | |LINC01828 | ||
|NA | |NA | ||
| Line 7,815: | Line 8,791: | ||
|pathogenic process | |pathogenic process | ||
|polycystic ovary syndrome | |polycystic ovary syndrome | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290388 HSALNT0290388] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290388 HSALNT0290388] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142503 HSALNG0142503] |
|XLOC_011402 | |XLOC_011402 | ||
|NA | |NA | ||
| Line 7,823: | Line 8,800: | ||
|pathogenic process | |pathogenic process | ||
|polycystic ovary syndrome | |polycystic ovary syndrome | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289873 HSALNT0289873] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289873 HSALNT0289873] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141988 HSALNG0141988] |
|ICAM-1 | |ICAM-1 | ||
|NA | |NA | ||
| Line 7,831: | Line 8,809: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289668 HSALNT0289668] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289668 HSALNT0289668] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141783 HSALNG0141783] |
|C5T1lncRNA | |C5T1lncRNA | ||
|NA | |NA | ||
| Line 7,839: | Line 8,818: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289667 HSALNT0289667] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289667 HSALNT0289667] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141782 HSALNG0141782] |
|C5T1 | |C5T1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289666 HSALNT0289666] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289666 HSALNT0289666] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141781 HSALNG0141781] |
|C5-OT1 | |C5-OT1 | ||
|C5T1lncRNA | |C5T1lncRNA | ||
| Line 7,855: | Line 8,836: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289626 HSALNT0289626] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289626 HSALNT0289626] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141741 HSALNG0141741] |
|AX800134 | |AX800134 | ||
|NA | |NA | ||
| Line 7,863: | Line 8,845: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290338 HSALNT0290338] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290338 HSALNT0290338] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142453 HSALNG0142453] |
|uc001ncr | |uc001ncr | ||
|NA | |NA | ||
| Line 7,871: | Line 8,854: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290330 HSALNT0290330] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290330 HSALNT0290330] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142445 HSALNG0142445] |
|uc.48+ | |uc.48+ | ||
|NA | |NA | ||
| Line 7,879: | Line 8,863: | ||
|pathogenic process | |pathogenic process | ||
|diabetic neuropathic pain | |diabetic neuropathic pain | ||
| + | |Male Urogenital Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289098 HSALNT0289098] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289098 HSALNT0289098] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0038313 HSALNG0038313] |
|LINC01207 | |LINC01207 | ||
|NA | |NA | ||
| Line 7,887: | Line 8,872: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289628 HSALNT0289628] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289628 HSALNT0289628] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141743 HSALNG0141743] |
|BALR-6 | |BALR-6 | ||
|NA | |NA | ||
| Line 7,895: | Line 8,881: | ||
|pathogenic process | |pathogenic process | ||
|B-lymphoblastic leukemia | |B-lymphoblastic leukemia | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290022 HSALNT0290022] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290022 HSALNT0290022] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142137 HSALNG0142137] |
|LOC389641 | |LOC389641 | ||
|NA | |NA | ||
| Line 7,903: | Line 8,890: | ||
|pathogenic process | |pathogenic process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289725 HSALNT0289725] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289725 HSALNT0289725] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141840 HSALNG0141840] |
|CTD-2541M15 | |CTD-2541M15 | ||
|NA | |NA | ||
| Line 7,911: | Line 8,899: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289940 HSALNT0289940] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289940 HSALNT0289940] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142055 HSALNG0142055] |
|LINK-A | |LINK-A | ||
|NA | |NA | ||
| Line 7,919: | Line 8,908: | ||
|pathogenic process | |pathogenic process | ||
|triple-negative breast cancer | |triple-negative breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290107 HSALNT0290107] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290107 HSALNT0290107] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142222 HSALNG0142222] |
|NUTF2P3 | |NUTF2P3 | ||
|NUTF2P3 | |NUTF2P3 | ||
| Line 7,927: | Line 8,917: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290095 HSALNT0290095] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290095 HSALNT0290095] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142210 HSALNG0142210] |
|NONHSAT123350 | |NONHSAT123350 | ||
|NA | |NA | ||
| Line 7,935: | Line 8,926: | ||
|pathogenic process | |pathogenic process | ||
|renal clear cell cancer | |renal clear cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290362 HSALNT0290362] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290362 HSALNT0290362] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142477 HSALNG0142477] |
|UHRF1 | |UHRF1 | ||
|NA | |NA | ||
| Line 7,943: | Line 8,935: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290366 HSALNT0290366] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290366 HSALNT0290366] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142481 HSALNG0142481] |
|UPAT | |UPAT | ||
|NA | |NA | ||
| Line 7,951: | Line 8,944: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289307 HSALNT0289307] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289307 HSALNT0289307] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0114404 HSALNG0114404] |
|LINC00324 | |LINC00324 | ||
|FLJ34790,MGC104931 | |FLJ34790,MGC104931 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289969 HSALNT0289969] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289969 HSALNT0289969] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142084 HSALNG0142084] |
|lnc-MX1-1 | |lnc-MX1-1 | ||
|NA | |NA | ||
| Line 7,967: | Line 8,962: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290024 HSALNT0290024] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290024 HSALNT0290024] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142139 HSALNG0142139] |
|LOC400891 | |LOC400891 | ||
|NA | |NA | ||
| Line 7,975: | Line 8,971: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289883 HSALNT0289883] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289883 HSALNT0289883] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141998 HSALNG0141998] |
|LA16c-313D11.11 | |LA16c-313D11.11 | ||
|NA | |NA | ||
| Line 7,983: | Line 8,980: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290192 HSALNT0290192] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290192 HSALNT0290192] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142307 HSALNG0142307] |
|RP11-395G23.3 | |RP11-395G23.3 | ||
|AC027031.2 | |AC027031.2 | ||
| Line 7,991: | Line 8,989: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289742 HSALNT0289742] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289742 HSALNT0289742] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141857 HSALNG0141857] |
|DILC | |DILC | ||
|NA | |NA | ||
| Line 7,999: | Line 8,998: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289957 HSALNT0289957] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289957 HSALNT0289957] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142072 HSALNG0142072] |
|lnc-DILC | |lnc-DILC | ||
|NA | |NA | ||
| Line 8,007: | Line 9,007: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289581 HSALNT0289581] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289581 HSALNT0289581] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141696 HSALNG0141696] |
|AK027294 | |AK027294 | ||
|NA | |NA | ||
| Line 8,015: | Line 9,016: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290371 HSALNT0290371] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290371 HSALNT0290371] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142486 HSALNG0142486] |
|WISP1 | |WISP1 | ||
|NA | |NA | ||
| Line 8,023: | Line 9,025: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206117 HSALNT0206117] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206117 HSALNT0206117] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0099020 HSALNG0099020] |
|FGF14-AS2 | |FGF14-AS2 | ||
|NA | |NA | ||
| Line 8,031: | Line 9,034: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290131 HSALNT0290131] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290131 HSALNT0290131] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142246 HSALNG0142246] |
|PCAT2 | |PCAT2 | ||
|CARLo-4,PCA2,TCONS_00015167 | |CARLo-4,PCA2,TCONS_00015167 | ||
| Line 8,039: | Line 9,043: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289528 HSALNT0289528] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289528 HSALNT0289528] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141643 HSALNG0141643] |
|2700086A05Rik | |2700086A05Rik | ||
|2700086A05Rik | |2700086A05Rik | ||
| Line 8,047: | Line 9,052: | ||
|pathogenic process | |pathogenic process | ||
|idiopathic pulmonary fibrosis | |idiopathic pulmonary fibrosis | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290251 HSALNT0290251] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290251 HSALNT0290251] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142366 HSALNG0142366] |
|SNED1 | |SNED1 | ||
|NA | |NA | ||
| Line 8,055: | Line 9,061: | ||
|pathogenic process | |pathogenic process | ||
|Idiopathic pulmonary fibrosis | |Idiopathic pulmonary fibrosis | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290333 HSALNT0290333] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290333 HSALNT0290333] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142448 HSALNG0142448] |
|uc.77 | |uc.77 | ||
|NA | |NA | ||
| Line 8,063: | Line 9,070: | ||
|pathogenic process | |pathogenic process | ||
|idiopathic pulmonary fibrosis | |idiopathic pulmonary fibrosis | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289816 HSALNT0289816] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289816 HSALNT0289816] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141931 HSALNG0141931] |
|ENST00000537266 | |ENST00000537266 | ||
|NA | |NA | ||
| Line 8,071: | Line 9,079: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289860 HSALNT0289860] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289860 HSALNT0289860] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141975 HSALNG0141975] |
|HAGLROS | |HAGLROS | ||
|NA | |NA | ||
| Line 8,079: | Line 9,088: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289881 HSALNT0289881] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289881 HSALNT0289881] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141996 HSALNG0141996] |
|KRT18P55 | |KRT18P55 | ||
|KRT18P55 | |KRT18P55 | ||
| Line 8,087: | Line 9,097: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0229266 HSALNT0229266] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0229266 HSALNT0229266] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0110450 HSALNG0110450] |
|IL21R-AS1 | |IL21R-AS1 | ||
|NA | |NA | ||
| Line 8,095: | Line 9,106: | ||
|pathogenic process | |pathogenic process | ||
|coronary artery disease | |coronary artery disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290112 HSALNT0290112] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290112 HSALNT0290112] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142227 HSALNG0142227] |
|OTTHUMT00000387022 | |OTTHUMT00000387022 | ||
|NA | |NA | ||
| Line 8,103: | Line 9,115: | ||
|pathogenic process | |pathogenic process | ||
|coronary artery disease | |coronary artery disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000551 HSALNT0000551] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000551 HSALNT0000551] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000226 HSALNG0000226] |
|PRKCZ-AS1 | |PRKCZ-AS1 | ||
|RP11-181G12.2 | |RP11-181G12.2 | ||
| Line 8,111: | Line 9,124: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030981 HSALNT0030981] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030981 HSALNT0030981] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0014612 HSALNG0014612] |
|LINC01833 | |LINC01833 | ||
|RP11-89,K21.1 | |RP11-89,K21.1 | ||
| Line 8,119: | Line 9,133: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290214 HSALNT0290214] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290214 HSALNT0290214] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142329 HSALNG0142329] |
|RP11-89K21 | |RP11-89K21 | ||
|NA | |NA | ||
| Line 8,127: | Line 9,142: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165271 HSALNT0165271] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165271 HSALNT0165271] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0079188 HSALNG0079188] |
|LINC00857 | |LINC00857 | ||
|NA | |NA | ||
| Line 8,135: | Line 9,151: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290109 HSALNT0290109] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290109 HSALNT0290109] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142224 HSALNG0142224] |
|OR3A4 | |OR3A4 | ||
|NA | |NA | ||
| Line 8,143: | Line 9,160: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290046 HSALNT0290046] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290046 HSALNT0290046] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142161 HSALNG0142161] |
|MAGI1-IT1 | |MAGI1-IT1 | ||
|NA | |NA | ||
| Line 8,151: | Line 9,169: | ||
|pathogenic process | |pathogenic process | ||
|cardiac hypertrophy | |cardiac hypertrophy | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290242 HSALNT0290242] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290242 HSALNT0290242] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142357 HSALNG0142357] |
|SLC26A4-AS1 | |SLC26A4-AS1 | ||
|NA | |NA | ||
| Line 8,159: | Line 9,178: | ||
|pathogenic process | |pathogenic process | ||
|cardiac hypertrophy | |cardiac hypertrophy | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289302 HSALNT0289302] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289302 HSALNT0289302] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141636 HSALNG0141636] |
|KRT7-AS | |KRT7-AS | ||
|NA | |NA | ||
| Line 8,167: | Line 9,187: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0218672 HSALNT0218672] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0218672 HSALNT0218672] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105101 HSALNG0105101] |
|LINC01852 | |LINC01852 | ||
|ENST00000434223 | |ENST00000434223 | ||
| Line 8,175: | Line 9,196: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290178 HSALNT0290178] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290178 HSALNT0290178] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142293 HSALNG0142293] |
|RP11-1008C21.2 | |RP11-1008C21.2 | ||
|NA | |NA | ||
| Line 8,183: | Line 9,205: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289592 HSALNT0289592] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289592 HSALNT0289592] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141707 HSALNG0141707] |
|AK123072 | |AK123072 | ||
|NA | |NA | ||
| Line 8,191: | Line 9,214: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289573 HSALNT0289573] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289573 HSALNT0289573] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141688 HSALNG0141688] |
|AK021954 | |AK021954 | ||
|NA | |NA | ||
| Line 8,199: | Line 9,223: | ||
|pathogenic process | |pathogenic process | ||
|atherosclerosis | |atherosclerosis | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288916 HSALNT0288916] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288916 HSALNT0288916] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105961 HSALNG0105961] |
|CERNA1 | |CERNA1 | ||
|LOC100129973 | |LOC100129973 | ||
| Line 8,207: | Line 9,232: | ||
|pathogenic process | |pathogenic process | ||
|cardiovascular disease | |cardiovascular disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018525 HSALNT0018525] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018525 HSALNT0018525] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008959 HSALNG0008959] |
|LAMC1-AS1 | |LAMC1-AS1 | ||
|lnc-LAMC2-1:1 | |lnc-LAMC2-1:1 | ||
| Line 8,215: | Line 9,241: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290087 HSALNT0290087] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290087 HSALNT0290087] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142202 HSALNG0142202] |
|NONHSAT040387 | |NONHSAT040387 | ||
|NA | |NA | ||
| Line 8,223: | Line 9,250: | ||
|pathogenic process | |pathogenic process | ||
|atrial fibrillation | |atrial fibrillation | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290092 HSALNT0290092] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290092 HSALNT0290092] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142207 HSALNG0142207] |
|NONHSAT098586 | |NONHSAT098586 | ||
|NA | |NA | ||
| Line 8,231: | Line 9,259: | ||
|pathogenic process | |pathogenic process | ||
|atrial fibrillation | |atrial fibrillation | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289213 HSALNT0289213] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289213 HSALNT0289213] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0108626 HSALNG0108626] |
|PCSK6-AS1 | |PCSK6-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 8,241: | Line 9,271: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289637 HSALNT0289637] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289637 HSALNT0289637] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141752 HSALNG0141752] |
|BC016831 | |BC016831 | ||
|NA | |NA | ||
| Line 8,247: | Line 9,277: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289874 HSALNT0289874] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289874 HSALNT0289874] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141989 HSALNG0141989] |
|IGKV | |IGKV | ||
|NA | |NA | ||
| Line 8,255: | Line 9,286: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290196 HSALNT0290196] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290196 HSALNT0290196] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142311 HSALNG0142311] |
|RP11-434D9.1 | |RP11-434D9.1 | ||
|AC112206.2 | |AC112206.2 | ||
| Line 8,263: | Line 9,295: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289885 HSALNT0289885] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289885 HSALNT0289885] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142000 HSALNG0142000] |
|LCAL6 | |LCAL6 | ||
|NA | |NA | ||
| Line 8,271: | Line 9,304: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289650 HSALNT0289650] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289650 HSALNT0289650] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141765 HSALNG0141765] |
|BC088254 | |BC088254 | ||
|NA | |NA | ||
| Line 8,279: | Line 9,313: | ||
|pathogenic process | |pathogenic process | ||
|myocardial hypertrophy | |myocardial hypertrophy | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289596 HSALNT0289596] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289596 HSALNT0289596] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141711 HSALNG0141711] |
|AK124454 | |AK124454 | ||
|NA | |NA | ||
| Line 8,287: | Line 9,322: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289731 HSALNT0289731] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289731 HSALNT0289731] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141846 HSALNG0141846] |
|CYP4B1-PS1 | |CYP4B1-PS1 | ||
|NA | |NA | ||
| Line 8,295: | Line 9,331: | ||
|pathogenic process | |pathogenic process | ||
|diabetic nephropathy | |diabetic nephropathy | ||
| + | |Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289106 HSALNT0289106] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289106 HSALNT0289106] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094020 HSALNG0094020] |
|LINC01405 | |LINC01405 | ||
|NA | |NA | ||
| Line 8,303: | Line 9,340: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290259 HSALNT0290259] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290259 HSALNT0290259] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142374 HSALNG0142374] |
|ST8SIA6-AS1 | |ST8SIA6-AS1 | ||
|NA | |NA | ||
| Line 8,311: | Line 9,349: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289278 HSALNT0289278] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289278 HSALNT0289278] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0047244 HSALNG0047244] |
|TRIM52-AS1 | |TRIM52-AS1 | ||
|NA | |NA | ||
| Line 8,319: | Line 9,358: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289634 HSALNT0289634] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289634 HSALNT0289634] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141749 HSALNG0141749] |
|BC012900 | |BC012900 | ||
|NA | |NA | ||
| Line 8,327: | Line 9,367: | ||
|pathogenic process | |pathogenic process | ||
|ulcerative colitis | |ulcerative colitis | ||
| + | |Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274011 HSALNT0274011] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274011 HSALNT0274011] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133283 HSALNG0133283] |
|UMODL1-AS1 | |UMODL1-AS1 | ||
|FLJ33471 | |FLJ33471 | ||
| Line 8,335: | Line 9,376: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289454 HSALNT0289454] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289454 HSALNT0289454] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075449 HSALNG0075449] |
|ARRDC1-AS1 | |ARRDC1-AS1 | ||
|NA | |NA | ||
| Line 8,343: | Line 9,385: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289456 HSALNT0289456] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289456 HSALNT0289456] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0071200 HSALNG0071200] |
|FAM74A3 | |FAM74A3 | ||
|OTTHUMG00000067149 | |OTTHUMG00000067149 | ||
| Line 8,351: | Line 9,394: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289834 HSALNT0289834] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289834 HSALNT0289834] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141949 HSALNG0141949] |
|FH | |FH | ||
|NA | |NA | ||
| Line 8,359: | Line 9,403: | ||
|pathogenic process | |pathogenic process | ||
|Fumarase deficiency | |Fumarase deficiency | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289961 HSALNT0289961] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289961 HSALNT0289961] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142076 HSALNG0142076] |
|lnc-HOXC4-3:1 | |lnc-HOXC4-3:1 | ||
|NA | |NA | ||
| Line 8,367: | Line 9,412: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289994 HSALNT0289994] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289994 HSALNT0289994] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142109 HSALNG0142109] |
|lnc-TEAD4-1:1 | |lnc-TEAD4-1:1 | ||
|NA | |NA | ||
| Line 8,375: | Line 9,421: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290270 HSALNT0290270] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290270 HSALNT0290270] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142385 HSALNG0142385] |
|TCONS_00003876 | |TCONS_00003876 | ||
|NA | |NA | ||
| Line 8,383: | Line 9,430: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289825 HSALNT0289825] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289825 HSALNT0289825] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141940 HSALNG0141940] |
|EVI1 | |EVI1 | ||
|NA | |NA | ||
| Line 8,391: | Line 9,439: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290235 HSALNT0290235] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290235 HSALNT0290235] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142350 HSALNG0142350] |
|SARCC | |SARCC | ||
|NA | |NA | ||
| Line 8,399: | Line 9,448: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290360 HSALNT0290360] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290360 HSALNT0290360] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142475 HSALNG0142475] |
|ucoo2kmd.1 | |ucoo2kmd.1 | ||
|NA | |NA | ||
| Line 8,407: | Line 9,457: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289015 HSALNT0289015] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289015 HSALNT0289015] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0001020 HSALNG0001020] |
|KAZN-AS1 | |KAZN-AS1 | ||
|NA | |NA | ||
| Line 8,415: | Line 9,466: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289722 HSALNT0289722] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289722 HSALNT0289722] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141837 HSALNG0141837] |
|CTB-89H12.4 | |CTB-89H12.4 | ||
|AC021078.1 | |AC021078.1 | ||
| Line 8,423: | Line 9,475: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289496 HSALNT0289496] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289496 HSALNT0289496] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141607 HSALNG0141607] |
|EPB41L4A-AS2 | |EPB41L4A-AS2 | ||
|FLJ11235 | |FLJ11235 | ||
| Line 8,431: | Line 9,484: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;breast cancer;kidney cancer | |lung cancer;breast cancer;kidney cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289146 HSALNT0289146] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289146 HSALNT0289146] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004554 HSALNG0004554] |
|LINC02567 | |LINC02567 | ||
|ENST00000427806 | |ENST00000427806 | ||
| Line 8,439: | Line 9,493: | ||
|pathogenic process | |pathogenic process | ||
|attention deficit hyperactivity disorder | |attention deficit hyperactivity disorder | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289833 HSALNT0289833] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289833 HSALNT0289833] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141948 HSALNG0141948] |
|FGFR3-AS1 | |FGFR3-AS1 | ||
|NA | |NA | ||
| Line 8,447: | Line 9,502: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289707 HSALNT0289707] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289707 HSALNT0289707] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141822 HSALNG0141822] |
|CILinc01 | |CILinc01 | ||
|NA | |NA | ||
| Line 8,455: | Line 9,511: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis | |osteoarthritis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289708 HSALNT0289708] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289708 HSALNT0289708] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141823 HSALNG0141823] |
|CILinc02 | |CILinc02 | ||
|NA | |NA | ||
| Line 8,463: | Line 9,520: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis | |osteoarthritis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286597 HSALNT0286597] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286597 HSALNT0286597] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140235 HSALNG0140235] |
|LINC00629 | |LINC00629 | ||
|LINC00629AB,LINC00629C,LINC00629D,LINC00629 | |LINC00629AB,LINC00629C,LINC00629D,LINC00629 | ||
| Line 8,471: | Line 9,529: | ||
|pathogenic process | |pathogenic process | ||
|choriocarcinoma | |choriocarcinoma | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289665 HSALNT0289665] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289665 HSALNT0289665] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141780 HSALNG0141780] |
|C2dat1 | |C2dat1 | ||
|NA | |NA | ||
| Line 8,479: | Line 9,538: | ||
|pathogenic process | |pathogenic process | ||
|ischemic brain injury | |ischemic brain injury | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289217 HSALNT0289217] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289217 HSALNT0289217] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0057357 HSALNG0057357] |
|POU6F2-AS2 | |POU6F2-AS2 | ||
|FLJ12971 | |FLJ12971 | ||
| Line 8,487: | Line 9,547: | ||
|pathogenic process | |pathogenic process | ||
|oesophageal squamous cell cancer | |oesophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289946 HSALNT0289946] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289946 HSALNT0289946] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142061 HSALNG0142061] |
|lnc13 | |lnc13 | ||
|NA | |NA | ||
| Line 8,495: | Line 9,556: | ||
|pathogenic process | |pathogenic process | ||
|celiac disease | |celiac disease | ||
| + | |Nutritional and Metabolic Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289729 HSALNT0289729] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289729 HSALNT0289729] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141844 HSALNG0141844] |
|CTD903 | |CTD903 | ||
|NA | |NA | ||
| Line 8,503: | Line 9,565: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290093 HSALNT0290093] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290093 HSALNT0290093] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142208 HSALNG0142208] |
|NONHSAT104436 | |NONHSAT104436 | ||
|NA | |NA | ||
| Line 8,511: | Line 9,574: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289550 HSALNT0289550] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289550 HSALNT0289550] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141665 HSALNG0141665] |
|AC024560.2 | |AC024560.2 | ||
|AC024560.1 | |AC024560.1 | ||
| Line 8,519: | Line 9,583: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289483 HSALNT0289483] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289483 HSALNT0289483] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134219 HSALNG0134219] |
|ENST00000436681 | |ENST00000436681 | ||
|AP000552.1 | |AP000552.1 | ||
| Line 8,527: | Line 9,592: | ||
|pathogenic process | |pathogenic process | ||
|congenital heart defect | |congenital heart defect | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289536 HSALNT0289536] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289536 HSALNT0289536] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141651 HSALNG0141651] |
|AA584040 | |AA584040 | ||
|NA | |NA | ||
| Line 8,535: | Line 9,601: | ||
|pathogenic process | |pathogenic process | ||
|congenital heart defect | |congenital heart defect | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289537 HSALNT0289537] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289537 HSALNT0289537] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141652 HSALNG0141652] |
|AA709223 | |AA709223 | ||
|NA | |NA | ||
| Line 8,543: | Line 9,610: | ||
|pathogenic process | |pathogenic process | ||
|congenital heart defect | |congenital heart defect | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289657 HSALNT0289657] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289657 HSALNT0289657] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141772 HSALNG0141772] |
|BX478947 | |BX478947 | ||
|NA | |NA | ||
| Line 8,551: | Line 9,619: | ||
|pathogenic process | |pathogenic process | ||
|congenital heart defect | |congenital heart defect | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247515 HSALNT0247515] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247515 HSALNT0247515] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119819 HSALNG0119819] |
|LINC00668 | |LINC00668 | ||
|NA | |NA | ||
| Line 8,559: | Line 9,628: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289719 HSALNT0289719] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289719 HSALNT0289719] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141834 HSALNG0141834] |
|CRNDE-h | |CRNDE-h | ||
|NA | |NA | ||
| Line 8,567: | Line 9,637: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142879 HSALNT0142879] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142879 HSALNT0142879] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068121 HSALNG0068121] |
|SMILR | |SMILR | ||
|NA | |NA | ||
| Line 8,575: | Line 9,646: | ||
|pathogenic process | |pathogenic process | ||
|vascular pathologies | |vascular pathologies | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290396 HSALNT0290396] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290396 HSALNT0290396] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142511 HSALNG0142511] |
|Z38 | |Z38 | ||
|NA | |NA | ||
| Line 8,583: | Line 9,655: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197213 HSALNT0197213] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197213 HSALNT0197213] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0095037 HSALNG0095037] |
|LINC00507 | |LINC00507 | ||
|NA | |NA | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289086 HSALNT0289086] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289086 HSALNT0289086] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113270 HSALNG0113270] |
|LINC01082 | |LINC01082 | ||
|TCONSNA00024492 | |TCONSNA00024492 | ||
| Line 8,599: | Line 9,673: | ||
|pathogenic process | |pathogenic process | ||
|alveolar capillary dysplasia with misalignment of pulmonary veins | |alveolar capillary dysplasia with misalignment of pulmonary veins | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289094 HSALNT0289094] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289094 HSALNT0289094] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0015253 HSALNG0015253] |
|LINC01185 | |LINC01185 | ||
|FLJ16341 | |FLJ16341 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290160 HSALNT0290160] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290160 HSALNT0290160] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142275 HSALNG0142275] |
|PTPRD-AS1 | |PTPRD-AS1 | ||
|NA | |NA | ||
| Line 8,615: | Line 9,691: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290186 HSALNT0290186] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290186 HSALNT0290186] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142301 HSALNG0142301] |
|RP11-254I22.1 | |RP11-254I22.1 | ||
|MIR583HG | |MIR583HG | ||
| Line 8,623: | Line 9,700: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290204 HSALNT0290204] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290204 HSALNT0290204] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142319 HSALNG0142319] |
|RP11-57P19.1 | |RP11-57P19.1 | ||
|AC009432.1 | |AC009432.1 | ||
| Line 8,631: | Line 9,709: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290211 HSALNT0290211] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290211 HSALNT0290211] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142326 HSALNG0142326] |
|RP11-80H5.7 | |RP11-80H5.7 | ||
|AL157400.4 | |AL157400.4 | ||
| Line 8,639: | Line 9,718: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290215 HSALNT0290215] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290215 HSALNT0290215] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142330 HSALNG0142330] |
|RP1-223E5.4 | |RP1-223E5.4 | ||
|AL441883.1 | |AL441883.1 | ||
| Line 8,647: | Line 9,727: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290224 HSALNT0290224] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290224 HSALNT0290224] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142339 HSALNG0142339] |
|RP4-799P18.3 | |RP4-799P18.3 | ||
|AL122008.4 | |AL122008.4 | ||
| Line 8,655: | Line 9,736: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289126 HSALNT0289126] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289126 HSALNT0289126] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045514 HSALNG0045514] |
|LINC01844 | |LINC01844 | ||
|LOC101926975 | |LOC101926975 | ||
| Line 8,663: | Line 9,745: | ||
|pathogenic process | |pathogenic process | ||
|hirschsprung disease | |hirschsprung disease | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289947 HSALNT0289947] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289947 HSALNT0289947] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142062 HSALNG0142062] |
|Lnc34a | |Lnc34a | ||
|NA | |NA | ||
| Line 8,671: | Line 9,754: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289150 HSALNT0289150] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289150 HSALNT0289150] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075977 HSALNG0075977] |
|LINP1 | |LINP1 | ||
|NA | |NA | ||
| Line 8,679: | Line 9,763: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289951 HSALNT0289951] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289951 HSALNT0289951] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142066 HSALNG0142066] |
|lncARSR | |lncARSR | ||
|NA | |NA | ||
| Line 8,687: | Line 9,772: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289392 HSALNT0289392] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289392 HSALNT0289392] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0005967 HSALNG0005967] |
|RBM15-AS1 | |RBM15-AS1 | ||
|AS-RBM15 | |AS-RBM15 | ||
| Line 8,695: | Line 9,781: | ||
|pathogenic process | |pathogenic process | ||
|acute megakaryocytic leukemia | |acute megakaryocytic leukemia | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290089 HSALNT0290089] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290089 HSALNT0290089] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142204 HSALNG0142204] |
|NONHSAT073641 | |NONHSAT073641 | ||
|NA | |NA | ||
| Line 8,703: | Line 9,790: | ||
|pathogenic process | |pathogenic process | ||
|vascular diseases | |vascular diseases | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290027 HSALNT0290027] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290027 HSALNT0290027] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142142 HSALNG0142142] |
|LOC572558 | |LOC572558 | ||
|NA | |NA | ||
| Line 8,711: | Line 9,799: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289582 HSALNT0289582] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289582 HSALNT0289582] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141697 HSALNG0141697] |
|AK033210 | |AK033210 | ||
|NA | |NA | ||
| Line 8,719: | Line 9,808: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|bronchopulmonary dysplasia | |bronchopulmonary dysplasia | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289848 HSALNT0289848] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289848 HSALNT0289848] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141963 HSALNG0141963] |
|GClnc1 | |GClnc1 | ||
|NA | |NA | ||
| Line 8,727: | Line 9,817: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289572 HSALNT0289572] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289572 HSALNT0289572] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141687 HSALNG0141687] |
|AK021630 | |AK021630 | ||
|NA | |NA | ||
| Line 8,735: | Line 9,826: | ||
|pathogenic process | |pathogenic process | ||
|Parkinson's disease | |Parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289603 HSALNT0289603] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289603 HSALNT0289603] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141718 HSALNG0141718] |
|AL049437 | |AL049437 | ||
|NA | |NA | ||
| Line 8,743: | Line 9,835: | ||
|pathogenic process | |pathogenic process | ||
|Parkinson's disease | |Parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290007 HSALNT0290007] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290007 HSALNT0290007] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142122 HSALNG0142122] |
|LOC100507661 | |LOC100507661 | ||
|NA | |NA | ||
| Line 8,751: | Line 9,844: | ||
|pathogenic process | |pathogenic process | ||
|thyroid cancer | |thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289084 HSALNT0289084] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289084 HSALNT0289084] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0122663 HSALNG0122663] |
|LINC01029 | |LINC01029 | ||
|NA | |NA | ||
| Line 8,759: | Line 9,853: | ||
|pathogenic process | |pathogenic process | ||
|cognitive functions and neuronal plasticity | |cognitive functions and neuronal plasticity | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290169 HSALNT0290169] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290169 HSALNT0290169] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142284 HSALNG0142284] |
|RMEL3 | |RMEL3 | ||
|NA | |NA | ||
| Line 8,767: | Line 9,862: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289959 HSALNT0289959] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289959 HSALNT0289959] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142074 HSALNG0142074] |
|lnc-FRG2C-3 | |lnc-FRG2C-3 | ||
|NA | |NA | ||
| Line 8,775: | Line 9,871: | ||
|pathogenic process | |pathogenic process | ||
|ankylosing spondylitis | |ankylosing spondylitis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289966 HSALNT0289966] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289966 HSALNT0289966] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142081 HSALNG0142081] |
|lnc-LIN54-1 | |lnc-LIN54-1 | ||
|NA | |NA | ||
| Line 8,783: | Line 9,880: | ||
|pathogenic process | |pathogenic process | ||
|ankylosing spondylitis | |ankylosing spondylitis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289997 HSALNT0289997] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289997 HSALNT0289997] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142112 HSALNG0142112] |
|lnc-USP50-2 | |lnc-USP50-2 | ||
|NA | |NA | ||
| Line 8,791: | Line 9,889: | ||
|pathogenic process | |pathogenic process | ||
|ankylosing spondylitis | |ankylosing spondylitis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290000 HSALNT0290000] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290000 HSALNT0290000] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142115 HSALNG0142115] |
|lnc-ZNF354A-1 | |lnc-ZNF354A-1 | ||
|NA | |NA | ||
| Line 8,799: | Line 9,898: | ||
|pathogenic process | |pathogenic process | ||
|ankylosing spondylitis | |ankylosing spondylitis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288949 HSALNT0288949] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288949 HSALNT0288949] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0017887 HSALNG0017887] |
|ENST00000455309 | |ENST00000455309 | ||
|NA | |NA | ||
| Line 8,807: | Line 9,907: | ||
|pathogenic process | |pathogenic process | ||
|primary Sjögren's syndrome | |primary Sjögren's syndrome | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289920 HSALNT0289920] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289920 HSALNT0289920] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142035 HSALNG0142035] |
|LINC02384 | |LINC02384 | ||
|NA | |NA | ||
| Line 8,815: | Line 9,916: | ||
|pathogenic process | |pathogenic process | ||
|primary Sjögren's syndrome | |primary Sjögren's syndrome | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289998 HSALNT0289998] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289998 HSALNT0289998] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142113 HSALNG0142113] |
|Lnc-UTS2D-1:1 | |Lnc-UTS2D-1:1 | ||
|NA | |NA | ||
| Line 8,823: | Line 9,925: | ||
|pathogenic process | |pathogenic process | ||
|primary Sjögren's syndrome | |primary Sjögren's syndrome | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290067 HSALNT0290067] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290067 HSALNT0290067] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142182 HSALNG0142182] |
|n336161 | |n336161 | ||
|NA | |NA | ||
| Line 8,831: | Line 9,934: | ||
|pathogenic process | |pathogenic process | ||
|primary Sjögren's syndrome | |primary Sjögren's syndrome | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290069 HSALNT0290069] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290069 HSALNT0290069] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142184 HSALNG0142184] |
|n340599 | |n340599 | ||
|NA | |NA | ||
| Line 8,839: | Line 9,943: | ||
|pathogenic process | |pathogenic process | ||
|primary Sjögren's syndrome | |primary Sjögren's syndrome | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290099 HSALNT0290099] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290099 HSALNT0290099] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142214 HSALNG0142214] |
|NR_002712 | |NR_002712 | ||
|NA | |NA | ||
| Line 8,847: | Line 9,952: | ||
|pathogenic process | |pathogenic process | ||
|primary Sjögren's syndrome | |primary Sjögren's syndrome | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290290 HSALNT0290290] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290290 HSALNT0290290] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142405 HSALNG0142405] |
|TCONS_l2_00014794 | |TCONS_l2_00014794 | ||
|NA | |NA | ||
| Line 8,855: | Line 9,961: | ||
|pathogenic process | |pathogenic process | ||
|primary Sjögren's syndrome | |primary Sjögren's syndrome | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290170 HSALNT0290170] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290170 HSALNT0290170] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142285 HSALNG0142285] |
|RMRP | |RMRP | ||
|CHH,NME1R,RRP2,RMRP | |CHH,NME1R,RRP2,RMRP | ||
| Line 8,863: | Line 9,970: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289900 HSALNT0289900] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289900 HSALNT0289900] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142015 HSALNG0142015] |
|LINC00961 | |LINC00961 | ||
|NA | |NA | ||
| Line 8,871: | Line 9,979: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289077 HSALNT0289077] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289077 HSALNT0289077] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068551 HSALNG0068551] |
|LINC00977 | |LINC00977 | ||
|NA | |NA | ||
| Line 8,879: | Line 9,988: | ||
|pathogenic process | |pathogenic process | ||
|primary spontaneous pneumothorax | |primary spontaneous pneumothorax | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289560 HSALNT0289560] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289560 HSALNT0289560] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141675 HSALNG0141675] |
|AF085995 | |AF085995 | ||
|NA | |NA | ||
| Line 8,887: | Line 9,997: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289566 HSALNT0289566] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289566 HSALNT0289566] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141681 HSALNG0141681] |
|AK000053 | |AK000053 | ||
|NA | |NA | ||
| Line 8,895: | Line 10,006: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289571 HSALNT0289571] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289571 HSALNT0289571] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141686 HSALNG0141686] |
|AK021595 | |AK021595 | ||
|NA | |NA | ||
| Line 8,903: | Line 10,015: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289574 HSALNT0289574] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289574 HSALNT0289574] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141689 HSALNG0141689] |
|AK022024 | |AK022024 | ||
|NA | |NA | ||
| Line 8,911: | Line 10,024: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289595 HSALNT0289595] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289595 HSALNT0289595] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141710 HSALNG0141710] |
|AK124307 | |AK124307 | ||
|NA | |NA | ||
| Line 8,919: | Line 10,033: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289639 HSALNT0289639] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289639 HSALNT0289639] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141754 HSALNG0141754] |
|BC020384 | |BC020384 | ||
|NA | |NA | ||
| Line 8,927: | Line 10,042: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289642 HSALNT0289642] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289642 HSALNT0289642] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141757 HSALNG0141757] |
|BC030759 | |BC030759 | ||
|NA | |NA | ||
| Line 8,935: | Line 10,051: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289715 HSALNT0289715] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289715 HSALNT0289715] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141830 HSALNG0141830] |
|CR615992 | |CR615992 | ||
|NA | |NA | ||
| Line 8,943: | Line 10,060: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289954 HSALNT0289954] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289954 HSALNT0289954] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142069 HSALNG0142069] |
|lnc-CC3 | |lnc-CC3 | ||
|NA | |NA | ||
| Line 8,951: | Line 10,069: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289614 HSALNT0289614] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289614 HSALNT0289614] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141729 HSALNG0141729] |
|APOC1P1-3 | |APOC1P1-3 | ||
|NA | |NA | ||
| Line 8,959: | Line 10,078: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290365 HSALNT0290365] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290365 HSALNT0290365] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142480 HSALNG0142480] |
|UNMIBC | |UNMIBC | ||
|NA | |NA | ||
| Line 8,967: | Line 10,087: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290323 HSALNT0290323] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290323 HSALNT0290323] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142438 HSALNG0142438] |
|uc.167 | |uc.167 | ||
|NA | |NA | ||
| Line 8,975: | Line 10,096: | ||
|pathogenic process | |pathogenic process | ||
|ventricular septal defects | |ventricular septal defects | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290212 HSALNT0290212] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290212 HSALNT0290212] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142327 HSALNG0142327] |
|RP11-838N2.4 | |RP11-838N2.4 | ||
|GAPLINC | |GAPLINC | ||
| Line 8,983: | Line 10,105: | ||
|pathogenic process | |pathogenic process | ||
|glioblastoma | |glioblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289109 HSALNT0289109] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289109 HSALNT0289109] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0121223 HSALNG0121223] |
|LINC01478 | |LINC01478 | ||
|NA | |NA | ||
| Line 8,991: | Line 10,114: | ||
|pathogenic process | |pathogenic process | ||
|blood pressure | |blood pressure | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289313 HSALNT0289313] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289313 HSALNT0289313] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0016990 HSALNG0016990] |
|LINC00342 | |LINC00342 | ||
|NA | |NA | ||
| Line 8,999: | Line 10,123: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289677 HSALNT0289677] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289677 HSALNT0289677] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141792 HSALNG0141792] |
|CAR10 | |CAR10 | ||
|NA | |NA | ||
| Line 9,007: | Line 10,132: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289365 HSALNT0289365] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289365 HSALNT0289365] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141638 HSALNG0141638] |
|MAPT-AS1 | |MAPT-AS1 | ||
|NA | |NA | ||
| Line 9,015: | Line 10,141: | ||
|pathogenic process | |pathogenic process | ||
|Parkinson's disease | |Parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289679 HSALNT0289679] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289679 HSALNT0289679] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141794 HSALNG0141794] |
|CAT104 | |CAT104 | ||
|NA | |NA | ||
| Line 9,023: | Line 10,150: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290260 HSALNT0290260] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290260 HSALNT0290260] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142375 HSALNG0142375] |
|STXBP5-AS1 | |STXBP5-AS1 | ||
|NA | |NA | ||
| Line 9,031: | Line 10,159: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289861 HSALNT0289861] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289861 HSALNT0289861] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141976 HSALNG0141976] |
|HAR1 | |HAR1 | ||
|NA | |NA | ||
| Line 9,039: | Line 10,168: | ||
|pathogenic process | |pathogenic process | ||
|Huntington disease | |Huntington disease | ||
| + | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290359 HSALNT0290359] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290359 HSALNT0290359] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142474 HSALNG0142474] |
|UCHL1-AS1 | |UCHL1-AS1 | ||
|NA | |NA | ||
| Line 9,047: | Line 10,177: | ||
|pathogenic process | |pathogenic process | ||
|Parkinson's disease | |Parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290238 HSALNT0290238] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290238 HSALNT0290238] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142353 HSALNG0142353] |
|SCAANT1-AS | |SCAANT1-AS | ||
|NA | |NA | ||
| Line 9,055: | Line 10,186: | ||
|pathogenic process | |pathogenic process | ||
|spinocerebellar ataxia | |spinocerebellar ataxia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289648 HSALNT0289648] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289648 HSALNT0289648] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141763 HSALNG0141763] |
|BC041488 | |BC041488 | ||
|NA | |NA | ||
| Line 9,063: | Line 10,195: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290188 HSALNT0290188] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290188 HSALNT0290188] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142303 HSALNG0142303] |
|RP11-359E19.2 | |RP11-359E19.2 | ||
|AC022733.1 | |AC022733.1 | ||
| Line 9,071: | Line 10,204: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289669 HSALNT0289669] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289669 HSALNT0289669] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141784 HSALNG0141784] |
|C6orf176-TV1 | |C6orf176-TV1 | ||
|NA | |NA | ||
| Line 9,079: | Line 10,213: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289670 HSALNT0289670] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289670 HSALNT0289670] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141785 HSALNG0141785] |
|C6orf176-TV2 | |C6orf176-TV2 | ||
|NA | |NA | ||
| Line 9,087: | Line 10,222: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289851 HSALNT0289851] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289851 HSALNT0289851] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141966 HSALNG0141966] |
|GIHCG | |GIHCG | ||
|NA | |NA | ||
| Line 9,095: | Line 10,231: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289649 HSALNT0289649] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289649 HSALNT0289649] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141764 HSALNG0141764] |
|BC087858 | |BC087858 | ||
|NA | |NA | ||
| Line 9,103: | Line 10,240: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290353 HSALNT0290353] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290353 HSALNT0290353] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142468 HSALNG0142468] |
|uc004cov.4 | |uc004cov.4 | ||
|NA | |NA | ||
| Line 9,111: | Line 10,249: | ||
|pathogenic process | |pathogenic process | ||
|hypertrophic cardiomyopathy | |hypertrophic cardiomyopathy | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290357 HSALNT0290357] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290357 HSALNT0290357] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142472 HSALNG0142472] |
|uc022bqu.1 | |uc022bqu.1 | ||
|NA | |NA | ||
| Line 9,119: | Line 10,258: | ||
|pathogenic process | |pathogenic process | ||
|hypertrophic cardiomyopathy | |hypertrophic cardiomyopathy | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127837 HSALNT0127837] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127837 HSALNT0127837] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060796 HSALNG0060796] |
|CFTR-AS1 | |CFTR-AS1 | ||
|BGas | |BGas | ||
| Line 9,127: | Line 10,267: | ||
|pathogenic process | |pathogenic process | ||
|cystic fibrosis | |cystic fibrosis | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046367 HSALNT0046367] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046367 HSALNT0046367] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0021858 HSALNG0021858] |
|MYOSLID | |MYOSLID | ||
|NA | |NA | ||
| Line 9,135: | Line 10,276: | ||
|pathogenic process | |pathogenic process | ||
|vascular smooth muscle cell (VSMC) contractile phenotype | |vascular smooth muscle cell (VSMC) contractile phenotype | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290331 HSALNT0290331] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290331 HSALNT0290331] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142446 HSALNG0142446] |
|uc.63 | |uc.63 | ||
|NA | |NA | ||
| Line 9,143: | Line 10,285: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290106 HSALNT0290106] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290106 HSALNT0290106] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142221 HSALNG0142221] |
|numb | |numb | ||
|NA | |NA | ||
| Line 9,151: | Line 10,294: | ||
|pathogenic process | |pathogenic process | ||
|uveal melanoma | |uveal melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289847 HSALNT0289847] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289847 HSALNT0289847] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141962 HSALNG0141962] |
|GCASPC | |GCASPC | ||
|TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1 | |TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1 | ||
| Line 9,159: | Line 10,303: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer | |gallbladder cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289568 HSALNT0289568] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289568 HSALNT0289568] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141683 HSALNG0141683] |
|AK001094 | |AK001094 | ||
|NA | |NA | ||
| Line 9,167: | Line 10,312: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289588 HSALNT0289588] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289588 HSALNT0289588] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141703 HSALNG0141703] |
|AK093735 | |AK093735 | ||
|NA | |NA | ||
| Line 9,175: | Line 10,321: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289631 HSALNT0289631] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289631 HSALNT0289631] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141746 HSALNG0141746] |
|BC003519 | |BC003519 | ||
|NA | |NA | ||
| Line 9,183: | Line 10,330: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290100 HSALNT0290100] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290100 HSALNT0290100] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142215 HSALNG0142215] |
|NR_003573 | |NR_003573 | ||
|ANXA2P2 | |ANXA2P2 | ||
| Line 9,191: | Line 10,339: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290119 HSALNT0290119] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290119 HSALNT0290119] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142234 HSALNG0142234] |
|P2RX7-V3 | |P2RX7-V3 | ||
|NA | |NA | ||
| Line 9,199: | Line 10,348: | ||
|pathogenic process | |pathogenic process | ||
|uveal melanoma | |uveal melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290308 HSALNT0290308] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290308 HSALNT0290308] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142423 HSALNG0142423] |
|TMSB4 | |TMSB4 | ||
|NA | |NA | ||
| Line 9,207: | Line 10,357: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis | |osteoarthritis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288928 HSALNT0288928] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288928 HSALNT0288928] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0090163 HSALNG0090163] |
|DDX11-AS1 | |DDX11-AS1 | ||
|CONCR | |CONCR | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290052 HSALNT0290052] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290052 HSALNT0290052] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142167 HSALNG0142167] |
|MELOE | |MELOE | ||
|NA | |NA | ||
| Line 9,223: | Line 10,375: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290231 HSALNT0290231] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290231 HSALNT0290231] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142346 HSALNG0142346] |
|RSU1P2 | |RSU1P2 | ||
|RSU1P2 | |RSU1P2 | ||
| Line 9,231: | Line 10,384: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290165 HSALNT0290165] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290165 HSALNT0290165] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142280 HSALNG0142280] |
|RBMY2FP | |RBMY2FP | ||
|RBMY2FP | |RBMY2FP | ||
| Line 9,239: | Line 10,393: | ||
|NA | |NA | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290071 HSALNT0290071] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290071 HSALNT0290071] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142186 HSALNG0142186] |
|n375709 | |n375709 | ||
|NA | |NA | ||
| Line 9,247: | Line 10,402: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289748 HSALNT0289748] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289748 HSALNT0289748] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141863 HSALNG0141863] |
|DUXAP8 | |DUXAP8 | ||
|DUXAP8 | |DUXAP8 | ||
| Line 9,255: | Line 10,411: | ||
|NA | |NA | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290030 HSALNT0290030] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290030 HSALNT0290030] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142145 HSALNG0142145] |
|LOC729966 | |LOC729966 | ||
|NA | |NA | ||
| Line 9,263: | Line 10,420: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290143 HSALNT0290143] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290143 HSALNT0290143] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142258 HSALNG0142258] |
|POIR | |POIR | ||
|NA | |NA | ||
| Line 9,271: | Line 10,429: | ||
|pathogenic process | |pathogenic process | ||
|periodontitis | |periodontitis | ||
| + | |Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0067481 HSALNT0067481] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0067481 HSALNT0067481] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0031988 HSALNG0031988] |
|MELTF-AS1 | |MELTF-AS1 | ||
|MFI2-AS1,AC068302.3 | |MFI2-AS1,AC068302.3 | ||
| Line 9,279: | Line 10,438: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290053 HSALNT0290053] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290053 HSALNT0290053] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142168 HSALNG0142168] |
|MFI2 | |MFI2 | ||
|NA | |NA | ||
| Line 9,287: | Line 10,447: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289922 HSALNT0289922] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289922 HSALNT0289922] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142037 HSALNG0142037] |
|linc-223 | |linc-223 | ||
|NA | |NA | ||
| Line 9,295: | Line 10,456: | ||
|pathogenic process | |pathogenic process | ||
|acute myeloid leukemia | |acute myeloid leukemia | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014603 HSALNT0014603] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014603 HSALNT0014603] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0006859 HSALNG0006859] |
|LINC01138 | |LINC01138 | ||
|LINC00875,FLJ39739 | |LINC00875,FLJ39739 | ||
| Line 9,303: | Line 10,465: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290262 HSALNT0290262] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290262 HSALNT0290262] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142377 HSALNG0142377] |
|SUZ12P1 | |SUZ12P1 | ||
|SUZ12P1 | |SUZ12P1 | ||
| Line 9,311: | Line 10,474: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290005 HSALNT0290005] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290005 HSALNT0290005] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142120 HSALNG0142120] |
|LOC100505976 | |LOC100505976 | ||
|NA | |NA | ||
| Line 9,319: | Line 10,483: | ||
|pathogenic process | |pathogenic process | ||
|laryngeal squamous cell cancer | |laryngeal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290392 HSALNT0290392] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290392 HSALNT0290392] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142507 HSALNG0142507] |
|XLOC_l2_010636 | |XLOC_l2_010636 | ||
|NA | |NA | ||
| Line 9,327: | Line 10,492: | ||
|pathogenic process | |pathogenic process | ||
|laryngeal squamous cell cancer | |laryngeal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090295 HSALNT0090295] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090295 HSALNT0090295] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043014 HSALNG0043014] |
|RASGRF2-AS1 | |RASGRF2-AS1 | ||
|CTC-459I6.1 | |CTC-459I6.1 | ||
| Line 9,335: | Line 10,501: | ||
|pathogenic process | |pathogenic process | ||
|sepsis-induced endothelial dysfunction | |sepsis-induced endothelial dysfunction | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289852 HSALNT0289852] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289852 HSALNT0289852] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141967 HSALNG0141967] |
|GPC3-AS1 | |GPC3-AS1 | ||
|NA | |NA | ||
| Line 9,343: | Line 10,510: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189472 HSALNT0189472] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189472 HSALNT0189472] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091321 HSALNG0091321] |
|HOXC-AS1 | |HOXC-AS1 | ||
|NA | |NA | ||
| Line 9,351: | Line 10,519: | ||
|pathogenic process | |pathogenic process | ||
|atherosclerosis | |atherosclerosis | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289157 HSALNT0289157] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289157 HSALNT0289157] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0057557 HSALNG0057557] |
|LUARIS | |LUARIS | ||
|lncRNA#32 | |lncRNA#32 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289371 HSALNT0289371] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289371 HSALNT0289371] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0044828 HSALNG0044828] |
|MIR3936HG | |MIR3936HG | ||
|LOC553103,SLC22A5-AS1 | |LOC553103,SLC22A5-AS1 | ||
| Line 9,367: | Line 10,537: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;nasopharyngeal cancer | |gastric cancer;nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290148 HSALNT0290148] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290148 HSALNT0290148] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142263 HSALNG0142263] |
|Ppp1r1b | |Ppp1r1b | ||
|NA | |NA | ||
| Line 9,375: | Line 10,546: | ||
|pathogenic process | |pathogenic process | ||
|congenital heart defect | |congenital heart defect | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289038 HSALNT0289038] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289038 HSALNT0289038] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0099182 HSALNG0099182] |
|LINC00460 | |LINC00460 | ||
|NA | |NA | ||
| Line 9,383: | Line 10,555: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290194 HSALNT0290194] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290194 HSALNT0290194] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142309 HSALNG0142309] |
|RP1-13P20.6 | |RP1-13P20.6 | ||
|NA | |NA | ||
| Line 9,391: | Line 10,564: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290364 HSALNT0290364] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290364 HSALNT0290364] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142479 HSALNG0142479] |
|Unigene56159 | |Unigene56159 | ||
|NA | |NA | ||
| Line 9,399: | Line 10,573: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290355 HSALNT0290355] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290355 HSALNT0290355] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142470 HSALNG0142470] |
|uc009yby.1 | |uc009yby.1 | ||
|NA | |NA | ||
| Line 9,407: | Line 10,582: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289406 HSALNT0289406] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289406 HSALNT0289406] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0048011 HSALNG0048011] |
|TFAP2A-AS2 | |TFAP2A-AS2 | ||
|HIPSTR | |HIPSTR | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289704 HSALNT0289704] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289704 HSALNT0289704] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141819 HSALNG0141819] |
|Chaer | |Chaer | ||
|NA | |NA | ||
| Line 9,423: | Line 10,600: | ||
|pathogenic process | |pathogenic process | ||
|cardiac hypertrophy | |cardiac hypertrophy | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289865 HSALNT0289865] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289865 HSALNT0289865] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141980 HSALNG0141980] |
|HIF-2α | |HIF-2α | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211378 HSALNT0211378] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211378 HSALNT0211378] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0101489 HSALNG0101489] |
|LINC00520 | |LINC00520 | ||
|C14orf34 | |C14orf34 | ||
| Line 9,439: | Line 10,618: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087374 HSALNT0087374] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087374 HSALNT0087374] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0041561 HSALNG0041561] |
|MRPS30-DT | |MRPS30-DT | ||
|BRCAT54 | |BRCAT54 | ||
| Line 9,447: | Line 10,627: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289388 HSALNT0289388] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289388 HSALNT0289388] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0092662 HSALNG0092662] |
|PPP1R12A-AS1 | |PPP1R12A-AS1 | ||
|R12A-AS1 | |R12A-AS1 | ||
|translational control | |translational control | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289013 HSALNT0289013] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289013 HSALNT0289013] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088600 HSALNG0088600] |
|ITFG2-AS1 | |ITFG2-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 9,465: | Line 10,648: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290088 HSALNT0290088] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290088 HSALNT0290088] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142203 HSALNG0142203] |
|NONHSAT041499 | |NONHSAT041499 | ||
|NA | |NA | ||
| Line 9,471: | Line 10,654: | ||
|pathogenic process | |pathogenic process | ||
|schizophrenia | |schizophrenia | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290091 HSALNT0290091] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290091 HSALNT0290091] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142206 HSALNG0142206] |
|NONHSAT089447 | |NONHSAT089447 | ||
|NA | |NA | ||
| Line 9,479: | Line 10,663: | ||
|pathogenic process | |pathogenic process | ||
|schizophrenia | |schizophrenia | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289970 HSALNT0289970] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289970 HSALNT0289970] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142085 HSALNG0142085] |
|lnc-NKX2-3-1 | |lnc-NKX2-3-1 | ||
|NA | |NA | ||
| Line 9,487: | Line 10,672: | ||
|pathogenic process | |pathogenic process | ||
|acute lymphoblastic leukemia | |acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289989 HSALNT0289989] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289989 HSALNT0289989] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142104 HSALNG0142104] |
|lnc-RTN4R-1 | |lnc-RTN4R-1 | ||
|NA | |NA | ||
| Line 9,495: | Line 10,681: | ||
|pathogenic process | |pathogenic process | ||
|acute lymphoblastic leukemia | |acute lymphoblastic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289821 HSALNT0289821] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289821 HSALNT0289821] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141936 HSALNG0141936] |
|ERL | |ERL | ||
|NA | |NA | ||
| Line 9,503: | Line 10,690: | ||
|pathogenic process | |pathogenic process | ||
|Marek's disease | |Marek's disease | ||
| + | |Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0192459 HSALNT0192459] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0192459 HSALNT0192459] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0092867 HSALNG0092867] |
|LINC02258 | |LINC02258 | ||
|RP11-248E9.5 | |RP11-248E9.5 | ||
| Line 9,511: | Line 10,699: | ||
|pathogenic process | |pathogenic process | ||
|pneumonia | |pneumonia | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241871 HSALNT0241871] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241871 HSALNT0241871] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0117085 HSALNG0117085] |
|SKAP1-AS1 | |SKAP1-AS1 | ||
|RP11-456D7.1 | |RP11-456D7.1 | ||
| Line 9,519: | Line 10,708: | ||
|pathogenic process | |pathogenic process | ||
|pneumonia | |pneumonia | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289439 HSALNT0289439] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289439 HSALNT0289439] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049760 HSALNG0049760] |
|DINOL | |DINOL | ||
|DINO | |DINO | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 9,529: | Line 10,720: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288901 HSALNT0288901] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288901 HSALNT0288901] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000547 HSALNG0000547] |
|CAMTA1-DT | |CAMTA1-DT | ||
|lncCAMTA1 | |lncCAMTA1 | ||
| Line 9,535: | Line 10,726: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290328 HSALNT0290328] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290328 HSALNT0290328] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142443 HSALNG0142443] |
|uc.345 | |uc.345 | ||
|NA | |NA | ||
| Line 9,543: | Line 10,735: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| + | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290060 HSALNT0290060] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290060 HSALNT0290060] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142175 HSALNG0142175] |
|MSNP1AS | |MSNP1AS | ||
|NA | |NA | ||
| Line 9,551: | Line 10,744: | ||
|pathogenic process | |pathogenic process | ||
|autism spectrum disorder | |autism spectrum disorder | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289376 HSALNT0289376] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289376 HSALNT0289376] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004596 HSALNG0004596] |
|NEXN-AS1 | |NEXN-AS1 | ||
|C1orf118,FLJ90637 | |C1orf118,FLJ90637 | ||
| Line 9,559: | Line 10,753: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183194 HSALNT0183194] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183194 HSALNT0183194] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088083 HSALNG0088083] |
|LINC02098 | |LINC02098 | ||
|RP11-702B10.1 | |RP11-702B10.1 | ||
| Line 9,567: | Line 10,762: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0198055 HSALNT0198055] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0198055 HSALNT0198055] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0095473 HSALNG0095473] |
|PSPC1-AS2 | |PSPC1-AS2 | ||
|RP11-523H24.3 | |RP11-523H24.3 | ||
| Line 9,575: | Line 10,771: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289155 HSALNT0289155] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289155 HSALNT0289155] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0114857 HSALNG0114857] |
|LRRC75A-AS1 | |LRRC75A-AS1 | ||
|C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157 | |C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157 | ||
| Line 9,583: | Line 10,780: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289220 HSALNT0289220] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289220 HSALNT0289220] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0077999 HSALNG0077999] |
|PRKG1-AS1 | |PRKG1-AS1 | ||
|RP11-573I11.2 | |RP11-573I11.2 | ||
| Line 9,591: | Line 10,789: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289262 HSALNT0289262] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289262 HSALNT0289262] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0076970 HSALNG0076970] |
|SVIL-AS1 | |SVIL-AS1 | ||
|RP11-534G20.3 | |RP11-534G20.3 | ||
| Line 9,599: | Line 10,798: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289281 HSALNT0289281] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289281 HSALNT0289281] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0108169 HSALNG0108169] |
|VPS33B-DT | |VPS33B-DT | ||
|NA | |NA | ||
| Line 9,607: | Line 10,807: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289804 HSALNT0289804] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289804 HSALNT0289804] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141919 HSALNG0141919] |
|ENST00000438399 | |ENST00000438399 | ||
|NA | |NA | ||
| Line 9,615: | Line 10,816: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290228 HSALNT0290228] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290228 HSALNT0290228] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142343 HSALNG0142343] |
|RPKG1-AS1 | |RPKG1-AS1 | ||
|NA | |NA | ||
| Line 9,623: | Line 10,825: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290350 HSALNT0290350] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290350 HSALNT0290350] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142465 HSALNG0142465] |
|uc004afb.1 | |uc004afb.1 | ||
|NA | |NA | ||
| Line 9,631: | Line 10,834: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis | |rheumatoid arthritis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289398 HSALNT0289398] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289398 HSALNT0289398] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0135015 HSALNG0135015] |
|SLC5A4-AS1 | |SLC5A4-AS1 | ||
|RP1-90G24.10 | |RP1-90G24.10 | ||
| Line 9,639: | Line 10,843: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289411 HSALNT0289411] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289411 HSALNT0289411] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0063964 HSALNG0063964] |
|TNFRSF10A-AS1 | |TNFRSF10A-AS1 | ||
|RP11-1149O23.2 | |RP11-1149O23.2 | ||
| Line 9,647: | Line 10,852: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289727 HSALNT0289727] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289727 HSALNT0289727] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141842 HSALNG0141842] |
|CTD-2616J11.14 | |CTD-2616J11.14 | ||
|AC008750.7 | |AC008750.7 | ||
| Line 9,655: | Line 10,861: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290182 HSALNT0290182] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290182 HSALNT0290182] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142297 HSALNG0142297] |
|RP11-150O12.3 | |RP11-150O12.3 | ||
|AC124067.4 | |AC124067.4 | ||
| Line 9,663: | Line 10,870: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289730 HSALNT0289730] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289730 HSALNT0289730] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141845 HSALNG0141845] |
|CXCL1P1 | |CXCL1P1 | ||
|CXCL1P1 | |CXCL1P1 | ||
| Line 9,671: | Line 10,879: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289803 HSALNT0289803] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289803 HSALNT0289803] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141918 HSALNG0141918] |
|ENST00000438347 | |ENST00000438347 | ||
|CCND3P1 | |CCND3P1 | ||
| Line 9,679: | Line 10,888: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289897 HSALNT0289897] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289897 HSALNT0289897] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142012 HSALNG0142012] |
|LINC00601 | |LINC00601 | ||
|NA | |NA | ||
| Line 9,687: | Line 10,897: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289503 HSALNT0289503] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289503 HSALNT0289503] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141614 HSALNG0141614] |
|KIAA0087 | |KIAA0087 | ||
|NA | |NA | ||
| Line 9,695: | Line 10,906: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289827 HSALNT0289827] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289827 HSALNT0289827] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141942 HSALNG0141942] |
|FAM212B-AS1 | |FAM212B-AS1 | ||
|NA | |NA | ||
| Line 9,703: | Line 10,915: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290010 HSALNT0290010] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290010 HSALNT0290010] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142125 HSALNG0142125] |
|LOC102723552 | |LOC102723552 | ||
|NA | |NA | ||
| Line 9,711: | Line 10,924: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290181 HSALNT0290181] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290181 HSALNT0290181] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142296 HSALNG0142296] |
|RP11-140I24 | |RP11-140I24 | ||
|LINC01568 | |LINC01568 | ||
| Line 9,719: | Line 10,933: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290201 HSALNT0290201] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290201 HSALNT0290201] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142316 HSALNG0142316] |
|RP11-501O2 | |RP11-501O2 | ||
|LINC02046 | |LINC02046 | ||
| Line 9,727: | Line 10,942: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290206 HSALNT0290206] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290206 HSALNT0290206] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142321 HSALNG0142321] |
|RP11-600K151 | |RP11-600K151 | ||
|NA | |NA | ||
| Line 9,735: | Line 10,951: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290084 HSALNT0290084] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290084 HSALNT0290084] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142199 HSALNG0142199] |
|NONHSAG051968 | |NONHSAG051968 | ||
|NA | |NA | ||
| Line 9,743: | Line 10,960: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290090 HSALNT0290090] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290090 HSALNT0290090] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142205 HSALNG0142205] |
|NONHSAT076747 | |NONHSAT076747 | ||
|NA | |NA | ||
| Line 9,751: | Line 10,969: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290094 HSALNT0290094] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290094 HSALNT0290094] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142209 HSALNG0142209] |
|NONHSAT122730 | |NONHSAT122730 | ||
|NA | |NA | ||
| Line 9,759: | Line 10,978: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138768 HSALNT0138768] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138768 HSALNT0138768] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0066240 HSALNG0066240] |
|MIR2052HG | |MIR2052HG | ||
|NA | |NA | ||
| Line 9,767: | Line 10,987: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289096 HSALNT0289096] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289096 HSALNT0289096] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0096884 HSALNG0096884] |
|LINC01198 | |LINC01198 | ||
|NA | |NA | ||
| Line 9,775: | Line 10,996: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289274 HSALNT0289274] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289274 HSALNT0289274] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0096821 HSALNG0096821] |
|TPT1-AS1 | |TPT1-AS1 | ||
|NA | |NA | ||
| Line 9,783: | Line 11,005: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289924 HSALNT0289924] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289924 HSALNT0289924] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142039 HSALNG0142039] |
|linc-cdh4-2 | |linc-cdh4-2 | ||
|NA | |NA | ||
| Line 9,791: | Line 11,014: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144641 HSALNT0144641] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144641 HSALNT0144641] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068878 HSALNG0068878] |
|LINC02055 | |LINC02055 | ||
|RP1130-1 | |RP1130-1 | ||
| Line 9,799: | Line 11,023: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289737 HSALNT0289737] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289737 HSALNT0289737] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141852 HSALNG0141852] |
|DBCCR1 | |DBCCR1 | ||
|NA | |NA | ||
| Line 9,807: | Line 11,032: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289547 HSALNT0289547] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289547 HSALNT0289547] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141662 HSALNG0141662] |
|AC012065.7 | |AC012065.7 | ||
|NA | |NA | ||
| Line 9,815: | Line 11,041: | ||
|pathogenic process | |pathogenic process | ||
|chronic lymphocytic leukemia | |chronic lymphocytic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289229 HSALNT0289229] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289229 HSALNT0289229] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0116565 HSALNG0116565] |
|RAMP2-AS1 | |RAMP2-AS1 | ||
|NA | |NA | ||
| Line 9,823: | Line 11,050: | ||
|pathogenic process | |pathogenic process | ||
|glioblastoma | |glioblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289591 HSALNT0289591] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289591 HSALNT0289591] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141706 HSALNG0141706] |
|AK098081 | |AK098081 | ||
|NA | |NA | ||
| Line 9,831: | Line 11,059: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289644 HSALNT0289644] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289644 HSALNT0289644] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141759 HSALNG0141759] |
|BC037331 | |BC037331 | ||
|NA | |NA | ||
| Line 9,839: | Line 11,068: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289646 HSALNT0289646] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289646 HSALNT0289646] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141761 HSALNG0141761] |
|BC040303 | |BC040303 | ||
|NA | |NA | ||
| Line 9,847: | Line 11,077: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289717 HSALNT0289717] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289717 HSALNT0289717] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141832 HSALNG0141832] |
|CR749831 | |CR749831 | ||
|NA | |NA | ||
| Line 9,855: | Line 11,086: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289250 HSALNT0289250] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289250 HSALNT0289250] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0040073 HSALNG0040073] |
|SNHG18 | |SNHG18 | ||
|NA | |NA | ||
| Line 9,863: | Line 11,095: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106140 HSALNT0106140] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106140 HSALNT0106140] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0050030 HSALNG0050030] |
|FOXP4-AS1 | |FOXP4-AS1 | ||
|NA | |NA | ||
| Line 9,871: | Line 11,104: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026202 HSALNT0026202] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026202 HSALNT0026202] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0012584 HSALNG0012584] |
|RNASEH1-AS1 | |RNASEH1-AS1 | ||
|LOC100506054 | |LOC100506054 | ||
| Line 9,879: | Line 11,113: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288993 HSALNT0288993] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288993 HSALNT0288993] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088026 HSALNG0088026] |
|GSEC | |GSEC | ||
|ST3GAL4-AS1,DCPS-AS1,FLJ39051 | |ST3GAL4-AS1,DCPS-AS1,FLJ39051 | ||
| Line 9,887: | Line 11,122: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060264 HSALNT0060264] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060264 HSALNT0060264] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0028799 HSALNG0028799] |
|DNAJB8-AS1 | |DNAJB8-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 9,897: | Line 11,134: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248137 HSALNT0248137] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248137 HSALNT0248137] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0120059 HSALNG0120059] |
|CHMP1B-AS1 | |CHMP1B-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 9,905: | Line 11,143: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021970 HSALNT0021970] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021970 HSALNT0021970] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0010602 HSALNG0010602] |
|TGFB2-AS1 | |TGFB2-AS1 | ||
|NR_046268 | |NR_046268 | ||
| Line 9,911: | Line 11,149: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078323 HSALNT0078323] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078323 HSALNT0078323] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0037356 HSALNG0037356] |
|SLC7A11-AS1 | |SLC7A11-AS1 | ||
|NA | |NA | ||
| Line 9,919: | Line 11,158: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134663 HSALNT0134663] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134663 HSALNT0134663] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0064248 HSALNG0064248] |
|INTS9-AS1 | |INTS9-AS1 | ||
|ENST00000520055 | |ENST00000520055 | ||
| Line 9,927: | Line 11,167: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231572 HSALNT0231572] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231572 HSALNT0231572] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0111641 HSALNG0111641] |
|MMP2-AS1 | |MMP2-AS1 | ||
|NA | |NA | ||
| Line 9,935: | Line 11,176: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267869 HSALNT0267869] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267869 HSALNT0267869] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0130456 HSALNG0130456] |
|SLC12A5-AS1 | |SLC12A5-AS1 | ||
|RP11-465L10.10 | |RP11-465L10.10 | ||
| Line 9,943: | Line 11,185: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288921 HSALNT0288921] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288921 HSALNT0288921] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0002415 HSALNG0002415] |
|CSMD2-AS1 | |CSMD2-AS1 | ||
|ENST00000434181 | |ENST00000434181 | ||
| Line 9,951: | Line 11,194: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288997 HSALNT0288997] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288997 HSALNT0288997] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0052934 HSALNG0052934] |
|HDAC2-AS2 | |HDAC2-AS2 | ||
|ENST00000421891 | |ENST00000421891 | ||
| Line 9,959: | Line 11,203: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289012 HSALNT0289012] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289012 HSALNT0289012] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105327 HSALNG0105327] |
|INO80-AS1 | |INO80-AS1 | ||
|NA | |NA | ||
| Line 9,967: | Line 11,212: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289140 HSALNT0289140] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289140 HSALNT0289140] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075065 HSALNG0075065] |
|LINC02247 | |LINC02247 | ||
|NA | |NA | ||
| Line 9,975: | Line 11,221: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289161 HSALNT0289161] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289161 HSALNT0289161] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0059170 HSALNG0059170] |
|MAGI2-AS3 | |MAGI2-AS3 | ||
|NA | |NA | ||
| Line 9,983: | Line 11,230: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289188 HSALNT0289188] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289188 HSALNT0289188] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062699 HSALNG0062699] |
|MNX1-AS2 | |MNX1-AS2 | ||
|NA | |NA | ||
| Line 9,991: | Line 11,239: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289245 HSALNT0289245] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289245 HSALNT0289245] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140277 HSALNG0140277] |
|SMIM10L2B-AS1 | |SMIM10L2B-AS1 | ||
|NA | |NA | ||
| Line 9,999: | Line 11,248: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289407 HSALNT0289407] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289407 HSALNT0289407] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0102543 HSALNG0102543] |
|TGFB3-AS1 | |TGFB3-AS1 | ||
|NA | |NA | ||
| Line 10,007: | Line 11,257: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289457 HSALNT0289457] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289457 HSALNT0289457] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0073036 HSALNG0073036] |
|HSD17B3-AS1 | |HSD17B3-AS1 | ||
|NA | |NA | ||
| Line 10,015: | Line 11,266: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289919 HSALNT0289919] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289919 HSALNT0289919] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142034 HSALNG0142034] |
|LINC02246 | |LINC02246 | ||
|NA | |NA | ||
| Line 10,023: | Line 11,275: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289288 HSALNT0289288] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289288 HSALNT0289288] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0100050 HSALNG0100050] |
|ZNF710-AS1 | |ZNF710-AS1 | ||
|ENST00000558334 | |ENST00000558334 | ||
| Line 10,031: | Line 11,284: | ||
|pathogenic process | |pathogenic process | ||
|early-onset preeclampsia | |early-onset preeclampsia | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289266 HSALNT0289266] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289266 HSALNT0289266] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007188 HSALNG0007188] |
|TDRKH-AS1 | |TDRKH-AS1 | ||
|RP11-98D18.9 | |RP11-98D18.9 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289128 HSALNT0289128] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289128 HSALNT0289128] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0057684 HSALNG0057684] |
|LINC01952 | |LINC01952 | ||
|AC004854.4 | |AC004854.4 | ||
| Line 10,047: | Line 11,302: | ||
|pathogenic process | |pathogenic process | ||
|recurrent miscarriage | |recurrent miscarriage | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290075 HSALNT0290075] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290075 HSALNT0290075] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142190 HSALNG0142190] |
|NCF4-AS1 | |NCF4-AS1 | ||
|CTA-833B7.2 | |CTA-833B7.2 | ||
| Line 10,055: | Line 11,311: | ||
|pathogenic process | |pathogenic process | ||
|recurrent miscarriage | |recurrent miscarriage | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289360 HSALNT0289360] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289360 HSALNT0289360] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0029603 HSALNG0029603] |
|LNCSRLR | |LNCSRLR | ||
|lncRNA-SRLR | |lncRNA-SRLR | ||
| Line 10,063: | Line 11,320: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288918 HSALNT0288918] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288918 HSALNT0288918] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0021529 HSALNG0021529] |
|CFLAR-AS1 | |CFLAR-AS1 | ||
|ALS2CR10 | |ALS2CR10 | ||
| Line 10,071: | Line 11,329: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289710 HSALNT0289710] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289710 HSALNT0289710] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141825 HSALNG0141825] |
|COL1A2-AS1 | |COL1A2-AS1 | ||
|TCONS_00013888,lncRNA8975-1 | |TCONS_00013888,lncRNA8975-1 | ||
| Line 10,079: | Line 11,338: | ||
|pathogenic process | |pathogenic process | ||
|hypertrophic scar | |hypertrophic scar | ||
| + | |Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0075075 HSALNT0075075] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0075075 HSALNT0075075] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0035847 HSALNG0035847] |
|LNCPRESS2 | |LNCPRESS2 | ||
|lncPRESS2 | |lncPRESS2 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011289 HSALNT0011289] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011289 HSALNT0011289] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0005432 HSALNG0005432] |
|LINC01930 | |LINC01930 | ||
|EU358092 | |EU358092 | ||
| Line 10,095: | Line 11,356: | ||
|pathogenic process | |pathogenic process | ||
|schizophrenia | |schizophrenia | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0097120 HSALNT0097120] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0097120 HSALNT0097120] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0046325 HSALNG0046325] |
|HMMR-AS1 | |HMMR-AS1 | ||
|NA | |NA | ||
| Line 10,103: | Line 11,365: | ||
|pathogenic process | |pathogenic process | ||
|basal-like breast cancer | |basal-like breast cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184498 HSALNT0184498] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184498 HSALNT0184498] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088703 HSALNG0088703] |
|CCND2-AS1 | |CCND2-AS1 | ||
|CCND2-AS2 | |CCND2-AS2 | ||
| Line 10,111: | Line 11,374: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289045 HSALNT0289045] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289045 HSALNT0289045] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0030884 HSALNG0030884] |
|LINC00578 | |LINC00578 | ||
|NA | |NA | ||
| Line 10,119: | Line 11,383: | ||
|pathogenic process | |pathogenic process | ||
|major depression disorder | |major depression disorder | ||
| + | |Behavior and Behavior Mechanisms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288884 HSALNT0288884] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288884 HSALNT0288884] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026576 HSALNG0026576] |
|ADAMTS9-AS1 | |ADAMTS9-AS1 | ||
|NA | |NA | ||
| Line 10,127: | Line 11,392: | ||
|pathogenic process | |pathogenic process | ||
|epithelial ovarian cancer | |epithelial ovarian cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080041 HSALNT0080041] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080041 HSALNT0080041] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0038152 HSALNG0038152] |
|FAM198B-AS1 | |FAM198B-AS1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103007 HSALNT0103007] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103007 HSALNT0103007] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0048820 HSALNG0048820] |
|LINC00240 | |LINC00240 | ||
|C6orf41,NCRNA00240,bA373D17.1 | |C6orf41,NCRNA00240,bA373D17.1 | ||
| Line 10,143: | Line 11,410: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer | |esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289071 HSALNT0289071] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289071 HSALNT0289071] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0122453 HSALNG0122453] |
|LINC00909 | |LINC00909 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,153: | Line 11,422: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289509 HSALNT0289509] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289509 HSALNT0289509] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141620 HSALNG0141620] |
|LINC00680 | |LINC00680 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,161: | Line 11,431: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129070 HSALNT0129070] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129070 HSALNT0129070] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0061394 HSALNG0061394] |
|LINC00513 | |LINC00513 | ||
|AC016831.7 | |AC016831.7 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,169: | Line 11,440: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289129 HSALNT0289129] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289129 HSALNT0289129] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0115960 HSALNG0115960] |
|LINC02001 | |LINC02001 | ||
|RP11-1094M14.11 | |RP11-1094M14.11 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,177: | Line 11,449: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289215 HSALNT0289215] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289215 HSALNT0289215] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0092950 HSALNG0092950] |
|POC1B-AS1 | |POC1B-AS1 | ||
|RP11-734K2.4 | |RP11-734K2.4 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,185: | Line 11,458: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289241 HSALNT0289241] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289241 HSALNT0289241] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060049 HSALNG0060049] |
|SLC12A9-AS1 | |SLC12A9-AS1 | ||
|RP11-126L15.4 | |RP11-126L15.4 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,193: | Line 11,467: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289275 HSALNT0289275] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289275 HSALNT0289275] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0050617 HSALNG0050617] |
|TRAM2-AS1 | |TRAM2-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,201: | Line 11,476: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002243 HSALNT0002243] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002243 HSALNT0002243] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0001176 HSALNG0001176] |
|LINC01772 | |LINC01772 | ||
|ENSG00000226029 | |ENSG00000226029 | ||
| Line 10,207: | Line 11,482: | ||
|pathogenic process | |pathogenic process | ||
|oesophageal cancer | |oesophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288941 HSALNT0288941] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288941 HSALNT0288941] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0009693 HSALNG0009693] |
|ELF3-AS1 | |ELF3-AS1 | ||
|ENST00000415582 | |ENST00000415582 | ||
| Line 10,215: | Line 11,491: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289134 HSALNT0289134] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289134 HSALNT0289134] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0025450 HSALNG0025450] |
|LINC02158 | |LINC02158 | ||
|NA | |NA | ||
| Line 10,223: | Line 11,500: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289350 HSALNT0289350] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289350 HSALNT0289350] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133329 HSALNG0133329] |
|LINC01671 | |LINC01671 | ||
|BC041455 | |BC041455 | ||
| Line 10,231: | Line 11,509: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289124 HSALNT0289124] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289124 HSALNT0289124] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132343 HSALNG0132343] |
|LINC01684 | |LINC01684 | ||
|lnc-JAM2-6 | |lnc-JAM2-6 | ||
| Line 10,239: | Line 11,518: | ||
|pathogenic process | |pathogenic process | ||
|nonalcoholic fatty liver disease | |nonalcoholic fatty liver disease | ||
| + | |Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289036 HSALNT0289036] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289036 HSALNT0289036] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0096092 HSALNG0096092] |
|LINC00365 | |LINC00365 | ||
|NA | |NA | ||
| Line 10,247: | Line 11,527: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289111 HSALNT0289111] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289111 HSALNT0289111] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043625 HSALNG0043625] |
|LINC01554 | |LINC01554 | ||
|C5orf27,FLJ38821,FIS | |C5orf27,FLJ38821,FIS | ||
| Line 10,255: | Line 11,536: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289132 HSALNT0289132] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289132 HSALNT0289132] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0136701 HSALNG0136701] |
|LINC02154 | |LINC02154 | ||
|GS1-600G8.5 | |GS1-600G8.5 | ||
| Line 10,263: | Line 11,545: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137721 HSALNT0137721] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137721 HSALNT0137721] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0065704 HSALNG0065704] |
|LINC02155 | |LINC02155 | ||
|RP11-705O24.1 | |RP11-705O24.1 | ||
| Line 10,271: | Line 11,554: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225363 HSALNT0225363] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225363 HSALNT0225363] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0108398 HSALNG0108398] |
|LINC02157 | |LINC02157 | ||
|RP11-327J17.1 | |RP11-327J17.1 | ||
| Line 10,279: | Line 11,563: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289133 HSALNT0289133] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289133 HSALNT0289133] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0090758 HSALNG0090758] |
|LINC02156 | |LINC02156 | ||
|RP1-90J4.1 | |RP1-90J4.1 | ||
| Line 10,287: | Line 11,572: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0133924 HSALNT0133924] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0133924 HSALNT0133924] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0063832 HSALNG0063832] |
|LINC02153 | |LINC02153 | ||
|NA | |NA | ||
| Line 10,295: | Line 11,581: | ||
|pathogenic process | |pathogenic process | ||
|major depression disorder | |major depression disorder | ||
| + | |Behavior and Behavior Mechanisms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0181656 HSALNT0181656] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0181656 HSALNT0181656] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0087394 HSALNG0087394] |
|LINC02151 | |LINC02151 | ||
|TCONS_00019174 | |TCONS_00019174 | ||
| Line 10,303: | Line 11,590: | ||
|pathogenic process | |pathogenic process | ||
|major depression disorder | |major depression disorder | ||
| + | |Behavior and Behavior Mechanisms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0227367 HSALNT0227367] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0227367 HSALNT0227367] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0109385 HSALNG0109385] |
|LINC02152 | |LINC02152 | ||
|NA | |NA | ||
| Line 10,311: | Line 11,599: | ||
|pathogenic process | |pathogenic process | ||
|major depression disorder | |major depression disorder | ||
| + | |Behavior and Behavior Mechanisms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029246 HSALNT0029246] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029246 HSALNT0029246] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0013844 HSALNG0013844] |
|BRE-AS1 | |BRE-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,321: | Line 11,611: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289251 HSALNT0289251] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289251 HSALNT0289251] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0056623 HSALNG0056623] |
|SNHG26 | |SNHG26 | ||
|AC005682.5 | |AC005682.5 | ||
| Line 10,327: | Line 11,617: | ||
|pathogenic process | |pathogenic process | ||
|bladder urothelial cancer | |bladder urothelial cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252719 HSALNT0252719] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252719 HSALNT0252719] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0122284 HSALNG0122284] |
|LIVAR | |LIVAR | ||
|lnc18q22.2 | |lnc18q22.2 | ||
| Line 10,335: | Line 11,626: | ||
|pathogenic process | |pathogenic process | ||
|nonalcoholic steatohepatiti | |nonalcoholic steatohepatiti | ||
| + | |Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289074 HSALNT0289074] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289074 HSALNT0289074] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0031832 HSALNG0031832] |
|LINC00969 | |LINC00969 | ||
|ENST00000453324 | |ENST00000453324 | ||
| Line 10,343: | Line 11,635: | ||
|pathogenic process | |pathogenic process | ||
|lung squamous cell cancer | |lung squamous cell cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289138 HSALNT0289138] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289138 HSALNT0289138] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140259 HSALNG0140259] |
|LINC02243 | |LINC02243 | ||
|ENST00000441841 | |ENST00000441841 | ||
| Line 10,351: | Line 11,644: | ||
|pathogenic process | |pathogenic process | ||
|lung squamous cell cancer | |lung squamous cell cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289399 HSALNT0289399] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289399 HSALNT0289399] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039449 HSALNG0039449] |
|SLC9A3-AS1 | |SLC9A3-AS1 | ||
|UC011CLY.2 | |UC011CLY.2 | ||
| Line 10,359: | Line 11,653: | ||
|pathogenic process | |pathogenic process | ||
|lung squamous cell cancer | |lung squamous cell cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288934 HSALNT0288934] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288934 HSALNT0288934] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0126602 HSALNG0126602] |
|DM1-AS | |DM1-AS | ||
|NA | |NA | ||
| Line 10,367: | Line 11,662: | ||
|pathogenic process | |pathogenic process | ||
|myotonic dystrophy type 1 | |myotonic dystrophy type 1 | ||
| + | |Musculoskeletal Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0009014 HSALNT0009014] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0009014 HSALNT0009014] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004475 HSALNG0004475] |
|LINC02238 | |LINC02238 | ||
|RP4-788P17.1 | |RP4-788P17.1 | ||
| Line 10,375: | Line 11,671: | ||
|pathogenic process | |pathogenic process | ||
|B cell lymphoma | |B cell lymphoma | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289163 HSALNT0289163] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289163 HSALNT0289163] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043374 HSALNG0043374] |
|MEF2C-AS2 | |MEF2C-AS2 | ||
|CTC-467M3.1 | |CTC-467M3.1 | ||
| Line 10,383: | Line 11,680: | ||
|pathogenic process | |pathogenic process | ||
|diffuse large B-cell lymphoma | |diffuse large B-cell lymphoma | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289181 HSALNT0289181] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289181 HSALNT0289181] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0003824 HSALNG0003824] |
|MIR4422HG | |MIR4422HG | ||
|RP11-101C11.1 | |RP11-101C11.1 | ||
| Line 10,391: | Line 11,689: | ||
|pathogenic process | |pathogenic process | ||
|diffuse large B-cell lymphoma | |diffuse large B-cell lymphoma | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289403 HSALNT0289403] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289403 HSALNT0289403] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082800 HSALNG0082800] |
|SPON1-AS1 | |SPON1-AS1 | ||
|RP11-21,L19.1 | |RP11-21,L19.1 | ||
| Line 10,399: | Line 11,698: | ||
|pathogenic process | |pathogenic process | ||
|diffuse large B-cell lymphoma | |diffuse large B-cell lymphoma | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289461 HSALNT0289461] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289461 HSALNT0289461] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0083610 HSALNG0083610] |
|CD44-AS1 | |CD44-AS1 | ||
|RP1-68D18.4 | |RP1-68D18.4 | ||
| Line 10,407: | Line 11,707: | ||
|pathogenic process | |pathogenic process | ||
|diffuse large B-cell lymphoma | |diffuse large B-cell lymphoma | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262277 HSALNT0262277] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262277 HSALNT0262277] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0127560 HSALNG0127560] |
|LILRB1-AS1 | |LILRB1-AS1 | ||
|AC009892.10 | |AC009892.10 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289546 HSALNT0289546] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289546 HSALNT0289546] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141661 HSALNG0141661] |
|AC009892.10 | |AC009892.10 | ||
|LILRB1-AS1 | |LILRB1-AS1 | ||
| Line 10,423: | Line 11,725: | ||
|NA | |NA | ||
|B cell lymphoma | |B cell lymphoma | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282241 HSALNT0282241] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282241 HSALNT0282241] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0137635 HSALNG0137635] |
|LINC01186 | |LINC01186 | ||
|NA | |NA | ||
| Line 10,431: | Line 11,734: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289168 HSALNT0289168] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289168 HSALNT0289168] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0131657 HSALNG0131657] |
|MHENCR | |MHENCR | ||
|NA | |NA | ||
| Line 10,439: | Line 11,743: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072994 HSALNT0072994] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072994 HSALNT0072994] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0034801 HSALNG0034801] |
|LINC02232 | |LINC02232 | ||
|RP11-707A18.1 | |RP11-707A18.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080161 HSALNT0080161] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080161 HSALNT0080161] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0038220 HSALNG0038220] |
|LINC02233 | |LINC02233 | ||
|RP11-6C14.1 | |RP11-6C14.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084027 HSALNT0084027] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084027 HSALNT0084027] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039930 HSALNG0039930] |
|LINC02236 | |LINC02236 | ||
|RP11-332J15.1 | |RP11-332J15.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091870 HSALNT0091870] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091870 HSALNT0091870] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043678 HSALNG0043678] |
|LINC02234 | |LINC02234 | ||
|RP11-455B3.1 | |RP11-455B3.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0139521 HSALNT0139521] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0139521 HSALNT0139521] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0066607 HSALNG0066607] |
|LINC02235 | |LINC02235 | ||
|RP11-354A14.1 | |RP11-354A14.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142040 HSALNT0142040] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142040 HSALNT0142040] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0067779 HSALNG0067779] |
|LINC02237 | |LINC02237 | ||
|RP11-1101K5.1 | |RP11-1101K5.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289135 HSALNT0289135] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289135 HSALNT0289135] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0111295 HSALNG0111295] |
|LINC02179 | |LINC02179 | ||
|RP11-189E14.4 | |RP11-189E14.4 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289351 HSALNT0289351] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289351 HSALNT0289351] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132340 HSALNG0132340] |
|LINC01689 | |LINC01689 | ||
|AP000469.2 | |AP000469.2 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289137 HSALNT0289137] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289137 HSALNT0289137] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091963 HSALNG0091963] |
|LINC02231 | |LINC02231 | ||
|RP11-766N7.4 | |RP11-766N7.4 | ||
| Line 10,511: | Line 11,824: | ||
|pathogenic process | |pathogenic process | ||
|Esophageal squamous cell cancer | |Esophageal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220239 HSALNT0220239] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220239 HSALNT0220239] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105903 HSALNG0105903] |
|MIR4713HG | |MIR4713HG | ||
|RP11-108K3.1 | |RP11-108K3.1 | ||
| Line 10,519: | Line 11,833: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288967 HSALNT0288967] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288967 HSALNT0288967] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0037858 HSALNG0037858] |
|FAM160A1-DT | |FAM160A1-DT | ||
|RP11-610P16.1 | |RP11-610P16.1 | ||
| Line 10,527: | Line 11,842: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289239 HSALNT0289239] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289239 HSALNT0289239] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0021423 HSALNG0021423] |
|SATB2-AS1 | |SATB2-AS1 | ||
|NA | |NA | ||
| Line 10,535: | Line 11,851: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289512 HSALNT0289512] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289512 HSALNT0289512] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141623 HSALNG0141623] |
|LINC01826 | |LINC01826 | ||
|lnc-MKI67IP-3 | |lnc-MKI67IP-3 | ||
| Line 10,543: | Line 11,860: | ||
|pathogenic process | |pathogenic process | ||
|atherosclerosis | |atherosclerosis | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289024 HSALNT0289024] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289024 HSALNT0289024] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104253 HSALNG0104253] |
|LINC00226 | |LINC00226 | ||
|C14orf97,NCRNA00226 | |C14orf97,NCRNA00226 | ||
| Line 10,551: | Line 11,869: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic ductaladenocarcinoma | |pancreatic ductaladenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082192 HSALNT0082192] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082192 HSALNT0082192] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039173 HSALNG0039173] |
|F11-AS1 | |F11-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,561: | Line 11,881: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0219108 HSALNT0219108] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0219108 HSALNT0219108] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105295 HSALNG0105295] |
|SPINT1-AS1 | |SPINT1-AS1 | ||
|RP11-532F12.5 | |RP11-532F12.5 | ||
| Line 10,567: | Line 11,887: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289177 HSALNT0289177] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289177 HSALNT0289177] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088950 HSALNG0088950] |
|MIR200CHG | |MIR200CHG | ||
|U47924.27 | |U47924.27 | ||
| Line 10,575: | Line 11,896: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289328 HSALNT0289328] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289328 HSALNT0289328] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0031153 HSALNG0031153] |
|LINC00888 | |LINC00888 | ||
|NA | |NA | ||
| Line 10,583: | Line 11,905: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289309 HSALNT0289309] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289309 HSALNT0289309] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0116205 HSALNG0116205] |
|LINC00672 | |LINC00672 | ||
|NA | |NA | ||
| Line 10,591: | Line 11,914: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289198 HSALNT0289198] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289198 HSALNT0289198] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0085691 HSALNG0085691] |
|P4HA3-AS1 | |P4HA3-AS1 | ||
|NA | |NA | ||
| Line 10,599: | Line 11,923: | ||
|pathogenic process | |pathogenic process | ||
|parkinson's disease | |parkinson's disease | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197312 HSALNT0197312] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197312 HSALNT0197312] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0095075 HSALNG0095075] |
|TMEM132D-AS1 | |TMEM132D-AS1 | ||
|LOC283352 | |LOC283352 | ||
| Line 10,607: | Line 11,932: | ||
|pathogenic process | |pathogenic process | ||
|human dermal fibroblasts | |human dermal fibroblasts | ||
| + | |Cell Physiological Phenomena | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289472 HSALNT0289472] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289472 HSALNT0289472] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113128 HSALNG0113128] |
|ATP2C2-AS1 | |ATP2C2-AS1 | ||
|RP11-517C16.2-001 | |RP11-517C16.2-001 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,617: | Line 11,944: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233849 HSALNT0233849] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233849 HSALNT0233849] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0112863 HSALNG0112863] |
|WWOX-AS1 | |WWOX-AS1 | ||
|RP11-190D6.2 | |RP11-190D6.2 | ||
| Line 10,623: | Line 11,950: | ||
|pathogenic process | |pathogenic process | ||
|epithelial ovarian cancer | |epithelial ovarian cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0128829 HSALNT0128829] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0128829 HSALNT0128829] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0061246 HSALNG0061246] |
|FLNC-AS1 | |FLNC-AS1 | ||
|NA | |NA | ||
| Line 10,631: | Line 11,959: | ||
|pathogenic process | |pathogenic process | ||
|cervical squamous cancer | |cervical squamous cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289889 HSALNT0289889] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289889 HSALNT0289889] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142004 HSALNG0142004] |
|LIF-AS1 | |LIF-AS1 | ||
|Lnc-LIF-AS | |Lnc-LIF-AS | ||
| Line 10,639: | Line 11,968: | ||
|pathogenic process | |pathogenic process | ||
|cervical squamous cancer | |cervical squamous cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011283 HSALNT0011283] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011283 HSALNT0011283] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0005428 HSALNG0005428] |
|DPYD-AS2 | |DPYD-AS2 | ||
|NA | |NA | ||
| Line 10,647: | Line 11,977: | ||
|pathogenic process | |pathogenic process | ||
|cervical squamous cancer | |cervical squamous cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289836 HSALNT0289836] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289836 HSALNT0289836] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141951 HSALNG0141951] |
|FLICR | |FLICR | ||
|NA | |NA | ||
| Line 10,655: | Line 11,986: | ||
|pathogenic process | |pathogenic process | ||
|autoimmune diabete | |autoimmune diabete | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289356 HSALNT0289356] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289356 HSALNT0289356] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0090563 HSALNG0090563] |
|LINC02402 | |LINC02402 | ||
|ENST00000550337.1 | |ENST00000550337.1 | ||
| Line 10,663: | Line 11,995: | ||
|pathogenic process | |pathogenic process | ||
|diabetes | |diabetes | ||
| + | |Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137118 HSALNT0137118] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137118 HSALNT0137118] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0065453 HSALNG0065453] |
|CERNA3 | |CERNA3 | ||
|CTA | |CTA | ||
| Line 10,671: | Line 12,004: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090838 HSALNT0090838] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090838 HSALNT0090838] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043312 HSALNG0043312] |
|LINC02488 | |LINC02488 | ||
|CTD-2316B1 | |CTD-2316B1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0174947 HSALNT0174947] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0174947 HSALNT0174947] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0083979 HSALNG0083979] |
|LINC02489 | |LINC02489 | ||
|CTD-2589M5 | |CTD-2589M5 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220441 HSALNT0220441] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220441 HSALNT0220441] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105991 HSALNG0105991] |
|LINC02490 | |LINC02490 | ||
|RP11-209E8 | |RP11-209E8 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289260 HSALNT0289260] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289260 HSALNT0289260] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045650 HSALNG0045650] |
|STK32A-AS1 | |STK32A-AS1 | ||
|CTC-255N20 | |CTC-255N20 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289143 HSALNT0289143] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289143 HSALNT0289143] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0055190 HSALNG0055190] |
|LINC02487 | |LINC02487 | ||
|NA | |NA | ||
| Line 10,711: | Line 12,049: | ||
|pathogenic process | |pathogenic process | ||
|squamous cell cancer | |squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095585 HSALNT0095585] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095585 HSALNT0095585] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045503 HSALNG0045503] |
|SPRY4-AS1 | |SPRY4-AS1 | ||
|THCAT68 | |THCAT68 | ||
| Line 10,719: | Line 12,058: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288927 HSALNT0288927] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288927 HSALNT0288927] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0090908 HSALNG0090908] |
|DDN-AS1 | |DDN-AS1 | ||
|CAT1507 | |CAT1507 | ||
| Line 10,727: | Line 12,067: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012862 HSALNT0012862] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012862 HSALNT0012862] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0006150 HSALNG0006150] |
|SLC16A1-AS1 | |SLC16A1-AS1 | ||
|NA | |NA | ||
| Line 10,735: | Line 12,076: | ||
|pathogenic process | |pathogenic process | ||
|acute myocardial infarction | |acute myocardial infarction | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289412 HSALNT0289412] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289412 HSALNT0289412] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000276 HSALNG0000276] |
|TNFRSF14-AS1 | |TNFRSF14-AS1 | ||
|ENST00000416860.2 | |ENST00000416860.2 | ||
| Line 10,743: | Line 12,085: | ||
|pathogenic process | |pathogenic process | ||
|acute myocardial infarction | |acute myocardial infarction | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0259139 HSALNT0259139] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0259139 HSALNT0259139] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0125745 HSALNG0125745] |
|LINC00665 | |LINC00665 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,753: | Line 12,097: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0040268 HSALNT0040268] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0040268 HSALNT0040268] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0019085 HSALNG0019085] |
|DARS-AS1 | |DARS-AS1 | ||
|NA | |NA | ||
| Line 10,759: | Line 12,103: | ||
|pathogenic process | |pathogenic process | ||
|renal disease | |renal disease | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288913 HSALNT0288913] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288913 HSALNT0288913] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0125425 HSALNG0125425] |
|CEBPA-AS1 | |CEBPA-AS1 | ||
|CEBPA-DT | |CEBPA-DT | ||
| Line 10,767: | Line 12,112: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289011 HSALNT0289011] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289011 HSALNT0289011] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0057479 HSALNG0057479] |
|INHBA-AS1 | |INHBA-AS1 | ||
|NA | |NA | ||
| Line 10,775: | Line 12,121: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288988 HSALNT0288988] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288988 HSALNT0288988] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0067472 HSALNG0067472] |
|GASAL1 | |GASAL1 | ||
|GASL1 | |GASL1 | ||
| Line 10,783: | Line 12,130: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289127 HSALNT0289127] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289127 HSALNT0289127] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0021881 HSALNG0021881] |
|LINC01857 | |LINC01857 | ||
|AC079767.4 | |AC079767.4 | ||
| Line 10,791: | Line 12,139: | ||
|pathogenic process | |pathogenic process | ||
|tuberculosis | |tuberculosis | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289091 HSALNT0289091] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289091 HSALNT0289091] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004949 HSALNG0004949] |
|LINC01140 | |LINC01140 | ||
|FLJ41676 | |FLJ41676 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,801: | Line 12,151: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281957 HSALNT0281957] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281957 HSALNT0281957] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0137521 HSALNG0137521] |
|PINCR | |PINCR | ||
|NA | |NA | ||
| Line 10,807: | Line 12,157: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289344 HSALNT0289344] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289344 HSALNT0289344] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0139543 HSALNG0139543] |
|LINC00890 | |LINC00890 | ||
|NA | |NA | ||
| Line 10,815: | Line 12,166: | ||
|pathogenic process | |pathogenic process | ||
|leiomyoma | |leiomyoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0019828 HSALNT0019828] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0019828 HSALNT0019828] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0009573 HSALNG0009573] |
|LINC00862 | |LINC00862 | ||
|C1orf98,SMIM16 | |C1orf98,SMIM16 | ||
| Line 10,823: | Line 12,175: | ||
|pathogenic process | |pathogenic process | ||
|cystic fibrosis | |cystic fibrosis | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0073790 HSALNT0073790] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0073790 HSALNT0073790] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0035237 HSALNG0035237] |
|LINC02562 | |LINC02562 | ||
|RP11-44F21.5 | |RP11-44F21.5 | ||
| Line 10,831: | Line 12,184: | ||
|pathogenic process | |pathogenic process | ||
|cystic fibrosis | |cystic fibrosis | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263101 HSALNT0263101] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263101 HSALNT0263101] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0127961 HSALNG0127961] |
|LINC02560 | |LINC02560 | ||
|CTD-2619J13.13 | |CTD-2619J13.13 | ||
| Line 10,839: | Line 12,193: | ||
|pathogenic process | |pathogenic process | ||
|cystic fibrosis | |cystic fibrosis | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289144 HSALNT0289144] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289144 HSALNT0289144] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088252 HSALNG0088252] |
|LINC02551 | |LINC02551 | ||
|RP11-890B15.2 | |RP11-890B15.2 | ||
| Line 10,847: | Line 12,202: | ||
|pathogenic process | |pathogenic process | ||
|cystic fibrosis | |cystic fibrosis | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289458 HSALNT0289458] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289458 HSALNT0289458] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0078773 HSALNG0078773] |
|DDIT4-AS1 | |DDIT4-AS1 | ||
|RP11-442H21.2 | |RP11-442H21.2 | ||
| Line 10,855: | Line 12,211: | ||
|pathogenic process | |pathogenic process | ||
|cystic Fibrosis | |cystic Fibrosis | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288992 HSALNT0288992] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288992 HSALNT0288992] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089423 HSALNG0089423] |
|GPRC5D-AS1 | |GPRC5D-AS1 | ||
|RP11-392P7.6 | |RP11-392P7.6 | ||
| Line 10,863: | Line 12,220: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289386 HSALNT0289386] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289386 HSALNT0289386] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0015768 HSALNG0015768] |
|PCBP1-AS1 | |PCBP1-AS1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289405 HSALNT0289405] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289405 HSALNT0289405] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0044141 HSALNG0044141] |
|STARD4-AS1 | |STARD4-AS1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0201547 HSALNT0201547] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0201547 HSALNT0201547] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0097004 HSALNG0097004] |
|LINC00462 | |LINC00462 | ||
|NA | |NA | ||
| Line 10,887: | Line 12,247: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207103 HSALNT0207103] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207103 HSALNT0207103] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0099453 HSALNG0099453] |
|SOX1-OT | |SOX1-OT | ||
|LINC00403 | |LINC00403 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002131 HSALNT0002131] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002131 HSALNT0002131] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0001107 HSALNG0001107] |
|SLC25A34-AS1 | |SLC25A34-AS1 | ||
|RP11-169K16.4 | |RP11-169K16.4 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,905: | Line 12,268: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289218 HSALNT0289218] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289218 HSALNT0289218] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075163 HSALNG0075163] |
|PPP1R26-AS1 | |PPP1R26-AS1 | ||
|NA | |NA | ||
| Line 10,911: | Line 12,274: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289047 HSALNT0289047] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289047 HSALNT0289047] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0064310 HSALNG0064310] |
|LINC00589 | |LINC00589 | ||
|C8orf75,TSLNC8 | |C8orf75,TSLNC8 | ||
| Line 10,919: | Line 12,283: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289516 HSALNT0289516] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289516 HSALNT0289516] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141627 HSALNG0141627] |
|TPM1-AS | |TPM1-AS | ||
|TPM1-AS1 | |TPM1-AS1 | ||
| Line 10,927: | Line 12,292: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289314 HSALNT0289314] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289314 HSALNT0289314] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141631 HSALNG0141631] |
|LINC01101 | |LINC01101 | ||
|FLJ14816 | |FLJ14816 | ||
| Line 10,935: | Line 12,301: | ||
|pathogenic process | |pathogenic process | ||
|HPV-induced cervical neoplasia | |HPV-induced cervical neoplasia | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289147 HSALNT0289147] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289147 HSALNT0289147] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0018748 HSALNG0018748] |
|LINC02572 | |LINC02572 | ||
|AC079776.2 | |AC079776.2 | ||
| Line 10,943: | Line 12,310: | ||
|pathogenic process | |pathogenic process | ||
|epithelial ovarian cancer | |epithelial ovarian cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096804 HSALNT0096804] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096804 HSALNT0096804] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0046188 HSALNG0046188] |
|LINC02202 | |LINC02202 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,953: | Line 12,322: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289076 HSALNT0289076] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289076 HSALNT0289076] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0027511 HSALNG0027511] |
|LINC00973 | |LINC00973 | ||
|CTD-2021J15.2 | |CTD-2021J15.2 | ||
| Line 10,959: | Line 12,328: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288625 HSALNT0288625] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288625 HSALNT0288625] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141401 HSALNG0141401] |
|TTTY10 | |TTTY10 | ||
|NCRNA00133 | |NCRNA00133 | ||
| Line 10,967: | Line 12,337: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNT0289323] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNT0289323] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133418 HSALNG0133418] |
|LINC00319 | |LINC00319 | ||
|C21orf125,NCRNA00319,PRED49,FLJ38036 | |C21orf125,NCRNA00319,PRED49,FLJ38036 | ||
| Line 10,975: | Line 12,346: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015533 HSALNT0015533] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015533 HSALNT0015533] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007394 HSALNG0007394] |
|IL6R-AS1 | |IL6R-AS1 | ||
|RP11-350G8.5 | |RP11-350G8.5 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,985: | Line 12,358: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090330 HSALNT0090330] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090330 HSALNT0090330] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043020 HSALNG0043020] |
|CKMT2-AS1 | |CKMT2-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 10,993: | Line 12,367: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012995 HSALNT0012995] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012995 HSALNT0012995] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0006203 HSALNG0006203] |
|HIPK1-AS1 | |HIPK1-AS1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,001: | Line 12,376: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289216 HSALNT0289216] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289216 HSALNT0289216] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0050214 HSALNG0050214] |
|POLH-AS1 | |POLH-AS1 | ||
|RP3-337H4.8 | |RP3-337H4.8 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,009: | Line 12,385: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289276 HSALNT0289276] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289276 HSALNT0289276] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0053237 HSALNG0053237] |
|TRDN-AS1 | |TRDN-AS1 | ||
|HRAT13 | |HRAT13 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,017: | Line 12,394: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289159 HSALNT0289159] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289159 HSALNT0289159] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069213 HSALNG0069213] |
|LY6E-DT | |LY6E-DT | ||
|LOC100133669 | |LOC100133669 | ||
| Line 11,023: | Line 12,400: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289434 HSALNT0289434] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289434 HSALNT0289434] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0040409 HSALNG0040409] |
|BASP1-AS1 | |BASP1-AS1 | ||
|LOC285696 | |LOC285696 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288991 HSALNT0288991] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288991 HSALNT0288991] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069691 HSALNG0069691] |
|GLIS3-AS1 | |GLIS3-AS1 | ||
|C9orf70,MGC16153 | |C9orf70,MGC16153 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,041: | Line 12,421: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288896 HSALNT0288896] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288896 HSALNT0288896] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0070213 HSALNG0070213] |
|BNC2-AS1 | |BNC2-AS1 | ||
|RP11-62F24.2 | |RP11-62F24.2 | ||
| Line 11,047: | Line 12,427: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289292 HSALNT0289292] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289292 HSALNT0289292] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0078947 HSALNG0078947] |
|ZNF503-AS1 | |ZNF503-AS1 | ||
|NA | |NA | ||
| Line 11,055: | Line 12,436: | ||
|pathogenic process | |pathogenic process | ||
|age-related macular degeneration | |age-related macular degeneration | ||
| + | |Eye Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0159506 HSALNT0159506] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0159506 HSALNT0159506] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0076434 HSALNG0076434] |
|VIM-AS1 | |VIM-AS1 | ||
|NA | |NA | ||
| Line 11,063: | Line 12,445: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288882 HSALNT0288882] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288882 HSALNT0288882] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0011058 HSALNG0011058] |
|ACBD3-AS1 | |ACBD3-AS1 | ||
|RP11-275I14.4 | |RP11-275I14.4 | ||
| Line 11,071: | Line 12,454: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289156 HSALNT0289156] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289156 HSALNT0289156] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0005074 HSALNG0005074] |
|LRRC8C-DT | |LRRC8C-DT | ||
|FLJ27354 | |FLJ27354 | ||
| Line 11,079: | Line 12,463: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289447 HSALNT0289447] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289447 HSALNT0289447] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0058889 HSALNG0058889] |
|ELN-AS1 | |ELN-AS1 | ||
|CTB-51J22.1 | |CTB-51J22.1 | ||
| Line 11,087: | Line 12,472: | ||
|pathogenic process | |pathogenic process | ||
|endometrial cancer | |endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076712 HSALNT0076712] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076712 HSALNT0076712] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0036645 HSALNG0036645] |
|LINC02264 | |LINC02264 | ||
|NA | |NA | ||
| Line 11,095: | Line 12,481: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093666 HSALNT0093666] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093666 HSALNT0093666] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0044495 HSALNG0044495] |
|LINC02201 | |LINC02201 | ||
|NA | |NA | ||
| Line 11,103: | Line 12,490: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271685 HSALNT0271685] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271685 HSALNT0271685] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132198 HSALNG0132198] |
|LINC02573 | |LINC02573 | ||
|NA | |NA | ||
| Line 11,111: | Line 12,499: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289125 HSALNT0289125] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289125 HSALNT0289125] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0015785 HSALNG0015785] |
|LINC01816 | |LINC01816 | ||
|LOC100133985 | |LOC100133985 | ||
| Line 11,119: | Line 12,508: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289355 HSALNT0289355] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289355 HSALNT0289355] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091335 HSALNG0091335] |
|LINC02381 | |LINC02381 | ||
|LOC400043 | |LOC400043 | ||
| Line 11,127: | Line 12,517: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289366 HSALNT0289366] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289366 HSALNT0289366] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0029874 HSALNG0029874] |
|MBNL1-AS1 | |MBNL1-AS1 | ||
|LOC401093 | |LOC401093 | ||
| Line 11,135: | Line 12,526: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289513 HSALNT0289513] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289513 HSALNT0289513] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141624 HSALNG0141624] |
|MIR4697HG | |MIR4697HG | ||
|LINC00947,LOC283174 | |LINC00947,LOC283174 | ||
| Line 11,143: | Line 12,535: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289073 HSALNT0289073] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289073 HSALNT0289073] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0065480 HSALNG0065480] |
|LINC00968 | |LINC00968 | ||
|NA | |NA | ||
| Line 11,151: | Line 12,544: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114453 HSALNT0114453] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114453 HSALNT0114453] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0053963 HSALNG0053963] |
|NMBR-AS1 | |NMBR-AS1 | ||
|RP11-137J7.2 | |RP11-137J7.2 | ||
| Line 11,159: | Line 12,553: | ||
|pathogenic process | |pathogenic process | ||
|non-melanoma skin cancer | |non-melanoma skin cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289300 HSALNT0289300] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289300 HSALNT0289300] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0077499 HSALNG0077499] |
|LINC01518 | |LINC01518 | ||
|NA | |NA | ||
| Line 11,167: | Line 12,562: | ||
|pathogenic process | |pathogenic process | ||
|non-melanoma skin cancer | |non-melanoma skin cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003783 HSALNT0003783] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003783 HSALNT0003783] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0002009 HSALNG0002009] |
|LINC02574 | |LINC02574 | ||
|RP11-288L9.1 | |RP11-288L9.1 | ||
| Line 11,175: | Line 12,571: | ||
|pathogenic process | |pathogenic process | ||
|UVB-irradiated KC & non-melanoma skin cancer | |UVB-irradiated KC & non-melanoma skin cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032721 HSALNT0032721] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032721 HSALNT0032721] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0015486 HSALNG0015486] |
|LINC02579 | |LINC02579 | ||
|AC007365.1 | |AC007365.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030828 HSALNT0030828] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030828 HSALNT0030828] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0014519 HSALNG0014519] |
|LINC02580 | |LINC02580 | ||
|AC093609.1 | |AC093609.1 | ||
| Line 11,191: | Line 12,589: | ||
|pathogenic process | |pathogenic process | ||
|UVB-irradiated KC & non-melanoma skin cancer | |UVB-irradiated KC & non-melanoma skin cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032808 HSALNT0032808] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032808 HSALNT0032808] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0015519 HSALNG0015519] |
|LINC02576 | |LINC02576 | ||
|NA | |NA | ||
| Line 11,199: | Line 12,598: | ||
|pathogenic process | |pathogenic process | ||
|UVB-irradiated KC & non-melanoma skin cancer | |UVB-irradiated KC & non-melanoma skin cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127022 HSALNT0127022] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127022 HSALNT0127022] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060386 HSALNG0060386] |
|LINC02577 | |LINC02577 | ||
|NA | |NA | ||
| Line 11,207: | Line 12,607: | ||
|pathogenic process | |pathogenic process | ||
|UVB-irradiated KC & non-melanoma skin cancer | |UVB-irradiated KC & non-melanoma skin cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154722 HSALNT0154722] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154722 HSALNT0154722] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074062 HSALNG0074062] |
|LINC02578 | |LINC02578 | ||
|RP11-127L21.1 | |RP11-127L21.1 | ||
| Line 11,215: | Line 12,616: | ||
|pathogenic process | |pathogenic process | ||
|UVB-irradiated KC & non-melanoma skin cancer | |UVB-irradiated KC & non-melanoma skin cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288962 HSALNT0288962] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288962 HSALNT0288962] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0084388 HSALNG0084388] |
|FAM111A-DT | |FAM111A-DT | ||
|NA | |NA | ||
| Line 11,223: | Line 12,625: | ||
|pathogenic process | |pathogenic process | ||
|UVB-irradiated KC & non-melanoma skin cancer | |UVB-irradiated KC & non-melanoma skin cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289148 HSALNT0289148] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289148 HSALNT0289148] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133545 HSALNG0133545] |
|LINC02575 | |LINC02575 | ||
|AP001065.15 | |AP001065.15 | ||
| Line 11,231: | Line 12,634: | ||
|pathogenic process | |pathogenic process | ||
|UVB-irradiated KC & non-melanoma skin cancer | |UVB-irradiated KC & non-melanoma skin cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0025249 HSALNT0025249] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0025249 HSALNT0025249] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0012143 HSALNG0012143] |
|KIF26B-AS1 | |KIF26B-AS1 | ||
|RP11-62I21.1 | |RP11-62I21.1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,241: | Line 12,646: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0177212 HSALNT0177212] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0177212 HSALNT0177212] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0085146 HSALNG0085146] |
|RPS6KB2-AS1 | |RPS6KB2-AS1 | ||
|AP003419.16 | |AP003419.16 | ||
| Line 11,247: | Line 12,652: | ||
|pathogenic process | |pathogenic process | ||
|agingâassociated idiopathic pulmonary fibrosis | |agingâassociated idiopathic pulmonary fibrosis | ||
| + | |Physiological Phenomena | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289072 HSALNT0289072] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289072 HSALNT0289072] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0090150 HSALNG0090150] |
|LINC00941 | |LINC00941 | ||
|lncRNA-MUF | |lncRNA-MUF | ||
| Line 11,255: | Line 12,661: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289338 HSALNT0289338] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289338 HSALNT0289338] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075045 HSALNG0075045] |
|LINC00094 | |LINC00094 | ||
|FLJ35348,bA374P20.3 | |FLJ35348,bA374P20.3 | ||
| Line 11,263: | Line 12,670: | ||
|pathogenic process | |pathogenic process | ||
|lung squamous cell cancer | |lung squamous cell cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114192 HSALNT0114192] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114192 HSALNT0114192] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0053894 HSALNG0053894] |
|FILNC1 | |FILNC1 | ||
|NA | |NA | ||
| Line 11,271: | Line 12,679: | ||
|pathogenic process | |pathogenic process | ||
|renal tumor | |renal tumor | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289199 HSALNT0289199] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289199 HSALNT0289199] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0128600 HSALNG0128600] |
|PARAL1 | |PARAL1 | ||
|NA | |NA | ||
| Line 11,279: | Line 12,688: | ||
|pathogenic process | |pathogenic process | ||
|obesity | |obesity | ||
| + | |Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244832 HSALNT0244832] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244832 HSALNT0244832] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0118528 HSALNG0118528] |
|SOX9-AS1 | |SOX9-AS1 | ||
|FLJ37644 | |FLJ37644 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289236 HSALNT0289236] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289236 HSALNT0289236] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0118528 HSALNG0118528] |
|ROCR | |ROCR | ||
|LINC02095 | |LINC02095 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0056667 HSALNT0056667] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0056667 HSALNT0056667] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0027060 HSALNG0027060] |
|LINC02027 | |LINC02027 | ||
|LOC728290 | |LOC728290 | ||
| Line 11,303: | Line 12,715: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289424 HSALNT0289424] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289424 HSALNT0289424] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141124 HSALNG0141124] |
|TTTY22 | |TTTY22 | ||
|NCRNA00147 | |NCRNA00147 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,313: | Line 12,727: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289069 HSALNT0289069] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289069 HSALNT0289069] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0030090 HSALNG0030090] |
|LINC00880 | |LINC00880 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,321: | Line 12,736: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252974 HSALNT0252974] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252974 HSALNT0252974] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0122396 HSALNG0122396] |
|LINC02582 | |LINC02582 | ||
|CTD-2354A18.1 | |CTD-2354A18.1 | ||
| Line 11,327: | Line 12,742: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289035 HSALNT0289035] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289035 HSALNT0289035] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0097712 HSALNG0097712] |
|LINC00364 | |LINC00364 | ||
|LncRNA00364 | |LncRNA00364 | ||
| Line 11,335: | Line 12,751: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060981 HSALNT0060981] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060981 HSALNT0060981] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0029189 HSALNG0029189] |
|NCK1-DT | |NCK1-DT | ||
|NCK1-AS1,SLC35G2-AS1 | |NCK1-AS1,SLC35G2-AS1 | ||
| Line 11,343: | Line 12,760: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288890 HSALNT0288890] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288890 HSALNT0288890] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0067505 HSALNG0067505] |
|BAALC-AS1 | |BAALC-AS1 | ||
|lncFZD6,FZD6-DT | |lncFZD6,FZD6-DT | ||
| Line 11,351: | Line 12,769: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046602 HSALNT0046602] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046602 HSALNT0046602] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0021972 HSALNG0021972] |
|CPS1-IT1 | |CPS1-IT1 | ||
|CPS1-IT,CPS1IT,CPS1IT1,PRO0132 | |CPS1-IT,CPS1IT,CPS1IT1,PRO0132 | ||
| Line 11,359: | Line 12,778: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma | |hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289445 HSALNT0289445] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289445 HSALNT0289445] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0059740 HSALNG0059740] |
|DLX6-AS1 | |DLX6-AS1 | ||
|DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048 | |DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048 | ||
| Line 11,367: | Line 12,787: | ||
|pathogenic process | |pathogenic process | ||
|split hand/split foot malformation disorder;lung adenocarcinoma | |split hand/split foot malformation disorder;lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289891 HSALNT0289891] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289891 HSALNT0289891] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142006 HSALNG0142006] |
|LINC00114 | |LINC00114 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,377: | Line 12,799: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289415 HSALNT0289415] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289415 HSALNT0289415] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0138601 HSALNG0138601] |
|TSIX | |TSIX | ||
|LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS | |LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS | ||
| Line 11,383: | Line 12,805: | ||
|pathogenic process | |pathogenic process | ||
|systemic sclerosis | |systemic sclerosis | ||
| + | |Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217334 HSALNT0217334] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217334 HSALNT0217334] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104503 HSALNG0104503] |
|MKRN3-AS1 | |MKRN3-AS1 | ||
|ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS | |ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS | ||
| Line 11,391: | Line 12,814: | ||
|pathogenic process | |pathogenic process | ||
|Prader-Willi syndrome | |Prader-Willi syndrome | ||
| + | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290256 HSALNT0290256] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290256 HSALNT0290256] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142371 HSALNG0142371] |
|SRA | |SRA | ||
|lnc-SRA1-1:1,SRA1,ENSG00000213523 | |lnc-SRA1-1:1,SRA1,ENSG00000213523 | ||
| Line 11,399: | Line 12,823: | ||
|pathogenic process | |pathogenic process | ||
|nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer | |nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289442 HSALNT0289442] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289442 HSALNT0289442] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049271 HSALNG0049271] |
|HCP5 | |HCP5 | ||
|6S2650E,D6S2650E,P5-1 | |6S2650E,D6S2650E,P5-1 | ||
| Line 11,407: | Line 12,832: | ||
|pathogenic process | |pathogenic process | ||
|AIDS | |AIDS | ||
| + | |Immune System Diseases;Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289284 HSALNT0289284] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289284 HSALNT0289284] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0083476 HSALNG0083476] |
|WT1-AS | |WT1-AS | ||
|WIT1,WIT-1,WT1A, WT1-AS1 | |WIT1,WIT-1,WT1A, WT1-AS1 | ||
| Line 11,415: | Line 12,841: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia | |gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia | ||
| + | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289421 HSALNT0289421] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289421 HSALNT0289421] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082235 HSALNG0082235] |
|KCNQ1OT1 | |KCNQ1OT1 | ||
|KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012 | |KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012 | ||
| Line 11,423: | Line 12,850: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer | |prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263784 HSALNT0263784] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263784 HSALNT0263784] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0128372 HSALNG0128372] |
|PCNA-AS1 | |PCNA-AS1 | ||
|PCNAA, PCNA-AS | |PCNAA, PCNA-AS | ||
| Line 11,431: | Line 12,859: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;hepatocelluar cancer | |gastric cancer;hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289524 HSALNT0289524] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289524 HSALNT0289524] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049107 HSALNG0049107] |
|HCG9 | |HCG9 | ||
|PERB11,HCGIX,HCGIX4,HCGIX-4 | |PERB11,HCGIX,HCGIX4,HCGIX-4 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,441: | Line 12,871: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289264 HSALNT0289264] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289264 HSALNT0289264] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0103448 HSALNG0103448] |
|TCL6 | |TCL6 | ||
|TCL6e1,TNG2,TNG1 | |TCL6e1,TNG2,TNG1 | ||
| Line 11,447: | Line 12,877: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|renal cell cancer;leukemia | |renal cell cancer;leukemia | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289203 HSALNT0289203] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289203 HSALNT0289203] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0072040 HSALNG0072040] |
|PCA3 | |PCA3 | ||
|DD3,NCRNA00019,PCAT3 | |DD3,NCRNA00019,PCAT3 | ||
| Line 11,455: | Line 12,886: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289462 HSALNT0289462] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289462 HSALNT0289462] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082178 HSALNG0082178] |
|H19 | |H19 | ||
|ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2 | |ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2 | ||
| Line 11,463: | Line 12,895: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor | |prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor | ||
| + | |Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288932 HSALNT0288932] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288932 HSALNT0288932] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0097105 HSALNG0097105] |
|DLEU1 | |DLEU1 | ||
|BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6 | |BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6 | ||
| Line 11,471: | Line 12,904: | ||
|pathogenic process | |pathogenic process | ||
|lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer | |lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289493 HSALNT0289493] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289493 HSALNT0289493] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141604 HSALNG0141604] |
|DBH-AS1 | |DBH-AS1 | ||
|NCRNA00118,BPR | |NCRNA00118,BPR | ||
| Line 11,479: | Line 12,913: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0088415 HSALNT0088415] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0088415 HSALNT0088415] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0042101 HSALNG0042101] |
|PART1 | |PART1 | ||
|DKFZP586D0823,NCRNA00206 | |DKFZP586D0823,NCRNA00206 | ||
| Line 11,487: | Line 12,922: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;glioblastoma | |prostate cancer;glioblastoma | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289463 HSALNT0289463] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289463 HSALNT0289463] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082197 HSALNG0082197] |
|IGF2-AS | |IGF2-AS | ||
|IGF2A,PEG8,IGF2-AS1 | |IGF2A,PEG8,IGF2-AS1 | ||
| Line 11,495: | Line 12,931: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer | |liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer | ||
| + | |Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269786 HSALNT0269786] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269786 HSALNT0269786] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0131285 HSALNG0131285] |
|GNAS-AS1 | |GNAS-AS1 | ||
|GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075 | |GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075 | ||
| Line 11,503: | Line 12,940: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;pseudohypoparathyroidism type Ib | |non-small cell lung cancer;pseudohypoparathyroidism type Ib | ||
| + | |Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289252 HSALNT0289252] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289252 HSALNT0289252] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0051709 HSALNG0051709] |
|SNHG5 | |SNHG5 | ||
|C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044 | |C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044 | ||
| Line 11,511: | Line 12,949: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;lymphoma;melanoma | |gastric cancer;lymphoma;melanoma | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0023827 HSALNT0023827] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0023827 HSALNT0023827] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0011462 HSALNG0011462] |
|DISC2 | |DISC2 | ||
|DISC1-AS1,DISC1O, NCRNA00015 | |DISC1-AS1,DISC1O, NCRNA00015 | ||
| Line 11,519: | Line 12,958: | ||
|pathogenic process | |pathogenic process | ||
|bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression | |bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression | ||
| + | |Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0203415 HSALNT0203415] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0203415 HSALNT0203415] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0097806 HSALNG0097806] |
|ATXN8OS | |ATXN8OS | ||
|SCA8,KLHL1A,NCRNA00003 | |SCA8,KLHL1A,NCRNA00003 | ||
| Line 11,527: | Line 12,967: | ||
|pathogenic process | |pathogenic process | ||
|spinocerebellar ataxia;spinocerebellar ataxia | |spinocerebellar ataxia;spinocerebellar ataxia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290312 HSALNT0290312] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290312 HSALNT0290312] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142427 HSALNG0142427] |
|TRAF3IP2-AS1 | |TRAF3IP2-AS1 | ||
|C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2 | |C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2 | ||
| Line 11,535: | Line 12,976: | ||
|pathogenic process | |pathogenic process | ||
|schizophrenia;cocaine abuse | |schizophrenia;cocaine abuse | ||
| + | |Chemically-Induced Disorders;Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289008 HSALNT0289008] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289008 HSALNT0289008] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0054049 HSALNG0054049] |
|HYMAI | |HYMAI | ||
|NCRNA00020 | |NCRNA00020 | ||
| Line 11,543: | Line 12,985: | ||
|pathogenic process | |pathogenic process | ||
|transient neonatal diabetes | |transient neonatal diabetes | ||
| + | |Nutritional and Metabolic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288968 HSALNT0288968] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288968 HSALNT0288968] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0071146 HSALNG0071146] |
|FAM201A | |FAM201A | ||
|C9orf122 | |C9orf122 | ||
| Line 11,551: | Line 12,994: | ||
|pathogenic process | |pathogenic process | ||
|leukemia | |leukemia | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288969 HSALNT0288969] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288969 HSALNT0288969] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0093910 HSALNG0093910] |
|FAM222A-AS1 | |FAM222A-AS1 | ||
|NA | |NA | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289484 HSALNT0289484] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289484 HSALNT0289484] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0138575 HSALNG0138575] |
|FAM226A | |FAM226A | ||
|CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827 | |CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289497 HSALNT0289497] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289497 HSALNT0289497] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141608 HSALNG0141608] |
|FAM215A | |FAM215A | ||
|C17orf88,APR-2,LINC00530 | |C17orf88,APR-2,LINC00530 | ||
| Line 11,575: | Line 13,021: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;leukemia | |ovarian cancer;leukemia | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289230 HSALNT0289230] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289230 HSALNT0289230] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0025991 HSALNG0025991] |
|RBM5-AS1 | |RBM5-AS1 | ||
|LUST | |LUST | ||
| Line 11,583: | Line 13,030: | ||
|pathogenic process | |pathogenic process | ||
|tumor | |tumor | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002923 HSALNT0002923] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002923 HSALNT0002923] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0001554 HSALNG0001554] |
|LINC00339 | |LINC00339 | ||
|NCRNA00339,HSPC157 | |NCRNA00339,HSPC157 | ||
| Line 11,591: | Line 13,039: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|Pancreatic ductal adenocarcinoma | |Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144027 HSALNT0144027] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144027 HSALNT0144027] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068615 HSALNG0068615] |
|ASAP1-IT1 | |ASAP1-IT1 | ||
|ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050 | |ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050 | ||
| Line 11,599: | Line 13,048: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289212 HSALNT0289212] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289212 HSALNT0289212] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0021208 HSALNG0021208] |
|PCGEM1 | |PCGEM1 | ||
|NCRNA00071,LINC00071,PCAT9 | |NCRNA00071,LINC00071,PCAT9 | ||
| Line 11,607: | Line 13,057: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis;prostate cancer;glioma | |osteoarthritis;prostate cancer;glioma | ||
| + | |Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289016 HSALNT0289016] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289016 HSALNT0289016] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082243 HSALNG0082243] |
|KCNQ1DN | |KCNQ1DN | ||
|BWRT,HSA404617 | |BWRT,HSA404617 | ||
| Line 11,615: | Line 13,066: | ||
|pathogenic process | |pathogenic process | ||
|aging;Wilms' tumor | |aging;Wilms' tumor | ||
| + | |Physiological Phenomena;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288933 HSALNT0288933] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288933 HSALNT0288933] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0097101 HSALNG0097101] |
|DLEU2 | |DLEU2 | ||
|DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG | |DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG | ||
| Line 11,623: | Line 13,075: | ||
|pathogenic process | |pathogenic process | ||
|lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer | |lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217624 HSALNT0217624] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217624 HSALNT0217624] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104558 HSALNG0104558] |
|PWAR4 | |PWAR4 | ||
|PAR4,PAR-4 | |PAR4,PAR-4 | ||
| Line 11,631: | Line 13,084: | ||
|pathogenic process | |pathogenic process | ||
|Prader-Willi syndrome and Angelman syndrome | |Prader-Willi syndrome and Angelman syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289165 HSALNT0289165] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289165 HSALNT0289165] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0103778 HSALNG0103778] |
|MEG8 | |MEG8 | ||
|SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC | |SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC | ||
| Line 11,639: | Line 13,093: | ||
|pathogenic process | |pathogenic process | ||
|Prader-Willi syndrome and Angelman syndrome;temple syndrome | |Prader-Willi syndrome and Angelman syndrome;temple syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289482 HSALNT0289482] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289482 HSALNT0289482] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133856 HSALNG0133856] |
|CECR7 | |CECR7 | ||
|SAHL1 | |SAHL1 | ||
| Line 11,647: | Line 13,102: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;cat eye syndrome | |hepatocellular cancer;cat eye syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074223 HSALNT0074223] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074223 HSALNT0074223] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0035451 HSALNG0035451] |
|PCAT4 | |PCAT4 | ||
|GDEP,PCAN1,PCA4 | |GDEP,PCAN1,PCA4 | ||
| Line 11,655: | Line 13,111: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0061175 HSALNT0061175] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0061175 HSALNT0061175] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0029318 HSALNG0029318] |
|PISRT1 | |PISRT1 | ||
|NCRNA00195 | |NCRNA00195 | ||
| Line 11,663: | Line 13,120: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|blepharophimosis syndrome | |blepharophimosis syndrome | ||
| + | |Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0190912 HSALNT0190912] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0190912 HSALNT0190912] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0092137 HSALNG0092137] |
|IFNG-AS1 | |IFNG-AS1 | ||
|Tmevpg1,LincR-Ifng-3'A, NEST | |Tmevpg1,LincR-Ifng-3'A, NEST | ||
| Line 11,671: | Line 13,129: | ||
|pathogenic process | |pathogenic process | ||
|Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome | |Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome | ||
| + | |Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038178 HSALNT0038178] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038178 HSALNT0038178] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0018067 HSALNG0018067] |
|FAM138B | |FAM138B | ||
|F379 | |F379 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,681: | Line 13,141: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145703 HSALNT0145703] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145703 HSALNT0145703] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069515 HSALNG0069515] |
|FAM138C | |FAM138C | ||
|F379 | |F379 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,689: | Line 13,150: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288963 HSALNT0288963] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288963 HSALNT0288963] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000006 HSALNG0000006] |
|FAM138A | |FAM138A | ||
|F379 | |F379 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,697: | Line 13,159: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183947 HSALNT0183947] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183947 HSALNT0183947] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088434 HSALNG0088434] |
|FAM138D | |FAM138D | ||
|F379 | |F379 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,705: | Line 13,168: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226092 HSALNT0226092] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226092 HSALNT0226092] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0108677 HSALNG0108677] |
|FAM138E | |FAM138E | ||
|F379 | |F379 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,713: | Line 13,177: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0253925 HSALNT0253925] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0253925 HSALNT0253925] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0122829 HSALNG0122829] |
|FAM138F | |FAM138F | ||
|F379 | |F379 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,721: | Line 13,186: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289326 HSALNT0289326] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289326 HSALNT0289326] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141632 HSALNG0141632] |
|LINC00312 | |LINC00312 | ||
|LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN | |LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN | ||
| Line 11,727: | Line 13,192: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer;bladder cancer;non-small cell lung cancer | |nasopharyngeal cancer;bladder cancer;non-small cell lung cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288886 HSALNT0288886] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288886 HSALNT0288886] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0054798 HSALNG0054798] |
|AIRN | |AIRN | ||
|AIR,NCRNA00088,IGF2RA, IGF2R-AS1 | |AIR,NCRNA00088,IGF2RA, IGF2R-AS1 | ||
|transcriptional regulation | |transcriptional regulation | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254857 HSALNT0254857] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254857 HSALNT0254857] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0123415 HSALNG0123415] |
|MIR7-3HG | |MIR7-3HG | ||
|C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2 | |C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2 | ||
| Line 11,743: | Line 13,210: | ||
|pathogenic process | |pathogenic process | ||
|liver cancer;hepatocelluar cancer | |liver cancer;hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185751 HSALNT0185751] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185751 HSALNT0185751] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0089375 HSALNG0089375] |
|LOH12CR2 | |LOH12CR2 | ||
|LOH2CR12 | |LOH2CR12 | ||
| Line 11,751: | Line 13,219: | ||
|pathogenic process | |pathogenic process | ||
|pre-B acute lymphoblastic leukaemia | |pre-B acute lymphoblastic leukaemia | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289479 HSALNT0289479] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289479 HSALNT0289479] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133055 HSALNG0133055] |
|DSCR8 | |DSCR8 | ||
|C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b | |C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b | ||
| Line 11,759: | Line 13,228: | ||
|pathogenic process | |pathogenic process | ||
|Down syndrome;melanoma | |Down syndrome;melanoma | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289030 HSALNT0289030] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289030 HSALNT0289030] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133422 HSALNG0133422] |
|LINC00313 | |LINC00313 | ||
|C21orf84,NCRNA00313, | |C21orf84,NCRNA00313, | ||
| Line 11,767: | Line 13,237: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289029 HSALNT0289029] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289029 HSALNT0289029] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132830 HSALNG0132830] |
|LINC00310 | |LINC00310 | ||
|C21orf82,NCRNA00310 | |C21orf82,NCRNA00310 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272435 HSALNT0272435] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272435 HSALNT0272435] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132500 HSALNG0132500] |
|LINC00161 | |LINC00161 | ||
|C21orf100,NCRNA00161 | |C21orf100,NCRNA00161 | ||
| Line 11,783: | Line 13,255: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289184 HSALNT0289184] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289184 HSALNT0289184] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132027 HSALNG0132027] |
|MIR99AHG | |MIR99AHG | ||
|C21orf35,FLJ38295,C21orf34,LINC00478,MONC | |C21orf35,FLJ38295,C21orf34,LINC00478,MONC | ||
| Line 11,791: | Line 13,264: | ||
|pathogenic process | |pathogenic process | ||
|myeloid leukemia | |myeloid leukemia | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289005 HSALNT0289005] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289005 HSALNT0289005] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0056865 HSALNG0056865] |
|HOXA11-AS | |HOXA11-AS | ||
|HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076 | |HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076 | ||
| Line 11,799: | Line 13,273: | ||
|pathogenic process | |pathogenic process | ||
|uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer | |uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193654 HSALNT0193654] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193654 HSALNT0193654] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0093342 HSALNG0093342] |
|RMST | |RMST | ||
|NCRM, NCRNA00054,LINC00054 | |NCRM, NCRNA00054,LINC00054 | ||
| Line 11,807: | Line 13,282: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|breast cancer;rhabdomyosarcoma | |breast cancer;rhabdomyosarcoma | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290079 HSALNT0290079] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290079 HSALNT0290079] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142194 HSALNG0142194] |
|ncR-PAR | |ncR-PAR | ||
|NCRUPAR,ENSG00000225407 | |NCRUPAR,ENSG00000225407 | ||
| Line 11,815: | Line 13,291: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|gastric cancer;colorectal cancer | |gastric cancer;colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289167 HSALNT0289167] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289167 HSALNT0289167] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0061370 HSALNG0061370] |
|MESTIT1 | |MESTIT1 | ||
|MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS | |MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS | ||
| Line 11,823: | Line 13,300: | ||
|pathogenic process | |pathogenic process | ||
|Silver-Russell syndrome | |Silver-Russell syndrome | ||
| + | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273791 HSALNT0273791] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273791 HSALNT0273791] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133168 HSALNG0133168] |
|DSCAM-AS1 | |DSCAM-AS1 | ||
|M41 | |M41 | ||
| Line 11,831: | Line 13,309: | ||
|pathogenic process | |pathogenic process | ||
|adolescent idiopathic scoliosis;breast cancer | |adolescent idiopathic scoliosis;breast cancer | ||
| + | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289391 HSALNT0289391] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289391 HSALNT0289391] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104546 HSALNG0104546] |
|PWARSN | |PWARSN | ||
|PAR-SN,PARSN | |PAR-SN,PARSN | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127791 HSALNT0127791] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127791 HSALNT0127791] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060774 HSALNG0060774] |
|ST7-AS1 | |ST7-AS1 | ||
|ST7OT1,ST7AS1 | |ST7OT1,ST7AS1 | ||
| Line 11,847: | Line 13,327: | ||
|pathogenic process | |pathogenic process | ||
|glioma;autism | |glioma;autism | ||
| + | |Mental Disorders;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206298 HSALNT0206298] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206298 HSALNT0206298] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0099122 HSALNG0099122] |
|DAOA-AS1 | |DAOA-AS1 | ||
|DAOAA, DAOA-A,G30 | |DAOAA, DAOA-A,G30 | ||
| Line 11,855: | Line 13,336: | ||
|pathogenic process | |pathogenic process | ||
|panic disorder;schizophrenia;bipolar disorder | |panic disorder;schizophrenia;bipolar disorder | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167060 HSALNT0167060] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167060 HSALNT0167060] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0080104 HSALNG0080104] |
|OLMALINC | |OLMALINC | ||
|C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80 | |C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80 | ||
| Line 11,863: | Line 13,345: | ||
|pathogenic process | |pathogenic process | ||
|type 2 diabetes | |type 2 diabetes | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026878 HSALNT0026878] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026878 HSALNT0026878] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0012802 HSALNG0012802] |
|LINC00299 | |LINC00299 | ||
|C2orf46,NCRNA00299,FLJ45673 | |C2orf46,NCRNA00299,FLJ45673 | ||
| Line 11,871: | Line 13,354: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|intellectual and developmental disability;neurodevelopmental disabilities | |intellectual and developmental disability;neurodevelopmental disabilities | ||
| + | |Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289081 HSALNT0289081] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289081 HSALNT0289081] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039816 HSALNG0039816] |
|LINC01020 | |LINC01020 | ||
|NA | |NA | ||
| Line 11,879: | Line 13,363: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101186 HSALNT0101186] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101186 HSALNT0101186] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0048016 HSALNG0048016] |
|LINC00518 | |LINC00518 | ||
|C6orf218,MGC40222 | |C6orf218,MGC40222 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083960 HSALNT0083960] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083960 HSALNT0083960] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0039909 HSALNG0039909] |
|LINC01018 | |LINC01018 | ||
|SRHC | |SRHC | ||
| Line 11,895: | Line 13,381: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289361 HSALNT0289361] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289361 HSALNT0289361] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0031463 HSALNG0031463] |
|LPP-AS2 | |LPP-AS2 | ||
|MYCLo-5,MYCLo-6 | |MYCLo-5,MYCLo-6 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,905: | Line 13,393: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143233 HSALNT0143233] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143233 HSALNT0143233] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068292 HSALNG0068292] |
|LINC00964 | |LINC00964 | ||
|NA | |NA | ||
| Line 11,911: | Line 13,399: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289364 HSALNT0289364] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289364 HSALNT0289364] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094063 HSALNG0094063] |
|MAPKAPK5-AS1 | |MAPKAPK5-AS1 | ||
|C12orf47,FLJ39616 | |C12orf47,FLJ39616 | ||
| Line 11,919: | Line 13,408: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289053 HSALNT0289053] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289053 HSALNT0289053] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0027872 HSALNG0027872] |
|LINC00635 | |LINC00635 | ||
|NA | |NA | ||
| Line 11,927: | Line 13,417: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289327 HSALNT0289327] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289327 HSALNT0289327] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141633 HSALNG0141633] |
|LINC00636 | |LINC00636 | ||
|NA | |NA | ||
| Line 11,935: | Line 13,426: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262657 HSALNT0262657] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262657 HSALNT0262657] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0127758 HSALNG0127758] |
|ZNF582-AS1 | |ZNF582-AS1 | ||
|NA | |NA | ||
| Line 11,943: | Line 13,435: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289020 HSALNT0289020] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289020 HSALNT0289020] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000022 HSALNG0000022] |
|LINC00115 | |LINC00115 | ||
|NCRNA00115,FLJ22639 | |NCRNA00115,FLJ22639 | ||
| Line 11,951: | Line 13,444: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289254 HSALNT0289254] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289254 HSALNT0289254] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075291 HSALNG0075291] |
|SNHG7 | |SNHG7 | ||
|MGC16037,NCRNA00061 | |MGC16037,NCRNA00061 | ||
| Line 11,959: | Line 13,453: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289162 HSALNT0289162] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289162 HSALNT0289162] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0020412 HSALNG0020412] |
|MAP3K20-AS1 | |MAP3K20-AS1 | ||
|MLK7-AS1 | |MLK7-AS1 | ||
| Line 11,967: | Line 13,462: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145357 HSALNT0145357] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145357 HSALNT0145357] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069280 HSALNG0069280] |
|RHPN1-AS1 | |RHPN1-AS1 | ||
|C8orf51,MGC3113 | |C8orf51,MGC3113 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 11,977: | Line 13,474: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289343 HSALNT0289343] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289343 HSALNT0289343] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0138602 HSALNG0138602] |
|XIST | |XIST | ||
|DXS399E,NCRNA00001,DXS1089,swd66,LINC00001 | |DXS399E,NCRNA00001,DXS1089,swd66,LINC00001 | ||
| Line 11,983: | Line 13,480: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis | |non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis | ||
| + | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289389 HSALNT0289389] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289389 HSALNT0289389] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0128330 HSALNG0128330] |
|PRNT | |PRNT | ||
|M8 | |M8 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288942 HSALNT0288942] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288942 HSALNT0288942] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0080912 HSALNG0080912] |
|EMX2OS | |EMX2OS | ||
|NCRNA00045,EMX2-AS1 | |NCRNA00045,EMX2-AS1 | ||
|transcriptional regulation | |transcriptional regulation | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200443 HSALNT0200443] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200443 HSALNT0200443] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0096546 HSALNG0096546] |
|LINC00598 | |LINC00598 | ||
|TTL | |TTL | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289517 HSALNT0289517] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289517 HSALNT0289517] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141628 HSALNG0141628] |
|TTTY17A | |TTTY17A | ||
|NCRNA00140 | |NCRNA00140 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,017: | Line 13,519: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027901 HSALNT0027901] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027901 HSALNT0027901] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0013206 HSALNG0013206] |
|MYCNOS | |MYCNOS | ||
|NCYM,N-CYM,MYCN-AS1 | |NCYM,N-CYM,MYCN-AS1 | ||
| Line 12,023: | Line 13,525: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0047175 HSALNT0047175] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0047175 HSALNT0047175] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0022192 HSALNG0022192] |
|DIRC3 | |DIRC3 | ||
|FLJ14199 | |FLJ14199 | ||
| Line 12,031: | Line 13,534: | ||
|pathogenic process | |pathogenic process | ||
|familial renal cell cancer;breast cancer | |familial renal cell cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289363 HSALNT0289363] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289363 HSALNT0289363] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0084905 HSALNG0084905] |
|MALAT1 | |MALAT1 | ||
|PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA | |PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA | ||
| Line 12,039: | Line 13,543: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis | |prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis | ||
| + | |Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289744 HSALNT0289744] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289744 HSALNT0289744] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141859 HSALNG0141859] |
|DLG2-AS1 | |DLG2-AS1 | ||
|DLG2A, DLG2-A,PSZA11q14,SZ-1 | |DLG2A, DLG2-A,PSZA11q14,SZ-1 | ||
| Line 12,047: | Line 13,552: | ||
|pathogenic process | |pathogenic process | ||
|schizophrenia;myotonic dystrophy type 1;heart failure | |schizophrenia;myotonic dystrophy type 1;heart failure | ||
| + | |Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289164 HSALNT0289164] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289164 HSALNT0289164] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0103778 HSALNG0103778] |
|MEG3 | |MEG3 | ||
|FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1 | |FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1 | ||
| Line 12,055: | Line 13,561: | ||
|pathogenic process | |pathogenic process | ||
|oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor | |oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor | ||
| + | |Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290298 HSALNT0290298] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290298 HSALNT0290298] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142413 HSALNG0142413] |
|TERC | |TERC | ||
|DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR | |DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR | ||
| Line 12,063: | Line 13,570: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;dyskeratosis congenita;lung squamous cell cancer | |prostate cancer;dyskeratosis congenita;lung squamous cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288907 HSALNT0288907] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288907 HSALNT0288907] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0080948 HSALNG0080948] |
|CASC2 | |CASC2 | ||
|NA | |NA | ||
| Line 12,071: | Line 13,579: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma | |colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma | ||
| + | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205332 HSALNT0205332] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205332 HSALNT0205332] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0098601 HSALNG0098601] |
|MIR17HG | |MIR17HG | ||
|C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048 | |C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048 | ||
| Line 12,079: | Line 13,588: | ||
|pathogenic process | |pathogenic process | ||
|diffuse large B-cell lymphoma;syndromic developmental defect;cancer | |diffuse large B-cell lymphoma;syndromic developmental defect;cancer | ||
| + | |Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288716 HSALNT0288716] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288716 HSALNT0288716] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141456 HSALNG0141456] |
|TTTY6 | |TTTY6 | ||
|TTY6,TTTY6A,LINC00127 | |TTY6,TTTY6A,LINC00127 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,089: | Line 13,600: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288731 HSALNT0288731] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288731 HSALNT0288731] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141468 HSALNG0141468] |
|TTTY4 | |TTTY4 | ||
|TTY4,TTTY4A,LINC00123 | |TTY4,TTTY4A,LINC00123 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,097: | Line 13,609: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288815 HSALNT0288815] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288815 HSALNT0288815] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141548 HSALNG0141548] |
|TTTY3 | |TTTY3 | ||
|TTY3,TTTY3A,LINC00121 | |TTY3,TTTY3A,LINC00121 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,105: | Line 13,618: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288703 HSALNT0288703] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288703 HSALNT0288703] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141450 HSALNG0141450] |
|TTTY5 | |TTTY5 | ||
|TTY5,LINC00126 | |TTY5,LINC00126 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,113: | Line 13,627: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289255 HSALNT0289255] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289255 HSALNT0289255] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0036656 HSALNG0036656] |
|SNHG8 | |SNHG8 | ||
|NCRNA00060,LINC00060 | |NCRNA00060,LINC00060 | ||
| Line 12,119: | Line 13,633: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;malignant pleural mesothelioma | |gastric cancer;malignant pleural mesothelioma | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289486 HSALNT0289486] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289486 HSALNT0289486] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141597 HSALNG0141597] |
|BCYRN1 | |BCYRN1 | ||
|BC200,BC200a,NCRNA00004,LINC00004 | |BC200,BC200a,NCRNA00004,LINC00004 | ||
| Line 12,127: | Line 13,642: | ||
|pathogenic process | |pathogenic process | ||
|aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer | |aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144426 HSALNT0144426] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144426 HSALNT0144426] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068805 HSALNG0068805] |
|ZFAT-AS1 | |ZFAT-AS1 | ||
|ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070 | |ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070 | ||
| Line 12,135: | Line 13,651: | ||
|pathogenic process | |pathogenic process | ||
|autoimmune disease | |autoimmune disease | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289285 HSALNT0289285] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289285 HSALNT0289285] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0077083 HSALNG0077083] |
|ZEB1-AS1 | |ZEB1-AS1 | ||
|NA | |NA | ||
| Line 12,143: | Line 13,660: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer | |esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer | ||
| + | |Immune System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289185 HSALNT0289185] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289185 HSALNT0289185] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0135987 HSALNG0135987] |
|MIRLET7BHG | |MIRLET7BHG | ||
|linc-Ppara | |linc-Ppara | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289374 HSALNT0289374] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289374 HSALNT0289374] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0116616 HSALNG0116616] |
|NBR2 | |NBR2 | ||
|NCRNA00192 | |NCRNA00192 | ||
| Line 12,159: | Line 13,678: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;breast cancer;cancer | |gastric cancer;breast cancer;cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289417 HSALNT0289417] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289417 HSALNT0289417] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134930 HSALNG0134930] |
|TUG1 | |TUG1 | ||
|FLJ20618,NCRNA00080,LINC00080 | |FLJ20618,NCRNA00080,LINC00080 | ||
| Line 12,167: | Line 13,687: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer | |osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288973 HSALNT0288973] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288973 HSALNT0288973] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0079552 HSALNG0079552] |
|FAS-AS1 | |FAS-AS1 | ||
|FASA, FAS-A,SAF | |FASA, FAS-A,SAF | ||
| Line 12,175: | Line 13,696: | ||
|pathogenic process | |pathogenic process | ||
|ataxia telangiectasia | |ataxia telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288996 HSALNT0288996] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288996 HSALNT0288996] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068110 HSALNG0068110] |
|HAS2-AS1 | |HAS2-AS1 | ||
|HAS2A, HAS2-A,HASNT,NCRNA00077 | |HAS2A, HAS2-A,HASNT,NCRNA00077 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289390 HSALNT0289390] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289390 HSALNT0289390] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049245 HSALNG0049245] |
|PSORS1C3 | |PSORS1C3 | ||
|NCRNA00196 | |NCRNA00196 | ||
| Line 12,191: | Line 13,714: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis;psoriasis | |rheumatoid arthritis;psoriasis | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289868 HSALNT0289868] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289868 HSALNT0289868] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141983 HSALNG0141983] |
|HLA-AS1 | |HLA-AS1 | ||
|NA | |NA | ||
| Line 12,199: | Line 13,723: | ||
|pathogenic process | |pathogenic process | ||
|psoriasis;liver injury;multiple sclerosis;AIDS | |psoriasis;liver injury;multiple sclerosis;AIDS | ||
| + | |Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290154 HSALNT0290154] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290154 HSALNT0290154] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142269 HSALNG0142269] |
|PRINS | |PRINS | ||
|NCRNA00074 | |NCRNA00074 | ||
| Line 12,207: | Line 13,732: | ||
|pathogenic process | |pathogenic process | ||
|psoriasis;prostate cancer | |psoriasis;prostate cancer | ||
| + | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262809 HSALNT0262809] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262809 HSALNT0262809] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0127790 HSALNG0127790] |
|PEG3-AS1 | |PEG3-AS1 | ||
|PEG3AS,PEG3-AS,APEG3,NCRNA00155 | |PEG3AS,PEG3-AS,APEG3,NCRNA00155 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,217: | Line 13,744: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289533 HSALNT0289533] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289533 HSALNT0289533] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141648 HSALNG0141648] |
|7SL | |7SL | ||
|7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1 | |7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1 | ||
| Line 12,223: | Line 13,750: | ||
|pathogenic process | |pathogenic process | ||
|AIDS;Leishmaniasis;dermatomyositis;polymyositis | |AIDS;Leishmaniasis;dermatomyositis;polymyositis | ||
| + | |Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290081 HSALNT0290081] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290081 HSALNT0290081] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142196 HSALNG0142196] |
|NDM29 | |NDM29 | ||
|29A,lnc-C11orf16-1:1 | |29A,lnc-C11orf16-1:1 | ||
| Line 12,231: | Line 13,759: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289382 HSALNT0289382] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289382 HSALNT0289382] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074439 HSALNG0074439] |
|NRON | |NRON | ||
|NCRNA00194 | |NCRNA00194 | ||
| Line 12,239: | Line 13,768: | ||
|pathogenic process | |pathogenic process | ||
|AIDS;Down syndrome;HIV | |AIDS;Down syndrome;HIV | ||
| + | |Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289253 HSALNT0289253] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289253 HSALNT0289253] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0065926 HSALNG0065926] |
|SNHG6 | |SNHG6 | ||
|U87HG,HBII-276HG,NCRNA00058 | |U87HG,HBII-276HG,NCRNA00058 | ||
| Line 12,247: | Line 13,777: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;hereditary haemorrhagic telangiectasia | |hepatocellular cancer;hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289653 HSALNT0289653] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289653 HSALNT0289653] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141768 HSALNG0141768] |
|Beta-globin transcript | |Beta-globin transcript | ||
|AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1,NONHSAT017676 | |AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1,NONHSAT017676 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,257: | Line 13,789: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290398 HSALNT0290398] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290398 HSALNT0290398] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142513 HSALNG0142513] |
|Zfhx2as | |Zfhx2as | ||
|Zfh-5AS,ENSG00000157306,ENST00000554403.1 | |Zfh-5AS,ENSG00000157306,ENST00000554403.1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,265: | Line 13,798: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011306 HSALNT0011306] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011306 HSALNT0011306] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0005433 HSALNG0005433] |
|MIR137HG | |MIR137HG | ||
|NA | |NA | ||
| Line 12,271: | Line 13,804: | ||
|pathogenic process | |pathogenic process | ||
|schizophrenia;lung cancer;malignant lymphoma | |schizophrenia;lung cancer;malignant lymphoma | ||
| + | |Respiratory Tract Diseases;Mental Disorders;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289449 HSALNT0289449] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289449 HSALNT0289449] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0056858 HSALNG0056858] |
|HOXA-AS3 | |HOXA-AS3 | ||
|HOXA6as | |HOXA6as | ||
| Line 12,279: | Line 13,813: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289451 HSALNT0289451] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289451 HSALNT0289451] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068551 HSALNG0068551] |
|CCDC26 | |CCDC26 | ||
|MGC27434,RAM | |MGC27434,RAM | ||
| Line 12,287: | Line 13,822: | ||
|pathogenic process | |pathogenic process | ||
|hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer | |hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289893 HSALNT0289893] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289893 HSALNT0289893] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142008 HSALNG0142008] |
|LINC00271 | |LINC00271 | ||
|C6orf217,NCRNA00271 | |C6orf217,NCRNA00271 | ||
| Line 12,295: | Line 13,831: | ||
|pathogenic process | |pathogenic process | ||
|type 2 diabetes;schizophrenia | |type 2 diabetes;schizophrenia | ||
| + | |Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288892 HSALNT0288892] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288892 HSALNT0288892] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0109621 HSALNG0109621] |
|BCAR4 | |BCAR4 | ||
|NA | |NA | ||
| Line 12,303: | Line 13,840: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;breast cancer;colorectal cancer | |osteosarcoma;breast cancer;colorectal cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289890 HSALNT0289890] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289890 HSALNT0289890] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142005 HSALNG0142005] |
|LINC00032 | |LINC00032 | ||
|C9orf14,NCRNA00032 | |C9orf14,NCRNA00032 | ||
| Line 12,311: | Line 13,849: | ||
|pathogenic process | |pathogenic process | ||
|narcolepsy;melanoma | |narcolepsy;melanoma | ||
| + | |Mental Disorders;Neoplasms;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274572 HSALNT0274572] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274572 HSALNT0274572] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133591 HSALNG0133591] |
|PICSAR | |PICSAR | ||
|C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74 | |C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74 | ||
| Line 12,319: | Line 13,858: | ||
|pathogenic process | |pathogenic process | ||
|testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer | |testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer | ||
| + | |Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0256354 HSALNT0256354] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0256354 HSALNT0256354] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0124398 HSALNG0124398] |
|UCA1 | |UCA1 | ||
|CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36 | |CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36 | ||
| Line 12,327: | Line 13,867: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer | |oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003871 HSALNT0003871] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003871 HSALNT0003871] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0002066 HSALNG0002066] |
|SNHG3 | |SNHG3 | ||
|NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB | |NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB | ||
| Line 12,335: | Line 13,876: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease | |ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease | ||
| + | |Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNT0289475] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNT0289475] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0131591 HSALNG0131591] |
|HAR1A | |HAR1A | ||
|HAR1F,NCRNA00064,LINC00064 | |HAR1F,NCRNA00064,LINC00064 | ||
| Line 12,343: | Line 13,885: | ||
|pathogenic process | |pathogenic process | ||
|Huntington disease;Alzheimer's disease | |Huntington disease;Alzheimer's disease | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288995 HSALNT0288995] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288995 HSALNT0288995] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0131589 HSALNG0131589] |
|HAR1B | |HAR1B | ||
|HAR1R,NCRNA00065,LINC00065 | |HAR1R,NCRNA00065,LINC00065 | ||
| Line 12,351: | Line 13,894: | ||
|pathogenic process | |pathogenic process | ||
|Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease | |Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease | ||
| + | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288958 HSALNT0288958] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288958 HSALNT0288958] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0044150 HSALNG0044150] |
|EPB41L4A-AS1 | |EPB41L4A-AS1 | ||
|C5orf26,NCRNA00219,TIGA1 | |C5orf26,NCRNA00219,TIGA1 | ||
| Line 12,359: | Line 13,903: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;cancer | |lung cancer;cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289170 HSALNT0289170] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289170 HSALNT0289170] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134655 HSALNG0134655] |
|MIAT | |MIAT | ||
|C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT | |C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT | ||
| Line 12,367: | Line 13,912: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease | |prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease | ||
| + | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289007 HSALNT0289007] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289007 HSALNT0289007] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0047947 HSALNG0047947] |
|HULC | |HULC | ||
|NCRNA00078,LINC00078,HCCAT1 | |NCRNA00078,LINC00078,HCCAT1 | ||
| Line 12,375: | Line 13,921: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer | |prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer | ||
| + | |Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288940 HSALNT0288940] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288940 HSALNT0288940] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0023880 HSALNG0023880] |
|EGOT | |EGOT | ||
|EGO,NCRNA00190 | |EGO,NCRNA00190 | ||
| Line 12,383: | Line 13,930: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|prostate cancer;breast cancer | |prostate cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289387 HSALNT0289387] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289387 HSALNT0289387] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0001461 HSALNG0001461] |
|PINK1-AS | |PINK1-AS | ||
|PINK1-AS1,FLJ00387,PINK1A, naPINK1 | |PINK1-AS1,FLJ00387,PINK1A, naPINK1 | ||
| Line 12,391: | Line 13,939: | ||
|pathogenic process | |pathogenic process | ||
|glucose metabolism disorder;Parkinson's disease;diabetes | |glucose metabolism disorder;Parkinson's disease;diabetes | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289225 HSALNT0289225] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289225 HSALNT0289225] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068477 HSALNG0068477] |
|PVT1 | |PVT1 | ||
|NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT | |NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT | ||
| Line 12,399: | Line 13,948: | ||
|pathogenic process | |pathogenic process | ||
|murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer | |murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289189 HSALNT0289189] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289189 HSALNT0289189] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0073233 HSALNG0073233] |
|NAMA | |NAMA | ||
|NA | |NA | ||
| Line 12,407: | Line 13,957: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246525 HSALNT0246525] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246525 HSALNT0246525] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119442 HSALNG0119442] |
|NARF-AS1 | |NARF-AS1 | ||
|NA | |NA | ||
| Line 12,415: | Line 13,966: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0147433 HSALNT0147433] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0147433 HSALNT0147433] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0070397 HSALNG0070397] |
|CDKN2B-AS1 | |CDKN2B-AS1 | ||
|CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12 | |CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12 | ||
| Line 12,423: | Line 13,975: | ||
|pathogenic process | |pathogenic process | ||
|glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis | |glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis | ||
| + | |Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050854 HSALNT0050854] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050854 HSALNT0050854] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0024099 HSALNG0024099] |
|GHRLOS | |GHRLOS | ||
|NCRNA00068,GHRL-AS1 | |NCRNA00068,GHRL-AS1 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288959 HSALNT0288959] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288959 HSALNT0288959] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026279 HSALNG0026279] |
|ESRG | |ESRG | ||
|HESRG | |HESRG | ||
| Line 12,439: | Line 13,993: | ||
|pathogenic process | |pathogenic process | ||
|embryonal cancer | |embryonal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287173 HSALNT0287173] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287173 HSALNT0287173] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140560 HSALNG0140560] |
|FMR1-AS1 | |FMR1-AS1 | ||
|FMR1A, FMR1-A,ASFMR1,FMR4 | |FMR1A, FMR1-A,ASFMR1,FMR4 | ||
| Line 12,447: | Line 14,002: | ||
|pathogenic process | |pathogenic process | ||
|fragile X syndrome;neurological disorder | |fragile X syndrome;neurological disorder | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289499 HSALNT0289499] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289499 HSALNT0289499] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141610 HSALNG0141610] |
|HCG4 | |HCG4 | ||
|HCGIV-10,HCGIV.9 | |HCGIV-10,HCGIV.9 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288994 HSALNT0288994] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288994 HSALNT0288994] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0038609 HSALNG0038609] |
|HAND2-AS1 | |HAND2-AS1 | ||
|DEIN,NBLA00301,FLJ11539 | |DEIN,NBLA00301,FLJ11539 | ||
| Line 12,463: | Line 14,020: | ||
|pathogenic process | |pathogenic process | ||
|neuroblastoma | |neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289286 HSALNT0289286] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289286 HSALNT0289286] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0019362 HSALNG0019362] |
|ZEB2-AS1 | |ZEB2-AS1 | ||
|ZEB2A, ZEB2-A,ZEB2NAT | |ZEB2A, ZEB2-A,ZEB2NAT | ||
| Line 12,471: | Line 14,029: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;hepatocellular cancer | |bladder cancer;hepatocellular cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017702 HSALNT0017702] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017702 HSALNT0017702] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008545 HSALNG0008545] |
|GAS5 | |GAS5 | ||
|SNHG2,NCRNA00030 | |SNHG2,NCRNA00030 | ||
| Line 12,479: | Line 14,038: | ||
|pathogenic process | |pathogenic process | ||
|varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer | |varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288891 HSALNT0288891] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288891 HSALNT0288891] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0087449 HSALNG0087449] |
|BACE1-AS | |BACE1-AS | ||
|BACE1A,FJ573250,NCRNA00177,BACE1-AS1 | |BACE1A,FJ573250,NCRNA00177,BACE1-AS1 | ||
| Line 12,487: | Line 14,047: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;colorectal cancer;Alzheimer's disease | |ovarian cancer;colorectal cancer;Alzheimer's disease | ||
| + | |Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289414 HSALNT0289414] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289414 HSALNT0289414] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133533 HSALNG0133533] |
|TRPM2-AS | |TRPM2-AS | ||
|TRPM2-AS1 | |TRPM2-AS1 | ||
| Line 12,495: | Line 14,056: | ||
|pathogenic process | |pathogenic process | ||
|melanoma;prostate cancer | |melanoma;prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288935 HSALNT0288935] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288935 HSALNT0288935] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008462 HSALNG0008462] |
|DNM3OS | |DNM3OS | ||
|DNM3-AS1,MIR199A2HG | |DNM3-AS1,MIR199A2HG | ||
| Line 12,503: | Line 14,065: | ||
|pathogenic process | |pathogenic process | ||
|epithelial ovarian cancer | |epithelial ovarian cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288930 HSALNT0288930] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288930 HSALNT0288930] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133982 HSALNG0133982] |
|DGCR5 | |DGCR5 | ||
|NCRNA00037,LINC00037 | |NCRNA00037,LINC00037 | ||
| Line 12,511: | Line 14,074: | ||
|pathogenic process | |pathogenic process | ||
|Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer | |Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288893 HSALNT0288893] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288893 HSALNT0288893] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0083307 HSALNG0083307] |
|BDNF-AS | |BDNF-AS | ||
|BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS | |BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS | ||
| Line 12,519: | Line 14,083: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|Huntington disease;schizophrenia;psychiatric disease;obesity | |Huntington disease;schizophrenia;psychiatric disease;obesity | ||
| + | |Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120317 HSALNT0120317] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120317 HSALNT0120317] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0056850 HSALNG0056850] |
|HOTAIRM1 | |HOTAIRM1 | ||
|HOXA-AS1,NCRNA00179,HOXA1-AS1 | |HOXA-AS1,NCRNA00179,HOXA1-AS1 | ||
| Line 12,527: | Line 14,092: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma | |colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma | ||
| + | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290158 HSALNT0290158] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290158 HSALNT0290158] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142273 HSALNG0142273] |
|PTCSC1 | |PTCSC1 | ||
|PTCSC,AK023948,NCRNA00197 | |PTCSC,AK023948,NCRNA00197 | ||
| Line 12,535: | Line 14,101: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289004 HSALNT0289004] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289004 HSALNT0289004] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091318 HSALNG0091318] |
|HOTAIR | |HOTAIR | ||
|HOXC-AS4,HOXC11-AS1,NCRNA00072 | |HOXC-AS4,HOXC11-AS1,NCRNA00072 | ||
| Line 12,543: | Line 14,110: | ||
|pathogenic process | |pathogenic process | ||
|oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer | |oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289192 HSALNT0289192] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289192 HSALNT0289192] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0084892 HSALNG0084892] |
|NEAT1 | |NEAT1 | ||
|NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC | |NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC | ||
| Line 12,551: | Line 14,119: | ||
|pathogenic process | |pathogenic process | ||
|oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer | |oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095094 HSALNT0095094] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095094 HSALNT0095094] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045213 HSALNG0045213] |
|SNHG4 | |SNHG4 | ||
|U19H,NCRNA00059 | |U19H,NCRNA00059 | ||
| Line 12,559: | Line 14,128: | ||
|pathogenic process | |pathogenic process | ||
|myelodysplastic syndrome | |myelodysplastic syndrome | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245443 HSALNT0245443] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245443 HSALNT0245443] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0118855 HSALNG0118855] |
|SNHG16 | |SNHG16 | ||
|ncRAN,Nbla12061,Nbla10727 | |ncRAN,Nbla12061,Nbla10727 | ||
| Line 12,567: | Line 14,137: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;bladder cancer;colorectal cancer;neuroblastoma | |bladder cancer;bladder cancer;colorectal cancer;neuroblastoma | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288897 HSALNT0288897] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288897 HSALNT0288897] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0023698 HSALNG0023698] |
|BOK-AS1 | |BOK-AS1 | ||
|BOKA,NCRNA00151,NAToB | |BOKA,NCRNA00151,NAToB | ||
| Line 12,575: | Line 14,146: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;testicular cancer;cancer | |esophageal squamous cell cancer;testicular cancer;cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289532 HSALNT0289532] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289532 HSALNT0289532] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141647 HSALNG0141647] |
|7SK | |7SK | ||
|7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149 | |7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149 | ||
| Line 12,583: | Line 14,155: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma | |cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma | ||
| + | |Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289182 HSALNT0289182] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289182 HSALNT0289182] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0017872 HSALNG0017872] |
|MIR4435-2HG | |MIR4435-2HG | ||
|MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID | |MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID | ||
| Line 12,591: | Line 14,164: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289200 HSALNT0289200] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289200 HSALNT0289200] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0016500 HSALNG0016500] |
|PARTICL | |PARTICL | ||
|PARTICLE | |PARTICLE | ||
| Line 12,599: | Line 14,173: | ||
|pathogenic process | |pathogenic process | ||
|low-dose irradiation | |low-dose irradiation | ||
| + | |Disorders of Environmental Origin | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289172 HSALNT0289172] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289172 HSALNT0289172] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069266 HSALNG0069266] |
|MINCR | |MINCR | ||
|LINC01604,TCONS_00015189 | |LINC01604,TCONS_00015189 | ||
| Line 12,607: | Line 14,182: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer;Burkitt lymphoma | |gallbladder cancer;Burkitt lymphoma | ||
| + | |Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001792 HSALNT0001792] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001792 HSALNT0001792] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000905 HSALNG0000905] |
|NPPA-AS1 | |NPPA-AS1 | ||
|NPPAA, NPPA-AS | |NPPAA, NPPA-AS | ||
| Line 12,615: | Line 14,191: | ||
|pathogenic process | |pathogenic process | ||
|cardiovascular disease | |cardiovascular disease | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290230 HSALNT0290230] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290230 HSALNT0290230] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142345 HSALNG0142345] |
|RRP1B | |RRP1B | ||
|NA | |NA | ||
| Line 12,623: | Line 14,200: | ||
|pathogenic process | |pathogenic process | ||
|spinocerebellar ataxia;laryngeal squamous cell cancer;cancer | |spinocerebellar ataxia;laryngeal squamous cell cancer;cancer | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289467 HSALNT0289467] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289467 HSALNT0289467] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0093062 HSALNG0093062] |
|CLLU1 | |CLLU1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,633: | Line 14,212: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289173 HSALNT0289173] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289173 HSALNT0289173] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0087764 HSALNG0087764] |
|MIR100HG | |MIR100HG | ||
|AGD1,lncRNA-N2,linc-NeD125 | |AGD1,lncRNA-N2,linc-NeD125 | ||
| Line 12,639: | Line 14,218: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|myeloid leukemia;myopia;cervical cancer;neuroblastoma | |myeloid leukemia;myopia;cervical cancer;neuroblastoma | ||
| + | |Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059175 HSALNT0059175] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059175 HSALNT0059175] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0028235 HSALNG0028235] |
|TUSC7 | |TUSC7 | ||
|LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295 | |LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295 | ||
| Line 12,647: | Line 14,227: | ||
|pathogenic process | |pathogenic process | ||
|glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer | |glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer | ||
| + | |Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289647 HSALNT0289647] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289647 HSALNT0289647] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141762 HSALNG0141762] |
|BC040587 | |BC040587 | ||
|NA | |NA | ||
| Line 12,655: | Line 14,236: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;breast cancer | |osteosarcoma;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059186 HSALNT0059186] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059186 HSALNT0059186] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0028242 HSALNG0028242] |
|LINC00901 | |LINC00901 | ||
|LSAMP-AS4,TCONS_00005428,BC040587 | |LSAMP-AS4,TCONS_00005428,BC040587 | ||
| Line 12,663: | Line 14,245: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;gastric cancer;breast cancer | |osteosarcoma;gastric cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233366 HSALNT0233366] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233366 HSALNT0233366] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0112604 HSALNG0112604] |
|HCCAT5 | |HCCAT5 | ||
|HTA,FJ222407 | |HTA,FJ222407 | ||
| Line 12,671: | Line 14,254: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290040 HSALNT0290040] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290040 HSALNT0290040] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142155 HSALNG0142155] |
|LSINCT5 | |LSINCT5 | ||
|NA | |NA | ||
| Line 12,679: | Line 14,263: | ||
|pathogenic process | |pathogenic process | ||
|chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer | |chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0179611 HSALNT0179611] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0179611 HSALNT0179611] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0086377 HSALNG0086377] |
|DISC1FP1 | |DISC1FP1 | ||
|Boymaw | |Boymaw | ||
| Line 12,687: | Line 14,272: | ||
|pathogenic process | |pathogenic process | ||
|schizophrenia | |schizophrenia | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217643 HSALNT0217643] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217643 HSALNT0217643] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104567 HSALNG0104567] |
|SNHG14 | |SNHG14 | ||
|115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS | |115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS | ||
| Line 12,695: | Line 14,281: | ||
|pathogenic process | |pathogenic process | ||
|Angelman syndrome;cerebral infarction;Prader-Willi syndrome | |Angelman syndrome;cerebral infarction;Prader-Willi syndrome | ||
| + | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289273 HSALNT0289273] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289273 HSALNT0289273] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000343 HSALNG0000343] |
|TP73-AS1 | |TP73-AS1 | ||
|KIAA0495,PDAM | |KIAA0495,PDAM | ||
| Line 12,703: | Line 14,290: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma | |esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma | ||
| + | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290311 HSALNT0290311] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290311 HSALNT0290311] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142426 HSALNG0142426] |
|TP53COR1 | |TP53COR1 | ||
|Trp53cor1 | |Trp53cor1 | ||
| Line 12,711: | Line 14,299: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer | |prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289221 HSALNT0289221] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289221 HSALNT0289221] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068414 HSALNG0068414] |
|PRNCR1 | |PRNCR1 | ||
|CARLo-3,PCAT8 | |CARLo-3,PCAT8 | ||
| Line 12,719: | Line 14,308: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;prostate cancer;glioma;colorectal cancer | |gastric cancer;prostate cancer;glioma;colorectal cancer | ||
| + | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020131 HSALNT0020131] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020131 HSALNT0020131] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0009743 HSALNG0009743] |
|PCAT6 | |PCAT6 | ||
|KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96 | |KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96 | ||
| Line 12,727: | Line 14,317: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;triple-negative breast cancer;lung cancer | |prostate cancer;triple-negative breast cancer;lung cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289277 HSALNT0289277] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289277 HSALNT0289277] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0130723 HSALNG0130723] |
|TRERNA1 | |TRERNA1 | ||
|LINC00651,ncRNA-a7,treRNA | |LINC00651,ncRNA-a7,treRNA | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014972 HSALNT0014972] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014972 HSALNT0014972] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007045 HSALNG0007045] |
|FALEC | |FALEC | ||
|LINC00568,ncRNA-a1,FAL1 | |LINC00568,ncRNA-a1,FAL1 | ||
| Line 12,743: | Line 14,335: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;thyroid cancer | |ovarian cancer;thyroid cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290008 HSALNT0290008] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290008 HSALNT0290008] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142123 HSALNG0142123] |
|LOC100887755 | |LOC100887755 | ||
|Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1 | |Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1 | ||
| Line 12,751: | Line 14,344: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290248 HSALNT0290248] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290248 HSALNT0290248] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142363 HSALNG0142363] |
|snaR | |snaR | ||
|EU035784.1,lnc-BSPH1-1:1 | |EU035784.1,lnc-BSPH1-1:1 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289342 HSALNT0289342] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289342 HSALNT0289342] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0138609 HSALNG0138609] |
|JPX | |JPX | ||
|NCRNA00183,ENOX,LINC00183,DCBALD06 | |NCRNA00183,ENOX,LINC00183,DCBALD06 | ||
| Line 12,767: | Line 14,362: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289231 HSALNT0289231] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289231 HSALNT0289231] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0001716 HSALNG0001716] |
|RCAN3AS | |RCAN3AS | ||
|TCONS_00001428 | |TCONS_00001428 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 12,777: | Line 14,374: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289280 HSALNT0289280] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289280 HSALNT0289280] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069631 HSALNG0069631] |
|VLDLR-AS1 | |VLDLR-AS1 | ||
|lincRNA-VLDLR | |lincRNA-VLDLR | ||
| Line 12,783: | Line 14,380: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288982 HSALNT0288982] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288982 HSALNT0288982] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0138614 HSALNG0138614] |
|FTX | |FTX | ||
|NCRNA00182,MIR374AHG,LINC00182,FLJ33139 | |NCRNA00182,MIR374AHG,LINC00182,FLJ33139 | ||
| Line 12,791: | Line 14,389: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer | |hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091079 HSALNT0091079] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091079 HSALNT0091079] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043383 HSALNG0043383] |
|MEF2C-AS1 | |MEF2C-AS1 | ||
|NA | |NA | ||
| Line 12,799: | Line 14,398: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;Prader-Willi syndrome and Angelman syndrome | |gastric cancer;Prader-Willi syndrome and Angelman syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189341 HSALNT0189341] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189341 HSALNT0189341] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091277 HSALNG0091277] |
|PCBP2-OT1 | |PCBP2-OT1 | ||
|TUC338 | |TUC338 | ||
| Line 12,807: | Line 14,407: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;tongue squamous cell cancer | |hepatocellular cancer;tongue squamous cell cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290373 HSALNT0290373] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290373 HSALNT0290373] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142488 HSALNG0142488] |
|WRAP53 | |WRAP53 | ||
|NA | |NA | ||
| Line 12,815: | Line 14,416: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;cancer;dyskeratosis congenita | |hepatocellular cancer;cancer;dyskeratosis congenita | ||
| + | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289265 HSALNT0289265] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289265 HSALNT0289265] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049949 HSALNG0049949] |
|TDRG1 | |TDRG1 | ||
|LINC00532,lincRNA-NRNA024015 | |LINC00532,lincRNA-NRNA024015 | ||
| Line 12,823: | Line 14,425: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia | |esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia | ||
| + | |Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289175 HSALNT0289175] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289175 HSALNT0289175] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132382 HSALNG0132382] |
|MIR155HG | |MIR155HG | ||
|MIRHG2,BIC,NCRNA00172 | |MIRHG2,BIC,NCRNA00172 | ||
| Line 12,831: | Line 14,434: | ||
|pathogenic process | |pathogenic process | ||
|B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma | |B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma | ||
| + | |Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289051 HSALNT0289051] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289051 HSALNT0289051] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0024293 HSALNG0024293] |
|LINC00620 | |LINC00620 | ||
|NA | |NA | ||
| Line 12,839: | Line 14,443: | ||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120390 HSALNT0120390] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120390 HSALNT0120390] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0056871 HSALNG0056871] |
|HOTTIP | |HOTTIP | ||
|NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1 | |NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1 | ||
| Line 12,847: | Line 14,452: | ||
|pathogenic process | |pathogenic process | ||
|hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma | |hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289287 HSALNT0289287] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289287 HSALNT0289287] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0130661 HSALNG0130661] |
|ZFAS1 | |ZFAS1 | ||
|C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2 | |C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2 | ||
| Line 12,855: | Line 14,461: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer | |gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289259 HSALNT0289259] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289259 HSALNT0289259] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045502 HSALNG0045502] |
|SPRY4-IT1 | |SPRY4-IT1 | ||
|SPRIGHTLY | |SPRIGHTLY | ||
| Line 12,863: | Line 14,470: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer | |prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105595 HSALNT0105595] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105595 HSALNT0105595] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049759 HSALNG0049759] |
|PANDAR | |PANDAR | ||
|PANDA | |PANDA | ||
| Line 12,871: | Line 14,479: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer | |colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068185 HSALNT0068185] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068185 HSALNT0068185] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0032415 HSALNG0032415] |
|HTT-AS | |HTT-AS | ||
|HTT-AS1,HTTAS | |HTT-AS1,HTTAS | ||
| Line 12,879: | Line 14,488: | ||
|pathogenic process | |pathogenic process | ||
|Huntington disease | |Huntington disease | ||
| + | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099036 HSALNT0099036] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099036 HSALNT0099036] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0047200 HSALNG0047200] |
|HEIH | |HEIH | ||
|LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2 | |LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2 | ||
| Line 12,887: | Line 14,497: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222533 HSALNT0222533] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222533 HSALNT0222533] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0107117 HSALNG0107117] |
|NPTN-IT1 | |NPTN-IT1 | ||
|lncRNA-LET | |lncRNA-LET | ||
| Line 12,895: | Line 14,506: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer | |gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer | ||
| + | |Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289747 HSALNT0289747] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289747 HSALNT0289747] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141862 HSALNG0141862] |
|DQ786243 | |DQ786243 | ||
|NA | |NA | ||
| Line 12,903: | Line 14,515: | ||
|pathogenic process | |pathogenic process | ||
|crohn's disease;colorectal cancer;hepatocelluar cancer | |crohn's disease;colorectal cancer;hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289204 HSALNT0289204] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289204 HSALNT0289204] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068414 HSALNG0068414] |
|PCAT1 | |PCAT1 | ||
|PCAT-1,PCA1 | |PCAT-1,PCA1 | ||
| Line 12,911: | Line 14,524: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer | |prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275894 HSALNT0275894] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275894 HSALNT0275894] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134403 HSALNG0134403] |
|PCAT14 | |PCAT14 | ||
|NA | |NA | ||
| Line 12,919: | Line 14,533: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211999 HSALNT0211999] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211999 HSALNT0211999] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0101780 HSALNG0101780] |
|HIF1A-AS2 | |HIF1A-AS2 | ||
|3'aHIF-1A,aHIF | |3'aHIF-1A,aHIF | ||
| Line 12,927: | Line 14,542: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer | |bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288999 HSALNT0288999] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288999 HSALNT0288999] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0101776 HSALNG0101776] |
|HIF1A-AS1 | |HIF1A-AS1 | ||
|5'aHIF-1A,5'aHIF1alpha | |5'aHIF-1A,5'aHIF1alpha | ||
| Line 12,935: | Line 14,551: | ||
|pathogenic process | |pathogenic process | ||
|acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer | |acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289258 HSALNT0289258] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289258 HSALNT0289258] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0031034 HSALNG0031034] |
|SOX2-OT | |SOX2-OT | ||
|SOX2OT,DKFZp761J1324,NCRNA00043 | |SOX2OT,DKFZp761J1324,NCRNA00043 | ||
| Line 12,943: | Line 14,560: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease | |colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease | ||
| + | |Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289700 HSALNT0289700] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289700 HSALNT0289700] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141815 HSALNG0141815] |
|CDR1-AS | |CDR1-AS | ||
|CDR1NAT,ciRS-7,CDR1as | |CDR1NAT,ciRS-7,CDR1as | ||
|ceRNA | |ceRNA | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289149 HSALNT0289149] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289149 HSALNT0289149] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0050599 HSALNG0050599] |
|LINCMD1 | |LINCMD1 | ||
|MIR133BHG,LINC-MD1 | |MIR133BHG,LINC-MD1 | ||
| Line 12,959: | Line 14,578: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|Duchenne muscular dystrophy | |Duchenne muscular dystrophy | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288894 HSALNT0288894] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288894 HSALNT0288894] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0082362 HSALNG0082362] |
|BGLT3 | |BGLT3 | ||
|LINC01083,BGL3,lncRNA-BGL3 | |LINC01083,BGL3,lncRNA-BGL3 | ||
| Line 12,967: | Line 14,587: | ||
|pathogenic process | |pathogenic process | ||
|chronic myeloid leukemia | |chronic myeloid leukemia | ||
| + | |Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289042 HSALNT0289042] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289042 HSALNT0289042] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0055058 HSALNG0055058] |
|LINC00473 | |LINC00473 | ||
|C6orf176,bA142J11.1 | |C6orf176,bA142J11.1 | ||
| Line 12,975: | Line 14,596: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;renal cell cancer | |non-small cell lung cancer;renal cell cancer | ||
| + | |Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101681 HSALNT0101681] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101681 HSALNT0101681] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0048223 HSALNG0048223] |
|LINC01108 | |LINC01108 | ||
|LncRNA-ES1 | |LncRNA-ES1 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289418 HSALNT0289418] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289418 HSALNT0289418] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0103465 HSALNG0103465] |
|TUNAR | |TUNAR | ||
|LINC00617,TUNA,HI-LNC78 | |LINC00617,TUNA,HI-LNC78 | ||
| Line 12,991: | Line 14,614: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289197 HSALNT0289197] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289197 HSALNT0289197] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0105343 HSALNG0105343] |
|OIP5-AS1 | |OIP5-AS1 | ||
|cyrano,linc-OIP5 | |cyrano,linc-OIP5 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289046 HSALNT0289046] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289046 HSALNT0289046] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0048515 HSALNG0048515] |
|LINC00581 | |LINC00581 | ||
|NA | |NA | ||
| Line 13,007: | Line 14,632: | ||
|pathogenic process | |pathogenic process | ||
|West Syndrome;West syndrome | |West Syndrome;West syndrome | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289656 HSALNT0289656] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289656 HSALNT0289656] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141771 HSALNG0141771] |
|BX118339 | |BX118339 | ||
|NA | |NA | ||
| Line 13,015: | Line 14,641: | ||
|pathogenic process | |pathogenic process | ||
|West syndrome | |West syndrome | ||
| + | |Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021726 HSALNT0021726] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021726 HSALNT0021726] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0010465 HSALNG0010465] |
|LINC00538 | |LINC00538 | ||
|Yiya,PROX1UT | |Yiya,PROX1UT | ||
| Line 13,023: | Line 14,650: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer;cancer | |colorectal cancer;cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273249 HSALNT0273249] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273249 HSALNT0273249] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132926 HSALNG0132926] |
|CBR3-AS1 | |CBR3-AS1 | ||
|PlncRNA-1,PlncRNA1 | |PlncRNA-1,PlncRNA1 | ||
| Line 13,031: | Line 14,659: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;hepatocellular cancer;prostate cancer | |esophageal squamous cell cancer;hepatocellular cancer;prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289179 HSALNT0289179] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289179 HSALNT0289179] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0070363 HSALNG0070363] |
|MIR31HG | |MIR31HG | ||
|LOC554202,hsa-lnc-31,LncHIFCAR | |LOC554202,hsa-lnc-31,LncHIFCAR | ||
| Line 13,039: | Line 14,668: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma | |bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288925 HSALNT0288925] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288925 HSALNT0288925] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0034419 HSALNG0034419] |
|DANCR | |DANCR | ||
|KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR | |KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR | ||
| Line 13,047: | Line 14,677: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer | |prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290329 HSALNT0290329] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290329 HSALNT0290329] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142444 HSALNG0142444] |
|uc.388 | |uc.388 | ||
|NA | |NA | ||
| Line 13,055: | Line 14,686: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289842 HSALNT0289842] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289842 HSALNT0289842] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141957 HSALNG0141957] |
|FR0348383 | |FR0348383 | ||
|NA | |NA | ||
| Line 13,063: | Line 14,695: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289279 HSALNT0289279] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289279 HSALNT0289279] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141211 HSALNG0141211] |
|TTTY15 | |TTTY15 | ||
|DKFZP434I143,NCRNA00138 | |DKFZP434I143,NCRNA00138 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289718 HSALNT0289718] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289718 HSALNT0289718] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141833 HSALNG0141833] |
|CRNDE | |CRNDE | ||
|LOC643911,LINC00180,CRNDEP | |LOC643911,LINC00180,CRNDEP | ||
| Line 13,079: | Line 14,713: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma | |gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma | ||
| + | |Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289685 HSALNT0289685] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289685 HSALNT0289685] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141800 HSALNG0141800] |
|CCND1 | |CCND1 | ||
|NA | |NA | ||
| Line 13,087: | Line 14,722: | ||
|pathogenic process | |pathogenic process | ||
|tumor;cervical cancer | |tumor;cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289935 HSALNT0289935] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289935 HSALNT0289935] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142050 HSALNG0142050] |
|lincRNA-p21 | |lincRNA-p21 | ||
|NA | |NA | ||
| Line 13,095: | Line 14,731: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer;cancer | |lung cancer;cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290134 HSALNT0290134] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290134 HSALNT0290134] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142249 HSALNG0142249] |
|PCNCR1 | |PCNCR1 | ||
|NA | |NA | ||
| Line 13,103: | Line 14,740: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289492 HSALNT0289492] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289492 HSALNT0289492] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141603 HSALNG0141603] |
|DBET | |DBET | ||
|DBE-T,DUX4L30 | |DBE-T,DUX4L30 | ||
| Line 13,111: | Line 14,749: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|facioscapulohumeral muscular dystrophy | |facioscapulohumeral muscular dystrophy | ||
| + | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289455 HSALNT0289455] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289455 HSALNT0289455] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0071734 HSALNG0071734] |
|BANCR | |BANCR | ||
|LINC00586 | |LINC00586 | ||
| Line 13,119: | Line 14,758: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer | |osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209589 HSALNT0209589] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209589 HSALNT0209589] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0100636 HSALNG0100636] |
|PTCSC3 | |PTCSC3 | ||
|NA | |NA | ||
| Line 13,127: | Line 14,767: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer;thyroid cancer | |papillary thyroid cancer;thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290063 HSALNT0290063] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290063 HSALNT0290063] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142178 HSALNG0142178] |
|MVIH | |MVIH | ||
|NA | |NA | ||
| Line 13,135: | Line 14,776: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;non-small cell lung cancer;breast cancer;microvascular invasion in hepatocellular cancer;hepatocelluar cancer | |hepatocellular cancer;non-small cell lung cancer;breast cancer;microvascular invasion in hepatocellular cancer;hepatocelluar cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289103 HSALNT0289103] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289103 HSALNT0289103] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0052921 HSALNG0052921] |
|LINC01268 | |LINC01268 | ||
|LOC285758 | |LOC285758 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289070 HSALNT0289070] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289070 HSALNT0289070] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0031716 HSALNG0031716] |
|LINC00887 | |LINC00887 | ||
|linc-ATP13A4-8,HEIRCC | |linc-ATP13A4-8,HEIRCC | ||
| Line 13,151: | Line 14,794: | ||
|pathogenic process | |pathogenic process | ||
|hypoxic and inflammatory renal epithelial injury;renal clear cell cancer | |hypoxic and inflammatory renal epithelial injury;renal clear cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288931 HSALNT0288931] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288931 HSALNT0288931] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0100075 HSALNG0100075] |
|DHRS4-AS1 | |DHRS4-AS1 | ||
|C14orf167,PRO1488,AS1DHRS4 | |C14orf167,PRO1488,AS1DHRS4 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288974 HSALNT0288974] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288974 HSALNT0288974] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113304 HSALNG0113304] |
|FENDRR | |FENDRR | ||
|FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21 | |FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21 | ||
| Line 13,167: | Line 14,812: | ||
|developmental process;pathogenic process | |developmental process;pathogenic process | ||
|osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer | |osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106473 HSALNT0106473] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106473 HSALNT0106473] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0050235 HSALNG0050235] |
|LINC01512 | |LINC01512 | ||
|LOC100132354,TCONS_00011120,HI-LNC77 | |LOC100132354,TCONS_00011120,HI-LNC77 | ||
| Line 13,175: | Line 14,821: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma;type 2 diabetes | |lung adenocarcinoma;type 2 diabetes | ||
| + | |Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289059 HSALNT0289059] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289059 HSALNT0289059] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0118547 HSALNG0118547] |
|LINC00673 | |LINC00673 | ||
|HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1 | |HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1 | ||
| Line 13,183: | Line 14,830: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma | |pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma | ||
| + | |Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289107 HSALNT0289107] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289107 HSALNT0289107] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0128306 HSALNG0128306] |
|LINC01433 | |LINC01433 | ||
|LOC728228 | |LOC728228 | ||
| Line 13,191: | Line 14,839: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143571 HSALNT0143571] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143571 HSALNT0143571] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068424 HSALNG0068424] |
|CCAT1 | |CCAT1 | ||
|CARLo-5,onco-lncRNA-40 | |CARLo-5,onco-lncRNA-40 | ||
| Line 13,199: | Line 14,848: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer | |gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289408 HSALNT0289408] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289408 HSALNT0289408] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0123467 HSALNG0123467] |
|TINCR | |TINCR | ||
|ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16 | |ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16 | ||
| Line 13,207: | Line 14,857: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer | |bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289152 HSALNT0289152] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289152 HSALNT0289152] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060113 HSALNG0060113] |
|LNCPRESS1 | |LNCPRESS1 | ||
|lncPRESS1 | |lncPRESS1 | ||
|translational control | |translational control | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289145 HSALNT0289145] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289145 HSALNT0289145] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075843 HSALNG0075843] |
|LINC02561 | |LINC02561 | ||
|RP11-445P17.8 | |RP11-445P17.8 | ||
| Line 13,223: | Line 14,875: | ||
|pathogenic process | |pathogenic process | ||
|cystic fibrosis | |cystic fibrosis | ||
| + | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289065 HSALNT0289065] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289065 HSALNT0289065] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140616 HSALNG0140616] |
|LINC00850 | |LINC00850 | ||
|KUCG1 | |KUCG1 | ||
| Line 13,231: | Line 14,884: | ||
|pathogenic process | |pathogenic process | ||
|Duchenne muscular dystrophy | |Duchenne muscular dystrophy | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289431 HSALNT0289431] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289431 HSALNT0289431] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0032699 HSALNG0032699] |
|AFAP1-AS1 | |AFAP1-AS1 | ||
|AFAP1A, AFAP1-A,MGC10981 | |AFAP1A, AFAP1-A,MGC10981 | ||
| Line 13,239: | Line 14,893: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer | |non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289519 HSALNT0289519] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289519 HSALNT0289519] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141630 HSALNG0141630] |
|XACT | |XACT | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 13,249: | Line 14,905: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248684 HSALNT0248684] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248684 HSALNT0248684] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0120344 HSALNG0120344] |
|GATA6-AS1 | |GATA6-AS1 | ||
|locus5689,BM742401 | |locus5689,BM742401 | ||
| Line 13,255: | Line 14,911: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;chronic lymphocytic leukemia | |gastric cancer;chronic lymphocytic leukemia | ||
| + | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289222 HSALNT0289222] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289222 HSALNT0289222] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0073144 HSALNG0073144] |
|PTCSC2 | |PTCSC2 | ||
|NA | |NA | ||
| Line 13,263: | Line 14,920: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289655 HSALNT0289655] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289655 HSALNT0289655] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141770 HSALNG0141770] |
|BTG3-AS1 | |BTG3-AS1 | ||
|ASBEL | |ASBEL | ||
| Line 13,271: | Line 14,929: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;colorectal cancer | |ovarian cancer;colorectal cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289224 HSALNT0289224] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289224 HSALNT0289224] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0070801 HSALNG0070801] |
|PTENP1 | |PTENP1 | ||
|NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984 | |NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984 | ||
| Line 13,279: | Line 14,938: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer | |gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer | ||
| + | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290129 HSALNT0290129] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290129 HSALNT0290129] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142244 HSALNG0142244] |
|PAN | |PAN | ||
|NA | |NA | ||
| Line 13,287: | Line 14,947: | ||
|pathogenic process | |pathogenic process | ||
|Kaposi's sarcoma | |Kaposi's sarcoma | ||
| + | |Neoplasms;Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289939 HSALNT0289939] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289939 HSALNT0289939] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142054 HSALNG0142054] |
|LINC-ROR | |LINC-ROR | ||
|lincRNA-RoR,lincRNA-ST8SIA3,ROR | |lincRNA-RoR,lincRNA-ST8SIA3,ROR | ||
| Line 13,295: | Line 14,956: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer | |gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290322 HSALNT0290322] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290322 HSALNT0290322] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142437 HSALNG0142437] |
|UBE3A-ATS | |UBE3A-ATS | ||
|NA | |NA | ||
| Line 13,303: | Line 14,965: | ||
|pathogenic process | |pathogenic process | ||
|Angelman syndrome | |Angelman syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091004 HSALNT0091004] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091004 HSALNT0091004] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043367 HSALNG0043367] |
|LINC00461 | |LINC00461 | ||
|EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323 | |EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323 | ||
| Line 13,311: | Line 14,974: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|retinal and visual function | |retinal and visual function | ||
| + | |Eye Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289491 HSALNT0289491] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289491 HSALNT0289491] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141602 HSALNG0141602] |
|CTBP1-AS | |CTBP1-AS | ||
|PCAT10 | |PCAT10 | ||
| Line 13,319: | Line 14,983: | ||
|pathogenic process | |pathogenic process | ||
|chronic hepatitis C;prostate cancer;polycystic ovary syndrome | |chronic hepatitis C;prostate cancer;polycystic ovary syndrome | ||
| + | |Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037401 HSALNT0037401] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037401 HSALNT0037401] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0017694 HSALNG0017694] |
|GACAT1 | |GACAT1 | ||
|LINC00876,AC096655.1-002 | |LINC00876,AC096655.1-002 | ||
| Line 13,327: | Line 14,992: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120344 HSALNT0120344] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120344 HSALNT0120344] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0056854 HSALNG0056854] |
|HOXA-AS2 | |HOXA-AS2 | ||
|HOXA3as | |HOXA3as | ||
| Line 13,335: | Line 15,001: | ||
|pathogenic process | |pathogenic process | ||
|promyelocytic leukemia;gastric cancer | |promyelocytic leukemia;gastric cancer | ||
| + | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091313 HSALNT0091313] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091313 HSALNT0091313] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043441 HSALNG0043441] |
|LUCAT1 | |LUCAT1 | ||
|SCAL1 | |SCAL1 | ||
| Line 13,343: | Line 15,010: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;lung cancer | |non-small cell lung cancer;lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289425 HSALNT0289425] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289425 HSALNT0289425] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0009941 HSALNG0009941] |
|BLACAT1 | |BLACAT1 | ||
|linc-UBC1,LINC00912,onco-lncRNA-30 | |linc-UBC1,LINC00912,onco-lncRNA-30 | ||
| Line 13,351: | Line 15,019: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;gastric cancer | |bladder cancer;gastric cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149012 HSALNT0149012] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149012 HSALNT0149012] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0071221 HSALNG0071221] |
|GLIDR | |GLIDR | ||
|LINC01172,MGC21881,TCONS_00015562 | |LINC01172,MGC21881,TCONS_00015562 | ||
| Line 13,359: | Line 15,028: | ||
|pathogenic process | |pathogenic process | ||
|glioblastoma | |glioblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217561 HSALNT0217561] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217561 HSALNT0217561] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104548 HSALNG0104548] |
|PWAR5 | |PWAR5 | ||
|PAR5,PAR-5 | |PAR5,PAR-5 | ||
| Line 13,367: | Line 15,037: | ||
|pathogenic process | |pathogenic process | ||
|glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome | |glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome | ||
| + | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289272 HSALNT0289272] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289272 HSALNT0289272] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0059377 HSALNG0059377] |
|TP53TG1 | |TP53TG1 | ||
|TP53AP1,H_RG012D21.9,LINC00096 | |TP53AP1,H_RG012D21.9,LINC00096 | ||
| Line 13,375: | Line 15,046: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;ataxia telangiectasia | |non-small cell lung cancer;ataxia telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289598 HSALNT0289598] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289598 HSALNT0289598] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141713 HSALNG0141713] |
|AK126698 | |AK126698 | ||
|NA | |NA | ||
| Line 13,383: | Line 15,055: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217598 HSALNT0217598] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217598 HSALNT0217598] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104558 HSALNG0104558] |
|IPW | |IPW | ||
|NCRNA00002 | |NCRNA00002 | ||
| Line 13,391: | Line 15,064: | ||
|pathogenic process | |pathogenic process | ||
|Prader-Willi syndrome | |Prader-Willi syndrome | ||
| + | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143633 HSALNT0143633] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143633 HSALNT0143633] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068443 HSALNG0068443] |
|CCAT2 | |CCAT2 | ||
|NCCP1,LINC00873 | |NCCP1,LINC00873 | ||
| Line 13,399: | Line 15,073: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer | |non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289026 HSALNT0289026] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289026 HSALNT0289026] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129180 HSALNG0129180] |
|LINC00261 | |LINC00261 | ||
|C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17 | |C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17 | ||
| Line 13,407: | Line 15,082: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer;non-small cell lung cancer;gastric cancer | |pancreatic cancer;non-small cell lung cancer;gastric cancer | ||
| + | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289078 HSALNT0289078] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289078 HSALNT0289078] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0000303 HSALNG0000303] |
|LINC00982 | |LINC00982 | ||
|FLJ42875 | |FLJ42875 | ||
| Line 13,415: | Line 15,091: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290082 HSALNT0290082] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290082 HSALNT0290082] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142197 HSALNG0142197] |
|NEAT1_2 | |NEAT1_2 | ||
|NEAT1_2 | |NEAT1_2 | ||
| Line 13,423: | Line 15,100: | ||
|pathogenic process | |pathogenic process | ||
|amyotrophic lateral sclerosis | |amyotrophic lateral sclerosis | ||
| + | |Nutritional and Metabolic Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288989 HSALNT0288989] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288989 HSALNT0288989] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0076040 HSALNG0076040] |
|GATA3-AS1 | |GATA3-AS1 | ||
|NA | |NA | ||
| Line 13,431: | Line 15,109: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289427 HSALNT0289427] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289427 HSALNT0289427] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004297 HSALNG0004297] |
|GNG12-AS1 | |GNG12-AS1 | ||
|NA | |NA | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290395 HSALNT0290395] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290395 HSALNT0290395] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142510 HSALNG0142510] |
|YAM1 | |YAM1 | ||
|Yam-1 | |Yam-1 | ||
| Line 13,447: | Line 15,127: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|skeletal myogenesis | |skeletal myogenesis | ||
| + | |Musculoskeletal Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289202 HSALNT0289202] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289202 HSALNT0289202] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0018036 HSALNG0018036] |
|PAX8-AS1 | |PAX8-AS1 | ||
|NA | |NA | ||
| Line 13,455: | Line 15,136: | ||
|pathogenic process | |pathogenic process | ||
|malignant pleural mesothelioma;cervical cancer | |malignant pleural mesothelioma;cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0054469 HSALNT0054469] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0054469 HSALNT0054469] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026023 HSALNG0026023] |
|RASSF1-AS1 | |RASSF1-AS1 | ||
|ANRASSF1 | |ANRASSF1 | ||
| Line 13,463: | Line 15,145: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290261 HSALNT0290261] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290261 HSALNT0290261] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142376 HSALNG0142376] |
|SUMO1P3 | |SUMO1P3 | ||
|SUMO1P3 | |SUMO1P3 | ||
| Line 13,471: | Line 15,154: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;gastric cancer | |bladder cancer;gastric cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289002 HSALNT0289002] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289002 HSALNT0289002] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094549 HSALNG0094549] |
|HNF1A-AS1 | |HNF1A-AS1 | ||
|C12orf27,NCRNA00262,FLJ38690,HAS1 | |C12orf27,NCRNA00262,FLJ38690,HAS1 | ||
| Line 13,479: | Line 15,163: | ||
|pathogenic process | |pathogenic process | ||
|esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer | |esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer | ||
| + | |Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289377 HSALNT0289377] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289377 HSALNT0289377] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0041218 HSALNG0041218] |
|NIPBL-AS1 | |NIPBL-AS1 | ||
|NIPBL-DT,NIPBL-AS | |NIPBL-DT,NIPBL-AS | ||
| Line 13,487: | Line 15,172: | ||
|pathogenic process | |pathogenic process | ||
|autism spectrum disorder | |autism spectrum disorder | ||
| + | |Mental Disorders | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289249 HSALNT0289249] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289249 HSALNT0289249] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0057702 HSALNG0057702] |
|SNHG15 | |SNHG15 | ||
|C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g | |C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g | ||
| Line 13,495: | Line 15,181: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia | |gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113835 HSALNG0113835] |
|MIR22HG | |MIR22HG | ||
|C17orf91,MGC14376,DKFZp686O06159 | |C17orf91,MGC14376,DKFZp686O06159 | ||
| Line 13,503: | Line 15,190: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113835 HSALNG0113835] |
|MIR22HG | |MIR22HG | ||
|C17orf91,MGC14376,DKFZp686O06159 | |C17orf91,MGC14376,DKFZp686O06159 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 13,513: | Line 15,202: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288984 HSALNT0288984] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288984 HSALNT0288984] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119881 HSALNG0119881] |
|GACAT2 | |GACAT2 | ||
|MTCL1-AS1,HMlincRNA717 | |MTCL1-AS1,HMlincRNA717 | ||
| Line 13,519: | Line 15,208: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer;non-small cell lung cancer;gastric cancer | |pancreatic cancer;non-small cell lung cancer;gastric cancer | ||
| + | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289369 HSALNT0289369] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289369 HSALNT0289369] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0134448 HSALNG0134448] |
|MIF-AS1 | |MIF-AS1 | ||
|LOC284889,MIF-AS | |LOC284889,MIF-AS | ||
| Line 13,527: | Line 15,217: | ||
|pathogenic process | |pathogenic process | ||
|malaria;nephrolithiasis | |malaria;nephrolithiasis | ||
| + | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129086 HSALNT0129086] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129086 HSALNT0129086] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0061385 HSALNG0061385] |
|LINC-PINT | |LINC-PINT | ||
|MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint | |MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint | ||
| Line 13,535: | Line 15,226: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer;heart failure | |colorectal cancer;heart failure | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289240 HSALNT0289240] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289240 HSALNT0289240] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0020769 HSALNG0020769] |
|SCHLAP1 | |SCHLAP1 | ||
|LINC00913,SChLAP1,PCAT11 | |LINC00913,SChLAP1,PCAT11 | ||
| Line 13,543: | Line 15,235: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;prostate cancer | |bladder cancer;prostate cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193241 HSALNT0193241] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193241 HSALNT0193241] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0093119 HSALNG0093119] |
|SOCS2-AS1 | |SOCS2-AS1 | ||
|NA | |NA | ||
| Line 13,551: | Line 15,244: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138824 HSALNT0138824] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138824 HSALNT0138824] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0066261 HSALNG0066261] |
|CASC9 | |CASC9 | ||
|ESCCAL-1,ESSCAL1,LINC00981 | |ESCCAL-1,ESSCAL1,LINC00981 | ||
| Line 13,559: | Line 15,253: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;esophageal cancer | |esophageal squamous cell cancer;esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267627 HSALNT0267627] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267627 HSALNT0267627] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0130306 HSALNG0130306] |
|HNF4A-AS1 | |HNF4A-AS1 | ||
|uc002xlx | |uc002xlx | ||
| Line 13,567: | Line 15,262: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289194 HSALNT0289194] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289194 HSALNT0289194] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0131196 HSALNG0131196] |
|NKILA | |NKILA | ||
|NA | |NA | ||
| Line 13,575: | Line 15,271: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer;breast cancer;tongue squamous cell cancer | |nasopharyngeal cancer;breast cancer;tongue squamous cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289304 HSALNT0289304] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289304 HSALNT0289304] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0088539 HSALNG0088539] |
|LINC00942 | |LINC00942 | ||
|NA | |NA | ||
| Line 13,583: | Line 15,280: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;autism spectrum disorder | |ovarian cancer;autism spectrum disorder | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289187 HSALNT0289187] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289187 HSALNT0289187] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062700 HSALNG0062700] |
|MNX1-AS1 | |MNX1-AS1 | ||
|CCAT5,LOC645249 | |CCAT5,LOC645249 | ||
| Line 13,591: | Line 15,289: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;colorectal cancer | |ovarian cancer;colorectal cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289518 HSALNT0289518] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289518 HSALNT0289518] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141629 HSALNG0141629] |
|VPS9D1-AS1 | |VPS9D1-AS1 | ||
|MYU | |MYU | ||
| Line 13,599: | Line 15,298: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;colorectal cancer | |ovarian cancer;colorectal cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290266 HSALNT0290266] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290266 HSALNT0290266] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142381 HSALNG0142381] |
|TC0101441 | |TC0101441 | ||
|NA | |NA | ||
| Line 13,607: | Line 15,307: | ||
|pathogenic process | |pathogenic process | ||
|epithelial ovarian cancer | |epithelial ovarian cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289426 HSALNT0289426] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289426 HSALNT0289426] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0009856 HSALNG0009856] |
|ERLNC1 | |ERLNC1 | ||
|TC0101441,ElncRNA1 | |TC0101441,ElncRNA1 | ||
| Line 13,615: | Line 15,316: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290050 HSALNT0290050] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290050 HSALNT0290050] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142165 HSALNG0142165] |
|Mdgt | |Mdgt | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 13,625: | Line 15,328: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043560 HSALNT0043560] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043560 HSALNT0043560] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0020594 HSALNG0020594] |
|HAGLR | |HAGLR | ||
|HOXD-AS1,Mdgt | |HOXD-AS1,Mdgt | ||
| Line 13,631: | Line 15,334: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;neuroblastoma | |bladder cancer;neuroblastoma | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289092 HSALNT0289092] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289092 HSALNT0289092] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0017541 HSALNG0017541] |
|LINC01158 | |LINC01158 | ||
|PANTR1,linc-Brn1a,linc-POU3F3 | |PANTR1,linc-Brn1a,linc-POU3F3 | ||
| Line 13,639: | Line 15,343: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|esophageal squamous cell cancer;gastric cancer;glioma | |esophageal squamous cell cancer;gastric cancer;glioma | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289448 HSALNT0289448] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289448 HSALNT0289448] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0062110 HSALNG0062110] |
|GHET1 | |GHET1 | ||
|lncRNA-GHET1 | |lncRNA-GHET1 | ||
| Line 13,647: | Line 15,352: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;gastric cancer;colorectal cancer | |bladder cancer;gastric cancer;colorectal cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289514 HSALNT0289514] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289514 HSALNT0289514] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141625 HSALNG0141625] |
|PEG13 | |PEG13 | ||
|NA | |NA | ||
| Line 13,655: | Line 15,361: | ||
|pathogenic process | |pathogenic process | ||
|intellectual disabilities | |intellectual disabilities | ||
| + | |Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289183 HSALNT0289183] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289183 HSALNT0289183] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0140233 HSALNG0140233] |
|MIR503HG | |MIR503HG | ||
|MGC16121,H19X | |MGC16121,H19X | ||
| Line 13,663: | Line 15,370: | ||
|pathogenic process | |pathogenic process | ||
|choriocarcinoma | |choriocarcinoma | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289201 HSALNT0289201] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289201 HSALNT0289201] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0083445 HSALNG0083445] |
|PAUPAR | |PAUPAR | ||
|NA | |NA | ||
| Line 13,671: | Line 15,379: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|uveal melanoma | |uveal melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094171 HSALNG0094171] |
|LINC01234 | |LINC01234 | ||
|LCAL84,onco-lncRNA-32 | |LCAL84,onco-lncRNA-32 | ||
| Line 13,679: | Line 15,388: | ||
|pathogenic process | |pathogenic process | ||
|oesophageal squamous cell cancer;breast cancer | |oesophageal squamous cell cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289021 HSALNT0289021] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289021 HSALNT0289021] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0016642 HSALNG0016642] |
|CYTOR | |CYTOR | ||
|C2orf59,NCRNA00152,MGC4677 | |C2orf59,NCRNA00152,MGC4677 | ||
| Line 13,687: | Line 15,397: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer | |colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289706 HSALNT0289706] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289706 HSALNT0289706] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141821 HSALNG0141821] |
|CHRF | |CHRF | ||
|NA | |NA | ||
| Line 13,695: | Line 15,406: | ||
|pathogenic process | |pathogenic process | ||
|cardiac hypertrophy;silicosis | |cardiac hypertrophy;silicosis | ||
| + | |Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143635 HSALNT0143635] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143635 HSALNT0143635] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068436 HSALNG0068436] |
|CASC8 | |CASC8 | ||
|LINC00860,CARLo-1 | |LINC00860,CARLo-1 | ||
| Line 13,703: | Line 15,415: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143672 HSALNT0143672] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143672 HSALNT0143672] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0068465 HSALNG0068465] |
|CASC11 | |CASC11 | ||
|TCONS_00014535,LINC00990,CARLo-7,ENST00000518376 | |TCONS_00014535,LINC00990,CARLo-7,ENST00000518376 | ||
| Line 13,711: | Line 15,424: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;colorectal cancer | |hepatocellular cancer;colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289032 HSALNT0289032] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289032 HSALNT0289032] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133191 HSALNG0133191] |
|LINC00323 | |LINC00323 | ||
|PRED42,FLJ37173 | |PRED42,FLJ37173 | ||
| Line 13,719: | Line 15,433: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer;hereditary haemorrhagic telangiectasia | |breast cancer;hereditary haemorrhagic telangiectasia | ||
| + | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0024655 HSALNT0024655] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0024655 HSALNT0024655] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0011845 HSALNG0011845] |
|LINC01139 | |LINC01139 | ||
|LINK-A,TCONS_00000027 | |LINK-A,TCONS_00000027 | ||
| Line 13,727: | Line 15,442: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289018 HSALNT0289018] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289018 HSALNT0289018] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0036270 HSALNG0036270] |
|LEF1-AS1 | |LEF1-AS1 | ||
|NA | |NA | ||
| Line 13,735: | Line 15,451: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia;colorectal cancer | |hereditary haemorrhagic telangiectasia;colorectal cancer | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247326 HSALNT0247326] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247326 HSALNT0247326] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119753 HSALNG0119753] |
|LINC00667 | |LINC00667 | ||
|NA | |NA | ||
| Line 13,743: | Line 15,460: | ||
|pathogenic process | |pathogenic process | ||
|hereditary haemorrhagic telangiectasia | |hereditary haemorrhagic telangiectasia | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290145 HSALNT0290145] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290145 HSALNT0290145] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142260 HSALNG0142260] |
|POU3F3 | |POU3F3 | ||
|NA | |NA | ||
| Line 13,751: | Line 15,469: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;glioma | |esophageal squamous cell cancer;glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199349 HSALNT0199349] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199349 HSALNT0199349] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0096112 HSALNG0096112] |
|LINC00426 | |LINC00426 | ||
|NA | |NA | ||
| Line 13,759: | Line 15,478: | ||
|pathogenic process | |pathogenic process | ||
|primary Sjögren's syndrome | |primary Sjögren's syndrome | ||
| + | |Immune System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155974 HSALNT0155974] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155974 HSALNT0155974] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074744 HSALNG0074744] |
|LINC00963 | |LINC00963 | ||
|MetaLnc9 | |MetaLnc9 | ||
| Line 13,767: | Line 15,487: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;renal cell cancer | |prostate cancer;renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289211 HSALNT0289211] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289211 HSALNT0289211] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0086124 HSALNG0086124] |
|PCF11-AS1 | |PCF11-AS1 | ||
|NA | |NA | ||
| Line 13,775: | Line 15,496: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;adolescent idiopathic scoliosis | |hepatocellular cancer;adolescent idiopathic scoliosis | ||
| + | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289534 HSALNT0289534] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289534 HSALNT0289534] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141649 HSALNG0141649] |
|91H | |91H | ||
|NA | |NA | ||
| Line 13,783: | Line 15,505: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer | |osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289446 HSALNT0289446] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289446 HSALNT0289446] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0055679 HSALNG0055679] |
|ELFN1-AS1 | |ELFN1-AS1 | ||
|MYCLo-2 | |MYCLo-2 | ||
| Line 13,791: | Line 15,514: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288883 HSALNT0288883] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288883 HSALNT0288883] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0079547 HSALNG0079547] |
|ACTA2-AS1 | |ACTA2-AS1 | ||
|uc001kfo.1,ZXF1 | |uc001kfo.1,ZXF1 | ||
| Line 13,799: | Line 15,523: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289443 HSALNT0289443] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289443 HSALNT0289443] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0059132 HSALNG0059132] |
|APTR | |APTR | ||
|RSBN1L-AS1 | |RSBN1L-AS1 | ||
| Line 13,807: | Line 15,532: | ||
|pathogenic process | |pathogenic process | ||
|liver fibrosis;glioblastoma | |liver fibrosis;glioblastoma | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289986 HSALNT0289986] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289986 HSALNT0289986] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142101 HSALNG0142101] |
|lncRNA-MVIH | |lncRNA-MVIH | ||
|NA | |NA | ||
| Line 13,815: | Line 15,541: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;non-small cell lung cancer | |hepatocellular cancer;non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289977 HSALNT0289977] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289977 HSALNT0289977] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142092 HSALNG0142092] |
|lncRNA-ATB | |lncRNA-ATB | ||
|NA | |NA | ||
| Line 13,823: | Line 15,550: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis | |colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis | ||
| + | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289622 HSALNT0289622] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289622 HSALNT0289622] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141737 HSALNG0141737] |
|ATB | |ATB | ||
|NA | |NA | ||
| Line 13,831: | Line 15,559: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer | |prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer | ||
| + | |Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289586 HSALNT0289586] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289586 HSALNT0289586] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141701 HSALNG0141701] |
|AK057054 | |AK057054 | ||
|NA | |NA | ||
| Line 13,839: | Line 15,568: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278370 HSALNT0278370] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278370 HSALNT0278370] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0135702 HSALNG0135702] |
|LINC01315 | |LINC01315 | ||
|lnc-C22orf32-1,C22orf32-1 | |lnc-C22orf32-1,C22orf32-1 | ||
| Line 13,847: | Line 15,577: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055601 HSALNT0055601] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055601 HSALNT0055601] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026583 HSALNG0026583] |
|ADAMTS9-AS2 | |ADAMTS9-AS2 | ||
|NA | |NA | ||
| Line 13,855: | Line 15,586: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;glioma | |non-small cell lung cancer;glioma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289383 HSALNT0289383] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289383 HSALNT0289383] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0009103 HSALNG0009103] |
|PACERR | |PACERR | ||
|PACER,PTGS2-AS1 | |PACER,PTGS2-AS1 | ||
| Line 13,863: | Line 15,595: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;osteoarthritis;inflammation and cancer | |osteosarcoma;osteoarthritis;inflammation and cancer | ||
| + | |Musculoskeletal Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289268 HSALNT0289268] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289268 HSALNT0289268] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0010604 HSALNG0010604] |
|TGFB2-OT1 | |TGFB2-OT1 | ||
|FLJ11812 | |FLJ11812 | ||
|ceRNA | |ceRNA | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288938 HSALNT0288938] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288938 HSALNT0288938] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0027860 HSALNG0027860] |
|DUBR | |DUBR | ||
|LINC00883 | |LINC00883 | ||
| Line 13,879: | Line 15,613: | ||
|pathogenic process | |pathogenic process | ||
|asthma and chronic obstructive pulmonary disease | |asthma and chronic obstructive pulmonary disease | ||
| + | |Respiratory Tract Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290147 HSALNT0290147] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290147 HSALNT0290147] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142262 HSALNG0142262] |
|POXCUT | |POXCUT | ||
|TCONS_00011636 | |TCONS_00011636 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 13,889: | Line 15,625: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289440 HSALNT0289440] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289440 HSALNT0289440] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0047407 HSALNG0047407] |
|FOXCUT | |FOXCUT | ||
|LINC01379,TCONS_00011636 | |LINC01379,TCONS_00011636 | ||
| Line 13,895: | Line 15,631: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer | |esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288924 HSALNT0288924] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288924 HSALNT0288924] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0059521 HSALNG0059521] |
|CYP51A1-AS1 | |CYP51A1-AS1 | ||
|ENST00000453068,LRRD1-AS1 | |ENST00000453068,LRRD1-AS1 | ||
| Line 13,903: | Line 15,640: | ||
|pathogenic process | |pathogenic process | ||
|renal cell cancer | |renal cell cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289395 HSALNT0289395] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289395 HSALNT0289395] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0036288 HSALNG0036288] |
|RPL34-AS1 | |RPL34-AS1 | ||
|FLJ37673,RP11-462C24.1 | |FLJ37673,RP11-462C24.1 | ||
| Line 13,911: | Line 15,649: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;colorectal cancer | |gastric cancer;colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289435 HSALNT0289435] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289435 HSALNT0289435] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045015 HSALNG0045015] |
|C5orf66-AS1 | |C5orf66-AS1 | ||
|CTC-276P9.1,Epist | |CTC-276P9.1,Epist | ||
| Line 13,919: | Line 15,658: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;bladder cancer | |esophageal squamous cell cancer;bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289052 HSALNT0289052] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289052 HSALNT0289052] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0006924 HSALNG0006924] |
|LINC00623 | |LINC00623 | ||
|NA | |NA | ||
| Line 13,927: | Line 15,667: | ||
|pathogenic process | |pathogenic process | ||
|nasopharyngeal cancer | |nasopharyngeal cancer | ||
| + | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289831 HSALNT0289831] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289831 HSALNT0289831] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141946 HSALNG0141946] |
|FER1L4 | |FER1L4 | ||
|FER1L4 | |FER1L4 | ||
| Line 13,935: | Line 15,676: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;endometrial cancer;colorectal cancer | |gastric cancer;endometrial cancer;colorectal cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288985 HSALNT0288985] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288985 HSALNT0288985] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0013215 HSALNG0013215] |
|GACAT3 | |GACAT3 | ||
|LINC01458,lncRNA-AC130710 | |LINC01458,lncRNA-AC130710 | ||
| Line 13,943: | Line 15,685: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;gastric cancer | |ovarian cancer;gastric cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288881 HSALNT0288881] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288881 HSALNT0288881] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0058863 HSALNG0058863] |
|ABHD11-AS1 | |ABHD11-AS1 | ||
|WBSCR26,LINC00035,NCRNA00035 | |WBSCR26,LINC00035,NCRNA00035 | ||
| Line 13,951: | Line 15,694: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;mutant huntingtin | |gastric cancer;mutant huntingtin | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282263 HSALNT0282263] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282263 HSALNT0282263] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0137651 HSALNG0137651] |
|ZNF674-AS1 | |ZNF674-AS1 | ||
|NA | |NA | ||
| Line 13,959: | Line 15,703: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289207 HSALNT0289207] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289207 HSALNT0289207] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0106864 HSALNG0106864] |
|PCAT29 | |PCAT29 | ||
|NA | |NA | ||
| Line 13,967: | Line 15,712: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | |prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | ||
| + | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289672 HSALNT0289672] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289672 HSALNT0289672] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141787 HSALNG0141787] |
|CADM1 | |CADM1 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 13,977: | Line 15,724: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289297 HSALNT0289297] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289297 HSALNT0289297] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007253 HSALNG0007253] |
|LINC01527 | |LINC01527 | ||
|lnc-SPRR2D-1,RP1-13P20.6 | |lnc-SPRR2D-1,RP1-13P20.6 | ||
| Line 13,983: | Line 15,730: | ||
|pathogenic process | |pathogenic process | ||
|squamous cell cancer | |squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289158 HSALNT0289158] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289158 HSALNT0289158] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0108520 HSALNG0108520] |
|LUNAR1 | |LUNAR1 | ||
|NA | |NA | ||
| Line 13,991: | Line 15,739: | ||
|pathogenic process | |pathogenic process | ||
|diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia | |diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia | ||
| + | |Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289830 HSALNT0289830] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289830 HSALNT0289830] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141945 HSALNG0141945] |
|FAR2P1 | |FAR2P1 | ||
|NA | |NA | ||
| Line 13,999: | Line 15,748: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma;non-small cell lung cancer | |lung adenocarcinoma;non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289263 HSALNT0289263] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289263 HSALNT0289263] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0053580 HSALNG0053580] |
|TARID | |TARID | ||
|EYA4-AS1 | |EYA4-AS1 | ||
| Line 14,007: | Line 15,757: | ||
|pathogenic process | |pathogenic process | ||
|kidney clear cell sarcoma | |kidney clear cell sarcoma | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145373 HSALNT0145373] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145373 HSALNT0145373] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069286 HSALNG0069286] |
|MAFA-AS1 | |MAFA-AS1 | ||
|RP11-909N17.3,TCONS_00014882 | |RP11-909N17.3,TCONS_00014882 | ||
| Line 14,015: | Line 15,766: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma;non-small cell lung cancer | |lung adenocarcinoma;non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290229 HSALNT0290229] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290229 HSALNT0290229] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142344 HSALNG0142344] |
|RPLP0P2 | |RPLP0P2 | ||
|RPLP0P2 | |RPLP0P2 | ||
| Line 14,023: | Line 15,775: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma | |lung adenocarcinoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289291 HSALNT0289291] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289291 HSALNT0289291] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133273 HSALNG0133273] |
|ZNF295-AS1 | |ZNF295-AS1 | ||
|C21orf121,NCRNA00318,PRED87 | |C21orf121,NCRNA00318,PRED87 | ||
| Line 14,031: | Line 15,784: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma;epithelial ovarian cancer | |lung adenocarcinoma;epithelial ovarian cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084473 HSALNT0084473] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084473 HSALNT0084473] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0040150 HSALNG0040150] |
|LINC01513 | |LINC01513 | ||
|RP11-1C1.7,TCONS_00009352 | |RP11-1C1.7,TCONS_00009352 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289471 HSALNT0289471] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289471 HSALNT0289471] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0108507 HSALNG0108507] |
|IRAIN | |IRAIN | ||
|IGF1R-AS | |IGF1R-AS | ||
| Line 14,047: | Line 15,802: | ||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer | |pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290402 HSALNT0290402] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290402 HSALNT0290402] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142517 HSALNG0142517] |
|ZNRD1-AS1 | |ZNRD1-AS1 | ||
|NA | |NA | ||
| Line 14,055: | Line 15,811: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;lung cancer;cervical cancer | |hepatocellular cancer;lung cancer;cervical cancer | ||
| + | |Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289504 HSALNT0289504] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289504 HSALNT0289504] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141615 HSALNG0141615] |
|LCAL1 | |LCAL1 | ||
|onco-lncRNA-27 | |onco-lncRNA-27 | ||
| Line 14,063: | Line 15,820: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289169 HSALNT0289169] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289169 HSALNT0289169] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0100038 HSALNG0100038] |
|MHRT | |MHRT | ||
|Myheart | |Myheart | ||
| Line 14,071: | Line 15,829: | ||
|pathogenic process | |pathogenic process | ||
|heart hypertrophy;acute myocardial infarction | |heart hypertrophy;acute myocardial infarction | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289859 HSALNT0289859] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289859 HSALNT0289859] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141974 HSALNG0141974] |
|HA117 | |HA117 | ||
|NA | |NA | ||
| Line 14,079: | Line 15,838: | ||
|pathogenic process | |pathogenic process | ||
|hirschsprung disease | |hirschsprung disease | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026673 HSALNT0026673] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026673 HSALNT0026673] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0012722 HSALNG0012722] |
|NRIR | |NRIR | ||
|lncRNA-CMPK2 | |lncRNA-CMPK2 | ||
| Line 14,087: | Line 15,847: | ||
|pathogenic process | |pathogenic process | ||
|chronic hepatitis C;HCV | |chronic hepatitis C;HCV | ||
| + | |Digestive System Diseases;Virus Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289887 HSALNT0289887] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289887 HSALNT0289887] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142002 HSALNG0142002] |
|LET | |LET | ||
|NA | |NA | ||
| Line 14,095: | Line 15,856: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer | |gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer | ||
| + | |Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0007921 HSALNT0007921] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0007921 HSALNT0007921] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004023 HSALNG0004023] |
|NFIA-AS1 | |NFIA-AS1 | ||
|RP5-833A20.1 | |RP5-833A20.1 | ||
| Line 14,103: | Line 15,865: | ||
|pathogenic process | |pathogenic process | ||
|atherosclerosis;glioma | |atherosclerosis;glioma | ||
| + | |Cardiovascular Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247156 HSALNT0247156] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247156 HSALNT0247156] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119710 HSALNG0119710] |
|GAPLINC | |GAPLINC | ||
|LINC01540,TCONS_00026238,lncRNA-uc002kmd.1 | |LINC01540,TCONS_00026238,lncRNA-uc002kmd.1 | ||
| Line 14,111: | Line 15,874: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;colorectal cancer | |gastric cancer;colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288917 HSALNT0288917] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288917 HSALNT0288917] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0079313 HSALNG0079313] |
|CERNA2 | |CERNA2 | ||
|HOST2,lncRNA-HOST2 | |HOST2,lncRNA-HOST2 | ||
| Line 14,119: | Line 15,883: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;epithelial ovarian cancer | |hepatocellular cancer;epithelial ovarian cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289113 HSALNT0289113] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289113 HSALNT0289113] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0050689 HSALNG0050689] |
|LINC01564 | |LINC01564 | ||
|TCONS_00011314 | |TCONS_00011314 | ||
| Line 14,127: | Line 15,892: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289088 HSALNT0289088] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289088 HSALNT0289088] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0012685 HSALNG0012685] |
|LINC01105 | |LINC01105 | ||
|FLJ30594,LOC150622 | |FLJ30594,LOC150622 | ||
| Line 14,135: | Line 15,901: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;leukemia and neuroblastoma | |gastric cancer;leukemia and neuroblastoma | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289464 HSALNT0289464] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289464 HSALNT0289464] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0091650 HSALNG0091650] |
|AGAP2-AS1 | |AGAP2-AS1 | ||
|LOC100130776,PUNISHER | |LOC100130776,PUNISHER | ||
| Line 14,143: | Line 15,910: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;glioma;leukemia and neuroblastoma | |non-small cell lung cancer;glioma;leukemia and neuroblastoma | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288960 HSALNT0288960] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288960 HSALNT0288960] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0106834 HSALNG0106834] |
|EWSAT1 | |EWSAT1 | ||
|TMEM84,NCRNA00277,LINC00277,FLJ33768 | |TMEM84,NCRNA00277,LINC00277,FLJ33768 | ||
| Line 14,151: | Line 15,919: | ||
|pathogenic process | |pathogenic process | ||
|Ewing sarcoma | |Ewing sarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289242 HSALNT0289242] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289242 HSALNT0289242] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0074573 HSALNG0074573] |
|SLC25A25-AS1 | |SLC25A25-AS1 | ||
|NA | |NA | ||
| Line 14,159: | Line 15,928: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289317 HSALNT0289317] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289317 HSALNT0289317] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0130331 HSALNG0130331] |
|KCNK15-AS1 | |KCNK15-AS1 | ||
|RP11-445H22.4 | |RP11-445H22.4 | ||
| Line 14,167: | Line 15,937: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis;breast cancer | |osteoarthritis;breast cancer | ||
| + | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289864 HSALNT0289864] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289864 HSALNT0289864] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141979 HSALNG0141979] |
|HIF2PUT | |HIF2PUT | ||
|NA | |NA | ||
| Line 14,175: | Line 15,946: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;colorectal cancer | |osteosarcoma;colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289267 HSALNT0289267] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289267 HSALNT0289267] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0019370 HSALNG0019370] |
|TEX41 | |TEX41 | ||
|DKFZp686O1327,LINC00953 | |DKFZp686O1327,LINC00953 | ||
|transcriptional regulation | |transcriptional regulation | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290361 HSALNT0290361] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290361 HSALNT0290361] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142476 HSALNG0142476] |
|UFC1 | |UFC1 | ||
|NA | |NA | ||
| Line 14,191: | Line 15,964: | ||
|pathogenic process | |pathogenic process | ||
|osteoarthritis;hepatocellular cancer | |osteoarthritis;hepatocellular cancer | ||
| + | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289886 HSALNT0289886] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289886 HSALNT0289886] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142001 HSALNG0142001] |
|LEIGC | |LEIGC | ||
|NA | |NA | ||
| Line 14,199: | Line 15,973: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289367 HSALNT0289367] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289367 HSALNT0289367] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049188 HSALNG0049188] |
|MDC1-AS1 | |MDC1-AS1 | ||
|MDC1-AS | |MDC1-AS | ||
| Line 14,207: | Line 15,982: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer;glioma | |bladder cancer;glioma | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289190 HSALNT0289190] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289190 HSALNT0289190] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0048542 HSALNG0048542] |
|NBAT1 | |NBAT1 | ||
|CASC14,NBAT-1 | |CASC14,NBAT-1 | ||
| Line 14,215: | Line 15,991: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer;renal clear cell cancer;neuroblastoma | |breast cancer;renal clear cell cancer;neuroblastoma | ||
| + | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234826 HSALNT0234826] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234826 HSALNT0234826] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113287 HSALNG0113287] |
|LINC00917 | |LINC00917 | ||
|NA | |NA | ||
| Line 14,223: | Line 16,000: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration;breast cancer | |intervertebral disc degeneration;breast cancer | ||
| + | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289419 HSALNT0289419] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289419 HSALNT0289419] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094327 HSALNG0094327] |
|LINC00173 | |LINC00173 | ||
|NCRNA00173,FLJ42957 | |NCRNA00173,FLJ42957 | ||
| Line 14,231: | Line 16,009: | ||
|pathogenic process | |pathogenic process | ||
|HIV-1-infected;hepatocelluar cancer | |HIV-1-infected;hepatocelluar cancer | ||
| + | |Virus Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290138 HSALNT0290138] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290138 HSALNT0290138] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142253 HSALNG0142253] |
|PEG10 | |PEG10 | ||
|NA | |NA | ||
| Line 14,239: | Line 16,018: | ||
|pathogenic process | |pathogenic process | ||
|diffuse large B-cell lymphoma;esophageal cancer | |diffuse large B-cell lymphoma;esophageal cancer | ||
| + | |Neoplasms;Hemic and Lymphatic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289136 HSALNT0289136] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289136 HSALNT0289136] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0041549 HSALNG0041549] |
|LINC02224 | |LINC02224 | ||
|BRCAT107,ENST00000505706 | |BRCAT107,ENST00000505706 | ||
| Line 14,247: | Line 16,027: | ||
|pathogenic process | |pathogenic process | ||
|active tuberculosis | |active tuberculosis | ||
| + | |Bacterial Infections and Mycoses | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289866 HSALNT0289866] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289866 HSALNT0289866] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141981 HSALNG0141981] |
|HIT | |HIT | ||
|NA | |NA | ||
| Line 14,255: | Line 16,036: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;breast cancer | |non-small cell lung cancer;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003927 HSALNT0003927] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003927 HSALNT0003927] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0002075 HSALNG0002075] |
|SNHG12 | |SNHG12 | ||
|ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123 | |ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123 | ||
| Line 14,263: | Line 16,045: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma;endometrial cancer | |osteosarcoma;endometrial cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289099 HSALNT0289099] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289099 HSALNT0289099] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0002236 HSALNG0002236] |
|LINC01225 | |LINC01225 | ||
|NA | |NA | ||
| Line 14,271: | Line 16,054: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290047 HSALNT0290047] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290047 HSALNT0290047] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142162 HSALNG0142162] |
|MALAT2 | |MALAT2 | ||
|NA | |NA | ||
| Line 14,279: | Line 16,063: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0176345 HSALNT0176345] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0176345 HSALNT0176345] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0084672 HSALNG0084672] |
|SNHG1 | |SNHG1 | ||
|LINC00057,NCRNA00057,U22HG,UHG,lncRNA16 | |LINC00057,NCRNA00057,U22HG,UHG,lncRNA16 | ||
| Line 14,287: | Line 16,072: | ||
|pathogenic process | |pathogenic process | ||
|astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma | |astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma | ||
| + | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0094592 HSALNT0094592] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0094592 HSALNT0094592] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0044933 HSALNG0044933] |
|WSPAR | |WSPAR | ||
|TCONS_00009511-XLOC_004555,lncTCF7 | |TCONS_00009511-XLOC_004555,lncTCF7 | ||
| Line 14,295: | Line 16,081: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;liver cancer | |hepatocellular cancer;liver cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289308 HSALNT0289308] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289308 HSALNT0289308] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0118552 HSALNG0118552] |
|LINC00511 | |LINC00511 | ||
|onco-lncRNA-12 | |onco-lncRNA-12 | ||
| Line 14,303: | Line 16,090: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma;breast cancer | |lung adenocarcinoma;breast cancer | ||
| + | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289452 HSALNT0289452] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289452 HSALNT0289452] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0069321 HSALNG0069321] |
|FAM83H-AS1 | |FAM83H-AS1 | ||
|onco-lncRNA-3 | |onco-lncRNA-3 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289041 HSALNT0289041] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289041 HSALNT0289041] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0051162 HSALNG0051162] |
|LINC00472 | |LINC00472 | ||
|C6orf155,dJ288M22.3,FLJ13189 | |C6orf155,dJ288M22.3,FLJ13189 | ||
| Line 14,319: | Line 16,108: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;breast cancer | |ovarian cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289925 HSALNT0289925] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289925 HSALNT0289925] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142040 HSALNG0142040] |
|linc-ITGB1 | |linc-ITGB1 | ||
|NA | |NA | ||
| Line 14,327: | Line 16,117: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer;breast cancer | |gallbladder cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0016239 HSALNT0016239] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0016239 HSALNT0016239] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007801 HSALNG0007801] |
|LINC01133 | |LINC01133 | ||
|lncRNA-PAGBC | |lncRNA-PAGBC | ||
| Line 14,335: | Line 16,126: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer;colorectal cancer;lung squamous cell cancer | |non-small cell lung cancer;colorectal cancer;lung squamous cell cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289489 HSALNT0289489] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289489 HSALNT0289489] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141600 HSALNG0141600] |
|CCEPR | |CCEPR | ||
|CCHE1,lncRNA-CCHE1 | |CCHE1,lncRNA-CCHE1 | ||
| Line 14,343: | Line 16,135: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;cervical cancer | |hepatocellular cancer;cervical cancer | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289402 HSALNT0289402] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289402 HSALNT0289402] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0098682 HSALNG0098682] |
|SOX21-AS1 | |SOX21-AS1 | ||
|NA | |NA | ||
| Line 14,351: | Line 16,144: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma;oral squamous cell cancer | |lung adenocarcinoma;oral squamous cell cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288905 HSALNT0288905] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288905 HSALNT0288905] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0048533 HSALNG0048533] |
|CASC15 | |CASC15 | ||
|LINC00340,lnc-SOX4-1 | |LINC00340,lnc-SOX4-1 | ||
| Line 14,359: | Line 16,153: | ||
|pathogenic process | |pathogenic process | ||
|basal cell cancer;melanoma;neuroblastoma | |basal cell cancer;melanoma;neuroblastoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289555 HSALNT0289555] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289555 HSALNT0289555] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141670 HSALNG0141670] |
|AC104699.1 | |AC104699.1 | ||
|NA | |NA | ||
| Line 14,367: | Line 16,162: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096322 HSALNT0096322] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096322 HSALNT0096322] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045923 HSALNG0045923] |
|CLMAT3 | |CLMAT3 | ||
|SPARC-AS1 | |SPARC-AS1 | ||
| Line 14,375: | Line 16,171: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289233 HSALNT0289233] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289233 HSALNT0289233] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0043698 HSALNG0043698] |
|RGMB-AS1 | |RGMB-AS1 | ||
|NA | |NA | ||
| Line 14,383: | Line 16,180: | ||
|pathogenic process | |pathogenic process | ||
|lung adenocarcinoma;non-small cell lung cancer | |lung adenocarcinoma;non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289908 HSALNT0289908] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289908 HSALNT0289908] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142023 HSALNG0142023] |
|LINC01419 | |LINC01419 | ||
|LVCAT7,TCONS_00014497 | |LVCAT7,TCONS_00014497 | ||
| Line 14,391: | Line 16,189: | ||
|pathogenic process | |pathogenic process | ||
|hepatocelluar cancer | |hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289541 HSALNT0289541] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289541 HSALNT0289541] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141656 HSALNG0141656] |
|AB209630 | |AB209630 | ||
|NA | |NA | ||
| Line 14,399: | Line 16,198: | ||
|pathogenic process | |pathogenic process | ||
|hypopharyngeal squamous cell cancer | |hypopharyngeal squamous cell cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289608 HSALNT0289608] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289608 HSALNT0289608] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141723 HSALNG0141723] |
|AOC4P | |AOC4P | ||
|AOC4P | |AOC4P | ||
| Line 14,407: | Line 16,207: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer;hepatocelluar cancer | |colorectal cancer;hepatocelluar cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289082 HSALNT0289082] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289082 HSALNT0289082] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0040781 HSALNG0040781] |
|PURPL | |PURPL | ||
|LINC01021,LOC643401,RP11-46C20.1 | |LINC01021,LOC643401,RP11-46C20.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196121 HSALNT0196121] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196121 HSALNT0196121] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0094605 HSALNG0094605] |
|LINC01089 | |LINC01089 | ||
|LIMT | |LIMT | ||
| Line 14,423: | Line 16,225: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer;astrocytoma | |breast cancer;astrocytoma | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123080 HSALNT0123080] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123080 HSALNT0123080] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0058166 HSALNG0058166] |
|EGFR-AS1 | |EGFR-AS1 | ||
|NA | |NA | ||
| Line 14,431: | Line 16,234: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer | |hepatocellular cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289539 HSALNT0289539] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289539 HSALNT0289539] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141654 HSALNG0141654] |
|AB073614 | |AB073614 | ||
|NA | |NA | ||
| Line 14,439: | Line 16,243: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;glioma | |ovarian cancer;glioma | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242418 HSALNT0242418] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242418 HSALNT0242418] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0117322 HSALNG0117322] |
|CACNA1G-AS1 | |CACNA1G-AS1 | ||
|NA | |NA | ||
| Line 14,447: | Line 16,252: | ||
|pathogenic process | |pathogenic process | ||
|keloid | |keloid | ||
| + | |Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170814 HSALNT0170814] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170814 HSALNT0170814] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0081992 HSALNG0081992] |
|MIR210HG | |MIR210HG | ||
|NA | |NA | ||
| Line 14,455: | Line 16,261: | ||
|pathogenic process | |pathogenic process | ||
|hypoxic and inflammatory stress | |hypoxic and inflammatory stress | ||
| + | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288979 HSALNT0288979] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288979 HSALNT0288979] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113319 HSALNG0113319] |
|FOXC2-AS1 | |FOXC2-AS1 | ||
|ODRUL | |ODRUL | ||
| Line 14,463: | Line 16,270: | ||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289022 HSALNT0289022] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289022 HSALNT0289022] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0132865 HSALNG0132865] |
|LINC00160 | |LINC00160 | ||
|C21orf52,NCRNA00160 | |C21orf52,NCRNA00160 | ||
| Line 14,471: | Line 16,279: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105274 HSALNT0105274] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105274 HSALNT0105274] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0049582 HSALNG0049582] |
|LINC01016 | |LINC01016 | ||
|NA | |NA | ||
| Line 14,479: | Line 16,288: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288904 HSALNT0288904] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288904 HSALNT0288904] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0045753 HSALNG0045753] |
|CARMN | |CARMN | ||
|MIR143HG,CARMEN | |MIR143HG,CARMEN | ||
| Line 14,487: | Line 16,297: | ||
|pathogenic process | |pathogenic process | ||
|cardiac differentiation | |cardiac differentiation | ||
| + | |Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289123 HSALNT0289123] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289123 HSALNT0289123] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0121579 HSALNG0121579] |
|LINC01630 | |LINC01630 | ||
|LOC100287225 | |LOC100287225 | ||
| Line 14,495: | Line 16,306: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288971 HSALNT0288971] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288971 HSALNT0288971] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104253 HSALNG0104253] |
|FAM30A | |FAM30A | ||
|C14orf110,KIAA0125,HSPC053 | |C14orf110,KIAA0125,HSPC053 | ||
| Line 14,503: | Line 16,315: | ||
|pathogenic process | |pathogenic process | ||
|gallbladder cancer | |gallbladder cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289506 HSALNT0289506] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289506 HSALNT0289506] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141617 HSALNG0141617] |
|LINC00346 | |LINC00346 | ||
|C13orf29,NCRNA00346 | |C13orf29,NCRNA00346 | ||
| Line 14,511: | Line 16,324: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;breast cancer | |hepatocellular cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289643 HSALNT0289643] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289643 HSALNT0289643] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141758 HSALNG0141758] |
|BC032469 | |BC032469 | ||
|NA | |NA | ||
| Line 14,519: | Line 16,333: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;gastric cancer | |esophageal squamous cell cancer;gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289580 HSALNT0289580] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289580 HSALNT0289580] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141695 HSALNG0141695] |
|AK024171 | |AK024171 | ||
|NA | |NA | ||
| Line 14,527: | Line 16,342: | ||
|pathogenic process | |pathogenic process | ||
|intervertebral disc degeneration;gastric cancer | |intervertebral disc degeneration;gastric cancer | ||
| + | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290187 HSALNT0290187] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290187 HSALNT0290187] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142302 HSALNG0142302] |
|RP11-284N8.3.1 | |RP11-284N8.3.1 | ||
|NA | |NA | ||
| Line 14,535: | Line 16,351: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289839 HSALNT0289839] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289839 HSALNT0289839] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141954 HSALNG0141954] |
|FMR6 | |FMR6 | ||
|NA | |NA | ||
| Line 14,543: | Line 16,360: | ||
|pathogenic process | |pathogenic process | ||
|fragile X syndrome;fragile X-associated premature ovarian insufficiency | |fragile X syndrome;fragile X-associated premature ovarian insufficiency | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290152 HSALNT0290152] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290152 HSALNT0290152] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142267 HSALNG0142267] |
|PRAL | |PRAL | ||
|lncRNA-PRAL | |lncRNA-PRAL | ||
| Line 14,551: | Line 16,369: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;lung cancer | |hepatocellular cancer;lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289380 HSALNT0289380] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289380 HSALNT0289380] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0129818 HSALNG0129818] |
|NORAD | |NORAD | ||
|LINC00657 | |LINC00657 | ||
| Line 14,559: | Line 16,378: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086803 HSALNT0086803] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086803 HSALNT0086803] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0041283 HSALNG0041283] |
|LIFR-AS1 | |LIFR-AS1 | ||
|NA | |NA | ||
| Line 14,567: | Line 16,387: | ||
|pathogenic process | |pathogenic process | ||
|preterm | |preterm | ||
| + | |Female Urogenital Diseases and Pregnancy Complications | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076183 HSALNT0076183] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076183 HSALNT0076183] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0036373 HSALNG0036373] |
|PANCR | |PANCR | ||
|NA | |NA | ||
| Line 14,575: | Line 16,396: | ||
|pathogenic process | |pathogenic process | ||
|atrial fibrillation | |atrial fibrillation | ||
| + | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288975 HSALNT0288975] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288975 HSALNT0288975] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060982 HSALNG0060982] |
|FEZF1-AS1 | |FEZF1-AS1 | ||
|NA | |NA | ||
| Line 14,583: | Line 16,405: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer;colorectal cancer | |gastric cancer;colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238475 HSALNT0238475] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238475 HSALNT0238475] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0115230 HSALNG0115230] |
|CCDC144NL-AS1 | |CCDC144NL-AS1 | ||
|NA | |NA | ||
| Line 14,591: | Line 16,414: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;cardiac hypertrophy | |ovarian cancer;cardiac hypertrophy | ||
| + | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290102 HSALNT0290102] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290102 HSALNT0290102] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142217 HSALNG0142217] |
|NR_026689 | |NR_026689 | ||
|NA | |NA | ||
| Line 14,599: | Line 16,423: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer;lung cancer | |ovarian cancer;lung cancer | ||
| + | |Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289522 HSALNT0289522] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289522 HSALNT0289522] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075559 HSALNG0075559] |
|ADARB2-AS1 | |ADARB2-AS1 | ||
|C10orf109,NCRNA00168,bA466B20.1 | |C10orf109,NCRNA00168,bA466B20.1 | ||
| Line 14,607: | Line 16,432: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer;pancreatic ductal adenocarcinoma | |breast cancer;pancreatic ductal adenocarcinoma | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288936 HSALNT0288936] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288936 HSALNT0288936] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0018139 HSALNG0018139] |
|DPP10-AS1 | |DPP10-AS1 | ||
|BC032913 | |BC032913 | ||
| Line 14,615: | Line 16,441: | ||
|pathogenic process | |pathogenic process | ||
|breast cancer;colorectal cancer | |breast cancer;colorectal cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289474 HSALNT0289474] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289474 HSALNT0289474] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0113682 HSALNG0113682] |
|GAS8-AS1 | |GAS8-AS1 | ||
|C16orf3 | |C16orf3 | ||
| Line 14,623: | Line 16,450: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer;breast cancer | |papillary thyroid cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289063 HSALNT0289063] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289063 HSALNT0289063] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0075802 HSALNG0075802] |
|MANCR | |MANCR | ||
|LINC00704 | |LINC00704 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289238 HSALNT0289238] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289238 HSALNT0289238] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026715 HSALNG0026715] |
|SAMMSON | |SAMMSON | ||
|LINC01212 | |LINC01212 | ||
| Line 14,639: | Line 16,468: | ||
|pathogenic process | |pathogenic process | ||
|melanoma | |melanoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289027 HSALNT0289027] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289027 HSALNT0289027] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007238 HSALNG0007238] |
|LINC00302 | |LINC00302 | ||
|C1orf46,NCRNA00302,XP33 | |C1orf46,NCRNA00302,XP33 | ||
|NA | |NA | ||
|developmental process | |developmental process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245543 HSALNT0245543] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245543 HSALNT0245543] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0118895 HSALNG0118895] |
|SNHG20 | |SNHG20 | ||
|C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG | |C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG | ||
| Line 14,655: | Line 16,486: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;colorectal cancer | |hepatocellular cancer;colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015631 HSALNT0015631] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015631 HSALNT0015631] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0007463 HSALNG0007463] |
|DCST1-AS1 | |DCST1-AS1 | ||
|RP11-307C12.11 | |RP11-307C12.11 | ||
| Line 14,663: | Line 16,495: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149810 HSALNT0149810] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149810 HSALNT0149810] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0071682 HSALNG0071682] |
|PGM5-AS1 | |PGM5-AS1 | ||
|FAM233A,LOC572558 | |FAM233A,LOC572558 | ||
| Line 14,671: | Line 16,504: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290236 HSALNT0290236] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290236 HSALNT0290236] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142351 HSALNG0142351] |
|SBF2-AS1 | |SBF2-AS1 | ||
|NA | |NA | ||
| Line 14,679: | Line 16,513: | ||
|pathogenic process | |pathogenic process | ||
|non-small cell lung cancer | |non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290325 HSALNT0290325] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290325 HSALNT0290325] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142440 HSALNG0142440] |
|uc.338 | |uc.338 | ||
|NA | |NA | ||
| Line 14,687: | Line 16,522: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;lung cancer | |hepatocellular cancer;lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289973 HSALNT0289973] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289973 HSALNT0289973] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142088 HSALNG0142088] |
|LNCRI | |LNCRI | ||
|lnc-RI | |lnc-RI | ||
|ceRNA | |ceRNA | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290002 HSALNT0290002] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290002 HSALNT0290002] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0142117 HSALNG0142117] |
|LOC100130476 | |LOC100130476 | ||
|NA | |NA | ||
| Line 14,703: | Line 16,540: | ||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell cancer;gastric cardia adenocarcinoma | |esophageal squamous cell cancer;gastric cardia adenocarcinoma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289049 HSALNT0289049] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289049 HSALNT0289049] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0063356 HSALNG0063356] |
|LINC00599 | |LINC00599 | ||
|Rncr3 | |Rncr3 | ||
| Line 14,711: | Line 16,549: | ||
|pathogenic process | |pathogenic process | ||
|diabetes | |diabetes | ||
| + | |Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020406 HSALNT0020406] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020406 HSALNT0020406] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0009871 HSALNG0009871] |
|LINC00628 | |LINC00628 | ||
|NA | |NA | ||
| Line 14,719: | Line 16,558: | ||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289478 HSALNT0289478] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289478 HSALNT0289478] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133031 HSALNG0133031] |
|DSCR4 | |DSCR4 | ||
|DCRB | |DCRB | ||
| Line 14,727: | Line 16,567: | ||
|pathogenic process | |pathogenic process | ||
|Down syndrome | |Down syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017675 HSALNT0017675] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017675 HSALNT0017675] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0008546 HSALNG0008546] |
|GAS5-AS1 | |GAS5-AS1 | ||
|NA | |NA | ||
| Line 14,735: | Line 16,576: | ||
|pathogenic process | |pathogenic process | ||
|oral submucous fibrosis;non-small cell lung cancer | |oral submucous fibrosis;non-small cell lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms;Stomatognathic Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289523 HSALNT0289523] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289523 HSALNT0289523] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0048782 HSALNG0048782] |
|HCG11 | |HCG11 | ||
|bK14H9.3,FLJ14049,FLJ30357 | |bK14H9.3,FLJ14049,FLJ30357 | ||
| Line 14,743: | Line 16,585: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer | |prostate cancer | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134828 HSALNT0134828] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134828 HSALNT0134828] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0064314 HSALNG0064314] |
|LINC02099 | |LINC02099 | ||
|AC145110.1 | |AC145110.1 | ||
| Line 14,751: | Line 16,594: | ||
|pathogenic process | |pathogenic process | ||
|rheumatoid arthritis;breast cancer | |rheumatoid arthritis;breast cancer | ||
| + | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209098 HSALNT0209098] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209098 HSALNT0209098] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0100348 HSALNG0100348] |
|G2E3-AS1 | |G2E3-AS1 | ||
|CAT1647 | |CAT1647 | ||
| Line 14,759: | Line 16,603: | ||
|pathogenic process | |pathogenic process | ||
|bladder cancer | |bladder cancer | ||
| + | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289139 HSALNT0289139] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289139 HSALNT0289139] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0015506 HSALNG0015506] |
|LINC02245 | |LINC02245 | ||
|lnc-SERTAD2-3,AC007386.2 | |lnc-SERTAD2-3,AC007386.2 | ||
| Line 14,767: | Line 16,612: | ||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| + | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008167 HSALNT0008167] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008167 HSALNT0008167] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0004109 HSALNG0004109] |
|FOXD3-AS1 | |FOXD3-AS1 | ||
|pasFOXD3 | |pasFOXD3 | ||
| Line 14,775: | Line 16,621: | ||
|pathogenic process | |pathogenic process | ||
|glioma | |glioma | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289335 HSALNT0289335] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289335 HSALNT0289335] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0060638 HSALNG0060638] |
|LINC00998 | |LINC00998 | ||
|NA | |NA | ||
| Line 14,783: | Line 16,630: | ||
|pathogenic process | |pathogenic process | ||
|major depression disorder | |major depression disorder | ||
| + | |Behavior and Behavior Mechanisms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289379 HSALNT0289379] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289379 HSALNT0289379] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0041522 HSALNG0041522] |
|NNT-AS1 | |NNT-AS1 | ||
|NA | |NA | ||
| Line 14,791: | Line 16,639: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055497 HSALNT0055497] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055497 HSALNT0055497] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0026555 HSALNG0026555] |
|PSMD6-AS1 | |PSMD6-AS1 | ||
|ENST00000462717,lnc00462717 | |ENST00000462717,lnc00462717 | ||
| Line 14,799: | Line 16,648: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer;glioma | |papillary thyroid cancer;glioma | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289130 HSALNT0289130] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289130 HSALNT0289130] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0119047 HSALNG0119047] |
|LINC02081 | |LINC02081 | ||
|CTD-2357A8.3,XLOC_012582 | |CTD-2357A8.3,XLOC_012582 | ||
| Line 14,807: | Line 16,657: | ||
|pathogenic process | |pathogenic process | ||
|esophageal cancer | |esophageal cancer | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289306 HSALNT0289306] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289306 HSALNT0289306] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0107939 HSALNG0107939] |
|LINC00052 | |LINC00052 | ||
|TMEM83,NCRNA00052,FLJ31461 | |TMEM83,NCRNA00052,FLJ31461 | ||
| Line 14,815: | Line 16,666: | ||
|pathogenic process | |pathogenic process | ||
|hepatocellular cancer;breast cancer | |hepatocellular cancer;breast cancer | ||
| + | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199070 HSALNT0199070] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199070 HSALNT0199070] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0095970 HSALNG0095970] |
|PLUT | |PLUT | ||
|PDX1-AS1,PLUTO,HI-LNC71 | |PDX1-AS1,PLUTO,HI-LNC71 | ||
| Line 14,823: | Line 16,675: | ||
|pathogenic process | |pathogenic process | ||
|type 2 diabetes | |type 2 diabetes | ||
| + | |Nutritional and Metabolic Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289341 HSALNT0289341] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289341 HSALNT0289341] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0073476 HSALNG0073476] |
|LINC01505 | |LINC01505 | ||
|RP11-308N19.1 | |RP11-308N19.1 | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289315 HSALNT0289315] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289315 HSALNT0289315] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0020625 HSALNG0020625] |
|LINC01116 | |LINC01116 | ||
|TALNEC2 | |TALNEC2 | ||
| Line 14,839: | Line 16,693: | ||
|pathogenic process | |pathogenic process | ||
|prostate cancer;glioblastoma | |prostate cancer;glioblastoma | ||
| + | |Male Urogenital Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006439 HSALNT0006439] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006439 HSALNT0006439] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0003395 HSALNG0003395] |
|FOXD2-AS1 | |FOXD2-AS1 | ||
|MGC12982 | |MGC12982 | ||
| Line 14,847: | Line 16,702: | ||
|pathogenic process | |pathogenic process | ||
|lung cancer | |lung cancer | ||
| + | |Respiratory Tract Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252387 HSALNT0252387] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252387 HSALNT0252387] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0122085 HSALNG0122085] |
|LINC00305 | |LINC00305 | ||
|C18orf20,NCRNA00305,MGC39571,HsT1235 | |C18orf20,NCRNA00305,MGC39571,HsT1235 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 14,857: | Line 16,714: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289473 HSALNT0289473] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289473 HSALNT0289473] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0110794 HSALNG0110794] |
|FBXL19-AS1 | |FBXL19-AS1 | ||
|NCRNA00095,MGC125469,MGC125470,MGC125472 | |NCRNA00095,MGC125469,MGC125470,MGC125472 | ||
| Line 14,863: | Line 16,720: | ||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| + | |Neoplasms;Digestive System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0187807 HSALNT0187807] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0187807 HSALNT0187807] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0090479 HSALNG0090479] |
|LINC02555 | |LINC02555 | ||
|AC079630.2 | |AC079630.2 | ||
| Line 14,871: | Line 16,729: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0251493 HSALNT0251493] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0251493 HSALNT0251493] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0121679 HSALNG0121679] |
|LINC01929 | |LINC01929 | ||
|CTD-2171N6.1 | |CTD-2171N6.1 | ||
| Line 14,879: | Line 16,738: | ||
|pathogenic process | |pathogenic process | ||
|papillary thyroid cancer | |papillary thyroid cancer | ||
| + | |Endocrine System Diseases;Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244776 HSALNT0244776] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244776 HSALNT0244776] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0118529 HSALNG0118529] |
|LINC01152 | |LINC01152 | ||
|TCONS_00025128,CMPD | |TCONS_00025128,CMPD | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0284591 HSALNT0284591] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0284591 HSALNT0284591] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0139113 HSALNG0139113] |
|DIAPH2-AS1 | |DIAPH2-AS1 | ||
|NA | |NA | ||
| Line 14,895: | Line 16,756: | ||
|pathogenic process | |pathogenic process | ||
|Hodgkin's disease | |Hodgkin's disease | ||
| + | |Neoplasms | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289226 HSALNT0289226] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289226 HSALNT0289226] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0104558 HSALNG0104558] |
|PWAR1 | |PWAR1 | ||
|PAR1,PAR-1 | |PAR1,PAR-1 | ||
| Line 14,903: | Line 16,765: | ||
|pathogenic process | |pathogenic process | ||
|Prader-Willi syndrome and Angelman syndrome | |Prader-Willi syndrome and Angelman syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289339 HSALNT0289339] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289339 HSALNT0289339] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0070961 HSALNG0070961] |
|LINC00950 | |LINC00950 | ||
|FP588 | |FP588 | ||
| + | |NA | ||
|NA | |NA | ||
|NA | |NA | ||
| Line 14,913: | Line 16,777: | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289740 HSALNT0289740] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289740 HSALNT0289740] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141855 HSALNG0141855] |
|DGCR12 | |DGCR12 | ||
|DGS-E | |DGS-E | ||
| Line 14,919: | Line 16,783: | ||
|pathogenic process;developmental process | |pathogenic process;developmental process | ||
|DiGeorge syndrome | |DiGeorge syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275220 HSALNT0275220] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275220 HSALNT0275220] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133987 HSALNG0133987] |
|DGCR9 | |DGCR9 | ||
|DGS-A,POM121L5P | |DGS-A,POM121L5P | ||
| Line 14,927: | Line 16,792: | ||
|pathogenic process | |pathogenic process | ||
|DiGeorge syndrome | |DiGeorge syndrome | ||
| + | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288929 HSALNT0288929] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288929 HSALNT0288929] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0133982 HSALNG0133982] |
|DGCR10 | |DGCR10 | ||
|DGS-B | |DGS-B | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289494 HSALNT0289494] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289494 HSALNT0289494] | ||
| − | |[https://bigd.big.ac.cn/lncbook/ | + | |[https://bigd.big.ac.cn/lncbook/gene?geneid=HSALNG0141605 HSALNG0141605] |
|DGCR11 | |DGCR11 | ||
|DGS-D | |DGS-D | ||
|NA | |NA | ||
|pathogenic process | |pathogenic process | ||
| + | |NA | ||
|NA | |NA | ||
|- | |- | ||
|} | |} | ||
Revision as of 06:00, 26 August 2019
| Gene ID | Symbol | Synonyms | Functional Mechanism | Biological Process | Disease | Mesh Ontology | |
|---|---|---|---|---|---|---|---|
| HSALNT0289501 | HSALNG0141612 | HPVC1 | PE5L,HPV18E5L | NA | pathogenic process | NA | NA |
| HSALNT0289605 | HSALNG0141720 | Alpha 250/ Alpha 280 | NONHSAT104559,lnc-C9orf53-2:1 | NA | NA | NA | NA |
| HSALNT0199632 | HSALNG0096226 | N4BP2L2-IT2 | CG030 | NA | NA | NA | NA |
| HSALNT0171094 | HSALNG0082161 | LINC01150 | 2G7,TCONS_00019134 | NA | pathogenic process | Wilms' tumor | Neoplasms |
| HSALNT0289115 | HSALNG0032599 | LINC01587 | C4orf6,aC1 | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0290105 | HSALNG0142220 | NTT | NONHSAT115106 | NA | NA | NA | NA |
| HSALNT0289234 | HSALNG0053252 | RNF217-AS1 | STL | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0280481 | HSALNG0136795 | INE2 | NCRNA00011 | NA | NA | NA | NA |
| HSALNT0289485 | HSALNG0137683 | INE1 | NCRNA00010 | NA | NA | NA | NA |
| HSALNT0289511 | HSALNG0141622 | LINC01565 | C3orf27,GR6 | NA | pathogenic process | leukemia | Neoplasms |
| HSALNT0289068 | HSALNG0006924 | LINC00869 | KIAA0493 | NA | NA | NA | NA |
| HSALNT0289430 | HSALNG0026312 | ERC2-IT1 | C1orf1,C3orf51,Po42 | NA | pathogenic process | NA | NA |
| HSALNT0290394 | HSALNG0142509 | Y RNAs | lnc-PDIA4-1:1 | NA | NA | NA | NA |
| HSALNT0289195 | HSALNG0032409 | NOP14-AS1 | C4orf10,RES4-24 | NA | NA | NA | NA |
| HSALNT0290309 | HSALNG0142424 | TncRNA | NONHSAT022116,AF080092,TSU | NA | developmental process | NA | NA |
| HSALNT0289243 | HSALNG0045080 | SMAD5-AS1 | SMAD5O,DAMS | NA | pathogenic process | malignant hematopoietic | Cell Physiological Phenomena |
| HSALNT0289025 | HSALNG0062672 | LINC00244 | C7orf4,NCRNA00244 | NA | pathogenic process | preaxial polydactyly | NA |
| HSALNT0289017 | HSALNG0055219 | KIF25-AS1 | C6orf54,NCRNA00300,HGC6.1.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289332 | HSALNG0055207 | LINC01558 | C6orf123,LINC01557,HGC6.2,dJ431P23.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289438 | HSALNG0055209 | AFDN-AS1 | C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 | NA | pathogenic process | NA | NA |
| HSALNT0289232 | HSALNG0135027 | RFPL3S | RFPL3-AS1,RFPL3-A, NCRNA00005 | NA | pathogenic process | opitz syndrome | NA |
| HSALNT0289393 | HSALNG0134830 | RFPL1S | RFPL1-AS1,RFPL1-A, NCRNA00006 | NA | pathogenic process | NA | NA |
| HSALNT0289500 | HSALNG0141611 | HCG4B | HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 | NA | NA | NA | NA |
| HSALNT0289894 | HSALNG0142009 | LINC00294 | NA | NA | NA | NA | NA |
| HSALNT0289345 | HSALNG0140599 | LINC00893 | NA | NA | pathogenic process | hunter syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0290133 | HSALNG0142248 | PCBP3-OT1 | PCBP3-OT1,FLJ44028 | NA | NA | NA | NA |
| HSALNT0289488 | HSALNG0141599 | BPESC1 | NCRNA00187 | NA | pathogenic process | blepharophimosis syndrome | Eye Diseases |
| HSALNT0289712 | HSALNG0141827 | COPG2IT1 | CIT1,NCRNA00170,COPG2AS | NA | NA | NA | NA |
| HSALNT0265040 | HSALNG0128978 | LINC00652 | HSPC072 | NA | developmental process | NA | NA |
| HSALNT0289282 | HSALNG0108689 | WASIR2 | NCRNA00286A | NA | NA | NA | NA |
| HSALNT0246856 | HSALNG0119601 | LINC00470 | C18orf2 | NA | pathogenic process | age-related macular degeneration | Eye Diseases |
| HSALNT0289507 | HSALNG0141618 | LINC00588 | C8orf71,DKFZP434F122 | NA | NA | NA | NA |
| HSALNT0276604 | HSALNG0134754 | TTC28-AS1 | TTC28AS,TTC28-AS,KIAA1648 | NA | NA | NA | NA |
| HSALNT0237577 | HSALNG0114754 | CDRT7 | NCRNA00025,LINC00025 | NA | NA | NA | NA |
| HSALNT0288912 | HSALNG0114755 | CDRT8 | NA | NA | NA | NA | NA |
| HSALNT0275048 | HSALNG0133887 | CECR3 | NA | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0288915 | HSALNG0133890 | CECR9 | NA | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0288998 | HSALNG0133878 | HDHD5-AS1 | CECR4,CECR5-AS1,NCRNA00017 | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0288914 | HSALNG0133878 | CECR5-AS1 | NCRNA00017 | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0288919 | HSALNG0029809 | CLRN1-AS1 | CLRN1O,UCRP | NA | pathogenic process | usher syndrome type 3 | NA |
| HSALNT0289271 | HSALNG0082585 | TMEM9B-AS1 | C11orf18 | NA | NA | NA | NA |
| HSALNT0289324 | HSALNG0133586 | LINC01547 | C21orf69,C21orf67 | NA | pathogenic process | Down syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0270409 | HSALNG0131587 | LINC00029 | C20orf51,NCRNA00029,bA305P22.4 | NA | NA | NA | NA |
| HSALNT0289336 | HSALNG0141634 | LINC00529 | C8orf8 | NA | pathogenic process | keratolytic winter erythema | NA |
| HSALNT0288978 | HSALNG0010403 | FLVCR1-AS1 | FLVCR1-DT,LQK1 | NA | NA | NA | NA |
| HSALNT0238050 | HSALNG0114969 | SMCR2 | NA | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289401 | HSALNG0114982 | SMCR5 | NCRNA00034 | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290246 | HSALNG0142361 | SMCR6 | NA | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0274626 | HSALNG0133620 | LINC00205 | C21orf86,NCRNA00205, | NA | pathogenic process | NA | NA |
| HSALNT0271512 | HSALNG0132117 | C21orf91-OT1 | NCRNA00285,D21S2089E | NA | NA | NA | NA |
| HSALNT0272596 | HSALNG0132582 | LINC00307 | NCRNA00307,D21S2091E | NA | NA | NA | NA |
| HSALNT0274502 | HSALNG0133549 | TSPEAR-AS2 | C21orf90 | NA | NA | NA | NA |
| HSALNT0274807 | HSALNG0133721 | MCM3AP-AS1 | C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 | NA | NA | NA | NA |
| HSALNT0288888 | HSALNG0133144 | B3GALT5-AS1 | C21orf88 | NA | NA | NA | NA |
| HSALNT0288898 | HSALNG0133127 | BRWD1-AS2 | C21orf87,NCRNA00257,BRWD1-IT2 | NA | NA | NA | NA |
| HSALNT0289031 | HSALNG0133621 | LINC00315 | C21orf93,NCRNA00315 | NA | NA | NA | NA |
| HSALNT0289033 | HSALNG0133612 | LINC00334 | C21orf89,NCRNA00334 | NA | NA | NA | NA |
| HSALNT0289322 | HSALNG0132477 | LINC00314 | C21orf94,NCRNA00314 | NA | NA | NA | NA |
| HSALNT0271821 | HSALNG0132261 | LINC00308 | C21orf74,NCRNA00308,PRED16 | NA | pathogenic process | NA | NA |
| HSALNT0289023 | HSALNG0132537 | LINC00189 | C21orf109,NCRNA00189 | NA | pathogenic process | NA | NA |
| HSALNT0289375 | HSALNG0042788 | NCRUPAR | ncR-uPAR,ncRuPAR,NCRNA00193 | transcriptional regulation | developmental process | NA | NA |
| HSALNT0273467 | HSALNG0133048 | DSCR10 | NA | NA | NA | NA | NA |
| HSALNT0289480 | HSALNG0132984 | DSCR9 | NCRNA00038 | NA | NA | NA | NA |
| HSALNT0290051 | HSALNG0142166 | MDS2 | NA | NA | pathogenic process | myelodysplastic syndrome | Hemic and Lymphatic Diseases |
| HSALNT0127810 | HSALNG0060777 | ST7-AS2 | ST7OT2,ST7AS2 | NA | pathogenic process | autism | Mental Disorders |
| HSALNT0127813 | HSALNG0060778 | ST7-OT3 | ST7OT3,NCRNA00026 | NA | pathogenic process | autism | Mental Disorders |
| HSALNT0290258 | HSALNG0142373 | ST7-OT4 | NA | NA | pathogenic process | autism | Mental Disorders |
| HSALNT0290257 | HSALNG0142372 | ST7OT | NONHSAT122926 | NA | NA | NA | NA |
| HSALNT0289372 | HSALNG0074272 | MIR600HG | C9orf45,NCRNA00287,GL012,FLJ22161 | NA | NA | NA | NA |
| HSALNT0013239 | HSALNG0006325 | ATP1A1-AS1 | C1orf203,ATP1A1OS,MGC16179 | NA | NA | NA | NA |
| HSALNT0048563 | HSALNG0022910 | SPATA3-AS1 | NA | NA | NA | NA | NA |
| HSALNT0050859 | HSALNG0024100 | LINC00852 | C3orf42,GHRLOS2,NAG73,GHRL-AS2 | NA | NA | NA | NA |
| HSALNT0069395 | HSALNG0033002 | LINC01096 | NA | NA | NA | NA | NA |
| HSALNT0072367 | HSALNG0034486 | LINC02260 | NA | NA | NA | NA | NA |
| HSALNT0077259 | HSALNG0036896 | LINC01091 | NA | NA | NA | NA | NA |
| HSALNT0096480 | HSALNG0046004 | SAP30L-AS1 | FLJ38109,GALNT10-AS1 | NA | NA | NA | NA |
| HSALNT0098558 | HSALNG0046927 | PRR7-AS1 | NA | NA | NA | NA | NA |
| HSALNT0099356 | HSALNG0047338 | LINC01622 | TCONS_00011202 | NA | NA | NA | NA |
| HSALNT0113415 | HSALNG0053588 | LINC01312 | MGC34034 | NA | NA | NA | NA |
| HSALNT0134652 | HSALNG0064240 | EXTL3-AS1 | C8orf50 | NA | NA | NA | NA |
| HSALNT0138253 | HSALNG0065979 | C8orf34-AS1 | NA | NA | NA | NA | NA |
| HSALNT0154876 | HSALNG0074139 | PSMD5-AS1 | NA | NA | NA | NA | NA |
| HSALNT0163228 | HSALNG0078227 | LINC01553 | C10orf40,AC023904.2 | NA | NA | NA | NA |
| HSALNT0175689 | HSALNG0084463 | LINC00301 | C11orf64,NCRNA00301,MGC39681 | NA | NA | NA | NA |
| HSALNT0247235 | HSALNG0119722 | DLGAP1-AS3 | NA | NA | NA | NA | NA |
| HSALNT0254200 | HSALNG0123001 | CIRBP-AS1 | C19orf23,MGC39338 | NA | NA | NA | NA |
| HSALNT0257335 | HSALNG0124987 | LINC01785 | NA | NA | NA | NA | NA |
| HSALNT0261582 | HSALNG0127139 | LINC01869 | MGC45922 | NA | NA | NA | NA |
| HSALNT0269743 | HSALNG0131262 | LINC01711 | MGC4294 | NA | NA | NA | NA |
| HSALNT0288468 | HSALNG0141311 | FAM41AY1 | FAM41AY | NA | NA | NA | NA |
| HSALNT0288899 | HSALNG0045020 | C5orf66-AS2 | NA | NA | NA | NA | NA |
| HSALNT0288922 | HSALNG0083517 | CSTF3-AS1 | CSTF3-DT | NA | NA | NA | NA |
| HSALNT0288923 | HSALNG0014289 | CYP1B1-AS1 | C2orf58,MGC34824 | NA | NA | NA | NA |
| HSALNT0288957 | HSALNG0025315 | ENTPD3-AS1 | FLJ36665 | NA | NA | NA | NA |
| HSALNT0288970 | HSALNG0071511 | FAM27E3 | MGC42630 | NA | NA | NA | NA |
| HSALNT0288972 | HSALNG0000046 | FAM41C | NA | NA | NA | NA | NA |
| HSALNT0288977 | HSALNG0007223 | FLG-AS1 | NA | NA | NA | NA | NA |
| HSALNT0288983 | HSALNG0105871 | GABPB1-IT1 | FLJ10038 | NA | NA | NA | NA |
| HSALNT0289010 | HSALNG0123950 | ILF3-AS1 | ILF3-DT | NA | NA | NA | NA |
| HSALNT0289034 | HSALNG0097943 | LINC00347 | NA | NA | NA | NA | NA |
| HSALNT0289039 | HSALNG0004105 | LINC00466 | NA | NA | NA | NA | NA |
| HSALNT0289040 | HSALNG0022951 | LINC00471 | C2orf52,MGC43122 | NA | NA | NA | NA |
| HSALNT0289044 | HSALNG0119752 | LINC00526 | C18orf18,MGC17515,HsT959 | NA | NA | NA | NA |
| HSALNT0289048 | HSALNG0106873 | LINC00593 | C15orf50,MGC42951 | NA | NA | NA | NA |
| HSALNT0289050 | HSALNG0022320 | LINC00608 | NA | NA | NA | NA | NA |
| HSALNT0289054 | HSALNG0104144 | LINC00638 | MGC23270 | NA | NA | NA | NA |
| HSALNT0289056 | HSALNG0124410 | LINC00661 | NA | NA | NA | NA | NA |
| HSALNT0289057 | HSALNG0125113 | LINC00662 | NA | NA | NA | NA | NA |
| HSALNT0289062 | HSALNG0024755 | LINC00692 | NA | NA | NA | NA | NA |
| HSALNT0289064 | HSALNG0075805 | LINC00705 | NA | NA | NA | NA | NA |
| HSALNT0289067 | HSALNG0118878 | LINC00868 | C17orf52 | NA | NA | NA | NA |
| HSALNT0130693 | HSALNG0062275 | LINC00996 | NA | NA | NA | NA | NA |
| HSALNT0289101 | HSALNG0089327 | LINC01252 | NA | NA | NA | NA | NA |
| HSALNT0289131 | HSALNG0113283 | LINC02135 | NA | NA | NA | NA | NA |
| HSALNT0289193 | HSALNG0018445 | NIFK-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289244 | HSALNG0008972 | SMG7-AS1 | DKFZP564C196 | NA | NA | NA | NA |
| HSALNT0235326 | HSALNG0113528 | SNAI3-AS1 | MGC23284 | NA | NA | NA | NA |
| HSALNT0215205 | HSALNG0103442 | SNHG10 | C14orf62,FLJ40557,NCRNA00063,LINC00063 | NA | NA | NA | NA |
| HSALNT0289290 | HSALNG0109122 | ZNF205-AS1 | MGC3771 | NA | NA | NA | NA |
| HSALNT0289294 | HSALNG0009820 | LINC00260 | C1orf217,NCRNA00260,MGC5457 | NA | NA | NA | NA |
| HSALNT0289295 | HSALNG0000511 | LINC00337 | C1orf211,NCRNA00337,MGC40168 | NA | NA | NA | NA |
| HSALNT0289298 | HSALNG0076905 | WAC-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289299 | HSALNG0077486 | LINC00839 | NA | NA | NA | NA | NA |
| HSALNT0289303 | HSALNG0089110 | LINC00612 | C12orf33,MGC40170,FLJ41814 | NA | NA | NA | NA |
| HSALNT0289312 | HSALNG0124755 | LINC00663 | MGC39821 | NA | NA | NA | NA |
| HSALNT0289320 | HSALNG0130611 | LINC00494 | NA | NA | NA | NA | NA |
| HSALNT0289330 | HSALNG0039733 | LINC01019 | NA | NA | NA | NA | NA |
| HSALNT0289333 | HSALNG0057380 | LINC00265 | NCRNA00265,NCRNA00265-1 | NA | NA | NA | NA |
| HSALNT0289334 | HSALNG0062824 | LINC00689 | NA | NA | NA | NA | NA |
| HSALNT0289337 | HSALNG0068847 | LINC01591 | NA | NA | NA | NA | NA |
| HSALNT0289340 | HSALNG0072666 | LINC01501 | NA | NA | NA | NA | NA |
| HSALNT0289346 | HSALNG0137712 | LINC01560 | CXorf24 | NA | NA | NA | NA |
| HSALNT0289352 | HSALNG0045051 | LINC01959 | NA | NA | NA | NA | NA |
| HSALNT0289353 | HSALNG0110333 | LINC02175 | NA | NA | NA | NA | NA |
| HSALNT0289354 | HSALNG0064321 | LINC02209 | FAM183CP | NA | NA | NA | NA |
| HSALNT0289359 | HSALNG0107406 | LINGO1-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289362 | HSALNG0119342 | MAFG-AS1 | MAFG-DT | NA | NA | NA | NA |
| HSALNT0289373 | HSALNG0139326 | MORF4L2-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289381 | HSALNG0029035 | NPHP3-AS1 | NCRNA00119 | NA | NA | NA | NA |
| HSALNT0289385 | HSALNG0062543 | PAXIP1-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289413 | HSALNG0082091 | TOLLIP-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289416 | HSALNG0113198 | LINC00311 | TMEM148,NCRNA00311,MGC22001 | NA | NA | NA | NA |
| HSALNT0289422 | HSALNG0069500 | ZNF252P-AS1 | C8orf77 | NA | NA | NA | NA |
| HSALNT0289423 | HSALNG0001624 | ZNF436-AS1 | C1orf213,FLJ90508 | NA | NA | NA | NA |
| HSALNT0289429 | HSALNG0029047 | BFSP2-AS1 | MGC2848 | NA | NA | NA | NA |
| HSALNT0289432 | HSALNG0032263 | CTBP1-AS1 | C4orf42,CTBP1-DT,CTBP1-DT,MGC21675 | NA | NA | NA | NA |
| HSALNT0289436 | HSALNG0039444 | EXOC3-AS1 | C5orf55 | NA | NA | NA | NA |
| HSALNT0289441 | HSALNG0049246 | HCG27 | bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 | NA | NA | NA | NA |
| HSALNT0289450 | HSALNG0067505 | BAALC-AS2 | C8orf56,BAALCOS,MGC39526 | NA | NA | NA | NA |
| HSALNT0289453 | HSALNG0062877 | FAM87A | NA | NA | NA | NA | NA |
| HSALNT0289459 | HSALNG0078365 | JMJD1C-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289465 | HSALNG0092957 | ATP2B1-AS1 | LINC00936 | NA | NA | NA | NA |
| HSALNT0289466 | HSALNG0093183 | CEP83-AS1 | CEP83-DT | NA | NA | NA | NA |
| HSALNT0289470 | HSALNG0107054 | HEXA-AS1 | C15orf34,FLJ13315 | NA | NA | NA | NA |
| HSALNT0289487 | HSALNG0141598 | BIN3-IT1 | FLJ14107 | NA | NA | NA | NA |
| HSALNT0289490 | HSALNG0141601 | CSNK1G2-AS1 | C19orf34,MGC39696 | NA | NA | NA | NA |
| HSALNT0289508 | HSALNG0141619 | LINC00634 | NA | NA | NA | NA | NA |
| HSALNT0289510 | HSALNG0141621 | LINC00685 | CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 | NA | NA | NA | NA |
| HSALNT0289515 | HSALNG0141626 | SHANK2-AS3 | C11orf76 | NA | NA | NA | NA |
| HSALNT0290073 | HSALNG0142188 | NCBP2-AS2 | NA | NA | NA | NA | NA |
| HSALNT0289502 | HSALNG0141613 | KCNIP4-IT1 | NCRNA00099,UM9-5 | NA | NA | NA | NA |
| HSALNT0289856 | HSALNG0141971 | GTSCR1 | NA | NA | pathogenic process | Gilles de la Tourette syndrome | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289325 | HSALNG0008917 | LINC00272 | C1orf120,NCRNA00272,RP1-223H12.3 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288512 | HSALNG0141348 | TTTY9B | NCRNA00132 | NA | NA | NA | NA |
| HSALNT0290155 | HSALNG0142270 | Prion-associated RNAs | NA | NA | pathogenic process | prion disease | Nervous System Diseases |
| HSALNT0289444 | HSALNG0062567 | BLACE | NA | NA | pathogenic process | acute B lymphoblastic leukemias | Hemic and Lymphatic Diseases |
| HSALNT0060411 | HSALNG0028877 | H1FX-AS1 | C3orf47,FLJ34151 | NA | NA | NA | NA |
| HSALNT0186668 | HSALNG0089868 | LINC00477 | C12orf67,FLJ32894,FAM191B | NA | NA | NA | NA |
| HSALNT0275096 | HSALNG0133923 | LINC00528 | C22orf37,FLJ40542 | NA | NA | NA | NA |
| HSALNT0287824 | HSALNG0140941 | ASMTL-AS1 | CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 | NA | NA | NA | NA |
| HSALNT0288887 | HSALNG0106820 | ANP32A-IT1 | C15orf28,NCRNA00321,FLJ11722,HsT18971 | NA | NA | NA | NA |
| HSALNT0289370 | HSALNG0010128 | MIR29B2CHG | C1orf132,FLJ35650 | NA | NA | NA | NA |
| HSALNT0289396 | HSALNG0007497 | RUSC1-AS1 | C1orf104,FLJ35976 | NA | NA | NA | NA |
| HSALNT0084628 | HSALNG0040236 | LINC01194 | CT49,TAG | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289468 | HSALNG0103838 | DIO3OS | C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 | NA | NA | NA | NA |
| HSALNT0121060 | HSALNG0057178 | NPSR1-AS1 | AAA1,IMAGE:4827585 | NA | NA | NA | NA |
| HSALNT0074370 | HSALNG0035535 | LINC00575 | C4orf11 | NA | pathogenic process | NA | NA |
| HSALNT0137345 | HSALNG0065537 | LINC01602 | T1560 | NA | pathogenic process | NA | NA |
| HSALNT0289433 | HSALNG0035768 | FAM13A-AS1 | FAM13A1OS,FAM13AOS,NCRNA00039 | NA | NA | NA | NA |
| HSALNT0289186 | HSALNG0072891 | MIRLET7DHG | NA | NA | NA | NA | NA |
| HSALNT0155254 | HSALNG0074353 | MIR181A2HG | NA | NA | NA | NA | NA |
| HSALNT0289283 | HSALNG0035624 | WDFY3-AS2 | C4orf12,NCRNA00247,FBI4 | NA | NA | NA | NA |
| HSALNT0154555 | HSALNG0073990 | PAPPA-AS1 | PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 | NA | NA | NA | NA |
| HSALNT0136307 | HSALNG0065020 | LINC00293 | BEYLA | NA | developmental process | NA | NA |
| HSALNT0030983 | HSALNG0014614 | SIX3-AS1 | SIX3OS | NA | developmental process | NA | NA |
| HSALNT0211503 | HSALNG0101546 | OTX2-AS1 | OTX2OS1 | NA | developmental process | NA | NA |
| HSALNT0063422 | HSALNG0030360 | LINC01192 | CT64 | NA | NA | NA | NA |
| HSALNT0217123 | HSALNG0104394 | LINC01193 | CT60,LOC348120 | NA | NA | NA | NA |
| HSALNT0289664 | HSALNG0141779 | C1QTNF9B-AS1 | PCOTH | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289623 | HSALNG0141738 | ATP6V1G2-DDX39B | NA | NA | pathogenic process | dilated cardiomyopathy | Cardiovascular Diseases |
| HSALNT0289498 | HSALNG0141609 | FAM226B | CXorf50B,NCRNA00246B,LINC00246B | NA | NA | NA | NA |
| HSALNT0289321 | HSALNG0133590 | LINC00163 | C21orf134,NCRNA00163,NLC1-A,NLC1A | NA | pathogenic process | narcolepsy | Mental Disorders;Nervous System Diseases |
| HSALNT0289505 | HSALNG0141616 | LINC00165 | C21orf135,NCRNA00165,NLC1-B | NA | NA | NA | NA |
| HSALNT0290297 | HSALNG0142412 | TEA-ncRNAs | ENSG00000251002 | NA | NA | NA | NA |
| HSALNT0274212 | HSALNG0133403 | LINC00322 | C21orf136,NCRNA00322,FLJ16545 | NA | NA | NA | NA |
| HSALNT0289741 | HSALNG0141856 | DHFR upstream transcripts | DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 | transcriptional regulation | NA | NA | NA |
| HSALNT0289527 | HSALNG0141642 | 21A | ncRNA 21A,NONHSAT128494 | NA | NA | NA | NA |
| HSALNT0289409 | HSALNG0080181 | TLX1NB | TD1,TDI,APT-B7 | NA | pathogenic process | leukemogenesis | Hemic and Lymphatic Diseases |
| HSALNT0289662 | HSALNG0141777 | C15orf2 | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290097 | HSALNG0142212 | NPAP1 | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0217406 | HSALNG0104530 | PWRN2 | NCRNA00199 | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289227 | HSALNG0104528 | PWRN1 | NCRNA00198 | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0262816 | HSALNG0127793 | MIMT1 | MIM1,NCRNA00067,LINC00067 | NA | NA | NA | NA |
| HSALNT0289180 | HSALNG0000682 | MIR34AHG | NA | NA | NA | NA | NA |
| HSALNT0289357 | HSALNG0049203 | LINC02570 | XXbac-BPG27H4.8 | NA | pathogenic process | MHC-associated diseases | Immune System Diseases |
| HSALNT0290177 | HSALNG0142292 | RNY1 | NA | NA | pathogenic process | cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0289378 | HSALNG0129114 | NKX2-2-AS1 | NKX2-2AS | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0290151 | HSALNG0142266 | PR antisense transcripts | FJ515872.1,NONHSAT023851 | transcriptional regulation | NA | NA | NA |
| HSALNT0180290 | HSALNG0086714 | PGR-AS1,PR antisense transcripts | AT1,AT2,AT3 | NA | NA | NA | NA |
| HSALNT0289607 | HSALNG0141722 | anti-NOS2A | NA | NA | pathogenic process | meningioma;glioblastoma | Neoplasms;Nervous System Diseases |
| HSALNT0289687 | HSALNG0141802 | CDKN1A-AS1 | p21NAT | transcriptional regulation | NA | NA | NA |
| HSALNT0289166 | HSALNG0103805 | MEG9 | LINC00584 | NA | NA | NA | NA |
| HSALNT0116668 | HSALNG0055114 | RPS6KA2-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289384 | HSALNG0073983 | PAPPA-AS2 | AGU1 | NA | NA | NA | NA |
| HSALNT0262802 | HSALNG0127785 | ZIM2-AS1 | ZIM2as | NA | NA | NA | NA |
| HSALNT0289824 | HSALNG0141939 | Evf2 | Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 | transcriptional regulation | NA | NA | NA |
| HSALNT0289481 | HSALNG0134495 | ADORA2A-AS1 | C22orf45,FLJ34651 | NA | NA | NA | NA |
| HSALNT0290146 | HSALNG0142261 | POU5F1P4 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290033 | HSALNG0142148 | LSINCT1 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290034 | HSALNG0142149 | LSINCT10 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290035 | HSALNG0142150 | LSINCT11 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290036 | HSALNG0142151 | LSINCT12 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290037 | HSALNG0142152 | LSINCT2 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290038 | HSALNG0142153 | LSINCT3 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290039 | HSALNG0142154 | LSINCT4 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290041 | HSALNG0142156 | LSINCT6 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290042 | HSALNG0142157 | LSINCT7 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290043 | HSALNG0142158 | LSINCT8 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290044 | HSALNG0142159 | LSINCT9 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289676 | HSALNG0141791 | CAR Intergenic 10 | FLJ31066,NONHSAT016928,lnc-FANK1-3:1 | transcriptional regulation | NA | NA | NA |
| HSALNT0290032 | HSALNG0142147 | LRRC3DN | C21orf30,DKFZP434C128 | transcriptional regulation | NA | NA | NA |
| HSALNT0266984 | HSALNG0129985 | SNHG11 | C20orf198,LINC00101,NCRNA00101 | NA | pathogenic process | obesity | Nutritional and Metabolic Diseases |
| HSALNT0289880 | HSALNG0141995 | KRASP1 | NONHSAT113225,ENSG00000220635 | ceRNA | NA | NA | NA |
| HSALNT0006368 | HSALNG0003376 | CYP4A22-AS1 | ncRNA-a3 | transcriptional regulation | NA | NA | NA |
| HSALNT0027470 | HSALNG0013045 | LINC00570 | ncRNA-a5 | transcriptional regulation | NA | NA | NA |
| HSALNT0289066 | HSALNG0003381 | LINC00853 | PDZK1IP1-AS1,ncRNA-a4 | transcriptional regulation | NA | NA | NA |
| HSALNT0289936 | HSALNG0142051 | lincRNA-ROR | ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 | NA | NA | NA | NA |
| HSALNT0289705 | HSALNG0141820 | CHL1-AS2 | NA | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
| HSALNT0076084 | HSALNG0036316 | SEC24B-AS1 | 1/2-SBSRNA4 | siRNA | NA | NA | NA |
| HSALNT0290137 | HSALNG0142252 | PDZRN3-AS1 | NA | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0290237 | HSALNG0142352 | SCAANT1 | ATXN7-AS1 | transcriptional regulation | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289594 | HSALNG0141709 | AK123790 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289911 | HSALNG0142026 | LINC01451 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290401 | HSALNG0142516 | ZNF350-AS1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289845 | HSALNG0141960 | GADD45G | NA | NA | pathogenic process | pituitary adenoma | Endocrine System Diseases;Neoplasms;Nervous System Diseases |
| HSALNT0289410 | HSALNG0043357 | TMEM161B-AS1 | AK082072,linc-POLR3G-8,ENSG00000247828 | NA | NA | NA | NA |
| HSALNT0289736 | HSALNG0141851 | DAPK1 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290048 | HSALNG0142163 | MAP3K14 | MAP3K14 | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290150 | HSALNG0142265 | PPP3CB | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0151531 | HSALNG0072477 | DAPK1-IT1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0288990 | HSALNG0041256 | GDNF-AS1 | GDNFOS | transcriptional regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0029702 | HSALNG0014093 | BIRC6-AS2 | megamind | NA | developmental process | NA | NA |
| HSALNT0029692 | HSALNG0014085 | BIRC6-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289310 | HSALNG0116623 | LINC00854 | NA | NA | NA | NA | NA |
| HSALNT0290332 | HSALNG0142447 | uc.73 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289841 | HSALNG0141956 | FR0257520 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290104 | HSALNG0142219 | NRG1 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289689 | HSALNG0141804 | CDKN2B-AS11 | NA | NA | pathogenic process;developmental process | stroke | Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289690 | HSALNG0141805 | CDKN2B-AS12 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289691 | HSALNG0141806 | CDKN2B-AS13 | NA | NA | pathogenic process | plexiform neurofibroma | Neoplasms;Nervous System Diseases |
| HSALNT0289697 | HSALNG0141812 | CDKN2B-AS7 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289826 | HSALNG0141941 | FADS1 | NA | NA | pathogenic process | lipid metabolism disorder | Nutritional and Metabolic Diseases |
| HSALNT0289698 | HSALNG0141813 | CDKN2B-AS8 | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289696 | HSALNG0141811 | CDKN2B-AS6 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289699 | HSALNG0141814 | CDKN2B-AS9 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289688 | HSALNG0141803 | CDKN2B-AS10 | NA | NA | pathogenic process | stroke | Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0288950 | HSALNG0031716 | ENST00000456816 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290021 | HSALNG0142136 | LOC389332 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290306 | HSALNG0142421 | TMEM72 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289641 | HSALNG0141756 | BC029135 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290374 | HSALNG0142489 | X91348 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289694 | HSALNG0141809 | CDKN2B-AS4 | NA | NA | pathogenic process | cancer | Neoplasms |
| HSALNT0289692 | HSALNG0141807 | CDKN2B-AS2 | NA | NA | pathogenic process | coronary heart disease | Cardiovascular Diseases |
| HSALNT0289693 | HSALNG0141808 | CDKN2B-AS3 | NA | NA | pathogenic process | intracranial aneurysm | Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289695 | HSALNG0141810 | CDKN2B-AS5 | NA | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0290319 | HSALNG0142434 | T-UCRs | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289530 | HSALNG0141645 | 51A | NA | splicing regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0290163 | HSALNG0142278 | RAB4B-EGLN2 | NA | NA | pathogenic process | cancer | Neoplasms |
| HSALNT0290167 | HSALNG0142282 | RERT | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0265263 | HSALNG0129088 | LINC00237 | NCRNA00237 | NA | pathogenic process | macrocephaly;obesity | Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena |
| HSALNT0267186 | HSALNG0130081 | LINC01370 | HI-LNC25,HILNC25 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0289114 | HSALNG0046884 | LINC01574 | HI-LNC12,TCONS_00009551 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0290159 | HSALNG0142274 | PTHLH | NA | NA | pathogenic process | brachydactyly | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0189394 | HSALNG0091306 | CISTR | CISTR-ACT,CISTRACT,re52431 | transcriptional regulation | pathogenic process | brachydactyly | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0289862 | HSALNG0141977 | HELLPAR | LINC-HELLP | NA | pathogenic process | HELLP syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289904 | HSALNG0142019 | LINC01125 | NA | NA | pathogenic process | uremia | Male Urogenital Diseases |
| HSALNT0289544 | HSALNG0141659 | AC002511.1 | LINC01531 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0289609 | HSALNG0141724 | AP000688.29 | AP000688.2 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0289832 | HSALNG0141947 | FFAR2 | NA | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0290222 | HSALNG0142337 | RP4-620F22.3 | AC099063.2 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0290227 | HSALNG0142342 | RP5-843L14.1 | LINC01716 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0287285 | HSALNG0140617 | MAGEA8-AS1 | RP5-869M20.2 | NA | NA | NA | NA |
| HSALNT0289019 | HSALNG0094159 | LHX5-AS1 | locus4010 | NA | NA | NA | NA |
| HSALNT0288902 | HSALNG0023597 | CAPN10-AS1 | CAPN10-DT,locus959 | NA | NA | NA | NA |
| HSALNT0289404 | HSALNG0076463 | STAM-AS1 | locus3182 | NA | NA | NA | NA |
| HSALNT0148276 | HSALNG0070806 | PTENP1-AS | PTENpg1-asRNA | transcriptional regulation | NA | NA | NA |
| HSALNT0289562 | HSALNG0141677 | AF116616 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289589 | HSALNG0141704 | AK094838 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289620 | HSALNG0141735 | ASLNC00339 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289629 | HSALNG0141744 | BC002350 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289651 | HSALNG0141766 | BC091525 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289652 | HSALNG0141767 | BE503655 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289753 | HSALNG0141868 | ENO1 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289835 | HSALNG0141950 | FKBP10 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0290064 | HSALNG0142179 | MYHAS | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289985 | HSALNG0142100 | LncRNA-LALR1 | NA | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289934 | HSALNG0142049 | lincRNA-LALR1 | NA | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0091577 | HSALNG0043527 | NR2F1-AS1 | FLJ42709 | NA | NA | NA | NA |
| HSALNT0289709 | HSALNG0141824 | CK19 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289943 | HSALNG0142058 | Llme23 | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289553 | HSALNG0141668 | AC096655.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289178 | HSALNG0137593 | MIR222HG | Lnc-Ang362 | NA | pathogenic process | Ang II-associated cardiovascular disease | Cardiovascular Diseases |
| HSALNT0289261 | HSALNG0032541 | STX18-AS1 | LOC100507266 | NA | pathogenic process | atrial septal defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289849 | HSALNG0141964 | GHSR | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289850 | HSALNG0141965 | GHSROS | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289210 | HSALNG0072923 | PCAT7 | PCAN-R2 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289702 | HSALNG0141817 | CES1P1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289892 | HSALNG0142007 | LINC00210 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290006 | HSALNG0142121 | LOC100506974 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290219 | HSALNG0142334 | RP3-508I15.14 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290243 | HSALNG0142358 | SLC6A6 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290342 | HSALNG0142457 | uc003bgl.1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289075 | HSALNG0008302 | LINC00970 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0211868 | HSALNG0101725 | SALRNA1 | SAL-RNA1,XLOC_023166 | NA | developmental process | NA | NA |
| HSALNT0222267 | HSALNG0106957 | SALRNA3 | SAL-RNA3,XLOC_025918 | NA | developmental process | NA | NA |
| HSALNT0222274 | HSALNG0106960 | SALRNA2 | SAL-RNA2,XLOC_025931 | NA | developmental process | NA | NA |
| HSALNT0289428 | HSALNG0021790 | GPR1-AS | GPR1-AS1,GPR1AS | transcriptional regulation | NA | NA | NA |
| HSALNT0226207 | HSALNG0108743 | LINC00235 | NA | NA | pathogenic process | anorexia nervosa | Mental Disorders |
| HSALNT0289526 | HSALNG0141641 | 1B FGF-antisense transcripts | NA | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290171 | HSALNG0142286 | RNA polymerase III-dependent lncRNAs | NA | NA | pathogenic process | diffuse cerebral hypomyelination | NA |
| HSALNT0290168 | HSALNG0142283 | REST/CoREST-regulated lncRNAs | NA | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289606 | HSALNG0141721 | Alu lncRNAs | NA | NA | pathogenic process | macular degeneration | Eye Diseases |
| HSALNT0290358 | HSALNG0142473 | UCH1LAS | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0290244 | HSALNG0142359 | SLC7A2-IT1A/B | NA | NA | pathogenic process | progressive encephalopathy with severe infantile anorexia | Nervous System Diseases |
| HSALNT0289877 | HSALNG0141992 | Kcna2-AS | NA | NA | pathogenic process | neuropathic pain | Nervous System Diseases |
| HSALNT0289191 | HSALNG0053305 | NCOA7-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0290020 | HSALNG0142135 | LOC389023 | NA | transcriptional regulation | pathogenic process | psychiatric disease | Nervous System Diseases |
| HSALNT0175124 | HSALNG0084108 | PTPRJ-AS1 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0289654 | HSALNG0141769 | BM742401 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289331 | HSALNG0049950 | LINC00951 | lincRNA-uc003opf.1,FLJ41649 | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290130 | HSALNG0142245 | PAWR | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0290264 | HSALNG0142379 | T-ALL-R-LncR1 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289599 | HSALNG0141714 | AK130977 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0289625 | HSALNG0141740 | AX746718 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0289738 | HSALNG0141853 | DDR2 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0290003 | HSALNG0142118 | LOC100131831 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0290144 | HSALNG0142259 | POT1-AS1 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0290253 | HSALNG0142368 | SNORA17B | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0207421 | HSALNG0099625 | GAS6-AS1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289838 | HSALNG0141953 | FMR5 | NA | NA | pathogenic process | fragile X syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0208907 | HSALNG0100287 | FOXG1-AS1 | FOXG1-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
| HSALNT0290263 | HSALNG0142378 | SYNGAP1-AS1 | SYNGAP1-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
| HSALNT0290176 | HSALNG0142291 | RNase MRP | NA | NA | pathogenic process | cartilage hair hypoplaisia | Cardiovascular Diseases |
| HSALNT0289469 | HSALNG0105872 | GABPB1-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289009 | HSALNG0075528 | IDI2-AS1 | C10orf110,IDI2-A,HT009,Em:AC022536.4 | NA | NA | NA | NA |
| HSALNT0289093 | HSALNG0044716 | LINC01184 | FLJ33630 | NA | NA | NA | NA |
| HSALNT0290108 | HSALNG0142223 | OGT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290077 | HSALNG0142192 | ncNRFR | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290337 | HSALNG0142452 | uc001lsz | NA | NA | pathogenic process | gastric cancer;prostate cancer;liver cancer;lung cancer | Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289087 | HSALNG0021008 | LINC01090 | NA | NA | pathogenic process | post-traumatic stress disorder | Mental Disorders |
| HSALNT0289746 | HSALNG0141861 | DQ786227 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289981 | HSALNG0142096 | lncRNA-DQ786227 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289876 | HSALNG0141991 | JADRR | LINC00915,lncRNA-JADE | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290254 | HSALNG0142369 | SOX2OT-S1 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290404 | HSALNG0142519 | SOX2OT-S2 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289870 | HSALNG0141985 | HOXA13 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0078946 | HSALNG0037661 | SMAD1-AS1 | ENST00000513542 | NA | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0087329 | HSALNG0041545 | FGF10-AS1 | RP11-473L15.2 | transcriptional regulation | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290318 | HSALNG0142433 | TUC339 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289819 | HSALNG0141934 | ERICD | LINC01130,TCONS_00014875,ERIC | transcriptional regulation | pathogenic process | retinoblastoma | Neoplasms |
| HSALNT0289615 | HSALNG0141730 | ARA | NA | NA | pathogenic process | cancer | Neoplasms |
| HSALNT0289822 | HSALNG0141937 | ESCCAL-5 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290074 | HSALNG0142189 | ncC11orf49 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290076 | HSALNG0142191 | ncHDAC5 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290078 | HSALNG0142193 | ncRAB31 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290080 | HSALNG0142195 | ncSRPK1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0018253 | HSALNG0008819 | OVAAL | LINC01131,OVAL | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289884 | HSALNG0141999 | LALR | NA | transcriptional regulation | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289701 | HSALNG0141816 | CEACAMP8 | CEACAMP8 | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290018 | HSALNG0142133 | LOC284100 | NA | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290023 | HSALNG0142138 | LOC391533 | NA | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0189558 | HSALNG0091365 | LINC01154 | NA | NA | NA | NA | NA |
| HSALNT0196616 | HSALNG0094870 | THRIL | BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260 | transcriptional regulation | pathogenic process | Kawasaki disease | Cardiovascular Diseases |
| HSALNT0289235 | HSALNG0098080 | RNF219-AS1 | NA | NA | pathogenic process | blood pressure | Cardiovascular Diseases |
| HSALNT0289561 | HSALNG0141676 | AF086415 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289583 | HSALNG0141698 | AK056098 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289590 | HSALNG0141705 | AK095147 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289600 | HSALNG0141715 | AK294004 | NA | transcriptional regulation | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289612 | HSALNG0141727 | AP5M1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0290110 | HSALNG0142225 | ORAOV1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0290210 | HSALNG0142325 | RP1-179N16.3 | Z95152.1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0037026 | HSALNG0017545 | LINC01159 | linc-Brn1b | NA | developmental process | NA | NA |
| HSALNT0289014 | HSALNG0137988 | KANTR | KDM5C adjacent non-coding transcript | NA | developmental process | NA | NA |
| HSALNT0289905 | HSALNG0142020 | LINC01157 | TCONS_00010378,linc-Enc1 | NA | developmental process | NA | NA |
| HSALNT0289460 | HSALNG0087416 | APOA1-AS | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0290400 | HSALNG0142515 | ZNF300P1 | ZNF300P1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289750 | HSALNG0141865 | EEF1A1P9 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289796 | HSALNG0141911 | ENST00000318333 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289797 | HSALNG0141912 | ENST00000374520 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289800 | HSALNG0141915 | ENST00000422362 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289808 | HSALNG0141923 | ENST00000455912 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289809 | HSALNG0141924 | ENST00000456007 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289810 | HSALNG0141925 | ENST00000456185 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289817 | HSALNG0141932 | EPOR | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289913 | HSALNG0142028 | LINC01550 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0290142 | HSALNG0142257 | PMS2P5 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0290269 | HSALNG0142384 | TCF7 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0290345 | HSALNG0142460 | uc003jfz.2 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289095 | HSALNG0018112 | LINC01191 | VIN,lnc-ACTR3 | transcriptional regulation | pathogenic process | influenza A virus | Virus Diseases |
| HSALNT0288976 | HSALNG0140165 | FIRRE | LINC01200 | transcriptional regulation | NA | NA | NA |
| HSALNT0289097 | HSALNG0046284 | LINC01202 | NA | NA | NA | NA | NA |
| HSALNT0290271 | HSALNG0142386 | TCONS_00014512 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290272 | HSALNG0142387 | TCONS_00014978 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290274 | HSALNG0142389 | TCONS_00024647 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290279 | HSALNG0142394 | TCONS_00090092_MEG3 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290280 | HSALNG0142395 | TCONS_l2_00000179 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290283 | HSALNG0142398 | TCONS_l2_00004424 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290284 | HSALNG0142399 | TCONS_l2_00006843 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290289 | HSALNG0142404 | TCONS_l2_00014091 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290291 | HSALNG0142406 | TCONS_l2_00018070 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290292 | HSALNG0142407 | TCONS_l2_00020565 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290293 | HSALNG0142408 | TCONS_l2_00021262 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290296 | HSALNG0142411 | TCONS_l2_00030560 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0289927 | HSALNG0142042 | lincRNA1611 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290149 | HSALNG0142264 | Ppp3ca | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290265 | HSALNG0142380 | TC0100223 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0290267 | HSALNG0142382 | TC0101686 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0290268 | HSALNG0142383 | TC1500845 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289318 | HSALNG0128589 | LAMP5-AS1 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0234022 | HSALNG0112916 | LINC01228 | lincRNA-DYNLRB2-2 | NA | pathogenic process | NA | NA |
| HSALNT0162654 | HSALNG0077963 | SGMS1-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289206 | HSALNG0126202 | PCAT19 | LOC100505495,LINC01190 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289521 | HSALNG0115583 | ABHD15-AS1 | linc-TP53I13,lnc-TP53I13 | NA | pathogenic process | cardiometabolic disease | Cardiovascular Diseases |
| HSALNT0289100 | HSALNG0069570 | LINC01230 | linc-DMRT2,lnc-DRMT2,TCONS_00015639 | NA | pathogenic process | cardiometabolic disease | Cardiovascular Diseases |
| HSALNT0249183 | HSALNG0120583 | PCAT18 | LINC01092 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290029 | HSALNG0142144 | LOC728606 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288956 | HSALNG0094171 | ENST00000547963.1 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289802 | HSALNG0141917 | ENST00000435885 | NA | NA | pathogenic process | oesophageal squamous cell cancer | Neoplasms |
| HSALNT0205898 | HSALNG0098920 | LINC01232 | FLJ41590,TCONS_00021520 | NA | pathogenic process | NA | NA |
| HSALNT0257311 | HSALNG0124979 | LINC01233 | XLOC_013014 | NA | pathogenic process | NA | NA |
| HSALNT0183247 | HSALNG0088110 | SENCR | FLI1-AS1 | NA | pathogenic process | vascular SMC phenotype | Cardiovascular Diseases |
| HSALNT0289296 | HSALNG0010286 | LINC00467 | C1orf97,MGC14801 | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0143586 | HSALNG0068435 | CASC21 | LINC01244,CARLo-2 | NA | pathogenic process | NA | NA |
| HSALNT0288906 | HSALNG0068424 | CASC19 | LINC01245,CARLo-6 | NA | pathogenic process | NA | NA |
| HSALNT0289754 | HSALNG0141869 | ENSG00000135253.9 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289755 | HSALNG0141870 | ENSG00000147753.5 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289756 | HSALNG0141871 | ENSG00000196096 | AC079610.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289757 | HSALNG0141872 | ENSG00000197251.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289758 | HSALNG0141873 | ENSG00000203325 | AL445248.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289759 | HSALNG0141874 | ENSG00000206129 | AC006305.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289760 | HSALNG0141875 | ENSG00000215231.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289761 | HSALNG0141876 | ENSG00000215374.4 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289762 | HSALNG0141877 | ENSG00000215808.2 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289763 | HSALNG0141878 | ENSG00000226496.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289764 | HSALNG0141879 | ENSG00000229563.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289765 | HSALNG0141880 | ENSG00000230133.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289766 | HSALNG0141881 | ENSG00000230544.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289767 | HSALNG0141882 | ENSG00000231133.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289768 | HSALNG0141883 | ENSG00000231185 | AC010317.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289769 | HSALNG0141884 | ENSG00000232021.2 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289770 | HSALNG0141885 | ENSG00000232046.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289771 | HSALNG0141886 | ENSG00000232956.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289772 | HSALNG0141887 | ENSG00000233154.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289773 | HSALNG0141888 | ENSG00000233251 | AC007743.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289774 | HSALNG0141889 | ENSG00000235285.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289775 | HSALNG0141890 | ENSG00000237036.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289776 | HSALNG0141891 | ENSG00000237548.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289777 | HSALNG0141892 | ENSG00000240453.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289778 | HSALNG0141893 | ENSG00000241269.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289779 | HSALNG0141894 | ENSG00000245910.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289780 | HSALNG0141895 | ENSG00000248176 | AC109349.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289781 | HSALNG0141896 | ENSG00000249364 | AC112206.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289782 | HSALNG0141897 | ENSG00000249772 | AC026427.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289783 | HSALNG0141898 | ENSG00000250195 | AC109927.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289784 | HSALNG0141899 | ENSG00000250608 | AC010210.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289785 | HSALNG0141900 | ENSG00000254154 | AL359075.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289786 | HSALNG0141901 | ENSG00000255471 | AP001528.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289787 | HSALNG0141902 | ENSG00000256218 | AC007848.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289788 | HSALNG0141903 | ENSG00000259150.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289789 | HSALNG0141904 | ENSG00000259334.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289790 | HSALNG0141905 | ENSG00000259484.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289791 | HSALNG0141906 | ENSG00000259758.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289793 | HSALNG0141908 | ENSG00000263753.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289794 | HSALNG0141909 | ENSG00000264772 | AC016876.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289795 | HSALNG0141910 | ENSG00000266952.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289828 | HSALNG0141943 | FAM66B | FAM66E | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289895 | HSALNG0142010 | LINC00336 | C6orf227,NCRNA00336 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289899 | HSALNG0142014 | LINC00929 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289906 | HSALNG0142021 | LINC01204 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289912 | HSALNG0142027 | LINC01538 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289915 | HSALNG0142030 | LINC01721 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289916 | HSALNG0142031 | LINC01762 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289917 | HSALNG0142032 | LINC01798 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290247 | HSALNG0142362 | SMIM2-IT1 | C13orf44-IT1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290316 | HSALNG0142431 | TTTY7 | CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289872 | HSALNG0141987 | HTTAS_v1 | NA | transcriptional regulation | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290175 | HSALNG0142290 | RNA-a | NA | transcriptional regulation | pathogenic process | Opitz-Kaveggia syndrome | NA |
| HSALNT0289525 | HSALNG0141640 | 116HG | NA | transcriptional regulation | pathogenic process | Prader-Willi syndrome | Nervous System Diseases |
| HSALNT0290320 | HSALNG0142435 | U1 spliceosomal lncRNA | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289102 | HSALNG0039360 | LINC01262 | TCONS_l2_00021807,RP11-462G22.1 | ceRNA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289681 | HSALNG0141796 | CCAT1-L | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290062 | HSALNG0142177 | MT-LIPCAR | uc022bqs.1,LIPCAR | NA | pathogenic process | heart disease | Cardiovascular Diseases |
| HSALNT0289941 | HSALNG0142056 | LIPCAR | NA | NA | pathogenic process | heart failure | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0200965 | HSALNG0096756 | TUSC8 | LINC01071,XLOC_010588 | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0161787 | HSALNG0077519 | LINC01264 | RP11-124O11.2 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289733 | HSALNG0141848 | D4Z4 | NA | NA | pathogenic process;developmental process | facioscapulohumeral muscular dystrophy | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289678 | HSALNG0141793 | CARL | NA | ceRNA | pathogenic process | myocardial infarction | Cardiovascular Diseases |
| HSALNT0289923 | HSALNG0142038 | linc-CBR1-2 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0243354 | HSALNG0117819 | WFDC21P | WAP four-disulfide core domain 21,pseudogene | transcriptional regulation | pathogenic process | DC dysfunction | NA |
| HSALNT0290232 | HSALNG0142347 | RUNX1 | NA | NA | pathogenic process | acute myeloid leukemia | Neoplasms |
| HSALNT0290234 | HSALNG0142349 | RUNXOR | NA | NA | pathogenic process | hematopoietic malignancies | Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289979 | HSALNG0142094 | lncRNA-CIR | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0290368 | HSALNG0142483 | VIM2P | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0289879 | HSALNG0141994 | KRAS1P | NA | NA | pathogenic process | cancer | Neoplasms |
| HSALNT0290054 | HSALNG0142169 | MINA | NA | NA | pathogenic process | esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289270 | HSALNG0117279 | TMEM92-AS1 | RP11-893F2.9,lncRNA-508851,TCONS_00025237 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288900 | HSALNG0054937 | CAHM | LINC00468 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289593 | HSALNG0141708 | AK123657 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289659 | HSALNG0141774 | BX648207 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289660 | HSALNG0141775 | BX649059 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289846 | HSALNG0141961 | GAS2L3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289633 | HSALNG0141748 | BC011663 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289867 | HSALNG0141982 | HIV1230 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290045 | HSALNG0142160 | M14574 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290245 | HSALNG0142360 | SLCO5A1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290326 | HSALNG0142441 | uc.341 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290344 | HSALNG0142459 | uc003iqu | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290346 | HSALNG0142461 | uc003tfx | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289950 | HSALNG0142065 | lnc-AL355149.1-1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0290001 | HSALNG0142116 | lnc-ZNF674-1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0286909 | HSALNG0140423 | LINC00632 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289105 | HSALNG0014134 | LINC01317 | NA | NA | NA | NA | NA |
| HSALNT0234804 | HSALNG0113279 | LINC01081 | TCONS_00024764 | transcriptional regulation | pathogenic process | alveolar capillary dysplasia | Respiratory Tract Diseases |
| HSALNT0289840 | HSALNG0141955 | FOSB | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289587 | HSALNG0141702 | AK093543 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289732 | HSALNG0141847 | D16366 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289814 | HSALNG0141929 | ENST00000501583 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290273 | HSALNG0142388 | TCONS_00018278 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289907 | HSALNG0142022 | LINC01374 | TCONS_00018278 | NA | pathogenic process | NA | NA |
| HSALNT0231106 | HSALNG0111452 | CASC22 | LINC01373,TCONS_00024290,LincRNA-ENST00000515084 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0058246 | HSALNG0027843 | LINC00882 | NA | ceRNA | pathogenic process | airway diseases | Respiratory Tract Diseases |
| HSALNT0018288 | HSALNG0008840 | KIAA1614-AS1 | RP11-46A10.4 | ceRNA | pathogenic process | airway smooth muscle (ASM) disease | Respiratory Tract Diseases |
| HSALNT0142310 | HSALNG0067913 | LINC00536 | NA | NA | pathogenic process | trichorhinophalangeal syndrome | NA |
| HSALNT0034200 | HSALNG0016063 | LBX2-AS1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0149799 | HSALNG0071679 | ENST00000414223 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290012 | HSALNG0142127 | LOC105374631 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290305 | HSALNG0142420 | TMEM179 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290315 | HSALNG0142430 | TSPAN8 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290334 | HSALNG0142449 | uc001aka.2 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290339 | HSALNG0142454 | uc001vjj.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290343 | HSALNG0142458 | uc003erl.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290354 | HSALNG0142469 | uc009wkz.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0027893 | HSALNG0013204 | MYCNUT | MYCNUN,lncUSMycN | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0273205 | HSALNG0132900 | LINC01436 | AP000688.8 | NA | pathogenic process | Down syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0266116 | HSALNG0129435 | MIR663AHG | RP3-410C9.1 | NA | pathogenic process | turner syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases |
| HSALNT0289108 | HSALNG0080498 | LINC01435 | RP11-215N21.1,TCONS_00018040 | NA | pathogenic process | NA | NA |
| HSALNT0289674 | HSALNG0141789 | CADM3-AS1 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289882 | HSALNG0141997 | KRT19P3 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290310 | HSALNG0142425 | TNXA | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0008750 | HSALNG0004412 | ZRANB2-AS2 | NA | NA | NA | NA | NA |
| HSALNT0289745 | HSALNG0141860 | DMTF1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290059 | HSALNG0142174 | MRUL | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0185163 | HSALNG0089050 | FAM66C | NA | NA | NA | NA | NA |
| HSALNT0289476 | HSALNG0132414 | CYYR1-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289535 | HSALNG0141650 | AA174084 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0266298 | HSALNG0129511 | ABALON | INXS | splicing regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290370 | HSALNG0142485 | VTRNA2-1 | CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289619 | HSALNG0141734 | ASK00420 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289749 | HSALNG0141864 | EBIC | NA | transcriptional regulation | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290299 | HSALNG0142414 | TI09485 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290300 | HSALNG0142415 | TI10124 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290301 | HSALNG0142416 | TI13831 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290302 | HSALNG0142417 | TI18318 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290303 | HSALNG0142418 | TI21327 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290304 | HSALNG0142419 | TI22687 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290307 | HSALNG0142422 | TMPOP2 | NA | transcriptional regulation | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289570 | HSALNG0141685 | AK021444 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289601 | HSALNG0141716 | AK307796 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289801 | HSALNG0141916 | ENST00000425785 | SEC63P1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289871 | HSALNG0141986 | HOXB-AS3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290367 | HSALNG0142482 | URHC | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289085 | HSALNG0098166 | LINC01080 | TCONS_00021856 | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0289751 | HSALNG0141866 | EFNA3 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289798 | HSALNG0141913 | ENST00000395084 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289829 | HSALNG0141944 | FAM83A-AS1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290164 | HSALNG0142279 | RAD1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289585 | HSALNG0141700 | AK056988 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289638 | HSALNG0141753 | BC017743 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290156 | HSALNG0142271 | PRR26 | C10orf108 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290349 | HSALNG0142464 | uc003yqb.1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289675 | HSALNG0141790 | CAI2 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289673 | HSALNG0141788 | CADM1-AS1 | NA | transcriptional regulation | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290313 | HSALNG0142428 | TSLC1-AS1 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0013359 | HSALNG0006378 | LINC01525 | lnc-MAN1A2-1 | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0109106 | HSALNG0051540 | LINC01526 | Lnc-FAM46A-1 | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0162774 | HSALNG0078013 | LINC01468 | lnc-MBL2-4 | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0289110 | HSALNG0074718 | LINC01503 | lnc-PPP2R4-5 | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
| HSALNT0289968 | HSALNG0142083 | lnc-MBL2-4:3 | NA | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
| HSALNT0289993 | HSALNG0142108 | lnc-STXBP5-1 | NA | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
| HSALNT0289563 | HSALNG0141678 | AF118081 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289597 | HSALNG0141712 | AK124939 | NA | NA | pathogenic process | pulmonary adenocarcinoma | Neoplasms |
| HSALNT0290153 | HSALNG0142268 | PRAS | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290249 | HSALNG0142364 | SNAR-A1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289929 | HSALNG0142044 | lincRNA-BC2 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289930 | HSALNG0142045 | lincRNA-BC4 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289931 | HSALNG0142046 | lincRNA-BC5 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289932 | HSALNG0142047 | lincRNA-BC8 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0083190 | HSALNG0039551 | LINC01511 | RP11-325I22.2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290026 | HSALNG0142141 | LOC440905 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0083190 | HSALNG0039551 | LINC01511 | RP11-325I22.2 | NA | NA | NA | NA |
| HSALNT0289552 | HSALNG0141667 | AC079776.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289720 | HSALNG0141835 | CTA-363E6.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289901 | HSALNG0142016 | LINC00987 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290185 | HSALNG0142300 | RP11-1C1.7 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290197 | HSALNG0142312 | RP11-445K13.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290199 | HSALNG0142314 | RP11-473M20.11 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290213 | HSALNG0142328 | RP11-893F2.6 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290217 | HSALNG0142332 | RP13-514E23.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290218 | HSALNG0142333 | RP1-90D4.3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290220 | HSALNG0142335 | RP4-575N6.5 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290226 | HSALNG0142341 | RP5-826L7.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290378 | HSALNG0142493 | XLOC_003286 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290379 | HSALNG0142494 | XLOC_003405 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290389 | HSALNG0142504 | XLOC_012255 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290056 | HSALNG0142171 | MIR21 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0289621 | HSALNG0141736 | ASncmtRNAs | NA | transcriptional regulation | pathogenic process | cancer | Neoplasms |
| HSALNT0289316 | HSALNG0022090 | LINC01614 | LCAL4,TCONS_00003105 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289982 | HSALNG0142097 | lncRNA-FER1L4 | NA | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290016 | HSALNG0142131 | LOC283177 | NA | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0289003 | HSALNG0134860 | HORMAD2-AS1 | MTMR3-AS1,NONHSAG033653 | NA | pathogenic process | type 1 diabetes;bowel disease | Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0290372 | HSALNG0142487 | WNT4 | NA | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289540 | HSALNG0141655 | AB074278 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290166 | HSALNG0142281 | RCCRT1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289043 | HSALNG0043862 | LINC00491 | BC008363 | NA | pathogenic process | pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0289632 | HSALNG0141747 | BC008363 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0289858 | HSALNG0141973 | H1.3 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289896 | HSALNG0142011 | LINC00582 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289301 | HSALNG0141635 | LINC01537 | RP11-169D4.1-001 | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0289551 | HSALNG0141666 | AC026166.2 | MTCO1P5 | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0290184 | HSALNG0142299 | RP11-169D4.1-001 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0289545 | HSALNG0141660 | AC006050.3 | NA | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289556 | HSALNG0141671 | AC138128.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289818 | HSALNG0141933 | ERCC1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290061 | HSALNG0142176 | MT1DP | MT1DP | NA | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289578 | HSALNG0141693 | AK023096 | NA | NA | pathogenic process | Wilmsâ tumor;uterine leiomyomas | Neoplasms |
| HSALNT0289112 | HSALNG0003560 | LINC01562 | RP11-296A18.3 | transcriptional regulation | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0289567 | HSALNG0141682 | AK000974 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289579 | HSALNG0141694 | AK024118 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289645 | HSALNG0141760 | BC040204 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290321 | HSALNG0142436 | U79277 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289869 | HSALNG0141984 | HOST2 | NA | ceRNA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0289368 | HSALNG0135509 | MGAT3-AS1 | TapSAKI | NA | pathogenic process | acute kidney injury | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289624 | HSALNG0141739 | ATXN7L3B | NA | NA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289990 | HSALNG0142105 | lnc-SCA7 | NA | ceRNA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290004 | HSALNG0142119 | LOC100287482 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290383 | HSALNG0142498 | XLOC_007697 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290384 | HSALNG0142499 | XLOC_008559 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290385 | HSALNG0142500 | XLOC_009911 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289813 | HSALNG0141928 | ENST00000480739 | RPL13AP23 | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290111 | HSALNG0142226 | OS9 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290324 | HSALNG0142439 | uc.283-plus | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289117 | HSALNG0051652 | LINC01611 | RP1-90L14.1,TCONS_l2_00025430 | NA | pathogenic process | diabetic retinopathy | Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases |
| HSALNT0289529 | HSALNG0141644 | 2900055J20Rik | 2900055J20Rik | NA | pathogenic process | left ventricular hypertrophy | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0289792 | HSALNG0141907 | ENSG00000261777 | AC012184.3 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289618 | HSALNG0141733 | Asb3 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
| HSALNT0289703 | HSALNG0141818 | Chac2 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
| HSALNT0290139 | HSALNG0142254 | Pex11b | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
| HSALNT0290255 | HSALNG0142370 | Sp5 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
| HSALNT0211639 | HSALNG0101614 | PSMA3-AS1 | FLJ31306 | NA | pathogenic process | NA | NA |
| HSALNT0289319 | HSALNG0141639 | LINC00493 | LOC388789 | NA | pathogenic process | NA | NA |
| HSALNT0288903 | HSALNG0126842 | CARD8-AS1 | LOC100505812 | transcriptional regulation | pathogenic process | leukemia and neuroblastoma | Neoplasms |
| HSALNT0064729 | HSALNG0030929 | KCNMB2-AS1 | RP11-385J1.2 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289548 | HSALNG0141663 | AC013264.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289857 | HSALNG0141972 | GUCY1B2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290190 | HSALNG0142305 | RP11-385J1.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290216 | HSALNG0142331 | RP1-317E23.3 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290317 | HSALNG0142432 | TUBA4B | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290375 | HSALNG0142490 | XLOC_000371 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290397 | HSALNG0142512 | Z82214.3 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289735 | HSALNG0141850 | DALIR | DALI | transcriptional regulation | NA | NA | NA |
| HSALNT0290376 | HSALNG0142491 | XLOC_000620 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290380 | HSALNG0142495 | XLOC_004122 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290381 | HSALNG0142496 | XLOC_004562 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290382 | HSALNG0142497 | XLOC_005912 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290391 | HSALNG0142506 | XLOC_014388 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290028 | HSALNG0142143 | LOC652276 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290162 | HSALNG0142277 | R05532 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0098175 | HSALNG0046752 | LINC01411 | RP11-267A15.1 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290025 | HSALNG0142140 | LOC401317 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289726 | HSALNG0141841 | CTD-2574D22.4 | AC120114.2 | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0290141 | HSALNG0142256 | PMS2L2 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0289974 | HSALNG0142089 | lncRNA-422 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289520 | HSALNG0133454 | AATBC | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289311 | HSALNG0141637 | LINC00974 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0089943 | HSALNG0042820 | ZBED3-AS1 | NA | NA | developmental process | NA | NA |
| HSALNT0289116 | HSALNG0135958 | LINC01589 | CTA-941F9.9,TCONS_00029353 | NA | pathogenic process | NA | NA |
| HSALNT0289910 | HSALNG0142025 | LINC01426 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290341 | HSALNG0142456 | uc002yug.2 | NA | splicing regulation | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290250 | HSALNG0142365 | SNCG | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289949 | HSALNG0142064 | lnc-AF085935 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289996 | HSALNG0142111 | lnc-uc003wbd | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289559 | HSALNG0141674 | AF085935 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290347 | HSALNG0142462 | uc003wbd | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290098 | HSALNG0142213 | NR_001284 | TNXA | NA | pathogenic process | chronic thromboembolic pulmonary hypertension | Cardiovascular Diseases |
| HSALNT0290327 | HSALNG0142442 | uc.343 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0289196 | HSALNG0094525 | NRAV | DYNLL1-AS1 | transcriptional regulation | pathogenic process | influenza A virus | Virus Diseases |
| HSALNT0290140 | HSALNG0142255 | PLEC | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0290172 | HSALNG0142287 | UCSC-2000-3182 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0290173 | HSALNG0142288 | UCSC-9199-1005 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0290174 | HSALNG0142289 | CombinedLit_316_550 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0289714 | HSALNG0141829 | CR613944 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289933 | HSALNG0142048 | lincRNA-CALCA | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290200 | HSALNG0142315 | RP11-501G6.1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290208 | HSALNG0142323 | RP11-672F9.1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290405 | HSALNG0142520 | C14orf132 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289937 | HSALNG0142052 | lincRNA-TSPAN8 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290225 | HSALNG0142340 | RP5-1014O16.1 | AC244098.1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290275 | HSALNG0142390 | TCONS_00026102 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0290277 | HSALNG0142392 | TCONS_00032546 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0289037 | HSALNG0096978 | LINC00441 | RB1-DT,ncRNA-RB1 | NA | pathogenic process | NA | NA |
| HSALNT0289661 | HSALNG0141776 | C1401f132 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289141 | HSALNG0039030 | LINC02365 | LVCAT8 | NA | pathogenic process | NA | NA |
| HSALNT0288885 | HSALNG0095161 | ADGRD1-AS1 | LACAT8 | NA | NA | NA | NA |
| HSALNT0289142 | HSALNG0034152 | LINC02475 | LVCAT1 | NA | NA | NA | NA |
| HSALNT0289542 | HSALNG0141657 | Abhd11os | NA | NA | pathogenic process | neurodegenerative diseases | Nervous System Diseases |
| HSALNT0288895 | HSALNG0124521 | BISPR | NA | NA | pathogenic process | virus infection | Virus Diseases |
| HSALNT0233975 | HSALNG0112910 | MAFTRR | linc-MAF-4 | transcriptional regulation | NA | NA | NA |
| HSALNT0290058 | HSALNG0142173 | MRAK052686 | NA | NA | pathogenic process | nonalcoholic fatty liver disease | Digestive System Diseases |
| HSALNT0290221 | HSALNG0142336 | RP4-583P15.10 | AL121845.1 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0211341 | HSALNG0101470 | KTN1-AS1 | C14orf33,MYCLo-3 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0266752 | HSALNG0129835 | DLGAP4-AS1 | CCAT7 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289682 | HSALNG0141797 | CCAT3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289684 | HSALNG0141799 | CCAT8 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289898 | HSALNG0142013 | LINC00659 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289683 | HSALNG0141798 | CCAT7 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289627 | HSALNG0141742 | BALR-2 | NA | NA | pathogenic process | B cell acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289948 | HSALNG0142063 | lnc-ACACA-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289953 | HSALNG0142068 | lnc-BMP2-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289955 | HSALNG0142070 | lnc-CPN2-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289958 | HSALNG0142073 | lnc-FOXG1-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289960 | HSALNG0142075 | lnc-FZD1-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289962 | HSALNG0142077 | lnc-ITPR2-3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289965 | HSALNG0142080 | lnc-LCP2-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289988 | HSALNG0142103 | lnc-RP3-368B9 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289991 | HSALNG0142106 | lnc-SLC30A4-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289992 | HSALNG0142107 | lnc-SPAM1-6 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289995 | HSALNG0142110 | lnc-TTC34-3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0222064 | HSALNG0106856 | DRAIC | NA | NA | pathogenic process | prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0005037 | HSALNG0002618 | LINC01137 | LOC728431 | NA | pathogenic process | NA | NA |
| HSALNT0290390 | HSALNG0142505 | XLOC_014172 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290014 | HSALNG0142129 | LOC149086 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290183 | HSALNG0142298 | RP11-160H22.5 | AL121983.2 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289945 | HSALNG0142060 | LNC00964-3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289616 | HSALNG0141731 | Arid2-IR | NA | NA | pathogenic process | renal inflammation | NA |
| HSALNT0289716 | HSALNG0141831 | CR619813 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289739 | HSALNG0141854 | DDX6P1 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289938 | HSALNG0142053 | lincRNA-ZNF532 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290011 | HSALNG0142126 | LOC105372753 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290013 | HSALNG0142128 | LOC105377769 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290205 | HSALNG0142320 | RP11-58D2.1 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0288946 | HSALNG0105101 | ENST00000434223 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288947 | HSALNG0082178 | ENST00000442037 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288953 | HSALNG0088449 | ENST00000540136 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290103 | HSALNG0142218 | NR_038125 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290136 | HSALNG0142251 | PDLIM3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290335 | HSALNG0142450 | uc001gch.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290336 | HSALNG0142451 | uc001gzl.3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290351 | HSALNG0142466 | uc004bbl.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290369 | HSALNG0142484 | VNN2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289577 | HSALNG0141692 | AK022798 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289663 | HSALNG0141778 | C1orf74 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289602 | HSALNG0141717 | AKR7L | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289711 | HSALNG0141826 | COL3A1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289878 | HSALNG0141993 | KCNE2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289636 | HSALNG0141751 | BC015134 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289713 | HSALNG0141828 | CR594506 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289928 | HSALNG0142043 | lincRNA-BBOX1-2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0271719 | HSALNG0132223 | LINC00320 | PRED14,FLJ37539 | NA | pathogenic process;developmental process | cortical white matter | Nervous System Diseases |
| HSALNT0289823 | HSALNG0141938 | EVADR | NA | NA | pathogenic process | pancreatic cancer;lung cancer;colorectal cancer;rectal cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289944 | HSALNG0142059 | Lnc_bc060912 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289952 | HSALNG0142067 | lnc-bc060912 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289613 | HSALNG0141728 | APF | NA | ceRNA | pathogenic process | myocardial infarction | Cardiovascular Diseases |
| HSALNT0289617 | HSALNG0141732 | AS Uchl1 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289104 | HSALNG0099739 | LINC01296 | FLJ39632 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290403 | HSALNG0142518 | ZXF2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290113 | HSALNG0142228 | P14695 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290114 | HSALNG0142229 | P16984 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290115 | HSALNG0142230 | P19780 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290116 | HSALNG0142231 | P23099 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290117 | HSALNG0142232 | P24363 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290118 | HSALNG0142233 | P28210 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290120 | HSALNG0142235 | P33863 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290121 | HSALNG0142236 | P4091 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290122 | HSALNG0142237 | P6391 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290123 | HSALNG0142238 | P6488 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290124 | HSALNG0142239 | P700 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290125 | HSALNG0142240 | P8611 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290126 | HSALNG0142241 | P8725 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290127 | HSALNG0142242 | P8860 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290128 | HSALNG0142243 | P9745 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289269 | HSALNG0044864 | TH2LCRR | TH2-LCR | transcriptional regulation | pathogenic process | allergic asthma | Respiratory Tract Diseases;Immune System Diseases |
| HSALNT0289964 | HSALNG0142079 | lnc-LCE5A-1 | NA | NA | pathogenic process | laryngeal cancer;head and neck squamous cell cancer | Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms |
| HSALNT0055198 | HSALNG0026441 | FAM3D-AS1 | lnc-KCTD6-3 | NA | pathogenic process | tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer | Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289843 | HSALNG0141958 | FRLnc1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0242005 | HSALNG0117109 | ENST00000575202 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288952 | HSALNG0089220 | ENST00000539009 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288954 | HSALNG0089242 | ENST00000544591 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289752 | HSALNG0141867 | EHHADH-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289812 | HSALNG0141927 | ENST00000468960 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290276 | HSALNG0142391 | TCONS_00026506 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0189952 | HSALNG0091595 | LRP1-AS | NA | transcriptional regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0032045 | HSALNG0015125 | LINC01122 | FLJ30838,AC007092.1 | NA | NA | NA | NA |
| HSALNT0289565 | HSALNG0141680 | AI364715 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289921 | HSALNG0142036 | LINC0949 | NA | NA | pathogenic process | systemic lupus erythematosus | Immune System Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289680 | HSALNG0141795 | CCAL | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289079 | HSALNG0077354 | LINC00993 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289811 | HSALNG0141926 | ENST00000460164 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290282 | HSALNG0142397 | TCONS_l2_00003938 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289888 | HSALNG0142003 | LGALS3 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289963 | HSALNG0142078 | lnc-KCMF1-2:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289967 | HSALNG0142082 | lnc-LLPH-2:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289971 | HSALNG0142086 | lnc-PLA2R1-1:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289972 | HSALNG0142087 | lnc-PSD4-1:14 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290066 | HSALNG0142181 | n335550 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290070 | HSALNG0142185 | n340790 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290072 | HSALNG0142187 | n386477 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290286 | HSALNG0142401 | TCONS_l2_00010365 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0288944 | HSALNG0129184 | ENST00000422494 | NA | NA | NA | NA | NA |
| HSALNT0289118 | HSALNG0038513 | LINC01612 | RP11-789C1.1,TCONS_00008319 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289610 | HSALNG0141725 | AP001439.2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289671 | HSALNG0141786 | CACNAICAS3 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289853 | HSALNG0141968 | GS1-5L10.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289875 | HSALNG0141990 | INTS7 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290065 | HSALNG0142180 | MYLK-AS1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290157 | HSALNG0142272 | PRSS21 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290202 | HSALNG0142317 | RP11-528G1.2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290207 | HSALNG0142322 | RP11-643M14.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290209 | HSALNG0142324 | RP11-789C1.1 | LINC01612 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290314 | HSALNG0142429 | TSNAX-DISC1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290386 | HSALNG0142501 | XLOC_010235 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289558 | HSALNG0141673 | AF075041 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289564 | HSALNG0141679 | AF339813 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289575 | HSALNG0141690 | AK022029 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289576 | HSALNG0141691 | AK022159 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289604 | HSALNG0141719 | AL389956 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289640 | HSALNG0141755 | BC023629 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290096 | HSALNG0142211 | NONHSAT125629 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290393 | HSALNG0142508 | XR_250621.1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288951 | HSALNG0033002 | ENST00000503938 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290085 | HSALNG0142200 | NONHSAT012762 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289151 | HSALNG0023952 | LMCD1-AS1 | NA | NA | pathogenic process | acute kidney injury | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289926 | HSALNG0142041 | linc-PXN-1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290281 | HSALNG0142396 | TCONS_l2_00001418 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290285 | HSALNG0142400 | TCONS_l2_00008237 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290287 | HSALNG0142402 | TCONS_l2_00011130 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290288 | HSALNG0142403 | TCONS_l2_00013175 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290294 | HSALNG0142409 | TCONS_l2_00022611 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290295 | HSALNG0142410 | TCONS_l2_00022670 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290352 | HSALNG0142467 | uc004bdv.3 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290363 | HSALNG0142478 | ULK4P2 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289942 | HSALNG0142057 | LK4P2 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289538 | HSALNG0141653 | AB019562 | NA | NA | pathogenic process | hypopharyngeal squamous cell cancer | Neoplasms |
| HSALNT0091661 | HSALNG0043585 | ENST00000503710 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289806 | HSALNG0141921 | ENST00000445734 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289807 | HSALNG0141922 | ENST00000448093 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289815 | HSALNG0141930 | ENST00000502941 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290340 | HSALNG0142455 | uc002nbr.3 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290348 | HSALNG0142463 | uc003xut. | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290356 | HSALNG0142471 | uc021re1.1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289549 | HSALNG0141664 | AC016745.3 | AC016745.1 | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0290180 | HSALNG0142295 | RP11-128A17.1 | AC078909.1 | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0290377 | HSALNG0142492 | XLOC_001711 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289975 | HSALNG0142090 | lncRNA-AK058003 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289061 | HSALNG0034072 | LINC00682 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289305 | HSALNG0089456 | LINC01559 | FLJ33810 | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289854 | HSALNG0141969 | GSTT1-AS1 | NA | transcriptional regulation | pathogenic process | mycobacterium tuberculosis infection | Bacterial Infections and Mycoses |
| HSALNT0289978 | HSALNG0142093 | lncRNA-CD244 | NA | transcriptional regulation | pathogenic process | tuberculosis infection | Bacterial Infections and Mycoses |
| HSALNT0289237 | HSALNG0068014 | SAMD12-AS1 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0290179 | HSALNG0142294 | RP11-119F7.4 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290278 | HSALNG0142393 | TCONS_00068220 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0285573 | HSALNG0139654 | DANT1 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0288926 | HSALNG0139662 | DANT2 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0290399 | HSALNG0142514 | ZMAT1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289554 | HSALNG0141669 | AC100865.1 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
| HSALNT0289228 | HSALNG0105273 | RAD51-AS1 | TODRA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289743 | HSALNG0141858 | DKFZP434K028 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289630 | HSALNG0141745 | BC002811 | NA | NA | pathogenic process | astrocytoma | Neoplasms |
| HSALNT0290387 | HSALNG0142502 | XLOC_010967 | NA | NA | pathogenic process | astrocytoma | Neoplasms |
| HSALNT0288955 | HSALNG0084672 | ENST00000545440 | NA | NA | pathogenic process | pediatric acute myeloid leukemia | Hemic and Lymphatic Diseases |
| HSALNT0288981 | HSALNG0133391 | FRGCA | LncRNA-AP001631.9 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289611 | HSALNG0141726 | AP001631.9 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289976 | HSALNG0142091 | LncRNA-AP001631.9 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289686 | HSALNG0141801 | CD99P1 | NA | ceRNA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0289119 | HSALNG0074097 | LINC01613 | n341773 | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0289844 | HSALNG0141959 | FTH1P3 | FTH1P3 | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
| HSALNT0289855 | HSALNG0141970 | GTF2IRD2P1 | GTF2IRD2P1 | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
| HSALNT0290135 | HSALNG0142250 | PDIA3F | NA | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
| HSALNT0289329 | HSALNG0026562 | LINC00994 | NA | NA | pathogenic process | inflammatory bowel disease | Digestive System Diseases |
| HSALNT0289208 | HSALNG0077290 | PCAT5 | LINC01452,TPCAT-10-36067 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0114870 | HSALNG0054158 | LUADT1 | NA | transcriptional regulation | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289154 | HSALNG0107133 | LOXL1-AS1 | NA | NA | pathogenic process | exfoliation syndrome | Eye Diseases |
| HSALNT0289734 | HSALNG0141849 | DACOR1 | TCONS_00023265 | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289060 | HSALNG0114548 | LINC00675 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0288889 | HSALNG0070759 | B4GALT1-AS1 | NA | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0289348 | HSALNG0083371 | LINC01616 | n341006 | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0290068 | HSALNG0142183 | n336934 | NA | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0290240 | HSALNG0142355 | SIRT1-AS | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290198 | HSALNG0142313 | RP11-457M11.2 | NA | ceRNA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0150768 | HSALNG0072141 | LINC01507 | XLOC_000303 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289903 | HSALNG0142018 | LINC01057 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289914 | HSALNG0142029 | LINC01617 | C8orf23,NCRNA00249,XLOC_006844 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290015 | HSALNG0142130 | LOC152578 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0072252 | HSALNG0034426 | LINC01618 | LOC152578 | NA | pathogenic process | NA | NA |
| HSALNT0156870 | HSALNG0075266 | NALT1 | MIR4674HG,LINC01573,TCONS_l2_00029132 | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289083 | HSALNG0045290 | MALINC1 | LINC01024,MA-linc1 | NA | pathogenic process | human breast and lung cancer | Neoplasms |
| HSALNT0289902 | HSALNG0142017 | LINC01024 | MA-linc1 | NA | pathogenic process | osteosarcoma;lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289120 | HSALNG0071043 | LINC01627 | RP11-397D12.4 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289121 | HSALNG0015617 | LINC01628 | AC007403.1 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289820 | HSALNG0141935 | ERICH1-AS1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290193 | HSALNG0142308 | RP11-397D12.4 | LINC01627 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289122 | HSALNG0102605 | LINC01629 | linc-KIAA1737-2 | transcriptional regulation | pathogenic process | hypoxic and inflammatory renal epithelial injury | NA |
| HSALNT0290161 | HSALNG0142276 | PTPRG-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289980 | HSALNG0142095 | lncRNA-DLEU1 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289983 | HSALNG0142098 | lncRNA-Hh | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288986 | HSALNG0072437 | GAS1RR | LncRNA-Hh | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288908 | HSALNG0005250 | CCDC18-AS1 | ENST00000440778.1 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
| HSALNT0289055 | HSALNG0132813 | LINC00649 | TCONS_00028768 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
| HSALNT0289219 | HSALNG0075966 | PRKCQ-AS1 | ENST00000414894.1 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
| HSALNT0290203 | HSALNG0142318 | RP11-567G11.1 | LINC02041 | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289805 | HSALNG0141920 | ENST00000438550 | RPS24P1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0290083 | HSALNG0142198 | NONHSAG011351 | NA | NA | pathogenic process | type 1 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0290049 | HSALNG0142164 | MCHR2-AS1 | NA | NA | pathogenic process | psychiatric disease | Nervous System Diseases |
| HSALNT0289799 | HSALNG0141914 | ENST00000414355 | NA | NA | pathogenic process | cadmium toxicology | Disorders of Environmental Origin |
| HSALNT0290241 | HSALNG0142356 | SKP2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289837 | HSALNG0141952 | FLJ90757 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290017 | HSALNG0142132 | LOC283663 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290019 | HSALNG0142134 | LOC338651 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290132 | HSALNG0142247 | PCATs | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0086786 | HSALNG0041277 | EGFLAM-AS1 | lncRNA-LOWEG | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290031 | HSALNG0142146 | LOWEG | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289635 | HSALNG0141750 | BC014579 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289721 | HSALNG0141836 | CTB-167B5.2 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289863 | HSALNG0141978 | HELLS | NA | NA | pathogenic process | leukemia | Neoplasms |
| HSALNT0290195 | HSALNG0142310 | RP11-401P9.4 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290252 | HSALNG0142367 | SNHG19 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289557 | HSALNG0141672 | AF070632 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289569 | HSALNG0141684 | AK021443 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289728 | HSALNG0141843 | CTD-3080P12.3 | NA | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289987 | HSALNG0142102 | lncRNA-n336928 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289723 | HSALNG0141838 | CTC-523E23.5 | AC008555.2 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0289724 | HSALNG0141839 | CTD-2246P4.1 | NA | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290055 | HSALNG0142170 | MIR132 | MIRN132,miRNA132,mir-132 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290189 | HSALNG0142304 | RP11-363G2.4 | NA | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290191 | HSALNG0142306 | RP11-38F22.1 | LINC02424 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290223 | HSALNG0142338 | RP4-639J15.1 | AC006967.2 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290233 | HSALNG0142348 | RUNX1-IT1 | C21orf96 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288943 | HSALNG0053446 | ENST00000415964 | NA | NA | pathogenic process | pediatric acute myeloid leukemia | Hemic and Lymphatic Diseases |
| HSALNT0290009 | HSALNG0142124 | LOC101927497 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289956 | HSALNG0142071 | lnc-CYP4A22-2/3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289999 | HSALNG0142114 | lnc-ZNF180-2 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290086 | HSALNG0142201 | NONHSAT037832 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289658 | HSALNG0141773 | BX647187 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288920 | HSALNG0017086 | CNNM3-DT | LOC100506036 | NA | NA | NA | NA |
| HSALNT0289584 | HSALNG0141699 | AK056155 | NA | NA | pathogenic process | Loeys-Dietz syndrome | Musculoskeletal Diseases |
| HSALNT0290057 | HSALNG0142172 | MR1 | NA | NA | pathogenic process | Loeys-Dietz syndrome | Musculoskeletal Diseases |
| HSALNT0289543 | HSALNG0141658 | AC002454.1 | AC002454.1 | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289909 | HSALNG0142024 | LINC01420 | NA | NA | pathogenic process | systemic lupus erythematosus | Immune System Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289531 | HSALNG0141646 | 53BP1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290101 | HSALNG0142216 | NR_024118 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0290239 | HSALNG0142354 | SGO1-AS1 | SGOL1-AS1 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289293 | HSALNG0127764 | ZNF667-AS1 | MORT | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289984 | HSALNG0142099 | lncRNA-HIF2PUT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288945 | HSALNG0018617 | ENST00000433673 | AC068282.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0288948 | HSALNG0008353 | ENST00000454271 | AL021940.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289495 | HSALNG0141606 | ENST00000432431 | AC023128.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289918 | HSALNG0142033 | LINC01828 | NA | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290388 | HSALNG0142503 | XLOC_011402 | NA | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289873 | HSALNG0141988 | ICAM-1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289668 | HSALNG0141783 | C5T1lncRNA | NA | transcriptional regulation | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289667 | HSALNG0141782 | C5T1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289666 | HSALNG0141781 | C5-OT1 | C5T1lncRNA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289626 | HSALNG0141741 | AX800134 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290338 | HSALNG0142453 | uc001ncr | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290330 | HSALNG0142445 | uc.48+ | NA | NA | pathogenic process | diabetic neuropathic pain | Male Urogenital Diseases |
| HSALNT0289098 | HSALNG0038313 | LINC01207 | NA | transcriptional regulation | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289628 | HSALNG0141743 | BALR-6 | NA | transcriptional regulation | pathogenic process | B-lymphoblastic leukemia | Hemic and Lymphatic Diseases |
| HSALNT0290022 | HSALNG0142137 | LOC389641 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0289725 | HSALNG0141840 | CTD-2541M15 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289940 | HSALNG0142055 | LINK-A | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290107 | HSALNG0142222 | NUTF2P3 | NUTF2P3 | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290095 | HSALNG0142210 | NONHSAT123350 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290362 | HSALNG0142477 | UHRF1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290366 | HSALNG0142481 | UPAT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289307 | HSALNG0114404 | LINC00324 | FLJ34790,MGC104931 | NA | pathogenic process | NA | NA |
| HSALNT0289969 | HSALNG0142084 | lnc-MX1-1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290024 | HSALNG0142139 | LOC400891 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289883 | HSALNG0141998 | LA16c-313D11.11 | NA | ceRNA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290192 | HSALNG0142307 | RP11-395G23.3 | AC027031.2 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289742 | HSALNG0141857 | DILC | NA | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289957 | HSALNG0142072 | lnc-DILC | NA | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289581 | HSALNG0141696 | AK027294 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290371 | HSALNG0142486 | WISP1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0206117 | HSALNG0099020 | FGF14-AS2 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290131 | HSALNG0142246 | PCAT2 | CARLo-4,PCA2,TCONS_00015167 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289528 | HSALNG0141643 | 2700086A05Rik | 2700086A05Rik | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0290251 | HSALNG0142366 | SNED1 | NA | NA | pathogenic process | Idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0290333 | HSALNG0142448 | uc.77 | NA | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0289816 | HSALNG0141931 | ENST00000537266 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289860 | HSALNG0141975 | HAGLROS | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289881 | HSALNG0141996 | KRT18P55 | KRT18P55 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0229266 | HSALNG0110450 | IL21R-AS1 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
| HSALNT0290112 | HSALNG0142227 | OTTHUMT00000387022 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
| HSALNT0000551 | HSALNG0000226 | PRKCZ-AS1 | RP11-181G12.2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0030981 | HSALNG0014612 | LINC01833 | RP11-89,K21.1 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290214 | HSALNG0142329 | RP11-89K21 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0165271 | HSALNG0079188 | LINC00857 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290109 | HSALNG0142224 | OR3A4 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290046 | HSALNG0142161 | MAGI1-IT1 | NA | ceRNA | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
| HSALNT0290242 | HSALNG0142357 | SLC26A4-AS1 | NA | ceRNA | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
| HSALNT0289302 | HSALNG0141636 | KRT7-AS | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0218672 | HSALNG0105101 | LINC01852 | ENST00000434223 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290178 | HSALNG0142293 | RP11-1008C21.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289592 | HSALNG0141707 | AK123072 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289573 | HSALNG0141688 | AK021954 | NA | NA | pathogenic process | atherosclerosis | Cardiovascular Diseases |
| HSALNT0288916 | HSALNG0105961 | CERNA1 | LOC100129973 | ceRNA | pathogenic process | cardiovascular disease | Cardiovascular Diseases |
| HSALNT0018525 | HSALNG0008959 | LAMC1-AS1 | lnc-LAMC2-1:1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290087 | HSALNG0142202 | NONHSAT040387 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0290092 | HSALNG0142207 | NONHSAT098586 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0289213 | HSALNG0108626 | PCSK6-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289637 | HSALNG0141752 | BC016831 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289874 | HSALNG0141989 | IGKV | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290196 | HSALNG0142311 | RP11-434D9.1 | AC112206.2 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289885 | HSALNG0142000 | LCAL6 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289650 | HSALNG0141765 | BC088254 | NA | NA | pathogenic process | myocardial hypertrophy | Cardiovascular Diseases |
| HSALNT0289596 | HSALNG0141711 | AK124454 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289731 | HSALNG0141846 | CYP4B1-PS1 | NA | NA | pathogenic process | diabetic nephropathy | Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289106 | HSALNG0094020 | LINC01405 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290259 | HSALNG0142374 | ST8SIA6-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289278 | HSALNG0047244 | TRIM52-AS1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289634 | HSALNG0141749 | BC012900 | NA | NA | pathogenic process | ulcerative colitis | Digestive System Diseases |
| HSALNT0274011 | HSALNG0133283 | UMODL1-AS1 | FLJ33471 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289454 | HSALNG0075449 | ARRDC1-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289456 | HSALNG0071200 | FAM74A3 | OTTHUMG00000067149 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289834 | HSALNG0141949 | FH | NA | NA | pathogenic process | Fumarase deficiency | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289961 | HSALNG0142076 | lnc-HOXC4-3:1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289994 | HSALNG0142109 | lnc-TEAD4-1:1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290270 | HSALNG0142385 | TCONS_00003876 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289825 | HSALNG0141940 | EVI1 | NA | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290235 | HSALNG0142350 | SARCC | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290360 | HSALNG0142475 | ucoo2kmd.1 | NA | ceRNA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289015 | HSALNG0001020 | KAZN-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289722 | HSALNG0141837 | CTB-89H12.4 | AC021078.1 | ceRNA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289496 | HSALNG0141607 | EPB41L4A-AS2 | FLJ11235 | NA | pathogenic process | lung cancer;breast cancer;kidney cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289146 | HSALNG0004554 | LINC02567 | ENST00000427806 | NA | pathogenic process | attention deficit hyperactivity disorder | Mental Disorders |
| HSALNT0289833 | HSALNG0141948 | FGFR3-AS1 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289707 | HSALNG0141822 | CILinc01 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0289708 | HSALNG0141823 | CILinc02 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0286597 | HSALNG0140235 | LINC00629 | LINC00629AB,LINC00629C,LINC00629D,LINC00629 | NA | pathogenic process | choriocarcinoma | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289665 | HSALNG0141780 | C2dat1 | NA | NA | pathogenic process | ischemic brain injury | Cardiovascular Diseases |
| HSALNT0289217 | HSALNG0057357 | POU6F2-AS2 | FLJ12971 | protein localization | pathogenic process | oesophageal squamous cell cancer | Neoplasms |
| HSALNT0289946 | HSALNG0142061 | lnc13 | NA | NA | pathogenic process | celiac disease | Nutritional and Metabolic Diseases;Digestive System Diseases |
| HSALNT0289729 | HSALNG0141844 | CTD903 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290093 | HSALNG0142208 | NONHSAT104436 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289550 | HSALNG0141665 | AC024560.2 | AC024560.1 | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289483 | HSALNG0134219 | ENST00000436681 | AP000552.1 | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289536 | HSALNG0141651 | AA584040 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289537 | HSALNG0141652 | AA709223 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289657 | HSALNG0141772 | BX478947 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0247515 | HSALNG0119819 | LINC00668 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289719 | HSALNG0141834 | CRNDE-h | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0142879 | HSALNG0068121 | SMILR | NA | NA | pathogenic process | vascular pathologies | Cardiovascular Diseases |
| HSALNT0290396 | HSALNG0142511 | Z38 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0197213 | HSALNG0095037 | LINC00507 | NA | NA | developmental process | NA | NA |
| HSALNT0289086 | HSALNG0113270 | LINC01082 | TCONSNA00024492 | NA | pathogenic process | alveolar capillary dysplasia with misalignment of pulmonary veins | Cardiovascular Diseases |
| HSALNT0289094 | HSALNG0015253 | LINC01185 | FLJ16341 | NA | pathogenic process | NA | NA |
| HSALNT0290160 | HSALNG0142275 | PTPRD-AS1 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290186 | HSALNG0142301 | RP11-254I22.1 | MIR583HG | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290204 | HSALNG0142319 | RP11-57P19.1 | AC009432.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290211 | HSALNG0142326 | RP11-80H5.7 | AL157400.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290215 | HSALNG0142330 | RP1-223E5.4 | AL441883.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290224 | HSALNG0142339 | RP4-799P18.3 | AL122008.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289126 | HSALNG0045514 | LINC01844 | LOC101926975 | NA | pathogenic process | hirschsprung disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0289947 | HSALNG0142062 | Lnc34a | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289150 | HSALNG0075977 | LINP1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289951 | HSALNG0142066 | lncARSR | NA | ceRNA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289392 | HSALNG0005967 | RBM15-AS1 | AS-RBM15 | translational control | pathogenic process | acute megakaryocytic leukemia | Neoplasms |
| HSALNT0290089 | HSALNG0142204 | NONHSAT073641 | NA | NA | pathogenic process | vascular diseases | Cardiovascular Diseases |
| HSALNT0290027 | HSALNG0142142 | LOC572558 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289582 | HSALNG0141697 | AK033210 | NA | NA | pathogenic process;developmental process | bronchopulmonary dysplasia | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0289848 | HSALNG0141963 | GClnc1 | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289572 | HSALNG0141687 | AK021630 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289603 | HSALNG0141718 | AL049437 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0290007 | HSALNG0142122 | LOC100507661 | NA | NA | pathogenic process | thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289084 | HSALNG0122663 | LINC01029 | NA | NA | pathogenic process | cognitive functions and neuronal plasticity | Nervous System Diseases |
| HSALNT0290169 | HSALNG0142284 | RMEL3 | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289959 | HSALNG0142074 | lnc-FRG2C-3 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
| HSALNT0289966 | HSALNG0142081 | lnc-LIN54-1 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
| HSALNT0289997 | HSALNG0142112 | lnc-USP50-2 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
| HSALNT0290000 | HSALNG0142115 | lnc-ZNF354A-1 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
| HSALNT0288949 | HSALNG0017887 | ENST00000455309 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0289920 | HSALNG0142035 | LINC02384 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0289998 | HSALNG0142113 | Lnc-UTS2D-1:1 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290067 | HSALNG0142182 | n336161 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290069 | HSALNG0142184 | n340599 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290099 | HSALNG0142214 | NR_002712 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290290 | HSALNG0142405 | TCONS_l2_00014794 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290170 | HSALNG0142285 | RMRP | CHH,NME1R,RRP2,RMRP | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289900 | HSALNG0142015 | LINC00961 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289077 | HSALNG0068551 | LINC00977 | NA | NA | pathogenic process | primary spontaneous pneumothorax | Respiratory Tract Diseases |
| HSALNT0289560 | HSALNG0141675 | AF085995 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289566 | HSALNG0141681 | AK000053 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289571 | HSALNG0141686 | AK021595 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289574 | HSALNG0141689 | AK022024 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289595 | HSALNG0141710 | AK124307 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289639 | HSALNG0141754 | BC020384 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289642 | HSALNG0141757 | BC030759 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289715 | HSALNG0141830 | CR615992 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289954 | HSALNG0142069 | lnc-CC3 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289614 | HSALNG0141729 | APOC1P1-3 | NA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290365 | HSALNG0142480 | UNMIBC | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290323 | HSALNG0142438 | uc.167 | NA | NA | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290212 | HSALNG0142327 | RP11-838N2.4 | GAPLINC | ceRNA | pathogenic process | glioblastoma | Neoplasms |
| HSALNT0289109 | HSALNG0121223 | LINC01478 | NA | NA | pathogenic process | blood pressure | Cardiovascular Diseases |
| HSALNT0289313 | HSALNG0016990 | LINC00342 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289677 | HSALNG0141792 | CAR10 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289365 | HSALNG0141638 | MAPT-AS1 | NA | transcriptional regulation | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289679 | HSALNG0141794 | CAT104 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290260 | HSALNG0142375 | STXBP5-AS1 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289861 | HSALNG0141976 | HAR1 | NA | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290359 | HSALNG0142474 | UCHL1-AS1 | NA | translational control | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0290238 | HSALNG0142353 | SCAANT1-AS | NA | NA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289648 | HSALNG0141763 | BC041488 | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290188 | HSALNG0142303 | RP11-359E19.2 | AC022733.1 | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289669 | HSALNG0141784 | C6orf176-TV1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289670 | HSALNG0141785 | C6orf176-TV2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289851 | HSALNG0141966 | GIHCG | NA | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289649 | HSALNG0141764 | BC087858 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290353 | HSALNG0142468 | uc004cov.4 | NA | NA | pathogenic process | hypertrophic cardiomyopathy | Cardiovascular Diseases |
| HSALNT0290357 | HSALNG0142472 | uc022bqu.1 | NA | NA | pathogenic process | hypertrophic cardiomyopathy | Cardiovascular Diseases |
| HSALNT0127837 | HSALNG0060796 | CFTR-AS1 | BGas | transcriptional regulation | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0046367 | HSALNG0021858 | MYOSLID | NA | NA | pathogenic process | vascular smooth muscle cell (VSMC) contractile phenotype | Cardiovascular Diseases |
| HSALNT0290331 | HSALNG0142446 | uc.63 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290106 | HSALNG0142221 | numb | NA | NA | pathogenic process | uveal melanoma | Neoplasms |
| HSALNT0289847 | HSALNG0141962 | GCASPC | TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1 | NA | pathogenic process | gallbladder cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289568 | HSALNG0141683 | AK001094 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289588 | HSALNG0141703 | AK093735 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289631 | HSALNG0141746 | BC003519 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290100 | HSALNG0142215 | NR_003573 | ANXA2P2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290119 | HSALNG0142234 | P2RX7-V3 | NA | NA | pathogenic process | uveal melanoma | Neoplasms |
| HSALNT0290308 | HSALNG0142423 | TMSB4 | NA | ceRNA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0288928 | HSALNG0090163 | DDX11-AS1 | CONCR | NA | pathogenic process | NA | NA |
| HSALNT0290052 | HSALNG0142167 | MELOE | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0290231 | HSALNG0142346 | RSU1P2 | RSU1P2 | ceRNA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290165 | HSALNG0142280 | RBMY2FP | RBMY2FP | NA | NA | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290071 | HSALNG0142186 | n375709 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289748 | HSALNG0141863 | DUXAP8 | DUXAP8 | NA | NA | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290030 | HSALNG0142145 | LOC729966 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290143 | HSALNG0142258 | POIR | NA | ceRNA | pathogenic process | periodontitis | Stomatognathic Diseases |
| HSALNT0067481 | HSALNG0031988 | MELTF-AS1 | MFI2-AS1,AC068302.3 | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0290053 | HSALNG0142168 | MFI2 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289922 | HSALNG0142037 | linc-223 | NA | ceRNA | pathogenic process | acute myeloid leukemia | Neoplasms |
| HSALNT0014603 | HSALNG0006859 | LINC01138 | LINC00875,FLJ39739 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290262 | HSALNG0142377 | SUZ12P1 | SUZ12P1 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290005 | HSALNG0142120 | LOC100505976 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0290392 | HSALNG0142507 | XLOC_l2_010636 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0090295 | HSALNG0043014 | RASGRF2-AS1 | CTC-459I6.1 | NA | pathogenic process | sepsis-induced endothelial dysfunction | Bacterial Infections and Mycoses |
| HSALNT0289852 | HSALNG0141967 | GPC3-AS1 | NA | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0189472 | HSALNG0091321 | HOXC-AS1 | NA | transcriptional regulation | pathogenic process | atherosclerosis | Cardiovascular Diseases |
| HSALNT0289157 | HSALNG0057557 | LUARIS | lncRNA#32 | transcriptional regulation | NA | NA | NA |
| HSALNT0289371 | HSALNG0044828 | MIR3936HG | LOC553103,SLC22A5-AS1 | NA | pathogenic process | gastric cancer;nasopharyngeal cancer | Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290148 | HSALNG0142263 | Ppp1r1b | NA | transcriptional regulation | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289038 | HSALNG0099182 | LINC00460 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290194 | HSALNG0142309 | RP1-13P20.6 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290364 | HSALNG0142479 | Unigene56159 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290355 | HSALNG0142470 | uc009yby.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289406 | HSALNG0048011 | TFAP2A-AS2 | HIPSTR | NA | developmental process | NA | NA |
| HSALNT0289704 | HSALNG0141819 | Chaer | NA | transcriptional regulation | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
| HSALNT0289865 | HSALNG0141980 | HIF-2α | NA | NA | pathogenic process | NA | NA |
| HSALNT0211378 | HSALNG0101489 | LINC00520 | C14orf34 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0087374 | HSALNG0041561 | MRPS30-DT | BRCAT54 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289388 | HSALNG0092662 | PPP1R12A-AS1 | R12A-AS1 | translational control | NA | NA | NA |
| HSALNT0289013 | HSALNG0088600 | ITFG2-AS1 | NA | NA | NA | NA | NA |
| HSALNT0290088 | HSALNG0142203 | NONHSAT041499 | NA | NA | pathogenic process | schizophrenia | Mental Disorders |
| HSALNT0290091 | HSALNG0142206 | NONHSAT089447 | NA | NA | pathogenic process | schizophrenia | Mental Disorders |
| HSALNT0289970 | HSALNG0142085 | lnc-NKX2-3-1 | NA | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289989 | HSALNG0142104 | lnc-RTN4R-1 | NA | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289821 | HSALNG0141936 | ERL | NA | NA | pathogenic process | Marek's disease | Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases |
| HSALNT0192459 | HSALNG0092867 | LINC02258 | RP11-248E9.5 | NA | pathogenic process | pneumonia | Respiratory Tract Diseases |
| HSALNT0241871 | HSALNG0117085 | SKAP1-AS1 | RP11-456D7.1 | NA | pathogenic process | pneumonia | Respiratory Tract Diseases |
| HSALNT0289439 | HSALNG0049760 | DINOL | DINO | NA | NA | NA | NA |
| HSALNT0288901 | HSALNG0000547 | CAMTA1-DT | lncCAMTA1 | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290328 | HSALNG0142443 | uc.345 | NA | transcriptional regulation | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290060 | HSALNG0142175 | MSNP1AS | NA | translational control | pathogenic process | autism spectrum disorder | Mental Disorders |
| HSALNT0289376 | HSALNG0004596 | NEXN-AS1 | C1orf118,FLJ90637 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0183194 | HSALNG0088083 | LINC02098 | RP11-702B10.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0198055 | HSALNG0095473 | PSPC1-AS2 | RP11-523H24.3 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289155 | HSALNG0114857 | LRRC75A-AS1 | C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289220 | HSALNG0077999 | PRKG1-AS1 | RP11-573I11.2 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289262 | HSALNG0076970 | SVIL-AS1 | RP11-534G20.3 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289281 | HSALNG0108169 | VPS33B-DT | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289804 | HSALNG0141919 | ENST00000438399 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0290228 | HSALNG0142343 | RPKG1-AS1 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0290350 | HSALNG0142465 | uc004afb.1 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289398 | HSALNG0135015 | SLC5A4-AS1 | RP1-90G24.10 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289411 | HSALNG0063964 | TNFRSF10A-AS1 | RP11-1149O23.2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289727 | HSALNG0141842 | CTD-2616J11.14 | AC008750.7 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290182 | HSALNG0142297 | RP11-150O12.3 | AC124067.4 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289730 | HSALNG0141845 | CXCL1P1 | CXCL1P1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289803 | HSALNG0141918 | ENST00000438347 | CCND3P1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289897 | HSALNG0142012 | LINC00601 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289503 | HSALNG0141614 | KIAA0087 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289827 | HSALNG0141942 | FAM212B-AS1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290010 | HSALNG0142125 | LOC102723552 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290181 | HSALNG0142296 | RP11-140I24 | LINC01568 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290201 | HSALNG0142316 | RP11-501O2 | LINC02046 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290206 | HSALNG0142321 | RP11-600K151 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290084 | HSALNG0142199 | NONHSAG051968 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290090 | HSALNG0142205 | NONHSAT076747 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290094 | HSALNG0142209 | NONHSAT122730 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0138768 | HSALNG0066240 | MIR2052HG | NA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289096 | HSALNG0096884 | LINC01198 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289274 | HSALNG0096821 | TPT1-AS1 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289924 | HSALNG0142039 | linc-cdh4-2 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0144641 | HSALNG0068878 | LINC02055 | RP1130-1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289737 | HSALNG0141852 | DBCCR1 | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289547 | HSALNG0141662 | AC012065.7 | NA | NA | pathogenic process | chronic lymphocytic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289229 | HSALNG0116565 | RAMP2-AS1 | NA | NA | pathogenic process | glioblastoma | Neoplasms |
| HSALNT0289591 | HSALNG0141706 | AK098081 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289644 | HSALNG0141759 | BC037331 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289646 | HSALNG0141761 | BC040303 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289717 | HSALNG0141832 | CR749831 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289250 | HSALNG0040073 | SNHG18 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0106140 | HSALNG0050030 | FOXP4-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0026202 | HSALNG0012584 | RNASEH1-AS1 | LOC100506054 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288993 | HSALNG0088026 | GSEC | ST3GAL4-AS1,DCPS-AS1,FLJ39051 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0060264 | HSALNG0028799 | DNAJB8-AS1 | NA | NA | NA | NA | NA |
| HSALNT0248137 | HSALNG0120059 | CHMP1B-AS1 | NA | NA | NA | NA | NA |
| HSALNT0021970 | HSALNG0010602 | TGFB2-AS1 | NR_046268 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0078323 | HSALNG0037356 | SLC7A11-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0134663 | HSALNG0064248 | INTS9-AS1 | ENST00000520055 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0231572 | HSALNG0111641 | MMP2-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0267869 | HSALNG0130456 | SLC12A5-AS1 | RP11-465L10.10 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0288921 | HSALNG0002415 | CSMD2-AS1 | ENST00000434181 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0288997 | HSALNG0052934 | HDAC2-AS2 | ENST00000421891 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289012 | HSALNG0105327 | INO80-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289140 | HSALNG0075065 | LINC02247 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289161 | HSALNG0059170 | MAGI2-AS3 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289188 | HSALNG0062699 | MNX1-AS2 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289245 | HSALNG0140277 | SMIM10L2B-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289407 | HSALNG0102543 | TGFB3-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289457 | HSALNG0073036 | HSD17B3-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289919 | HSALNG0142034 | LINC02246 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289288 | HSALNG0100050 | ZNF710-AS1 | ENST00000558334 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289266 | HSALNG0007188 | TDRKH-AS1 | RP11-98D18.9 | NA | pathogenic process | NA | NA |
| HSALNT0289128 | HSALNG0057684 | LINC01952 | AC004854.4 | NA | pathogenic process | recurrent miscarriage | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290075 | HSALNG0142190 | NCF4-AS1 | CTA-833B7.2 | NA | pathogenic process | recurrent miscarriage | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289360 | HSALNG0029603 | LNCSRLR | lncRNA-SRLR | transcriptional regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288918 | HSALNG0021529 | CFLAR-AS1 | ALS2CR10 | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289710 | HSALNG0141825 | COL1A2-AS1 | TCONS_00013888,lncRNA8975-1 | transcriptional regulation | pathogenic process | hypertrophic scar | Skin and Connective Tissue Diseases |
| HSALNT0075075 | HSALNG0035847 | LNCPRESS2 | lncPRESS2 | transcriptional regulation | NA | NA | NA |
| HSALNT0011289 | HSALNG0005432 | LINC01930 | EU358092 | NA | pathogenic process | schizophrenia | Mental Disorders |
| HSALNT0097120 | HSALNG0046325 | HMMR-AS1 | NA | NA | pathogenic process | basal-like breast cancer | Neoplasms |
| HSALNT0184498 | HSALNG0088703 | CCND2-AS1 | CCND2-AS2 | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289045 | HSALNG0030884 | LINC00578 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0288884 | HSALNG0026576 | ADAMTS9-AS1 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0080041 | HSALNG0038152 | FAM198B-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0103007 | HSALNG0048820 | LINC00240 | C6orf41,NCRNA00240,bA373D17.1 | ceRNA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289071 | HSALNG0122453 | LINC00909 | NA | NA | NA | NA | NA |
| HSALNT0289509 | HSALNG0141620 | LINC00680 | NA | NA | NA | NA | NA |
| HSALNT0129070 | HSALNG0061394 | LINC00513 | AC016831.7 | NA | NA | NA | NA |
| HSALNT0289129 | HSALNG0115960 | LINC02001 | RP11-1094M14.11 | NA | NA | NA | NA |
| HSALNT0289215 | HSALNG0092950 | POC1B-AS1 | RP11-734K2.4 | NA | NA | NA | NA |
| HSALNT0289241 | HSALNG0060049 | SLC12A9-AS1 | RP11-126L15.4 | NA | NA | NA | NA |
| HSALNT0289275 | HSALNG0050617 | TRAM2-AS1 | NA | NA | NA | NA | NA |
| HSALNT0002243 | HSALNG0001176 | LINC01772 | ENSG00000226029 | ceRNA | pathogenic process | oesophageal cancer | Neoplasms |
| HSALNT0288941 | HSALNG0009693 | ELF3-AS1 | ENST00000415582 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289134 | HSALNG0025450 | LINC02158 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289350 | HSALNG0133329 | LINC01671 | BC041455 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289124 | HSALNG0132343 | LINC01684 | lnc-JAM2-6 | NA | pathogenic process | nonalcoholic fatty liver disease | Digestive System Diseases |
| HSALNT0289036 | HSALNG0096092 | LINC00365 | NA | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289111 | HSALNG0043625 | LINC01554 | C5orf27,FLJ38821,FIS | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289132 | HSALNG0136701 | LINC02154 | GS1-600G8.5 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0137721 | HSALNG0065704 | LINC02155 | RP11-705O24.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0225363 | HSALNG0108398 | LINC02157 | RP11-327J17.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289133 | HSALNG0090758 | LINC02156 | RP1-90J4.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0133924 | HSALNG0063832 | LINC02153 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0181656 | HSALNG0087394 | LINC02151 | TCONS_00019174 | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0227367 | HSALNG0109385 | LINC02152 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0029246 | HSALNG0013844 | BRE-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289251 | HSALNG0056623 | SNHG26 | AC005682.5 | NA | pathogenic process | bladder urothelial cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0252719 | HSALNG0122284 | LIVAR | lnc18q22.2 | NA | pathogenic process | nonalcoholic steatohepatiti | Digestive System Diseases |
| HSALNT0289074 | HSALNG0031832 | LINC00969 | ENST00000453324 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289138 | HSALNG0140259 | LINC02243 | ENST00000441841 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289399 | HSALNG0039449 | SLC9A3-AS1 | UC011CLY.2 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288934 | HSALNG0126602 | DM1-AS | NA | NA | pathogenic process | myotonic dystrophy type 1 | Musculoskeletal Diseases;Nervous System Diseases |
| HSALNT0009014 | HSALNG0004475 | LINC02238 | RP4-788P17.1 | NA | pathogenic process | B cell lymphoma | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289163 | HSALNG0043374 | MEF2C-AS2 | CTC-467M3.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0289181 | HSALNG0003824 | MIR4422HG | RP11-101C11.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0289403 | HSALNG0082800 | SPON1-AS1 | RP11-21,L19.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0289461 | HSALNG0083610 | CD44-AS1 | RP1-68D18.4 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0262277 | HSALNG0127560 | LILRB1-AS1 | AC009892.10 | NA | pathogenic process | NA | NA |
| HSALNT0289546 | HSALNG0141661 | AC009892.10 | LILRB1-AS1 | NA | NA | B cell lymphoma | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0282241 | HSALNG0137635 | LINC01186 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289168 | HSALNG0131657 | MHENCR | NA | ceRNA | pathogenic process | melanoma | Neoplasms |
| HSALNT0072994 | HSALNG0034801 | LINC02232 | RP11-707A18.1 | NA | pathogenic process | NA | NA |
| HSALNT0080161 | HSALNG0038220 | LINC02233 | RP11-6C14.1 | NA | pathogenic process | NA | NA |
| HSALNT0084027 | HSALNG0039930 | LINC02236 | RP11-332J15.1 | NA | pathogenic process | NA | NA |
| HSALNT0091870 | HSALNG0043678 | LINC02234 | RP11-455B3.1 | NA | pathogenic process | NA | NA |
| HSALNT0139521 | HSALNG0066607 | LINC02235 | RP11-354A14.1 | NA | pathogenic process | NA | NA |
| HSALNT0142040 | HSALNG0067779 | LINC02237 | RP11-1101K5.1 | NA | pathogenic process | NA | NA |
| HSALNT0289135 | HSALNG0111295 | LINC02179 | RP11-189E14.4 | NA | pathogenic process | NA | NA |
| HSALNT0289351 | HSALNG0132340 | LINC01689 | AP000469.2 | NA | pathogenic process | NA | NA |
| HSALNT0289137 | HSALNG0091963 | LINC02231 | RP11-766N7.4 | NA | pathogenic process | Esophageal squamous cell cancer | Neoplasms |
| HSALNT0220239 | HSALNG0105903 | MIR4713HG | RP11-108K3.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288967 | HSALNG0037858 | FAM160A1-DT | RP11-610P16.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289239 | HSALNG0021423 | SATB2-AS1 | NA | translational control | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289512 | HSALNG0141623 | LINC01826 | lnc-MKI67IP-3 | ceRNA | pathogenic process | atherosclerosis | Cardiovascular Diseases |
| HSALNT0289024 | HSALNG0104253 | LINC00226 | C14orf97,NCRNA00226 | NA | pathogenic process | pancreatic ductaladenocarcinoma | Neoplasms |
| HSALNT0082192 | HSALNG0039173 | F11-AS1 | NA | NA | NA | NA | NA |
| HSALNT0219108 | HSALNG0105295 | SPINT1-AS1 | RP11-532F12.5 | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289177 | HSALNG0088950 | MIR200CHG | U47924.27 | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289328 | HSALNG0031153 | LINC00888 | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289309 | HSALNG0116205 | LINC00672 | NA | transcriptional regulation | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289198 | HSALNG0085691 | P4HA3-AS1 | NA | NA | pathogenic process | parkinson's disease | Nervous System Diseases |
| HSALNT0197312 | HSALNG0095075 | TMEM132D-AS1 | LOC283352 | NA | pathogenic process | human dermal fibroblasts | Cell Physiological Phenomena |
| HSALNT0289472 | HSALNG0113128 | ATP2C2-AS1 | RP11-517C16.2-001 | NA | NA | NA | NA |
| HSALNT0233849 | HSALNG0112863 | WWOX-AS1 | RP11-190D6.2 | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0128829 | HSALNG0061246 | FLNC-AS1 | NA | NA | pathogenic process | cervical squamous cancer | Neoplasms |
| HSALNT0289889 | HSALNG0142004 | LIF-AS1 | Lnc-LIF-AS | NA | pathogenic process | cervical squamous cancer | Neoplasms |
| HSALNT0011283 | HSALNG0005428 | DPYD-AS2 | NA | NA | pathogenic process | cervical squamous cancer | Neoplasms |
| HSALNT0289836 | HSALNG0141951 | FLICR | NA | transcriptional regulation | pathogenic process | autoimmune diabete | Immune System Diseases |
| HSALNT0289356 | HSALNG0090563 | LINC02402 | ENST00000550337.1 | NA | pathogenic process | diabetes | Endocrine System Diseases |
| HSALNT0137118 | HSALNG0065453 | CERNA3 | CTA | ceRNA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0090838 | HSALNG0043312 | LINC02488 | CTD-2316B1 | NA | pathogenic process | NA | NA |
| HSALNT0174947 | HSALNG0083979 | LINC02489 | CTD-2589M5 | NA | pathogenic process | NA | NA |
| HSALNT0220441 | HSALNG0105991 | LINC02490 | RP11-209E8 | NA | pathogenic process | NA | NA |
| HSALNT0289260 | HSALNG0045650 | STK32A-AS1 | CTC-255N20 | NA | pathogenic process | NA | NA |
| HSALNT0289143 | HSALNG0055190 | LINC02487 | NA | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0095585 | HSALNG0045503 | SPRY4-AS1 | THCAT68 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0288927 | HSALNG0090908 | DDN-AS1 | CAT1507 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0012862 | HSALNG0006150 | SLC16A1-AS1 | NA | NA | pathogenic process | acute myocardial infarction | Cardiovascular Diseases |
| HSALNT0289412 | HSALNG0000276 | TNFRSF14-AS1 | ENST00000416860.2 | NA | pathogenic process | acute myocardial infarction | Cardiovascular Diseases |
| HSALNT0259139 | HSALNG0125745 | LINC00665 | NA | NA | NA | NA | NA |
| HSALNT0040268 | HSALNG0019085 | DARS-AS1 | NA | NA | pathogenic process | renal disease | NA |
| HSALNT0288913 | HSALNG0125425 | CEBPA-AS1 | CEBPA-DT | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289011 | HSALNG0057479 | INHBA-AS1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288988 | HSALNG0067472 | GASAL1 | GASL1 | NA | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289127 | HSALNG0021881 | LINC01857 | AC079767.4 | NA | pathogenic process | tuberculosis | Bacterial Infections and Mycoses |
| HSALNT0289091 | HSALNG0004949 | LINC01140 | FLJ41676 | NA | NA | NA | NA |
| HSALNT0281957 | HSALNG0137521 | PINCR | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289344 | HSALNG0139543 | LINC00890 | NA | NA | pathogenic process | leiomyoma | Neoplasms |
| HSALNT0019828 | HSALNG0009573 | LINC00862 | C1orf98,SMIM16 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0073790 | HSALNG0035237 | LINC02562 | RP11-44F21.5 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0263101 | HSALNG0127961 | LINC02560 | CTD-2619J13.13 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0289144 | HSALNG0088252 | LINC02551 | RP11-890B15.2 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0289458 | HSALNG0078773 | DDIT4-AS1 | RP11-442H21.2 | NA | pathogenic process | cystic Fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0288992 | HSALNG0089423 | GPRC5D-AS1 | RP11-392P7.6 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289386 | HSALNG0015768 | PCBP1-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289405 | HSALNG0044141 | STARD4-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0201547 | HSALNG0097004 | LINC00462 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0207103 | HSALNG0099453 | SOX1-OT | LINC00403 | NA | pathogenic process | NA | NA |
| HSALNT0002131 | HSALNG0001107 | SLC25A34-AS1 | RP11-169K16.4 | NA | NA | NA | NA |
| HSALNT0289218 | HSALNG0075163 | PPP1R26-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289047 | HSALNG0064310 | LINC00589 | C8orf75,TSLNC8 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289516 | HSALNG0141627 | TPM1-AS | TPM1-AS1 | splicing regulation | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289314 | HSALNG0141631 | LINC01101 | FLJ14816 | NA | pathogenic process | HPV-induced cervical neoplasia | Neoplasms |
| HSALNT0289147 | HSALNG0018748 | LINC02572 | AC079776.2 | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0096804 | HSALNG0046188 | LINC02202 | NA | NA | NA | NA | NA |
| HSALNT0289076 | HSALNG0027511 | LINC00973 | CTD-2021J15.2 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288625 | HSALNG0141401 | TTTY10 | NCRNA00133 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289323 | HSALNG0133418 | LINC00319 | C21orf125,NCRNA00319,PRED49,FLJ38036 | ceRNA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0015533 | HSALNG0007394 | IL6R-AS1 | RP11-350G8.5 | NA | NA | NA | NA |
| HSALNT0090330 | HSALNG0043020 | CKMT2-AS1 | NA | NA | NA | NA | NA |
| HSALNT0012995 | HSALNG0006203 | HIPK1-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289216 | HSALNG0050214 | POLH-AS1 | RP3-337H4.8 | NA | NA | NA | NA |
| HSALNT0289276 | HSALNG0053237 | TRDN-AS1 | HRAT13 | NA | NA | NA | NA |
| HSALNT0289159 | HSALNG0069213 | LY6E-DT | LOC100133669 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289434 | HSALNG0040409 | BASP1-AS1 | LOC285696 | NA | pathogenic process | NA | NA |
| HSALNT0288991 | HSALNG0069691 | GLIS3-AS1 | C9orf70,MGC16153 | NA | NA | NA | NA |
| HSALNT0288896 | HSALNG0070213 | BNC2-AS1 | RP11-62F24.2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289292 | HSALNG0078947 | ZNF503-AS1 | NA | NA | pathogenic process | age-related macular degeneration | Eye Diseases |
| HSALNT0159506 | HSALNG0076434 | VIM-AS1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0288882 | HSALNG0011058 | ACBD3-AS1 | RP11-275I14.4 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289156 | HSALNG0005074 | LRRC8C-DT | FLJ27354 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289447 | HSALNG0058889 | ELN-AS1 | CTB-51J22.1 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0076712 | HSALNG0036645 | LINC02264 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0093666 | HSALNG0044495 | LINC02201 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0271685 | HSALNG0132198 | LINC02573 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289125 | HSALNG0015785 | LINC01816 | LOC100133985 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289355 | HSALNG0091335 | LINC02381 | LOC400043 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289366 | HSALNG0029874 | MBNL1-AS1 | LOC401093 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289513 | HSALNG0141624 | MIR4697HG | LINC00947,LOC283174 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289073 | HSALNG0065480 | LINC00968 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0114453 | HSALNG0053963 | NMBR-AS1 | RP11-137J7.2 | NA | pathogenic process | non-melanoma skin cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289300 | HSALNG0077499 | LINC01518 | NA | NA | pathogenic process | non-melanoma skin cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0003783 | HSALNG0002009 | LINC02574 | RP11-288L9.1 | transcriptional regulation | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0032721 | HSALNG0015486 | LINC02579 | AC007365.1 | NA | pathogenic process | NA | NA |
| HSALNT0030828 | HSALNG0014519 | LINC02580 | AC093609.1 | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0032808 | HSALNG0015519 | LINC02576 | NA | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0127022 | HSALNG0060386 | LINC02577 | NA | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0154722 | HSALNG0074062 | LINC02578 | RP11-127L21.1 | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288962 | HSALNG0084388 | FAM111A-DT | NA | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289148 | HSALNG0133545 | LINC02575 | AP001065.15 | transcriptional regulation | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0025249 | HSALNG0012143 | KIF26B-AS1 | RP11-62I21.1 | NA | NA | NA | NA |
| HSALNT0177212 | HSALNG0085146 | RPS6KB2-AS1 | AP003419.16 | NA | pathogenic process | agingâassociated idiopathic pulmonary fibrosis | Physiological Phenomena |
| HSALNT0289072 | HSALNG0090150 | LINC00941 | lncRNA-MUF | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289338 | HSALNG0075045 | LINC00094 | FLJ35348,bA374P20.3 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0114192 | HSALNG0053894 | FILNC1 | NA | translational control | pathogenic process | renal tumor | Neoplasms |
| HSALNT0289199 | HSALNG0128600 | PARAL1 | NA | ceRNA | pathogenic process | obesity | Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena |
| HSALNT0244832 | HSALNG0118528 | SOX9-AS1 | FLJ37644 | transcriptional regulation | NA | NA | NA |
| HSALNT0289236 | HSALNG0118528 | ROCR | LINC02095 | transcriptional regulation | NA | NA | NA |
| HSALNT0056667 | HSALNG0027060 | LINC02027 | LOC728290 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289424 | HSALNG0141124 | TTTY22 | NCRNA00147 | NA | NA | NA | NA |
| HSALNT0289069 | HSALNG0030090 | LINC00880 | NA | NA | NA | NA | NA |
| HSALNT0252974 | HSALNG0122396 | LINC02582 | CTD-2354A18.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289035 | HSALNG0097712 | LINC00364 | LncRNA00364 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0060981 | HSALNG0029189 | NCK1-DT | NCK1-AS1,SLC35G2-AS1 | ceRNA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0288890 | HSALNG0067505 | BAALC-AS1 | lncFZD6,FZD6-DT | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0046602 | HSALNG0021972 | CPS1-IT1 | CPS1-IT,CPS1IT,CPS1IT1,PRO0132 | NA | pathogenic process | hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289445 | HSALNG0059740 | DLX6-AS1 | DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048 | transcriptional regulation | pathogenic process | split hand/split foot malformation disorder;lung adenocarcinoma | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms |
| HSALNT0289891 | HSALNG0142006 | LINC00114 | NA | NA | NA | NA | NA |
| HSALNT0289415 | HSALNG0138601 | TSIX | LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS | transcriptional regulation | pathogenic process | systemic sclerosis | Skin and Connective Tissue Diseases |
| HSALNT0217334 | HSALNG0104503 | MKRN3-AS1 | ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290256 | HSALNG0142371 | SRA | lnc-SRA1-1:1,SRA1,ENSG00000213523 | transcriptional regulation | pathogenic process | nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer | Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289442 | HSALNG0049271 | HCP5 | 6S2650E,D6S2650E,P5-1 | NA | pathogenic process | AIDS | Immune System Diseases;Virus Diseases |
| HSALNT0289284 | HSALNG0083476 | WT1-AS | WIT1,WIT-1,WT1A, WT1-AS1 | transcriptional regulation | pathogenic process | gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0289421 | HSALNG0082235 | KCNQ1OT1 | KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012 | transcriptional regulation | pathogenic process | prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases |
| HSALNT0263784 | HSALNG0128372 | PCNA-AS1 | PCNAA, PCNA-AS | transcriptional regulation | pathogenic process | gastric cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289524 | HSALNG0049107 | HCG9 | PERB11,HCGIX,HCGIX4,HCGIX-4 | NA | NA | NA | NA |
| HSALNT0289264 | HSALNG0103448 | TCL6 | TCL6e1,TNG2,TNG1 | NA | pathogenic process;developmental process | renal cell cancer;leukemia | Male Urogenital Diseases;Neoplasms |
| HSALNT0289203 | HSALNG0072040 | PCA3 | DD3,NCRNA00019,PCAT3 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289462 | HSALNG0082178 | H19 | ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2 | transcriptional regulation;ceRNA | developmental process;pathogenic process | prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor | Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases |
| HSALNT0288932 | HSALNG0097105 | DLEU1 | BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6 | transcriptional regulation;ceRNA | pathogenic process | lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
| HSALNT0289493 | HSALNG0141604 | DBH-AS1 | NCRNA00118,BPR | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0088415 | HSALNG0042101 | PART1 | DKFZP586D0823,NCRNA00206 | NA | pathogenic process | prostate cancer;glioblastoma | Male Urogenital Diseases;Neoplasms |
| HSALNT0289463 | HSALNG0082197 | IGF2-AS | IGF2A,PEG8,IGF2-AS1 | transcriptional regulation | pathogenic process | liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer | Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0269786 | HSALNG0131285 | GNAS-AS1 | GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075 | transcriptional regulation | pathogenic process | non-small cell lung cancer;pseudohypoparathyroidism type Ib | Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms |
| HSALNT0289252 | HSALNG0051709 | SNHG5 | C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044 | NA | pathogenic process | gastric cancer;lymphoma;melanoma | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0023827 | HSALNG0011462 | DISC2 | DISC1-AS1,DISC1O, NCRNA00015 | transcriptional regulation | pathogenic process | bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression | Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms |
| HSALNT0203415 | HSALNG0097806 | ATXN8OS | SCA8,KLHL1A,NCRNA00003 | transcriptional regulation | pathogenic process | spinocerebellar ataxia;spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290312 | HSALNG0142427 | TRAF3IP2-AS1 | C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2 | transcriptional regulation | pathogenic process | schizophrenia;cocaine abuse | Chemically-Induced Disorders;Mental Disorders |
| HSALNT0289008 | HSALNG0054049 | HYMAI | NCRNA00020 | NA | pathogenic process | transient neonatal diabetes | Nutritional and Metabolic Diseases |
| HSALNT0288968 | HSALNG0071146 | FAM201A | C9orf122 | NA | pathogenic process | leukemia | Neoplasms |
| HSALNT0288969 | HSALNG0093910 | FAM222A-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289484 | HSALNG0138575 | FAM226A | CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827 | NA | pathogenic process | NA | NA |
| HSALNT0289497 | HSALNG0141608 | FAM215A | C17orf88,APR-2,LINC00530 | NA | pathogenic process | ovarian cancer;leukemia | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289230 | HSALNG0025991 | RBM5-AS1 | LUST | transcriptional regulation | pathogenic process | tumor | Neoplasms |
| HSALNT0002923 | HSALNG0001554 | LINC00339 | NCRNA00339,HSPC157 | NA | pathogenic process;developmental process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0144027 | HSALNG0068615 | ASAP1-IT1 | ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289212 | HSALNG0021208 | PCGEM1 | NCRNA00071,LINC00071,PCAT9 | transcriptional regulation;ceRNA | pathogenic process | osteoarthritis;prostate cancer;glioma | Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0289016 | HSALNG0082243 | KCNQ1DN | BWRT,HSA404617 | NA | pathogenic process | aging;Wilms' tumor | Physiological Phenomena;Neoplasms |
| HSALNT0288933 | HSALNG0097101 | DLEU2 | DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG | transcriptional regulation | pathogenic process | lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
| HSALNT0217624 | HSALNG0104558 | PWAR4 | PAR4,PAR-4 | NA | pathogenic process | Prader-Willi syndrome and Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289165 | HSALNG0103778 | MEG8 | SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC | NA | pathogenic process | Prader-Willi syndrome and Angelman syndrome;temple syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289482 | HSALNG0133856 | CECR7 | SAHL1 | NA | pathogenic process | hepatocellular cancer;cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
| HSALNT0074223 | HSALNG0035451 | PCAT4 | GDEP,PCAN1,PCA4 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0061175 | HSALNG0029318 | PISRT1 | NCRNA00195 | transcriptional regulation | developmental process;pathogenic process | blepharophimosis syndrome | Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0190912 | HSALNG0092137 | IFNG-AS1 | Tmevpg1,LincR-Ifng-3'A, NEST | transcriptional regulation | pathogenic process | Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome | Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0038178 | HSALNG0018067 | FAM138B | F379 | NA | NA | NA | NA |
| HSALNT0145703 | HSALNG0069515 | FAM138C | F379 | NA | NA | NA | NA |
| HSALNT0288963 | HSALNG0000006 | FAM138A | F379 | NA | NA | NA | NA |
| HSALNT0183947 | HSALNG0088434 | FAM138D | F379 | NA | NA | NA | NA |
| HSALNT0226092 | HSALNG0108677 | FAM138E | F379 | NA | NA | NA | NA |
| HSALNT0253925 | HSALNG0122829 | FAM138F | F379 | NA | NA | NA | NA |
| HSALNT0289326 | HSALNG0141632 | LINC00312 | LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN | transcriptional regulation | pathogenic process | nasopharyngeal cancer;bladder cancer;non-small cell lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases |
| HSALNT0288886 | HSALNG0054798 | AIRN | AIR,NCRNA00088,IGF2RA, IGF2R-AS1 | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0254857 | HSALNG0123415 | MIR7-3HG | C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2 | NA | pathogenic process | liver cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0185751 | HSALNG0089375 | LOH12CR2 | LOH2CR12 | NA | pathogenic process | pre-B acute lymphoblastic leukaemia | Hemic and Lymphatic Diseases |
| HSALNT0289479 | HSALNG0133055 | DSCR8 | C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b | NA | pathogenic process | Down syndrome;melanoma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
| HSALNT0289030 | HSALNG0133422 | LINC00313 | C21orf84,NCRNA00313, | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289029 | HSALNG0132830 | LINC00310 | C21orf82,NCRNA00310 | NA | pathogenic process | NA | NA |
| HSALNT0272435 | HSALNG0132500 | LINC00161 | C21orf100,NCRNA00161 | ceRNA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289184 | HSALNG0132027 | MIR99AHG | C21orf35,FLJ38295,C21orf34,LINC00478,MONC | NA | pathogenic process | myeloid leukemia | Hemic and Lymphatic Diseases |
| HSALNT0289005 | HSALNG0056865 | HOXA11-AS | HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076 | ceRNA | pathogenic process | uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0193654 | HSALNG0093342 | RMST | NCRM, NCRNA00054,LINC00054 | transcriptional regulation | developmental process;pathogenic process | breast cancer;rhabdomyosarcoma | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290079 | HSALNG0142194 | ncR-PAR | NCRUPAR,ENSG00000225407 | transcriptional regulation | developmental process;pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289167 | HSALNG0061370 | MESTIT1 | MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS | NA | pathogenic process | Silver-Russell syndrome | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0273791 | HSALNG0133168 | DSCAM-AS1 | M41 | NA | pathogenic process | adolescent idiopathic scoliosis;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289391 | HSALNG0104546 | PWARSN | PAR-SN,PARSN | NA | pathogenic process | NA | NA |
| HSALNT0127791 | HSALNG0060774 | ST7-AS1 | ST7OT1,ST7AS1 | NA | pathogenic process | glioma;autism | Mental Disorders;Neoplasms |
| HSALNT0206298 | HSALNG0099122 | DAOA-AS1 | DAOAA, DAOA-A,G30 | NA | pathogenic process | panic disorder;schizophrenia;bipolar disorder | Mental Disorders |
| HSALNT0167060 | HSALNG0080104 | OLMALINC | C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0026878 | HSALNG0012802 | LINC00299 | C2orf46,NCRNA00299,FLJ45673 | NA | pathogenic process;developmental process | intellectual and developmental disability;neurodevelopmental disabilities | Mental Disorders;Nervous System Diseases |
| HSALNT0289081 | HSALNG0039816 | LINC01020 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0101186 | HSALNG0048016 | LINC00518 | C6orf218,MGC40222 | NA | pathogenic process | NA | NA |
| HSALNT0083960 | HSALNG0039909 | LINC01018 | SRHC | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289361 | HSALNG0031463 | LPP-AS2 | MYCLo-5,MYCLo-6 | NA | NA | NA | NA |
| HSALNT0143233 | HSALNG0068292 | LINC00964 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289364 | HSALNG0094063 | MAPKAPK5-AS1 | C12orf47,FLJ39616 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289053 | HSALNG0027872 | LINC00635 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289327 | HSALNG0141633 | LINC00636 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0262657 | HSALNG0127758 | ZNF582-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289020 | HSALNG0000022 | LINC00115 | NCRNA00115,FLJ22639 | ceRNA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289254 | HSALNG0075291 | SNHG7 | MGC16037,NCRNA00061 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289162 | HSALNG0020412 | MAP3K20-AS1 | MLK7-AS1 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0145357 | HSALNG0069280 | RHPN1-AS1 | C8orf51,MGC3113 | NA | NA | NA | NA |
| HSALNT0289343 | HSALNG0138602 | XIST | DXS399E,NCRNA00001,DXS1089,swd66,LINC00001 | transcriptional regulation;ceRNA | pathogenic process | non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289389 | HSALNG0128330 | PRNT | M8 | NA | pathogenic process | NA | NA |
| HSALNT0288942 | HSALNG0080912 | EMX2OS | NCRNA00045,EMX2-AS1 | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0200443 | HSALNG0096546 | LINC00598 | TTL | NA | pathogenic process | NA | NA |
| HSALNT0289517 | HSALNG0141628 | TTTY17A | NCRNA00140 | NA | NA | NA | NA |
| HSALNT0027901 | HSALNG0013206 | MYCNOS | NCYM,N-CYM,MYCN-AS1 | transcriptional regulation | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0047175 | HSALNG0022192 | DIRC3 | FLJ14199 | NA | pathogenic process | familial renal cell cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289363 | HSALNG0084905 | MALAT1 | PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA | splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA | pathogenic process | prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis | Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289744 | HSALNG0141859 | DLG2-AS1 | DLG2A, DLG2-A,PSZA11q14,SZ-1 | NA | pathogenic process | schizophrenia;myotonic dystrophy type 1;heart failure | Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289164 | HSALNG0103778 | MEG3 | FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1 | translational control;transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor | Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0290298 | HSALNG0142413 | TERC | DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR | NA | pathogenic process | prostate cancer;dyskeratosis congenita;lung squamous cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases |
| HSALNT0288907 | HSALNG0080948 | CASC2 | NA | ceRNA | pathogenic process | colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0205332 | HSALNG0098601 | MIR17HG | C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048 | NA | pathogenic process | diffuse large B-cell lymphoma;syndromic developmental defect;cancer | Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0288716 | HSALNG0141456 | TTTY6 | TTY6,TTTY6A,LINC00127 | NA | NA | NA | NA |
| HSALNT0288731 | HSALNG0141468 | TTTY4 | TTY4,TTTY4A,LINC00123 | NA | NA | NA | NA |
| HSALNT0288815 | HSALNG0141548 | TTTY3 | TTY3,TTTY3A,LINC00121 | NA | NA | NA | NA |
| HSALNT0288703 | HSALNG0141450 | TTTY5 | TTY5,LINC00126 | NA | NA | NA | NA |
| HSALNT0289255 | HSALNG0036656 | SNHG8 | NCRNA00060,LINC00060 | NA | pathogenic process | gastric cancer;malignant pleural mesothelioma | Neoplasms;Digestive System Diseases |
| HSALNT0289486 | HSALNG0141597 | BCYRN1 | BC200,BC200a,NCRNA00004,LINC00004 | splicing regulation;translational control | pathogenic process | aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0144426 | HSALNG0068805 | ZFAT-AS1 | ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070 | NA | pathogenic process | autoimmune disease | Immune System Diseases |
| HSALNT0289285 | HSALNG0077083 | ZEB1-AS1 | NA | NA | pathogenic process | esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer | Immune System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289185 | HSALNG0135987 | MIRLET7BHG | linc-Ppara | NA | developmental process | NA | NA |
| HSALNT0289374 | HSALNG0116616 | NBR2 | NCRNA00192 | transcriptional regulation | pathogenic process | gastric cancer;breast cancer;cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289417 | HSALNG0134930 | TUG1 | FLJ20618,NCRNA00080,LINC00080 | transcriptional regulation;ceRNA | pathogenic process | osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0288973 | HSALNG0079552 | FAS-AS1 | FASA, FAS-A,SAF | transcriptional regulation | pathogenic process | ataxia telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0288996 | HSALNG0068110 | HAS2-AS1 | HAS2A, HAS2-A,HASNT,NCRNA00077 | transcriptional regulation | NA | NA | NA |
| HSALNT0289390 | HSALNG0049245 | PSORS1C3 | NCRNA00196 | NA | pathogenic process | rheumatoid arthritis;psoriasis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289868 | HSALNG0141983 | HLA-AS1 | NA | NA | pathogenic process | psoriasis;liver injury;multiple sclerosis;AIDS | Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0290154 | HSALNG0142269 | PRINS | NCRNA00074 | transcriptional regulation | pathogenic process | psoriasis;prostate cancer | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0262809 | HSALNG0127790 | PEG3-AS1 | PEG3AS,PEG3-AS,APEG3,NCRNA00155 | NA | NA | NA | NA |
| HSALNT0289533 | HSALNG0141648 | 7SL | 7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1 | protein localization | pathogenic process | AIDS;Leishmaniasis;dermatomyositis;polymyositis | Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases |
| HSALNT0290081 | HSALNG0142196 | NDM29 | 29A,lnc-C11orf16-1:1 | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289382 | HSALNG0074439 | NRON | NCRNA00194 | NA | pathogenic process | AIDS;Down syndrome;HIV | Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases |
| HSALNT0289253 | HSALNG0065926 | SNHG6 | U87HG,HBII-276HG,NCRNA00058 | translational control;ceRNA | pathogenic process | hepatocellular cancer;hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289653 | HSALNG0141768 | Beta-globin transcript | AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1,NONHSAT017676 | NA | NA | NA | NA |
| HSALNT0290398 | HSALNG0142513 | Zfhx2as | Zfh-5AS,ENSG00000157306,ENST00000554403.1 | NA | NA | NA | NA |
| HSALNT0011306 | HSALNG0005433 | MIR137HG | NA | NA | pathogenic process | schizophrenia;lung cancer;malignant lymphoma | Respiratory Tract Diseases;Mental Disorders;Neoplasms |
| HSALNT0289449 | HSALNG0056858 | HOXA-AS3 | HOXA6as | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289451 | HSALNG0068551 | CCDC26 | MGC27434,RAM | transcriptional regulation | pathogenic process | hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289893 | HSALNG0142008 | LINC00271 | C6orf217,NCRNA00271 | NA | pathogenic process | type 2 diabetes;schizophrenia | Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases |
| HSALNT0288892 | HSALNG0109621 | BCAR4 | NA | transcriptional regulation | pathogenic process | osteosarcoma;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289890 | HSALNG0142005 | LINC00032 | C9orf14,NCRNA00032 | NA | pathogenic process | narcolepsy;melanoma | Mental Disorders;Neoplasms;Nervous System Diseases |
| HSALNT0274572 | HSALNG0133591 | PICSAR | C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74 | transcriptional regulation | pathogenic process | testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer | Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases |
| HSALNT0256354 | HSALNG0124398 | UCA1 | CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36 | transcriptional regulation;ceRNA | developmental process;pathogenic process | oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0003871 | HSALNG0002066 | SNHG3 | NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB | NA | pathogenic process | ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease | Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289475 | HSALNG0131591 | HAR1A | HAR1F,NCRNA00064,LINC00064 | transcriptional regulation | pathogenic process | Huntington disease;Alzheimer's disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases |
| HSALNT0288995 | HSALNG0131589 | HAR1B | HAR1R,NCRNA00065,LINC00065 | transcriptional regulation | pathogenic process | Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0288958 | HSALNG0044150 | EPB41L4A-AS1 | C5orf26,NCRNA00219,TIGA1 | NA | pathogenic process | lung cancer;cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289170 | HSALNG0134655 | MIAT | C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT | splicing regulation;ceRNA | pathogenic process | prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0289007 | HSALNG0047947 | HULC | NCRNA00078,LINC00078,HCCAT1 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer | Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0288940 | HSALNG0023880 | EGOT | EGO,NCRNA00190 | NA | pathogenic process;developmental process | prostate cancer;breast cancer | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0289387 | HSALNG0001461 | PINK1-AS | PINK1-AS1,FLJ00387,PINK1A, naPINK1 | transcriptional regulation | pathogenic process | glucose metabolism disorder;Parkinson's disease;diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0289225 | HSALNG0068477 | PVT1 | NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT | transcriptional regulation;translational control | pathogenic process | murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289189 | HSALNG0073233 | NAMA | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0246525 | HSALNG0119442 | NARF-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0147433 | HSALNG0070397 | CDKN2B-AS1 | CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12 | siRNA;transcriptional regulation;ceRNA | pathogenic process | glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis | Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0050854 | HSALNG0024099 | GHRLOS | NCRNA00068,GHRL-AS1 | transcriptional regulation | NA | NA | NA |
| HSALNT0288959 | HSALNG0026279 | ESRG | HESRG | NA | pathogenic process | embryonal cancer | Neoplasms |
| HSALNT0287173 | HSALNG0140560 | FMR1-AS1 | FMR1A, FMR1-A,ASFMR1,FMR4 | transcriptional regulation | pathogenic process | fragile X syndrome;neurological disorder | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289499 | HSALNG0141610 | HCG4 | HCGIV-10,HCGIV.9 | NA | pathogenic process | NA | NA |
| HSALNT0288994 | HSALNG0038609 | HAND2-AS1 | DEIN,NBLA00301,FLJ11539 | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289286 | HSALNG0019362 | ZEB2-AS1 | ZEB2A, ZEB2-A,ZEB2NAT | splicing regulation | pathogenic process | bladder cancer;hepatocellular cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0017702 | HSALNG0008545 | GAS5 | SNHG2,NCRNA00030 | transcriptional regulation;ceRNA | pathogenic process | varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0288891 | HSALNG0087449 | BACE1-AS | BACE1A,FJ573250,NCRNA00177,BACE1-AS1 | translational control;transcriptional regulation | pathogenic process | ovarian cancer;colorectal cancer;Alzheimer's disease | Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289414 | HSALNG0133533 | TRPM2-AS | TRPM2-AS1 | NA | pathogenic process | melanoma;prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288935 | HSALNG0008462 | DNM3OS | DNM3-AS1,MIR199A2HG | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0288930 | HSALNG0133982 | DGCR5 | NCRNA00037,LINC00037 | transcriptional regulation | pathogenic process | Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0288893 | HSALNG0083307 | BDNF-AS | BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS | siRNA;transcriptional regulation | developmental process;pathogenic process | Huntington disease;schizophrenia;psychiatric disease;obesity | Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases |
| HSALNT0120317 | HSALNG0056850 | HOTAIRM1 | HOXA-AS1,NCRNA00179,HOXA1-AS1 | transcriptional regulation | pathogenic process;developmental process | colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0290158 | HSALNG0142273 | PTCSC1 | PTCSC,AK023948,NCRNA00197 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289004 | HSALNG0091318 | HOTAIR | HOXC-AS4,HOXC11-AS1,NCRNA00072 | siRNA;transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289192 | HSALNG0084892 | NEAT1 | NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC | transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer | Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0095094 | HSALNG0045213 | SNHG4 | U19H,NCRNA00059 | NA | pathogenic process | myelodysplastic syndrome | Hemic and Lymphatic Diseases |
| HSALNT0245443 | HSALNG0118855 | SNHG16 | ncRAN,Nbla12061,Nbla10727 | NA | pathogenic process | bladder cancer;bladder cancer;colorectal cancer;neuroblastoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0288897 | HSALNG0023698 | BOK-AS1 | BOKA,NCRNA00151,NAToB | NA | pathogenic process | esophageal squamous cell cancer;testicular cancer;cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289532 | HSALNG0141647 | 7SK | 7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149 | transcriptional regulation | developmental process;pathogenic process | cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma | Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289182 | HSALNG0017872 | MIR4435-2HG | MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289200 | HSALNG0016500 | PARTICL | PARTICLE | transcriptional regulation | pathogenic process | low-dose irradiation | Disorders of Environmental Origin |
| HSALNT0289172 | HSALNG0069266 | MINCR | LINC01604,TCONS_00015189 | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;Burkitt lymphoma | Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases |
| HSALNT0001792 | HSALNG0000905 | NPPA-AS1 | NPPAA, NPPA-AS | splicing regulation | pathogenic process | cardiovascular disease | Cardiovascular Diseases |
| HSALNT0290230 | HSALNG0142345 | RRP1B | NA | transcriptional regulation | pathogenic process | spinocerebellar ataxia;laryngeal squamous cell cancer;cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
| HSALNT0289467 | HSALNG0093062 | CLLU1 | NA | NA | NA | NA | NA |
| HSALNT0289173 | HSALNG0087764 | MIR100HG | AGD1,lncRNA-N2,linc-NeD125 | NA | developmental process;pathogenic process | myeloid leukemia;myopia;cervical cancer;neuroblastoma | Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0059175 | HSALNG0028235 | TUSC7 | LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295 | transcriptional regulation;ceRNA | pathogenic process | glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer | Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289647 | HSALNG0141762 | BC040587 | NA | NA | pathogenic process | osteosarcoma;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0059186 | HSALNG0028242 | LINC00901 | LSAMP-AS4,TCONS_00005428,BC040587 | NA | pathogenic process | osteosarcoma;gastric cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0233366 | HSALNG0112604 | HCCAT5 | HTA,FJ222407 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290040 | HSALNG0142155 | LSINCT5 | NA | NA | pathogenic process | chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0179611 | HSALNG0086377 | DISC1FP1 | Boymaw | transcriptional regulation | pathogenic process | schizophrenia | Mental Disorders |
| HSALNT0217643 | HSALNG0104567 | SNHG14 | 115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS | ceRNA | pathogenic process | Angelman syndrome;cerebral infarction;Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289273 | HSALNG0000343 | TP73-AS1 | KIAA0495,PDAM | NA | pathogenic process | esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
| HSALNT0290311 | HSALNG0142426 | TP53COR1 | Trp53cor1 | transcriptional regulation | pathogenic process | prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0289221 | HSALNG0068414 | PRNCR1 | CARLo-3,PCAT8 | transcriptional regulation | pathogenic process | gastric cancer;prostate cancer;glioma;colorectal cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0020131 | HSALNG0009743 | PCAT6 | KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96 | transcriptional regulation | pathogenic process | prostate cancer;triple-negative breast cancer;lung cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0289277 | HSALNG0130723 | TRERNA1 | LINC00651,ncRNA-a7,treRNA | transcriptional regulation | NA | NA | NA |
| HSALNT0014972 | HSALNG0007045 | FALEC | LINC00568,ncRNA-a1,FAL1 | transcriptional regulation | pathogenic process | ovarian cancer;thyroid cancer | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms |
| HSALNT0290008 | HSALNG0142123 | LOC100887755 | Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1 | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290248 | HSALNG0142363 | snaR | EU035784.1,lnc-BSPH1-1:1 | transcriptional regulation | NA | NA | NA |
| HSALNT0289342 | HSALNG0138609 | JPX | NCRNA00183,ENOX,LINC00183,DCBALD06 | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289231 | HSALNG0001716 | RCAN3AS | TCONS_00001428 | NA | NA | NA | NA |
| HSALNT0289280 | HSALNG0069631 | VLDLR-AS1 | lincRNA-VLDLR | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288982 | HSALNG0138614 | FTX | NCRNA00182,MIR374AHG,LINC00182,FLJ33139 | transcriptional regulation | pathogenic process | hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0091079 | HSALNG0043383 | MEF2C-AS1 | NA | NA | pathogenic process | gastric cancer;Prader-Willi syndrome and Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases |
| HSALNT0189341 | HSALNG0091277 | PCBP2-OT1 | TUC338 | NA | pathogenic process | hepatocellular cancer;tongue squamous cell cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290373 | HSALNG0142488 | WRAP53 | NA | NA | pathogenic process | hepatocellular cancer;cancer;dyskeratosis congenita | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
| HSALNT0289265 | HSALNG0049949 | TDRG1 | LINC00532,lincRNA-NRNA024015 | NA | pathogenic process | esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia | Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0289175 | HSALNG0132382 | MIR155HG | MIRHG2,BIC,NCRNA00172 | NA | pathogenic process | B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma | Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289051 | HSALNG0024293 | LINC00620 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0120390 | HSALNG0056871 | HOTTIP | NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1 | transcriptional regulation | pathogenic process | hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289287 | HSALNG0130661 | ZFAS1 | C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2 | transcriptional regulation;ceRNA | pathogenic process | gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289259 | HSALNG0045502 | SPRY4-IT1 | SPRIGHTLY | transcriptional regulation | pathogenic process | prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0105595 | HSALNG0049759 | PANDAR | PANDA | transcriptional regulation | pathogenic process | colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0068185 | HSALNG0032415 | HTT-AS | HTT-AS1,HTTAS | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0099036 | HSALNG0047200 | HEIH | LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2 | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0222533 | HSALNG0107117 | NPTN-IT1 | lncRNA-LET | NA | pathogenic process | gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer | Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases |
| HSALNT0289747 | HSALNG0141862 | DQ786243 | NA | transcriptional regulation | pathogenic process | crohn's disease;colorectal cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289204 | HSALNG0068414 | PCAT1 | PCAT-1,PCA1 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0275894 | HSALNG0134403 | PCAT14 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0211999 | HSALNG0101780 | HIF1A-AS2 | 3'aHIF-1A,aHIF | translational control | pathogenic process | bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0288999 | HSALNG0101776 | HIF1A-AS1 | 5'aHIF-1A,5'aHIF1alpha | NA | pathogenic process | acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289258 | HSALNG0031034 | SOX2-OT | SOX2OT,DKFZp761J1324,NCRNA00043 | transcriptional regulation | pathogenic process | colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease | Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289700 | HSALNG0141815 | CDR1-AS | CDR1NAT,ciRS-7,CDR1as | ceRNA | NA | NA | NA |
| HSALNT0289149 | HSALNG0050599 | LINCMD1 | MIR133BHG,LINC-MD1 | ceRNA | developmental process;pathogenic process | Duchenne muscular dystrophy | Musculoskeletal Diseases |
| HSALNT0288894 | HSALNG0082362 | BGLT3 | LINC01083,BGL3,lncRNA-BGL3 | ceRNA | pathogenic process | chronic myeloid leukemia | Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289042 | HSALNG0055058 | LINC00473 | C6orf176,bA142J11.1 | transcriptional regulation | pathogenic process | non-small cell lung cancer;renal cell cancer | Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0101681 | HSALNG0048223 | LINC01108 | LncRNA-ES1 | NA | developmental process | NA | NA |
| HSALNT0289418 | HSALNG0103465 | TUNAR | LINC00617,TUNA,HI-LNC78 | transcriptional regulation | developmental process;pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289197 | HSALNG0105343 | OIP5-AS1 | cyrano,linc-OIP5 | NA | developmental process | NA | NA |
| HSALNT0289046 | HSALNG0048515 | LINC00581 | NA | NA | pathogenic process | West Syndrome;West syndrome | Nervous System Diseases |
| HSALNT0289656 | HSALNG0141771 | BX118339 | NA | NA | pathogenic process | West syndrome | Nervous System Diseases |
| HSALNT0021726 | HSALNG0010465 | LINC00538 | Yiya,PROX1UT | NA | pathogenic process | colorectal cancer;cancer | Neoplasms;Digestive System Diseases |
| HSALNT0273249 | HSALNG0132926 | CBR3-AS1 | PlncRNA-1,PlncRNA1 | ceRNA | pathogenic process | esophageal squamous cell cancer;hepatocellular cancer;prostate cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289179 | HSALNG0070363 | MIR31HG | LOC554202,hsa-lnc-31,LncHIFCAR | ceRNA | pathogenic process | bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0288925 | HSALNG0034419 | DANCR | KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR | transcriptional regulation | developmental process;pathogenic process | prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases |
| HSALNT0290329 | HSALNG0142444 | uc.388 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289842 | HSALNG0141957 | FR0348383 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289279 | HSALNG0141211 | TTTY15 | DKFZP434I143,NCRNA00138 | NA | pathogenic process | NA | NA |
| HSALNT0289718 | HSALNG0141833 | CRNDE | LOC643911,LINC00180,CRNDEP | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma | Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289685 | HSALNG0141800 | CCND1 | NA | NA | pathogenic process | tumor;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289935 | HSALNG0142050 | lincRNA-p21 | NA | transcriptional regulation | pathogenic process | lung cancer;cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290134 | HSALNG0142249 | PCNCR1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289492 | HSALNG0141603 | DBET | DBE-T,DUX4L30 | transcriptional regulation | developmental process;pathogenic process | facioscapulohumeral muscular dystrophy | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289455 | HSALNG0071734 | BANCR | LINC00586 | transcriptional regulation | pathogenic process | osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0209589 | HSALNG0100636 | PTCSC3 | NA | ceRNA | pathogenic process | papillary thyroid cancer;thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290063 | HSALNG0142178 | MVIH | NA | ceRNA | pathogenic process | hepatocellular cancer;non-small cell lung cancer;breast cancer;microvascular invasion in hepatocellular cancer;hepatocelluar cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Digestive System Diseases |
| HSALNT0289103 | HSALNG0052921 | LINC01268 | LOC285758 | NA | pathogenic process | NA | NA |
| HSALNT0289070 | HSALNG0031716 | LINC00887 | linc-ATP13A4-8,HEIRCC | transcriptional regulation | pathogenic process | hypoxic and inflammatory renal epithelial injury;renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288931 | HSALNG0100075 | DHRS4-AS1 | C14orf167,PRO1488,AS1DHRS4 | transcriptional regulation | NA | NA | NA |
| HSALNT0288974 | HSALNG0113304 | FENDRR | FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21 | transcriptional regulation | developmental process;pathogenic process | osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0106473 | HSALNG0050235 | LINC01512 | LOC100132354,TCONS_00011120,HI-LNC77 | NA | pathogenic process | lung adenocarcinoma;type 2 diabetes | Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms |
| HSALNT0289059 | HSALNG0118547 | LINC00673 | HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1 | transcriptional regulation | pathogenic process | pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289107 | HSALNG0128306 | LINC01433 | LOC728228 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0143571 | HSALNG0068424 | CCAT1 | CARLo-5,onco-lncRNA-40 | ceRNA | pathogenic process | gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289408 | HSALNG0123467 | TINCR | ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16 | translational control | pathogenic process;developmental process | bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0289152 | HSALNG0060113 | LNCPRESS1 | lncPRESS1 | translational control | NA | NA | NA |
| HSALNT0289145 | HSALNG0075843 | LINC02561 | RP11-445P17.8 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0289065 | HSALNG0140616 | LINC00850 | KUCG1 | NA | pathogenic process | Duchenne muscular dystrophy | Musculoskeletal Diseases |
| HSALNT0289431 | HSALNG0032699 | AFAP1-AS1 | AFAP1A, AFAP1-A,MGC10981 | NA | pathogenic process | non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer | Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289519 | HSALNG0141630 | XACT | NA | NA | NA | NA | NA |
| HSALNT0248684 | HSALNG0120344 | GATA6-AS1 | locus5689,BM742401 | NA | pathogenic process | gastric cancer;chronic lymphocytic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0289222 | HSALNG0073144 | PTCSC2 | NA | transcriptional regulation | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289655 | HSALNG0141770 | BTG3-AS1 | ASBEL | translational control | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289224 | HSALNG0070801 | PTENP1 | NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984 | transcriptional regulation;ceRNA | pathogenic process | gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290129 | HSALNG0142244 | PAN | NA | transcriptional regulation | pathogenic process | Kaposi's sarcoma | Neoplasms;Virus Diseases |
| HSALNT0289939 | HSALNG0142054 | LINC-ROR | lincRNA-RoR,lincRNA-ST8SIA3,ROR | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0290322 | HSALNG0142437 | UBE3A-ATS | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0091004 | HSALNG0043367 | LINC00461 | EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323 | NA | pathogenic process;developmental process | retinal and visual function | Eye Diseases |
| HSALNT0289491 | HSALNG0141602 | CTBP1-AS | PCAT10 | transcriptional regulation | pathogenic process | chronic hepatitis C;prostate cancer;polycystic ovary syndrome | Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0037401 | HSALNG0017694 | GACAT1 | LINC00876,AC096655.1-002 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0120344 | HSALNG0056854 | HOXA-AS2 | HOXA3as | transcriptional regulation | pathogenic process | promyelocytic leukemia;gastric cancer | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0091313 | HSALNG0043441 | LUCAT1 | SCAL1 | transcriptional regulation | pathogenic process | non-small cell lung cancer;lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289425 | HSALNG0009941 | BLACAT1 | linc-UBC1,LINC00912,onco-lncRNA-30 | transcriptional regulation | pathogenic process | bladder cancer;gastric cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0149012 | HSALNG0071221 | GLIDR | LINC01172,MGC21881,TCONS_00015562 | NA | pathogenic process | glioblastoma | Neoplasms |
| HSALNT0217561 | HSALNG0104548 | PWAR5 | PAR5,PAR-5 | NA | pathogenic process | glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
| HSALNT0289272 | HSALNG0059377 | TP53TG1 | TP53AP1,H_RG012D21.9,LINC00096 | NA | pathogenic process | non-small cell lung cancer;ataxia telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289598 | HSALNG0141713 | AK126698 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0217598 | HSALNG0104558 | IPW | NCRNA00002 | transcriptional regulation | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0143633 | HSALNG0068443 | CCAT2 | NCCP1,LINC00873 | transcriptional regulation | pathogenic process | non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289026 | HSALNG0129180 | LINC00261 | C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17 | NA | pathogenic process | pancreatic cancer;non-small cell lung cancer;gastric cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289078 | HSALNG0000303 | LINC00982 | FLJ42875 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290082 | HSALNG0142197 | NEAT1_2 | NEAT1_2 | protein localization | pathogenic process | amyotrophic lateral sclerosis | Nutritional and Metabolic Diseases;Nervous System Diseases |
| HSALNT0288989 | HSALNG0076040 | GATA3-AS1 | NA | transcriptional regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289427 | HSALNG0004297 | GNG12-AS1 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0290395 | HSALNG0142510 | YAM1 | Yam-1 | transcriptional regulation | pathogenic process;developmental process | skeletal myogenesis | Musculoskeletal Diseases |
| HSALNT0289202 | HSALNG0018036 | PAX8-AS1 | NA | NA | pathogenic process | malignant pleural mesothelioma;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0054469 | HSALNG0026023 | RASSF1-AS1 | ANRASSF1 | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290261 | HSALNG0142376 | SUMO1P3 | SUMO1P3 | NA | pathogenic process | bladder cancer;gastric cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289002 | HSALNG0094549 | HNF1A-AS1 | C12orf27,NCRNA00262,FLJ38690,HAS1 | ceRNA | pathogenic process | esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer | Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases |
| HSALNT0289377 | HSALNG0041218 | NIPBL-AS1 | NIPBL-DT,NIPBL-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
| HSALNT0289249 | HSALNG0057702 | SNHG15 | C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g | NA | pathogenic process | gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0235898 | HSALNG0113835 | MIR22HG | C17orf91,MGC14376,DKFZp686O06159 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0235898 | HSALNG0113835 | MIR22HG | C17orf91,MGC14376,DKFZp686O06159 | NA | NA | NA | NA |
| HSALNT0288984 | HSALNG0119881 | GACAT2 | MTCL1-AS1,HMlincRNA717 | NA | pathogenic process | pancreatic cancer;non-small cell lung cancer;gastric cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289369 | HSALNG0134448 | MIF-AS1 | LOC284889,MIF-AS | transcriptional regulation | pathogenic process | malaria;nephrolithiasis | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases |
| HSALNT0129086 | HSALNG0061385 | LINC-PINT | MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint | transcriptional regulation | pathogenic process | colorectal cancer;heart failure | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289240 | HSALNG0020769 | SCHLAP1 | LINC00913,SChLAP1,PCAT11 | transcriptional regulation | pathogenic process | bladder cancer;prostate cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0193241 | HSALNG0093119 | SOCS2-AS1 | NA | transcriptional regulation | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0138824 | HSALNG0066261 | CASC9 | ESCCAL-1,ESSCAL1,LINC00981 | NA | pathogenic process | esophageal squamous cell cancer;esophageal cancer | Neoplasms |
| HSALNT0267627 | HSALNG0130306 | HNF4A-AS1 | uc002xlx | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289194 | HSALNG0131196 | NKILA | NA | NA | pathogenic process | nasopharyngeal cancer;breast cancer;tongue squamous cell cancer | Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289304 | HSALNG0088539 | LINC00942 | NA | NA | pathogenic process | ovarian cancer;autism spectrum disorder | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms |
| HSALNT0289187 | HSALNG0062700 | MNX1-AS1 | CCAT5,LOC645249 | NA | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289518 | HSALNG0141629 | VPS9D1-AS1 | MYU | NA | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0290266 | HSALNG0142381 | TC0101441 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0289426 | HSALNG0009856 | ERLNC1 | TC0101441,ElncRNA1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290050 | HSALNG0142165 | Mdgt | NA | NA | NA | NA | NA |
| HSALNT0043560 | HSALNG0020594 | HAGLR | HOXD-AS1,Mdgt | NA | pathogenic process | bladder cancer;neuroblastoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289092 | HSALNG0017541 | LINC01158 | PANTR1,linc-Brn1a,linc-POU3F3 | transcriptional regulation | pathogenic process;developmental process | esophageal squamous cell cancer;gastric cancer;glioma | Neoplasms;Digestive System Diseases |
| HSALNT0289448 | HSALNG0062110 | GHET1 | lncRNA-GHET1 | NA | pathogenic process | bladder cancer;gastric cancer;colorectal cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289514 | HSALNG0141625 | PEG13 | NA | transcriptional regulation | pathogenic process | intellectual disabilities | Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases |
| HSALNT0289183 | HSALNG0140233 | MIR503HG | MGC16121,H19X | NA | pathogenic process | choriocarcinoma | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289201 | HSALNG0083445 | PAUPAR | NA | transcriptional regulation | pathogenic process;developmental process | uveal melanoma | Neoplasms |
| HSALNT0288956 | HSALNG0094171 | LINC01234 | LCAL84,onco-lncRNA-32 | ceRNA | pathogenic process | oesophageal squamous cell cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289021 | HSALNG0016642 | CYTOR | C2orf59,NCRNA00152,MGC4677 | transcriptional regulation;ceRNA | pathogenic process | colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289706 | HSALNG0141821 | CHRF | NA | ceRNA | pathogenic process | cardiac hypertrophy;silicosis | Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases |
| HSALNT0143635 | HSALNG0068436 | CASC8 | LINC00860,CARLo-1 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0143672 | HSALNG0068465 | CASC11 | TCONS_00014535,LINC00990,CARLo-7,ENST00000518376 | transcriptional regulation | pathogenic process | hepatocellular cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289032 | HSALNG0133191 | LINC00323 | PRED42,FLJ37173 | NA | pathogenic process | breast cancer;hereditary haemorrhagic telangiectasia | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms |
| HSALNT0024655 | HSALNG0011845 | LINC01139 | LINK-A,TCONS_00000027 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289018 | HSALNG0036270 | LEF1-AS1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia;colorectal cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0247326 | HSALNG0119753 | LINC00667 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290145 | HSALNG0142260 | POU3F3 | NA | transcriptional regulation | pathogenic process | esophageal squamous cell cancer;glioma | Neoplasms |
| HSALNT0199349 | HSALNG0096112 | LINC00426 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0155974 | HSALNG0074744 | LINC00963 | MetaLnc9 | NA | pathogenic process | prostate cancer;renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289211 | HSALNG0086124 | PCF11-AS1 | NA | NA | pathogenic process | hepatocellular cancer;adolescent idiopathic scoliosis | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289534 | HSALNG0141649 | 91H | NA | transcriptional regulation | pathogenic process | osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289446 | HSALNG0055679 | ELFN1-AS1 | MYCLo-2 | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288883 | HSALNG0079547 | ACTA2-AS1 | uc001kfo.1,ZXF1 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289443 | HSALNG0059132 | APTR | RSBN1L-AS1 | transcriptional regulation | pathogenic process | liver fibrosis;glioblastoma | Neoplasms;Digestive System Diseases |
| HSALNT0289986 | HSALNG0142101 | lncRNA-MVIH | NA | NA | pathogenic process | hepatocellular cancer;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289977 | HSALNG0142092 | lncRNA-ATB | NA | ceRNA | pathogenic process | colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289622 | HSALNG0141737 | ATB | NA | ceRNA | pathogenic process | prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer | Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289586 | HSALNG0141701 | AK057054 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0278370 | HSALNG0135702 | LINC01315 | lnc-C22orf32-1,C22orf32-1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0055601 | HSALNG0026583 | ADAMTS9-AS2 | NA | NA | pathogenic process | non-small cell lung cancer;glioma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289383 | HSALNG0009103 | PACERR | PACER,PTGS2-AS1 | transcriptional regulation | pathogenic process | osteosarcoma;osteoarthritis;inflammation and cancer | Musculoskeletal Diseases;Neoplasms |
| HSALNT0289268 | HSALNG0010604 | TGFB2-OT1 | FLJ11812 | ceRNA | NA | NA | NA |
| HSALNT0288938 | HSALNG0027860 | DUBR | LINC00883 | ceRNA | pathogenic process | asthma and chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0290147 | HSALNG0142262 | POXCUT | TCONS_00011636 | NA | NA | NA | NA |
| HSALNT0289440 | HSALNG0047407 | FOXCUT | LINC01379,TCONS_00011636 | transcriptional regulation | pathogenic process | esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer | Neoplasms |
| HSALNT0288924 | HSALNG0059521 | CYP51A1-AS1 | ENST00000453068,LRRD1-AS1 | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289395 | HSALNG0036288 | RPL34-AS1 | FLJ37673,RP11-462C24.1 | NA | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289435 | HSALNG0045015 | C5orf66-AS1 | CTC-276P9.1,Epist | NA | pathogenic process | esophageal squamous cell cancer;bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289052 | HSALNG0006924 | LINC00623 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289831 | HSALNG0141946 | FER1L4 | FER1L4 | ceRNA | pathogenic process | gastric cancer;endometrial cancer;colorectal cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0288985 | HSALNG0013215 | GACAT3 | LINC01458,lncRNA-AC130710 | NA | pathogenic process | ovarian cancer;gastric cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0288881 | HSALNG0058863 | ABHD11-AS1 | WBSCR26,LINC00035,NCRNA00035 | NA | pathogenic process | gastric cancer;mutant huntingtin | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
| HSALNT0282263 | HSALNG0137651 | ZNF674-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289207 | HSALNG0106864 | PCAT29 | NA | NA | pathogenic process | prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0289672 | HSALNG0141787 | CADM1 | NA | NA | NA | NA | NA |
| HSALNT0289297 | HSALNG0007253 | LINC01527 | lnc-SPRR2D-1,RP1-13P20.6 | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0289158 | HSALNG0108520 | LUNAR1 | NA | transcriptional regulation | pathogenic process | diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia | Hemic and Lymphatic Diseases |
| HSALNT0289830 | HSALNG0141945 | FAR2P1 | NA | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289263 | HSALNG0053580 | TARID | EYA4-AS1 | transcriptional regulation | pathogenic process | kidney clear cell sarcoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0145373 | HSALNG0069286 | MAFA-AS1 | RP11-909N17.3,TCONS_00014882 | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290229 | HSALNG0142344 | RPLP0P2 | RPLP0P2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289291 | HSALNG0133273 | ZNF295-AS1 | C21orf121,NCRNA00318,PRED87 | NA | pathogenic process | lung adenocarcinoma;epithelial ovarian cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0084473 | HSALNG0040150 | LINC01513 | RP11-1C1.7,TCONS_00009352 | NA | pathogenic process | NA | NA |
| HSALNT0289471 | HSALNG0108507 | IRAIN | IGF1R-AS | transcriptional regulation | pathogenic process | pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0290402 | HSALNG0142517 | ZNRD1-AS1 | NA | NA | pathogenic process | hepatocellular cancer;lung cancer;cervical cancer | Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289504 | HSALNG0141615 | LCAL1 | onco-lncRNA-27 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289169 | HSALNG0100038 | MHRT | Myheart | transcriptional regulation | pathogenic process | heart hypertrophy;acute myocardial infarction | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0289859 | HSALNG0141974 | HA117 | NA | NA | pathogenic process | hirschsprung disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0026673 | HSALNG0012722 | NRIR | lncRNA-CMPK2 | transcriptional regulation | pathogenic process | chronic hepatitis C;HCV | Digestive System Diseases;Virus Diseases |
| HSALNT0289887 | HSALNG0142002 | LET | NA | NA | pathogenic process | gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer | Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases |
| HSALNT0007921 | HSALNG0004023 | NFIA-AS1 | RP5-833A20.1 | transcriptional regulation | pathogenic process | atherosclerosis;glioma | Cardiovascular Diseases;Neoplasms |
| HSALNT0247156 | HSALNG0119710 | GAPLINC | LINC01540,TCONS_00026238,lncRNA-uc002kmd.1 | siRNA | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288917 | HSALNG0079313 | CERNA2 | HOST2,lncRNA-HOST2 | ceRNA | pathogenic process | hepatocellular cancer;epithelial ovarian cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289113 | HSALNG0050689 | LINC01564 | TCONS_00011314 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289088 | HSALNG0012685 | LINC01105 | FLJ30594,LOC150622 | NA | pathogenic process | gastric cancer;leukemia and neuroblastoma | Neoplasms;Digestive System Diseases |
| HSALNT0289464 | HSALNG0091650 | AGAP2-AS1 | LOC100130776,PUNISHER | transcriptional regulation | pathogenic process | non-small cell lung cancer;glioma;leukemia and neuroblastoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288960 | HSALNG0106834 | EWSAT1 | TMEM84,NCRNA00277,LINC00277,FLJ33768 | transcriptional regulation | pathogenic process | Ewing sarcoma | Neoplasms |
| HSALNT0289242 | HSALNG0074573 | SLC25A25-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289317 | HSALNG0130331 | KCNK15-AS1 | RP11-445H22.4 | NA | pathogenic process | osteoarthritis;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289864 | HSALNG0141979 | HIF2PUT | NA | NA | pathogenic process | osteosarcoma;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289267 | HSALNG0019370 | TEX41 | DKFZp686O1327,LINC00953 | transcriptional regulation | NA | NA | NA |
| HSALNT0290361 | HSALNG0142476 | UFC1 | NA | transcriptional regulation;ceRNA | pathogenic process | osteoarthritis;hepatocellular cancer | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289886 | HSALNG0142001 | LEIGC | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289367 | HSALNG0049188 | MDC1-AS1 | MDC1-AS | NA | pathogenic process | bladder cancer;glioma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289190 | HSALNG0048542 | NBAT1 | CASC14,NBAT-1 | transcriptional regulation | pathogenic process | breast cancer;renal clear cell cancer;neuroblastoma | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0234826 | HSALNG0113287 | LINC00917 | NA | NA | pathogenic process | intervertebral disc degeneration;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289419 | HSALNG0094327 | LINC00173 | NCRNA00173,FLJ42957 | NA | pathogenic process | HIV-1-infected;hepatocelluar cancer | Virus Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290138 | HSALNG0142253 | PEG10 | NA | NA | pathogenic process | diffuse large B-cell lymphoma;esophageal cancer | Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289136 | HSALNG0041549 | LINC02224 | BRCAT107,ENST00000505706 | NA | pathogenic process | active tuberculosis | Bacterial Infections and Mycoses |
| HSALNT0289866 | HSALNG0141981 | HIT | NA | transcriptional regulation | pathogenic process | non-small cell lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0003927 | HSALNG0002075 | SNHG12 | ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123 | NA | pathogenic process | osteosarcoma;endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289099 | HSALNG0002236 | LINC01225 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290047 | HSALNG0142162 | MALAT2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0176345 | HSALNG0084672 | SNHG1 | LINC00057,NCRNA00057,U22HG,UHG,lncRNA16 | NA | pathogenic process | astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases |
| HSALNT0094592 | HSALNG0044933 | WSPAR | TCONS_00009511-XLOC_004555,lncTCF7 | transcriptional regulation | pathogenic process | hepatocellular cancer;liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289308 | HSALNG0118552 | LINC00511 | onco-lncRNA-12 | NA | pathogenic process | lung adenocarcinoma;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289452 | HSALNG0069321 | FAM83H-AS1 | onco-lncRNA-3 | NA | pathogenic process | NA | NA |
| HSALNT0289041 | HSALNG0051162 | LINC00472 | C6orf155,dJ288M22.3,FLJ13189 | NA | pathogenic process | ovarian cancer;breast cancer | Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases |
| HSALNT0289925 | HSALNG0142040 | linc-ITGB1 | NA | NA | pathogenic process | gallbladder cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0016239 | HSALNG0007801 | LINC01133 | lncRNA-PAGBC | transcriptional regulation | pathogenic process | non-small cell lung cancer;colorectal cancer;lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289489 | HSALNG0141600 | CCEPR | CCHE1,lncRNA-CCHE1 | transcriptional regulation | pathogenic process | hepatocellular cancer;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289402 | HSALNG0098682 | SOX21-AS1 | NA | NA | pathogenic process | lung adenocarcinoma;oral squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288905 | HSALNG0048533 | CASC15 | LINC00340,lnc-SOX4-1 | NA | pathogenic process | basal cell cancer;melanoma;neuroblastoma | Neoplasms |
| HSALNT0289555 | HSALNG0141670 | AC104699.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0096322 | HSALNG0045923 | CLMAT3 | SPARC-AS1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289233 | HSALNG0043698 | RGMB-AS1 | NA | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289908 | HSALNG0142023 | LINC01419 | LVCAT7,TCONS_00014497 | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289541 | HSALNG0141656 | AB209630 | NA | NA | pathogenic process | hypopharyngeal squamous cell cancer | Neoplasms |
| HSALNT0289608 | HSALNG0141723 | AOC4P | AOC4P | NA | pathogenic process | colorectal cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289082 | HSALNG0040781 | PURPL | LINC01021,LOC643401,RP11-46C20.1 | NA | pathogenic process | NA | NA |
| HSALNT0196121 | HSALNG0094605 | LINC01089 | LIMT | NA | pathogenic process | breast cancer;astrocytoma | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0123080 | HSALNG0058166 | EGFR-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289539 | HSALNG0141654 | AB073614 | NA | NA | pathogenic process | ovarian cancer;glioma | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0242418 | HSALNG0117322 | CACNA1G-AS1 | NA | NA | pathogenic process | keloid | Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues |
| HSALNT0170814 | HSALNG0081992 | MIR210HG | NA | transcriptional regulation | pathogenic process | hypoxic and inflammatory stress | NA |
| HSALNT0288979 | HSALNG0113319 | FOXC2-AS1 | ODRUL | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289022 | HSALNG0132865 | LINC00160 | C21orf52,NCRNA00160 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0105274 | HSALNG0049582 | LINC01016 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288904 | HSALNG0045753 | CARMN | MIR143HG,CARMEN | transcriptional regulation | pathogenic process | cardiac differentiation | Cardiovascular Diseases |
| HSALNT0289123 | HSALNG0121579 | LINC01630 | LOC100287225 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288971 | HSALNG0104253 | FAM30A | C14orf110,KIAA0125,HSPC053 | NA | pathogenic process | gallbladder cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289506 | HSALNG0141617 | LINC00346 | C13orf29,NCRNA00346 | NA | pathogenic process | hepatocellular cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289643 | HSALNG0141758 | BC032469 | NA | ceRNA | pathogenic process | esophageal squamous cell cancer;gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289580 | HSALNG0141695 | AK024171 | NA | NA | pathogenic process | intervertebral disc degeneration;gastric cancer | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290187 | HSALNG0142302 | RP11-284N8.3.1 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289839 | HSALNG0141954 | FMR6 | NA | NA | pathogenic process | fragile X syndrome;fragile X-associated premature ovarian insufficiency | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases |
| HSALNT0290152 | HSALNG0142267 | PRAL | lncRNA-PRAL | NA | pathogenic process | hepatocellular cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289380 | HSALNG0129818 | NORAD | LINC00657 | transcriptional regulation;translational control | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0086803 | HSALNG0041283 | LIFR-AS1 | NA | NA | pathogenic process | preterm | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0076183 | HSALNG0036373 | PANCR | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0288975 | HSALNG0060982 | FEZF1-AS1 | NA | transcriptional regulation | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0238475 | HSALNG0115230 | CCDC144NL-AS1 | NA | ceRNA | pathogenic process | ovarian cancer;cardiac hypertrophy | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms |
| HSALNT0290102 | HSALNG0142217 | NR_026689 | NA | NA | pathogenic process | ovarian cancer;lung cancer | Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289522 | HSALNG0075559 | ADARB2-AS1 | C10orf109,NCRNA00168,bA466B20.1 | NA | pathogenic process | breast cancer;pancreatic ductal adenocarcinoma | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288936 | HSALNG0018139 | DPP10-AS1 | BC032913 | NA | pathogenic process | breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289474 | HSALNG0113682 | GAS8-AS1 | C16orf3 | NA | pathogenic process | papillary thyroid cancer;breast cancer | Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms |
| HSALNT0289063 | HSALNG0075802 | MANCR | LINC00704 | NA | pathogenic process | NA | NA |
| HSALNT0289238 | HSALNG0026715 | SAMMSON | LINC01212 | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289027 | HSALNG0007238 | LINC00302 | C1orf46,NCRNA00302,XP33 | NA | developmental process | NA | NA |
| HSALNT0245543 | HSALNG0118895 | SNHG20 | C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG | transcriptional regulation | pathogenic process | hepatocellular cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0015631 | HSALNG0007463 | DCST1-AS1 | RP11-307C12.11 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0149810 | HSALNG0071682 | PGM5-AS1 | FAM233A,LOC572558 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290236 | HSALNG0142351 | SBF2-AS1 | NA | transcriptional regulation | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290325 | HSALNG0142440 | uc.338 | NA | transcriptional regulation | pathogenic process | hepatocellular cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289973 | HSALNG0142088 | LNCRI | lnc-RI | ceRNA | NA | NA | NA |
| HSALNT0290002 | HSALNG0142117 | LOC100130476 | NA | NA | pathogenic process | esophageal squamous cell cancer;gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289049 | HSALNG0063356 | LINC00599 | Rncr3 | NA | pathogenic process | diabetes | Endocrine System Diseases |
| HSALNT0020406 | HSALNG0009871 | LINC00628 | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289478 | HSALNG0133031 | DSCR4 | DCRB | NA | pathogenic process | Down syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0017675 | HSALNG0008546 | GAS5-AS1 | NA | NA | pathogenic process | oral submucous fibrosis;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289523 | HSALNG0048782 | HCG11 | bK14H9.3,FLJ14049,FLJ30357 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0134828 | HSALNG0064314 | LINC02099 | AC145110.1 | NA | pathogenic process | rheumatoid arthritis;breast cancer | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0209098 | HSALNG0100348 | G2E3-AS1 | CAT1647 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289139 | HSALNG0015506 | LINC02245 | lnc-SERTAD2-3,AC007386.2 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0008167 | HSALNG0004109 | FOXD3-AS1 | pasFOXD3 | transcriptional regulation | pathogenic process | glioma | Neoplasms |
| HSALNT0289335 | HSALNG0060638 | LINC00998 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0289379 | HSALNG0041522 | NNT-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0055497 | HSALNG0026555 | PSMD6-AS1 | ENST00000462717,lnc00462717 | NA | pathogenic process | papillary thyroid cancer;glioma | Endocrine System Diseases;Neoplasms |
| HSALNT0289130 | HSALNG0119047 | LINC02081 | CTD-2357A8.3,XLOC_012582 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289306 | HSALNG0107939 | LINC00052 | TMEM83,NCRNA00052,FLJ31461 | ceRNA | pathogenic process | hepatocellular cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0199070 | HSALNG0095970 | PLUT | PDX1-AS1,PLUTO,HI-LNC71 | transcriptional regulation | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0289341 | HSALNG0073476 | LINC01505 | RP11-308N19.1 | NA | pathogenic process | NA | NA |
| HSALNT0289315 | HSALNG0020625 | LINC01116 | TALNEC2 | transcriptional regulation | pathogenic process | prostate cancer;glioblastoma | Male Urogenital Diseases;Neoplasms |
| HSALNT0006439 | HSALNG0003395 | FOXD2-AS1 | MGC12982 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0252387 | HSALNG0122085 | LINC00305 | C18orf20,NCRNA00305,MGC39571,HsT1235 | NA | NA | NA | NA |
| HSALNT0289473 | HSALNG0110794 | FBXL19-AS1 | NCRNA00095,MGC125469,MGC125470,MGC125472 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0187807 | HSALNG0090479 | LINC02555 | AC079630.2 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0251493 | HSALNG0121679 | LINC01929 | CTD-2171N6.1 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0244776 | HSALNG0118529 | LINC01152 | TCONS_00025128,CMPD | NA | pathogenic process | NA | NA |
| HSALNT0284591 | HSALNG0139113 | DIAPH2-AS1 | NA | NA | pathogenic process | Hodgkin's disease | Neoplasms |
| HSALNT0289226 | HSALNG0104558 | PWAR1 | PAR1,PAR-1 | NA | pathogenic process | Prader-Willi syndrome and Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289339 | HSALNG0070961 | LINC00950 | FP588 | NA | NA | NA | NA |
| HSALNT0289740 | HSALNG0141855 | DGCR12 | DGS-E | NA | pathogenic process;developmental process | DiGeorge syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;C |